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5
PREFACE 
 
The work, described in this thesis, was performed in two distinctly different research 
areas. Therefore, the thesis is split in two separate parts A and B. Each part has its own 
introduction to the relevant subject. In Part A (Chapters 1 – 5), the design, synthesis and 
properties of pyridinolic chain-breaking antioxidants will be discussed. In Part B (Chapters 6 – 
8), the design and synthesis of ligands for CdSe nanocrystals and the photochemistry of the 
resulting nanocrystal-ligand aggregates are described. In Chapter 9, summaries for both parts are 
given in English and in Dutch. 
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 1 
 
 
1.1 LDL and lipid peroxidation 
1.1.1 Cholesterol and Low Density Lipoproteins 
“Cholesterol is a Janusfaced molecule. The very property that makes it useful in cell 
membranes, namely its absolute insolubility in water, also makes it lethal….If cholesterol is to 
be transported safely in blood, its concentration must be kept low, and its tendency to escape 
from the bloodstream must be controlled.”1  
 
HO  
 
Cholesterol 
 
The importance of cholesterol regulation is well known in the current society. Cholesterol 
is a vital component of human beings (in fact, of all mammals) and serves a multitude of 
functions. It modulates the fluidity of mammalian membranes by inserting itself into bilayers. 
Furthermore, it is a key precursor for steroid hormones, such as progesterone, testosterone, 
estradiol and cortisol.2 Cholesterol can be obtained from the diet or it can be synthesized in the 
liver. For example, adults on a low-cholesterol diet typically synthesize 800 mg cholesterol per 
Introduction on lipid 
peroxidation and 
antioxidants 
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day. Either way, it needs to be transferred from the liver to cells at a variety of locations. The 
carriers of cholesterol in human bodies are lipoprotein particles, which can be classified into 
Chylomicrons (large particles of 180 to 500 nm diameter), Very Low Density Lipoproteins 
(VLDL), Intermediate Density Lipoproteins (IDL), Low Density Lipoproteins (LDL) and High 
Density Lipoproteins (HDL). HDL is considered “good cholesterol” since it picks up cholesterol 
released into plasma from decomposing cells and membranes, thus preventing accumulation of 
cholesterol. However, the major carrier of cholesterol in the blood is LDL which is also known 
as ‘bad cholesterol”.2 
 
 
Figure 1.1: Schematic representation of an LDL particle. Taken from ref. 2. 
 
An average LDL particle is shown in Figure 1.1. It has a molecular weight of 3000 kDa, a 
diameter of 22 nm, a density of about 1.05 g/mL, and a total volume of 3.2 x 10-21 L.3 LDL is a 
dynamic, micellar system with a large variety of molecules interacting with each other. The core 
consists of ca. 1000 cholesteryl esters and triacylglycerols (esterified glycerol), these being the 
common forms in which cholesterol gets transported through the body. The polar surface layer of 
the LDL contains some 600 unesterified cholesterol molecules in addition to some 700 
phospholipid molecules. The polar headgroups of the phospholipids and cholesterol effectively 
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make up the surface monolayer. A key factor in LDL is the Apo B-100 protein, which is located 
mostly in the surface area. This 550 kDa protein consists of 4536 amino acid residues and serves 
as a recognition site for LDL receptor proteins on target cells. After recognition, the LDL-
receptor complex is internalized into the cell, Apo B-100 degraded and the cholesteryl esters 
hydrolyzed to release free cholesterol into the target cell.2 Important constituents of LDL are 
antioxidants, which will be addressed separately. 
As stated, cholesterol is transferred inside LDL mostly in the form of hydrophobic esters. 
It is usually esterified to a polyunsaturated fatty acid (PUFA, Figure 1.2), notably linoleic acid 1 
(80 %) and arachidonic acid 2 (20 %). In addition to these components, the phospholipid 
molecules also contain chains derived from more saturated fatty acids, such as palmitoleic acid 3, 
oleic acid 4, palmitic acid 5 and stearic acid 6. All of these naturally occurring unsaturated acids 
or their esters have the cis-geometry around the double bond(s). 
 
COOH
COOH
COOH
COOH
Linoleic acid 1
Arachidonic acid 2
Palmitoleic acid 3
COOH Oleic acid 4
Palmitic acid 5
COOH
Stearic acid 6  
 
Figure 1.2: Fatty acids commonly present in LDL particles. 
 
As will be shown later, these cis-alkene functionalities play a role in the phenomenon that 
has been dubbed “the paradox of aerobic life”.4 It states that higher eukaryotic aerobic organisms 
cannot exist without oxygen, yet oxygen is inherently dangerous to their existence. The major 
reason for this paradox is the presence of two unpaired electrons on molecular oxygen. The 
ground state for oxygen is a triplet state, but spin-restrictions prevent it to react readily with other 
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species. However, its reactivity can be increased by removing the spin restriction, for example, 
by adding a single electron. The tetravalent reduction of oxygen by the mitochondrial electron-
transport chain to produce water is considered a relatively controlled and safe process, even 
though it has been shown to “leak” electrons.5 Yet, under certain circumstances, oxygen can 
undergo undesired one-electron reduction(s). This can lead to very reactive oxygen species 
(ROS), such as superoxide anion (O2
•−), hydrogen peroxide (H2O2) or hydroxyl radical (OH•), 
which are all extremely damaging to the cell.5 The general observation is that molecular oxygen 
reacts with other radicals leading to a range of reactive species, which in turn can react again 
with substrates, such as valuable biomolecules. This process is called “oxidative stress”. The 
general implications of oxidative stress cannot be underestimated. It has been implied in some 
form in numerous human conditions and diseases, such as aging,6,7 atherosclerosis,8,9,10 
cancer,11,12,13 Parkinson’s and Alzheimer disease,14,15,16,17 AIDS18,19 and others.4  
 
 
 
Figure 1.3: Schematic representation of the fate of oxidized LDL in artery. Taken from 
ref. 20. 
 
Specifically, oxidation of LDL particles has been associated with atherosclerosis, which 
can be defined as the progressive narrowing and hardening of the arteries over time leading to 
increased risk of heart attacks and strokes. A brief description of these processes will be given 
here.20 Oxidized LDL particles are no longer recognized by the usual LDL receptors, rather they 
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are now recognized by scavenger receptors on macrophages in the artery (Figure 1.3).20,21 The 
latter are formed from differentiation of monocytes and their formation is partially triggered by 
the presence of oxidized LDL. They may initially serve a protective function by taking up 
oxidized LDL. However, accumulation of oxidized LDL in these macrophages leads to the 
formation of “foam cells”,22 which contain large amounts of cholesterol esters (“fatty streaks”). 
These fatty streaks are an early hallmark of atherosclerosis. 
 
1.1.2 Lipid peroxidation 
It is evident that understanding the oxidation mechanisms of LDL could prove critical in 
treating and preventing all of the associated diseases. The major primary targets for oxidative 
damage inside LDL are the lipid fractions, i.e. the unsaturated alkyl chains, such as the ones 
depicted in Figure 1.2. Lipid peroxidation was first studied in an industrial context in the 40s,23,24 
but the general implications of lipid peroxidation were quickly recognized.25 A great deal of 
research was devoted to understand the mechanism of lipid peroxidation (Scheme 1.1).26,27,28 
 
In     +   L-H
ki In-H     +   L
Initiation
L     +   O2 LOO
Propagation
kO2
LOO     +   L-H LOOH + L
kp
LOO    + LOO
kt Non-radical 
products
Termination
 
 
Scheme 1.1: Mechanism of lipid peroxidation (L=lipid). 
 
The mechanism involves a radical chain sequence, in which the first step is the 
abstraction of an H-atom from any lipid by an initiator (In•). This lipid carbon centered radical 
(L•) reacts with O2 at a diffusion controlled rate (kO2 ≈ 109 M-1s-1) to afford the lipid peroxyl-
radical (LOO•). This radical can propagate the chain by abstracting a H-atom from another lipid 
at a relatively slow rate (kp=62 M
-1s-1).29  This step yields a lipid hydroperoxide (LOOH) and 
another lipid carbon radical (L•), thus propagating the radical chain. Termination occurs when 
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two lipid peroxyl radicals react to give non-radical products (NRP) by a Russell termination.30 
The rate constant for this step (kt) is very large, yet the reaction occurs only to a small extent 
because the overall [LOO•] is very low. In an uninhibited oxidation like this, many LOOH form 
from just one In•. One may expect that oxidation occurs more readily with substrates that have 
weaker C-H bonds at allylic positions. It was found that this indeed was the case28  with linoleic 
acid 1 and arachidonic acid 2 undergoing much faster autoxidation compared to substrates like 3 
or 4. The lower C-H bond strength in 1 and 2 is the result of the stabilization of the formed bis-
allylic L• radical (see Scheme 1.2).  
 
R R R R
R
R
H HH HH H
Decreasing C-H bond strength
Increasing stability of L
Higher oxidizability  
 
Scheme 1.2: Different reactivity of fatty acids/esters with respect to autoxidation. 
 
Thus, polyunsaturated fatty acids or esters, such as linoleates and arachidonates, are the 
most oxidizable lipids in the body and therefore the most widely studied. Linoleate esters, being 
the most abundant lipids in LDL particles, will be the focus of this part of the thesis. Oxidation 
of arachidonate esters gives rise to a complex pattern of products, since the resulting peroxyl 
radicals can undergo (multiple) cyclizations with the remaining double bonds yielding cyclic 
peroxides.31,32 Decomposition of these fatty acid peroxides can eventually lead to 
isoprostanes,32,33 4-hydroxy-nonenal,34 thromboxanes,35 neuroprostanes35 and others. Inside the 
LDL, some of these decomposition products can undergo a variety of secondary reactions with 
the protein Apo B-100,36 resulting in, amongst others, decreased recognizability by usual LDL 
receptors (Figure 1.3). It should be pointed out that there are various conditions that can trigger 
LDL oxidation to start the radical chain reactions.37 A combination of metal ions and 
hydroperoxides can lead to initiating radicals (Fenton reaction). Similar species can be formed 
from the action of metal ions and peroxynitrite (from NO). Furthermore, the enzyme 
myeloperoxidase can initiate peroxidation through a tyrosyl radical. 
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1.2 Antioxidants in solution and in LDL 
1.2.1 Nature’s antioxidants 
Nature’s best defense against oxidative damage is the use of antioxidants, a group of 
compounds that, by definition, can prevent or inhibit oxidation. Several classes of antioxidants 
exist and they are shown in Table 1.1.38 Enzymes like ferritin act by simply coordinating traces 
of metal ions, such as Fe(II), thus reducing their Fenton chemistry. Superoxide dismutase 
scavenges superoxide giving H2O2, while catalase and glutathione peroxidase (the latter in 
animals) decompose H2O2 into water. Antioxidants that can quench energy, such as β-carotene 
and other carotenoids, are vital components of chloroplast membranes since they can quench 
formed singlet oxygen (1O2).
38  
This thesis will deal with the class of scavenging antioxidants, also known as chain-
breaking antioxidants.  They can be divided into two classes: water-soluble and lipid-soluble 
antioxidants. Ascorbic acid (Vitamin C), uric acid, glutathione and bilirubin are all water-soluble 
antioxidants and are present in the blood plasma. All these act by quenching peroxyl and 
hydroxyl radicals and/or hypochlorous acid present outside the LDL particle, with ascorbic acid 
being particularly effective against peroxyl radicals.39  
 
Type Action Example 
Prevention Protein binding/inactivation of 
metal ions 
 
transferrin, ferritin, albumin 
Enzymatic diversion/ 
neutralization 
Decomposition of ROS into 
harmless products 
 
superoxide dismutase, catalase, 
glutathione peroxidase 
Scavenging Sacrificial interaction with ROS 
by expendable substrates 
 
ascorbic acid, α-tocopherol, 
uric acid, bilirubin, glutathione 
Quenching Absorption of electrons and/or 
energy 
α-tocopherol, β-carotene 
 
Table 1.1: Classes of antioxidants found in Nature. Taken from ref. 38. 
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As shown in Figure 1.1, a range of chain-breaking, mostly lipid-soluble antioxidants is 
present inside the LDL particle and their structures are depicted in Scheme 1.3. Except for 
bilirubin, all these antioxidants are highly lipophilic by virtue of their long alkyl chains. Bilirubin 
is able to migrate from the blood plasma into the polar phospholipid surface layer where it 
exhibits excellent antioxidant activity.40,41 Lycopene and carotenes act as inhibitors by allowing 
peroxyl radicals to react with the conjugated system, giving radicals that are less reactive as 
chain carriers.42,43  
 
N
H
N
H
N
H
N
H
OO
OH
OH
MeO
MeO
HO
O
HO
O
β-carotene (0.3)
α-carotene (0.1)
lycopene (0.15)
α-tocopherol (6.4)
γ-tocopherol (0.5)
ubiquinol (0.1)
9
bilirubin (<1)
HO2C CO2H
 
 
Scheme 1.3: Antioxidants present inside LDL particles and their average amounts in 
molecules/LDL.37 
 
By far the most abundant natural lipid-soluble antioxidant is α-Tocopherol (α-TOH, the 
most potent form of Vitamin E). Depending on the diet, LDL particles can contain 6 to 12 
molecules of this antioxidant. It should be pointed out that α-TOH has also found use as an 
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industrial antioxidant where it can stabilize plastics, such as polybutadiene and rubbers, in very 
low concentrations44. Together with the much less abundant γ-TOH and ubiquinol-10, it 
represents the class of phenolic chain-breaking antioxidants in LDL. The long C20-chain (phytyl 
chain) serves to hold α-TOH within biomembranes, such as LDL. The polar headgroup of α-
TOH resides mostly on the LDL surface according to 13C-NMR,45  spin labeling46 and medium 
effect studies.47 The stereochemistry of the α-TOH chain in naturally occurring α-TOH is RRR, 
which in rats has been shown to be the most active form of the 8 possible stereoisomers.48 The 
effect of stereochemistry of the ring-carbon has been studied in humans by Kayden et al.49 They 
found that both RRR- and SRR-α-TOH leave human plasma rapidly upon digestion, but only 
RRR-α-TOH is incorporated into VLDL and subsequently returned to the plasma. Thus, human 
plasma quickly became enriched in the RRR-α-TOH isomer. The preferred incorporation of 
RRR-α-TOH into lipoproteins is a result of its preferential binding to hepatic tocopherol binding 
protein which assists in the incorporation step.50 
 
1.2.2 Autoxidations of lipids in solution 
The general inhibition mechanism by phenolic antioxidants, in biological as well as in 
industrial applications, has been understood for a long time51 and antioxidant efficiencies of a 
variety of phenols have been measured.52,53 Regarding the general oxidation mechanism in 
Scheme 1.2, these phenols can effectively break two radical chains (Scheme 1.4). One step 
involves transfer of the phenolic H-atom to a peroxyl radical ROO• with a rate constant kinh. In 
addition, a phenoxyl radical ArO• can trap another ROO• to give non-radical products. For α-
TOH, kinh amounts to 3.5 x 10
6 M-1s-1 (at 37 °C)54 which is much higher than the rate-constant 
for linoleate chain propagation (62 M-1s-1),29 thus indicating that it indeed can interfere 
effectively with chain propagation even at much lower α-TOH concentrations.  
 
LOO     +   ArO-H
kinh
LOOH + ArO
Inhibition
LOO     +   ArO Non-radical 
products  
 
Scheme 1.4: Mechanism of inhibition by phenolic antioxidants ArOH. 
 
The antioxidant effect of α-TOH can be clearly illustrated by its effect on the product 
distribution of solution-phase model linoleate autoxidations. These autoxidations are typically 
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carried out with methyl linoleate 8 in benzene at 37 °C with small amounts of an azo-initiator, 
such as MeO-AMVN 7, in solution. MeO-AMVN decomposes slowly to give two initiating 
radicals (InOO•) and N2, as depicted in Scheme 1.5.55 In the presence of millimolar 
concentrations of α-TOH the products are cis, trans-9-OOH 11 and cis, trans-13-OOH 12, 
whereas uninhibited oxidation gives a mixture of 11 and 12 and the corresponding isomers trans, 
trans-9-OOH 9 and trans, trans-13-OOH 10.56 Only recently, it was discovered that in the 
presence of > 100 mM concentrations of α-TOH (or any good H-atom donor), the kinetic 
hydroperoxide product cis, cis-11-OOH 13 could be trapped.57,58 
 
MeO N N OMe
N
MeO
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Scheme 1.5: Decomposition of MeO-AMVN azo-initiator. 
 
The mechanism outlined in Scheme 1.6 explains the formation of all of these products.58 
The initiating radical abstracts a hydrogen atom from the bisallylic position of methyl linoleate 8 
to give pentadienyl radical 14a. At higher concentrations of α-TOH, the actual initiating species 
is α-TO• since reaction of α-TOH with InOO• occurs much faster than abstraction of the 
bisallylic H-atom by InOO• under those conditions. The rate constant ki for reaction of α-TO• 
with linoleate 8 is ca. 0.03 M-1s-1.59 This process is called TMP (Tocopherol Mediated 
Peroxidation). Oxygen can add at three positions to radical 14a. Reaction at the bis-allylic 
position (to the extent α) gives a peroxyl radical that β-fragments back to 14a so fast (kβ ≈ 106 
M-1s-1)58 that it can only be significantly trapped to the product 13 at very high α-TOH 
concentrations. Reaction at the terminal positions of 14a (to the extent 1-α) gives, after trapping 
by α-TOH, the corresponding hydroperoxides 11 and 12. However, in the absence of any 
hydrogen atom donor, the terminal peroxyl radicals can slowly (50-400 M-1s-1) undergo β-
fragmentation back to 14a or, if bond rotation occurs, to pentadienyl radicals 14b,c. Trapping of 
the latter serves as the thermodynamic sink and gives the stable trans, trans products 9 and 10.  
It was shown that the amount of trapping of the peroxyl radicals to 13 vs 11, 12 was 
related to the activity of the antioxidant.58 The kinetic expression Eq. 1 was derived and at low 
[AOX] the formula can be simplified to Eq. 2. Thus, at low [AOX] where kinh * [AOX] < kβ, the 
ratio of 13 / (11 + 12) is linearly related to kinh. It was therefore expected that these methyl 
linoleate autoxidations can be used as a radical clock to measure kinh of unknown antioxidants. 
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The clock was calibrated with α-TOH to deliver the values for α and for the rate constant kβ for 
the β-fragmentation of the bisallylic peroxyl radical. Both α and kβ are independent on the nature 
of the antioxidant. This clock was then successfully applied to a known and an unknown 
antioxidant.58 
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[13] / ([11] + [12]) = (α / [1 - α]) * kinh * [AOX] / (kinh * [AOX] + kβ)        Eq. 1 
 
[13] / ([11] + [12]) = (α / [1 - α]) * kinh * [AOX] / kβ          Eq. 2 
 
Scheme 1.6: Mechanism for methyl linoleate autoxidation and kinetic expressions 
derived from the mechanism.  
 
1.2.3 Autoxidations of lipids in LDL 
It is known that replacing methyl linoleates by cholesteryl linoleates has no effect on the 
outcome of the product distributions, i.e. any linoleate ester behaves the same. This is important 
to realize since cholesteryl linoleates are the esters of interest within LDL particles.  
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Scheme 1.7: Formation of water-soluble initiating radicals from C-0. 
 
A simple translation of solution antioxidant behavior of α-TOH to antioxidant behavior 
in LDL, however, is erratic because it is now known that α-TOH actually plays an ambiguous 
role in LDL oxidations.59,60 On the basis of simple solution results one would expect that a lower 
α-TOH content in LDL should lead to more oxidation products when exposed to water-soluble 
radicals, such as the decomposition products of C-0 (15, Scheme 1.7). It turns out this is not the 
case, in fact α-TOH depleted LDL is surprisingly stable to water-soluble initiators.61,62 The 
reason for this is that α-TOH, in addition to acting as an expected antioxidant inside the LDL, 
can also act as a phase and radical transfer agent. This is depicted in Scheme 1.8.61 
 
 
Scheme 1.8: Model of tocopherol mediated peroxidation of LDL. Taken from ref. 61.  
NRP=Non-radical products. 
 
Water soluble peroxyl radicals or other initiating species, such as Cu(II), are not able to 
penetrate an LDL particle because of its lipophilic interior and thus are not able to induce LDL 
   Introduction on lipid peroxidation and antioxidants  
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯ 
              
25
peroxidation by themselves. This is why α-TOH depleted LDL is stable to oxidative conditions. 
However, they can react with α-TOH located on the surface of the LDL particle (phase transfer, 
step [1]). The resulting α-TO• radical survives quite a long time inside the LDL particle and is 
therefore able to slowly initiate oxidation chains inside the LDL particle by a TMP process 
analogous to the one discussed in Section 1.2.2.63 Thus, α-TO• initiates the chain by reacting 
with a lipid to give L• (radical transfer, step [2]). These lipid radicals propagate the chain by 
oxygen addition (step [3]) and reaction with α-TOH (Step 4) thereby regenerating α-TO•. About 
20 to 50 molecules of LOOH per α-TO• can be formed in this chain process. Termination of the 
chain occurs after irreversible trapping of α-TO•. Thus, α-TOH can act both as an antioxidant as 
well as a pro-oxidant.  
The exact contributions of the two modes of action to the overall oxidation outcome 
depend on several factors.61 At high plasma peroxyl radical flux, the pro-oxidant behavior of α-
TOH is likely to be diminished since α-TO• will be engaged in radical-radical terminations at 
the LDL surface (step [5]). At low radical flux, however, it can survive long enough to start 
chains inside the particle by a slow TMP process. In fact, it was estimated that an α-TO• radical 
can survive for more than 10 minutes inside an LDL particle59 since diffusion of lipid-soluble 
components between LDL particles is very slow.64  
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Scheme 1.9: Radical export by ubiquinol (CoEnzyme Q) and Vitamin C. 
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Furthermore, co-antioxidants, such as ubiquinol (CoEnzyme Q), ascorbic acid (Vitamin 
C) and bilirubin, are able to efficiently and quickly reduce α-TO•, hence preventing the initiation 
of chains inside LDL (step [6]).65,66,41 The extremely high efficiency of these co-antioxidants 
relies on their ability to irreversibly transport radical character out of the LDL particle (Scheme 
1.9).59 Ascorbic acid reacts with α-TO• on the surface and the resulting relatively unreactive 
ascorbyl radical remains in the aqueous outer environment. Bilirubin acts similarly yielding 
biliverbin. Ubiquinol, on the other hand, reacts with α-TO• to afford a lipophilic ubiquinyl 
radical, which can undergo an addition of oxygen with concomitant release of the hydroperoxyl 
radical. This species is conceived to dissociate under physiological conditions and superoxide 
radical will migrate out of the LDL particle into the aqueous phase.  
Stocker proposed that, according to the model shown in Scheme 1.8, physiological 
conditions would be classified as conditions under which α-TOH is a pro-oxidant.62 However, 
given the proven beneficial effect of Vitamin E, the pro-oxidant behavior obviously must be very 
low and this can be explained by the co-antioxidant activity of Vitamin C. Yet, any participation 
of α-TOH as pro-oxidant, even if it is very low, can still induce a significant amount of oxidation 
over long periods of time. 
 
1.2.4 Design of better antioxidants – trying to beat Nature 
Many research efforts have been devoted to devise phenolic antioxidants (ArOH) better 
than α-TOH, both for biological and industrial applications. For biological applications, the 
selection criteria included stability, fast reaction with peroxyl radicals and less tendency to 
induce TMP-like processes by ArO•. 
 
ArOH    +     LOO                     ArO        +   LOOH Eq. 3 (ArO-H BDE important).
ArOH    +     O2                        ArOH        +   O2 Eq. 4 (ArOH IP important).
ArO
physiological
conditions
?? Eq. 5 (Fate of  ArO    important).
 
 
Scheme 1.10: Critical parameters in designing new phenolic antioxidants. 
 
The BDE will govern the stability (and reactivity) of ArO• and how fast the phenol will 
trap a peroxyl radical by H• donation (Eq. 3). The IP value is a measure for the ease of electron 
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transfer from ArOH to acceptors like molecular oxygen, which is an undesired process (Eq. 4). 
Practically, the IP value also translates into a measure for air-stability. Furthermore, the fate of 
ArO• in a biological system, such as the body, is important if the newly designed antioxidant 
were to be considered for clinical trials or other biological studies (Eq. 5). 
Thorough theoretical studies have shown that an increase in electron density of the 
aromatic ring leads to a lower BDE, by virtue of stabilization of the electron deficient ArO• 
radical.67,68,69 Thus, substituting the phenol ring with ortho- or para-groups like –MeO or –NMe2 
leads to species which react faster with peroxyl radicals than the parent phenol. However, a 
concomitant decrease in IP was also found for this substitution pattern, which would suggest 
lower air-stability by stabilization of the phenol radical cation. Indeed, some compounds (16-18) 
that were expected to be very fast in their reaction with peroxyl radicals, were found to 
decompose spontaneously upon exposure to air.70,71,72 This clearly illustrates the importance of 
the air-stability issue and puts a severe limit on the range of groups that can be incorporated in 
the aromatic ring. 
 
NH
OH
N
OH
16 17
OH OH
OMe
18  
 
The importance of the fate of ArO• in a biological system can be illustrated by the case 
of the catechols. These compounds possess excellent antioxidant activity, i.e. react with peroxyl 
radicals very fast.73,74 The resulting catechyl radicals undergo further reactions to yield 
secondary oxidation products, such as quinones. In simple solution chemistry, these quinones do 
not constitute many problems. This is different, though, for biological systems. Various 
structurally related quinones have been shown to inactivate tyrosine hydroxylase which is the 
initial and rate-limiting enzyme in the biosynthesis of the catecholamine neurotransmitters,75 
inhibit glutathione-dependent protection against lipid peroxididation76,77 and form depurinating 
adducts with DNA at the N-7 of guanine and the N-3 of adenine.78 Thus, even though catechols 
are formally excellent antioxidants, the by-products proved incompatible with biological 
systems. It should be pointed out that all these incompatibilities are the result of the same 
chemical process, i.e. Michael addition of nucleophilic residues to the quinone, as illustrated in 
Scheme 1.11 for an unsubstituted quinone. 
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Similar reactivities for quinone-imines (from aminophenols) and quinone-diimines (from 
phenylenediamines) have been described,79 rendering them less useful as antioxidants as well 
(Scheme 1.11). Even aminophenols or diamines with a tertiary exocyclic amine can eventually 
lead to quinone-imines because the former can be mono-dealkylated by enzymes, such as 
Cytochrome P-450 or peroxidases.80,81 It should be pointed out that Michael chemistry with 
ubiquinone-10 (Scheme 1.9) is hampered by steric and electronic factors. 
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Scheme 1.11: Fate of quinones and quinone-imines in biological systems. 
 
There are a few examples where antioxidants, that perform better than α-TOH, have been 
made and tested. Contracting the aliphatic ring from 6 to 5, Ingold et al. made isobenzofuran 
structure 19 which reacted 1.5 times faster with peroxyl radicals and thereby were the fastest 
phenolic antioxidants in solution at that time.53 The increased reactivity was attributed to 
improved stereo electronics, i.e. the oxygen lone pairs overlapped better with the aromatic ring. 
They also prepared a biologically active variant with the side-chain of α-TOH82 and found that it 
was superior to α-TOH in bioassays with rats.83 However, the fastest chain-breaking antioxidant 
known to date is actually an aromatic amine (3,7-dimethoxy-phenothiazine, 20).84 It traps 
peroxyl radicals about 10 times faster than α-TOH in solution. However, this compound has not 
been tested in biological systems. It should be mentioned that all of the compounds, mentioned 
in this paragraph, possessed only moderate air-stability. For example, just like with α-TOH, 
color formation occurs upon exposure of 20 to air.  
An example of a new antioxidant that was designed rationally for optimal in vivo activity 
is BO-653 (21), prepared by Niki et al.85 The features of this molecule include the two ortho t-
butyl groups and the two pentyl chains, presumably to provide lipophilic character. It was 
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reasoned that the two bulky t-butyl groups would hinder further reaction of ArO• and potentially 
reduce the pro-oxidant behavior in vivo. It was shown that in solution BO-653 had slightly lower 
antioxidant activity as α-TOH, but in Soybean PC liposomal membranes BO-653 actually spared 
or recycled α-TOH.85 It was speculated that this striking difference may be attributed to different 
locations of α-TOH and BO-653 in the membranes. In addition, evidence was obtained that 
suggested that the ArO• from BO-653 indeed possessed a lower reactivity, for example in its 
reactivity towards ascorbic acid or Cu(II) metal traces.86 Thus, the Niki group designed a new 
antioxidant by providing steric restrictions upon ArO• rather than electronically deactivating it. 
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1.3 The effect of nitrogens in the ring 
A different approach in the design of new antioxidants was followed by Pratt and 
Valgimigli. The OH-BDE of phenolic antioxidants is governed mostly by resonance π-
interaction with o- and p-substituents, while the IP is a result of σ-induced electron density in the 
ring. Therefore, they envisioned incorporating two nitrogen atoms in the phenolic ring to give 
substituted pyrimidinols, such as 22.87,88 For the reasons just outlined, it was speculated that these 
two electron-withdrawing nitrogen atoms would have a more substantial effect on the IP than on 
the BDE. Moreover, as will be addressed later, these compounds were expected to be less 
cytotoxic.  
 
N N
OH
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Theoretical calculations89,90 confirmed the expected trend (Table 1.2). For any given 
substitution pattern, the pyrimidinol possesses both higher BDE and IP values than the 
corresponding phenol. The calculated substituent effect proved very similar for both types of 
compounds as is evident from the values between parentheses. A comparison between 22 and α-
TOH shows the beneficial effect of the two nitrogen atoms: both have similar calculated BDEs, 
but the IP values differ by 8 kcal/mole. In practice, this would translate in similar antioxidant 
activity but higher air-stability for 22 with respect to α-TOH 
 
 
 
Substitution 
R1 R1
R2
OH
 
        BDE                 IP    
N N
R1 R1
R2
OH
 
BDE                   IP    
R1=H, R2=H 87.1 (0.0)      195.4 (0.0) 89.6 (0.0)     219.7 (0.0) 
R1=H, R2=CH3 84.6 (-2.5)    186.9 (-8.5) 86.8 (-2.8)    209.3 (-10.4) 
R1=CH3, R
2=CH3 80.4 (-6.7)    178.3 (-17.1) 83.2 (-6.4)    198.0 (-22.7) 
R1=H, R2=OCH3 81.0 (-6.1)    176.5 (-18.9) 83.6 (-6.0)    198.1 (-21.6) 
R1=CH3, R
2=OCH3 77.0 (-10.1)  169.2 (-26.2) 79.8 (-9.8)    188.3 (-31.4) 
R1=H, R2=N(CH3)2 77.0 (-10.1)  157.7 (-37.7) 78.3 (-11.3)  174.6 (-45.1) 
R1=CH3, R
2=N(CH3)2 
(compound 22)  
72.3 (-14.8)  152.3 (-43.1) 
 
74.1 (-15.5)  167.0 (-52.7) 
 
α-TOH 74.8 (-12.3)  159.3 (-36.1)  
 
Table 1.2: Calculated Substituent Effects on Gas Phase O-H BDEs at 298K and 
Adiabatic IPs at 0K of Substituted Phenols and 5-Pyrimidinols. Data presented BDE and IP in 
kcal/mol. Substituent effects (with respect to unsubstituted parent) are in parentheses. All data 
taken from ref. 87. 
 
.Experimental studies showed that 22 was perfectly stable in air but trapped peroxyl 
radicals 1.5 – 2 times as fast as α-TOH (Table 1.3). The fact that the kinh values for α-TOH and 
22 differ by a factor ∼2, despite the nearly equal experimental OH-BDEs, can be explained by 
the polar effect.87 This implies that the pyrimidine ring is more able to stabilize any developing 
negative charges on the oxygen in the transition state for hydrogen atom donation to a peroxyl 
radical. In conclusion, the inductive effect of the two nitrogen atoms allowed for further 
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incorporation of electron-donating ring-substituents and led to a novel class of very active 
antioxidants. 
 
Antioxidant kinh by oxygen uptake 
(x 107 M-1s-1)a 
kinh  by clock 
(x 107 M-1s-1)b 
Exp. O-H BDE  
(kcal/mol)c 
22 0.86 ± 0.05 0.65 ± 0.08 78.2 
α-TOH 0.41 ± 0.04 - 78.3 
a By inhibited styrene autoxidation in benzene at 50 °C b In benzene at 37 °C by methyl  
linoleate radical clock. c From EPR equilibration studies  
 
Table 1.3: Collected data for experimentally determined kinh and O-H BDEs. All data 
taken from ref. 87. 
 
A brief description of the experiments used to measure kinh and OH-BDE will be given 
here. The kinh values were determined by oxygen uptake experiments in styrene 
autoxidations.53,91 In these experiments, the thermally initiated autoxidation of styrene with an 
azo-initiator in the presence of the antioxidant was studied. The autoxidation was followed by 
monitoring the oxygen consumption with an automatic recording gas absorption apparatus using 
a differential pressure transducer. From a plot of the slope of the autoxidation traces vs the 
antioxidant concentration, kinh values for the antioxidant can be determined using the Darley-
Usmar protocol.92 In addition, kinh values could be determined by the peroxyl radical clock 
discussed in Scheme 1.6.58  
 
Ar1O     +    Ar2OH Ar1OH     +    Ar2O
K
 
 
Scheme 1.12: Equilibrating mixture of two phenols under radical conditions. 
 
The OH-BDE was determined from EPR equilibration studies68 by measuring the 
equilibrium constant for the hydrogen transfer reaction between the phenoxyl radical of the 
unknown antioxidant (Ar1O•) and a known reference phenol (Ar2OH) (Scheme 1.12). A mixture 
of the two phenols is irradiated in an EPR cavity in the presence of (t-BuO)2 serving as a light-
induced radical source. The molar ratio of the two phenoxyl radicals [Ar2O•]/[Ar1O•] in the 
resulting equilibrium is obtained from the EPR spectra either by double integration of 
appropriate lines or by comparison with computer-simulated spectra when the lines from the two 
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species strongly overlap. From K and the known BDE for Ar2OH, the BDE for the unknown 
phenol can then be calculated. 
N N
O
NR
blocked
Nu  
 
Scheme 1.13: Blocked Michael acceptor site in imine-quinones derived from 
pyrimidinols. 
 
A very important structural implication of the pyrimidinol skeleton involves the issue of 
potential Michael chemistry as outlined earlier. As shown in Scheme 1.13, the quinine-imine 
derived from 22, after dealkylation by P450, is no longer a good Michael acceptor for 
nucleophiles since all sites are blocked. Thus, their reactivity towards in vivo nucleophiles, such 
as DNA and thiols, might be reduced resulting in lower cytotoxicity. This has not been proven 
for 22 yet, but it is a very attractive potential advantage. 
 
1.4 Research objectives  
In comparing the phenol and pyrimidinols series it seemed logical that the pyridinol 
series, with only one nitrogen ring atom, represents an interesting class as well. The effects on 
the activity that have been observed for two ring-nitrogens (pyrimidinols) are likely to also hold 
true upon incorporation of one nitrogen, albeit to a lesser extent.  Indeed, Pratt and Valgimigli 
calculated that 3-pyridinol would have a BDE and IP between those of the corresponding 5-
pyrimidinol and phenol.87  
 
N
OH
.HX
Mexidol       X=succinate
Emoxipin    X=Cl
N N N
OH OH OH
Phenol 3-Pyridinol 5-Pyrimidinol
 
 
Some studies by Russian groups in the 60s showed that simple (di-)alkyl-substituted 3-
pyridinols possessed antioxidant activity in oleate autoxidations and in rats.93,94 A promising 
candidate, 2-ethyl-6-methyl-3-pyridinol, has been developed as a drug and is known by the 
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market names Mexidol, Emoxipin or Proxipin. Mexidol has been shown to scavenge ROS in 
vitro during oxidations in solution or phospholipids initiated by peroxyl radicals.95 Levels of 
lipid peroxidation and superoxide dismutase in the organs and blood of white mice under acute 
stress were reduced when Mexidol or Emoxipine (100 mg/kg) were administered.96 In addition, 
it prevented lipid peroxidation during penthylenetetrazole-induced epileptiform model seizures 
in rats97 and during oxidative stress in rabbits.98 Thus, this particular type of pyridinol has been 
shown to possess antioxidant activity in vitro and in vivo. The exact mechanism of action has not 
been clarified97 but H-atom donation seems likely.  
 
 
 
Substitution 
N
R1 R1
R2
OH
 
BDE                      IP    
R1=H, R2=H 88.2 (0.0)       206.4 (0.0) 
R1=H, R2=CH3 85.4 (-2.8)     196.6 (-9.8) 
R1=CH3, R
2=CH3 81.1 (-7.1)    186.3 (-20.1) 
R1=H, R2=OCH3 82.0 (-6.2)    186.1 (-20.3) 
R1=CH3, R
2=OCH3 78.1 (-10.1)  177.4 (-29.0) 
R1=H, R2=N(CH3)2 77.0 (-11.2)  164.6 (-41.8) 
R1=CH3, R
2=N(CH3)2 
(compound 23) 
73.5 (-14.7)  157.7 (-48.7) 
 
 
Table 1.4: Calculated substituent effects on gas phase O-H BDEs at 298K and adiabatic 
IPs at 0K of substituted 3-Pyridinols. Data presented BDE and IP in kcal/mol. Substituent effects 
(with respect to unsubstituted parent) are in parentheses. 
 
Yet, it is expected that the substitution pattern in Mexidol (o-Et, p-Me) does not give rise 
to optimal antioxidant activity if H-atom donation is involved. This can be rationalized by 
looking at the calculated substituent effects of alkyl groups versus, for example, amine 
substituents (Table 1.4). No literature reports could be found on the use of increasingly donating 
ring-substituents, such as ethers or amines. Conceivably, the lack of appropriate synthetic routes 
has hampered this. However, such a study would be of great interest since it has the potential to 
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push the antioxidant activity beyond the highest activities reported to date. The following three 
factors contribute to this. 
 
Inductive effect of one N atom on activity, stability and TMP behavior. Comparison 
of the trends observed in the phenol and pyrimidinol series leads one to expect that 3-pyridinols 
could have even lower OH-BDE values than the pyrimidinols while still possessing reduced yet 
moderate air-stability, similar to or slightly lower than α-TOH. The results with Mexidol indeed 
indicate good antioxidant activity for some 3-pyridinols. Taking increasingly electron-rich 
aromatic rings, the values for OH-BDE and IP for 3-pyridinols were calculated using an identical 
substitution trend as shown for phenols and pyrimidinols in Table 1.2 (Table 1.4). 99 
The outcome for dimethylamino-pyridinol 23 will be highlighted as a representative 
example. It can be seen that the calculated BDE and IP values for 23 are 73.5 and 157.7 
kcal/mole, respectively. Thus, a comparison with Table 1.2 reveals that 23 has a significantly 
lower BDE than both 22 and α-TOH, while having only slightly lower IP than α-TOH. Pyridinol 
23 therefore has high potential of being more reactive towards peroxyl radicals than 22. In 
addition, the lower BDE for 23 as compared to α-TOH means that the resulting ArO• is more 
stabilized than α-TO•. This is an important notion, since it is expected that a more stabilized 
phenoxyl radical is less likely to undergo AMP (Antioxidant Mediated Peroxidation), i.e. could 
have reduced phase and radical transfer characteristics in LDL (Scheme 1.8).  
 
N
OH
N
23
N
OH
N
24
N
OH
N
25  
 
Incorporation of fused rings. Ingold’s study clearly showed the beneficial effect of a 
second fused ring on antioxidant activity of phenols.70 This second ring forces the lone pair of 
the para-oxygen or (–amino) substituent more in conjugation with the aromatic ring and hence 
effectively increases the electron-density of the system. A 5-membered ring proved more 
effective than a 6-membered ring, a trend reflecting the increasing strain of the ring. The option 
for an additional ring was not available in the pyrimidinol series because all aromatic positions 
were blocked. However, the free aromatic position in pyridinol 23 clearly does allow for further 
substitution. Preliminary calculations for 24 and 25 reveal BDE values of 73.3 and 72.4 
kcal/mole, respectively.99 The corresponding IP values were computed to be 154.6 and 152.3 
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kcal/mole. It follows that incorporation of aliphatic rings in the pyridinol structures is expected 
to lead to even lower BDEs but also IPs than for 23 and this makes 24 and 25 also very 
interesting candidates. 
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Scheme 1.14: Different pathways for pyridinols with secondary exocyclic amine. 
 
Blocked Michael acceptor sites. Just like in the case of the pyrimidinol, quinone-imines 
can be obtained in vivo from amino-pyridinols after dealkylation by Cytochrome P450.81 For 
pyridinols with a secondary exocyclic amine, the same quinone-imines could also be formed by 
an alternative pathway, namely by similar chemistry as described for ubiquinol-10 (Scheme 1.9): 
trapping of two peroxyl radicals or trapping of a peroxyl and oxygen with concomitant 
superoxide formation (Scheme 1.14). Regardless by which pathway, quinone-imine formation 
leaves one Michael acceptor site blocked by the ring-nitrogen. The other acceptor sites are 
sterically hindered, especially in the case of bicyclic pyridinols 24 and 25 (R=alkyl). It might be 
expected that a combination of the above factors could render 6-amino-3-pyridinols less 
cytotoxic in the body than aminophenols. In fact, 6-amino-3-pyridinols or their O-sulfate esters 
have been detected as excreted metabolites in studies of certain 2-amino-pyridine drugs in rats 
and dogs.100,101 
 
The targets formulated for this project are: 
 
1)   Synthesis of the pyridinol candidates 23-25.  
2)   Measurement of their reactivity with peroxyl radicals in solution. 
3)  Synthesis of highly lipophilic derivatives from 23-25 and testing of their antioxidant and 
pro-oxidant behavior in LDL particles.  
4)  Approaches towards the synthesis of an aminopyridinolic isostere of α-Tocopherol in an 
effort to structurally mimic Nature’s best antioxidant. 
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1.5 Outlines of the chapters 
In Chapter 2, the progress made towards the syntheses of various 6-amino-3-pyridinols 
and their use of antioxidants in solution will be described. All interesting pyridinol structures 
discussed so far were successfully prepared by multi-step syntheses. This series includes 
monocyclic and bicyclic pyridinols, either with secondary or tertiary exocyclic amine groups. 
Chapter 3 deals with measurement of inhibition constants kinh of the pyridinols by the 
peroxyl radical clock and inhibited styrene autoxidation methods. Investigations on the tendency 
of pyridinols to undergo electron-transfer and on their stability in the presence of hydroperoxides 
will also be described. 
Chapter 4 is devoted to the use of lipophilic 6-amino-3-pyridinols as antioxidants in 
biological systems. Human LDL was isolated and supplemented with a variety of these lipid-
soluble pyridinols. Oxidations of both native and supplemented LDL, initiated by water-soluble 
peroxyl radicals, were carried out. The results will be discussed in terms of synergistic effects of 
antioxidants, patterns of oxidation products and protein damage. 
In Chapter 5, efforts made towards an aminopyridinol-isostere of α-Tocopherol will be 
reported. The chapter centers around novel additions of alkyllithiums to α,α’-disubstituted [1,8]-
naphthyridines to create the appropriate bicyclic skeleton 
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 2 
 
 
2.1 Introduction1 
The calculations discussed in Chapter 1 showed great potential for 6-amino-3-pyridinols 
as chain-breaking antioxidants. It was therefore decided to pursue the synthesis of a variety of 
these compounds for detailed experimental studies, both in solution as well as in human Low 
Density Lipoprotein (Figure 2.1). In contrast to the corresponding pyrimidinols, very little is 
known about the synthesis of these amino-pyridinols. This is likely due to the unsymmetrical 
substitution pattern of the pyridine ring and due to the known difficulties with hydroxylating 
pyridine rings. In fact, the structurally rather simple 2,4-dimethyl 6-dimethylamino-3-pyridinol 1 
(R1=H, R2=R3=Me) has not been described at all. 
 
N
N
OH
R2 R3
R1
 
 
Figure 2.1: General structure of substituted 6-amino-2,4-dimethyl-3-pyridinols. 
 
                                                 
*  Parts of the contents of this chapter are published: Wijtmans, M.; Pratt, D. A.; DiLabio, G. A.; Valgimigli, L.; Pedulli, G. F.; 
Porter, N. A. Angew. Chem. Int. Ed. 2003, 42, 4370.  
Synthesis of  
6-Amino-3-Pyridinols * 
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The Boyland-Sims peroxidation, the only general method to directly para-hydroxylate 
activated pyridine rings,1 is known to fail for aminopyridines when the ortho position with 
respect to the amino group is vacant.2 Therefore, direct oxidative para-hydroxylation of 
aminopyridine systems is not feasible, at least not for the desired monocyclic pyridinols (where 
R1=H). Some direct hydroxylations of electron-rich pyridines using aq. H2O2 (AcOH, 100 °C) 
have been reported,3,4 but in all cases very low yields were obtained and it is likely that for the 
more oxidation-sensitive substrates (where R1≠H) the outcome will be even worse. Baeyer-
Villiger approaches will need the appropriately substituted aldehydes followed by treatment with 
oxidants, such as m-CPBA.4 It has been shown that diazonium precursors of pyridine substrates, 
similar to the present target, gave rise to undesired coupling products upon attempted hydrolysis 
(CuSO4, H2O, 100 °C).5  
With regard to the general structure depicted in Figure 2.1, it seemed that a synthesis 
starting from a precursor, already having the pyridine nucleus, would be most straightforward. 
The introduction of the reactive hydroxyl group in the pyridine ring was deemed the key-step. A 
sequence including an initial construction of the appropriate mono- or bicyclic aminopyridine 
precursor was envisaged. Subsequently, it was decided to activate the ring first by bromination 
and then substitute the bromine by a hydroxy group, rather than direct hydroxylation.  
In this chapter the synthesis of a variety of monocyclic and bicyclic 6-amino-3-pyridinols 
using this general synthetic strategy will be described. A successful conceivable route to a free 
pyridinol (R2=R3=H) will also be given, even though there was no follow up on this. The 
abnormal 1H NMR behavior of these compounds will also be discussed. 
 
2.2 Synthesis of monocyclic amino-pyridinol  
The general synthetic strategy for the simple monocyclic pyridinol 1 is illustrated in 
Scheme 2.1. The appropriate starting material, 2-amino-4,6-lutidine, was commercially available 
and inexpensive. It was brominated regioselectively para to the amino group to give pyridine 2,6 
which was methylated under Eschweiler-Clark conditions to afford 3. Bromide 3 proved 
extremely unreactive towards various forcing conditions with methoxide7 or hydroxide ions.  
Therefore, it was decided to investigate the possibilities for oxygenation of aryllithium 
intermediates which is a general approach occasionally used in the literature. Reagents that have 
been reported for such conversions include bis(trimethylsilyl)peroxide,8 lithium tert-
butylhydroperoxide9 or trimethylborate/CH3CO3H.
5   However, all these reagents contain active 
peroxy-bonds and problems in their compatibility with very electron-rich aminopyridines were 
expected, especially for the corresponding pyridinols (see also Section 3.3.2). Therefore, an 
oxygenation method reported by Van Boeckel et al was selected.10 Bromide 3 underwent smooth 
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lithium/bromide exchange with n-BuLi and the resulting pyridyllithio-reagent was quenched 
with a nitroarene to afford compound 1 in 63 % isolated yield (see also Scheme 2.2). It could 
easily be purified by a base/acid extraction which circumvented the use of column 
chromatography. A 2D NOESY NMR experiment with 1 confirmed that the –OH group had 
been introduced at the desired ring carbon atom. Clear advantages of this nitroarene-method for 
the present targets are the low reaction temperature (-78 °C) and the fact that nitroarenes, which 
are usually not considered as oxidants, are compatible with electron-rich pyridines. Indeed, this 
protocol was successfully applied to all the present substrates. 
 
N
NH2
a)
N
NH2
b)
N
N
c)
N
N
2 3 1
OHBrBr
 
Key: a) dibromodimethylhydantoin, DCM, -40 °C, 45 min, 67 %. b) HCOOH, 
H2CO (aq), reflux, quant. c) (1) n-BuLi, THF, -78 °C (2) o-nitro-m-xylene, THF, 
63 %. 
 
Scheme 2.1: Synthesis of monocyclic pyridinol 1 by a general hydroxylation strategy. 
 
Some remarks regarding the hydroxylation step need to be made. The preparation of 
phenols by quenching of aryllithiums with nitrobenzene was accidentally discovered by Buck et 
al. in 1960.11 Their proposed mechanism involves the aryllithium attacking the nitro-group 
(Scheme 2.2, pathway A) giving an intermediate adduct, which decomposes to the lithium 
phenoxide and nitrosoarene. This reaction has been occasionally used over the last decades and 
in all cases suffered from modest to low yield due to the formation of substantial amounts of 
quenched aryllithium (4 in the present case).12,13,14 Cava et al. found that this is (partially) 
because the aryllithium abstracts an o-proton from PhNO2 (pathway B) but they were not able to 
improve the reaction by using alternatives, such as 1,3,5-tri-tert-butyl-nitrobenzene.14 For the 
present study, o-nitro-m-xylene was selected as the electrophile. It gave comparable or slightly 
higher yields than nitrobenzene and it was easier to remove from the crude product than the more 
hydrophilic and polar nitrobenzene, either by extraction or column chromatography. It should be 
emphasized, though, that reduced by-product was still formed with nitroxylene. This reduction 
did not occur by solvent quenching as was shown by experiments in d8-THF. Nitroxylene still 
contains potentially acidic centers (para-H, ortho-CH3). A few modifications in nitroarene 
structure,15 reaction temperature (down to -120 °C), and equivalents of reagents were attempted, 
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but in all cases a significant amount of reduced product was recovered and no improvements in 
the reaction were achieved. It was realized, though, that the hydroxylation with nitroxylene was 
very reproducible and reliable and gave rise to product mixtures that were always relatively easy 
to purify. Therefore, the lower yields were accepted, especially since no clear alternative was 
available. It should be mentioned that, during the course of the project, it was observed that the 
low yields in the hydroxylation steps were partially due to poor chromatography even on Et3N 
deactivated silica gel. In the case of 1, which did not require chromatographic purification, a 
good yield was obtained. 
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Scheme 2.2: Mechanism of hydroxylation of aryllithium by nitrobenzene and formation 
of the major by-product. 
 
For the studies with more biologically oriented systems (Chapter 4), pyridinols that 
possessed an amphiphilic structure were needed. It was reasoned that the pyridinol-moiety itself 
is already quite polar and simply functionalizing it with a long alkyl-chain would render the 
molecule amphiphilic to some extent. The best place for derivatization was the exocyclic amine 
in 2. The phytyl (3,7,11,15-tetramethyl-hexadecyl) group was selected because of its structural 
resemblance to the tail of Vitamin E and the commercial availability of its precursors. Formally, 
the unsaturated analogue of this chain is called ‘phytyl’ but for the sake of convenience this term 
was also adopted for the saturated chain. The synthetic sequence is depicted in Scheme 2.3. 
Rather than an SN2 substitution, a reductive amination was chosen as the method to introduce the 
long alkyl chain on the amine. Aldehyde 5 was prepared in 90 % yield by an improved metal-
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free oxidation of phytol16 using a catalytic amount of TEMPO and stoichiometric quantities of 
commercial bleach.17 To prevent double alkylation of 2 with 5 under usual reductive amination 
conditions, a two step procedure involving benzotriazole was used.18 Reaction of 5, bromide 2 
and benzotriazole in refluxing EtOH gave a solid 6. LAH reduction of this adduct afforded 
mono-phytylated product 7 in 85 % yield over two steps. Subsequent Eschweiler-Clark 
methylation was successful but i-PrOH had to be added to solubilize all components. 
Hydroxylation, as in Scheme 2.1, gave desired pyridinol 9 in ca. 30 % isolated yield. As 
mentioned earlier, this low yield was partially due to inefficient column chromatography, even 
on deactivated silica gel. 
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Key: a) 3,7,11,15-tetramethyl-hexadecylaldehyde (5), benzotriazole, EtOH, r.t. b) LiAlH4, THF, r.t., 85 % over 
two steps. c) HCOOH, H2CO(aq), i-PrOH, reflux, quant. d) (1) n-BuLi, THF, -78 °C. (2) o-nitro-m-xylene,    
30 %. 
 
Scheme 2.3: Synthesis of lipophilic pyridinols. 
 
Other interesting targets included pyridinols derived from bromide 7, i.e. with the 
exocyclic amine being secondary rather than tertiary. The presence of an acidic H-atom at the 
nitrogen in 7 was expected to give problems in the hydroxylation step.  For example, if the 
bromide/lithium exchange is faster than deprotonation of the amine, the desired aryllithium could 
be quenched by the amine.19 However, under modified conditions the hydroxylation could be 
performed without protection of the secondary amine (Scheme 2.4). Under the usual conditions 
with n-BuLi, with the exception that 3.3 eq instead of 2.3 eq was used, the bromide-lithium 
exchange was very slow and inefficient. This can be explained by assuming that all of substrate 7 
was now in its amide-form 10 which will probably be less reactive in a bromide-lithium 
exchange. However, 3.3 eq of the more reactive s-BuLi was sufficient to give a smooth exchange 
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on 10 which, after the usual quenching with nitroxylene, led to pyridinol 11 in ca. 30 % isolated 
yield.  
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Key: a) (1) s-BuLi (3.3 eq), THF, -78 °C. (2) o-nitro-m-xylene, 30 %. 
 
Scheme 2.4: Hydroxylation strategy for pyridinols containing secondary amines. 
 
2.3 Synthesis of pyridinols with an annelated aliphatic ring 
2.3.1 Pyridinols with an annelated six-membered ring 
Not surprisingly, the bicyclic pyridinols required considerably more synthetic effort. 
Analogues 17a, b required the formation of a tetrahydro-quinoline structure prior to bromination 
and hydroxylation. A Friedel-Crafts approach was used for the annelation process (Scheme 
2.5).20 A sluggish Michael reaction of 2-amino-4,6-lutidine with acrylic acid in refluxing 
pyridine afforded amino acid 12. As expected, this compound was highly polar which posed 
serious isolation problems. An isolation, comprising a crystallization from water using a pH-
shift, was employed which gave 12 of excellent quality but in only 30 % yield. The ring-closure 
proceeded in either hot polyphosphoric acid (PPA) or methanesulfonic acid. This step proved 
rather irreproducible, sometimes providing product in 75 % yield, sometimes giving rise to a 
series of undesired products. It was suspected that the quality of both starting material and PPA 
and temperature played a crucial role. The reduction of arylketone 13 could be achieved under 
typical Wolff-Kishner conditions (H2NNH2, tris-ethyleneglycol, KOH, heat), but it was very 
difficult to separate the product from the glycolic solvent. Milder and cleaner conditions were 
achieved by reacting 13 with BH3
.THF complex at reflux to afford 14 in 83 % yield and in high 
purity. The problem with this three-step sequence was the low yield of the first step but even 
more importantly the irreproducibility of the ring-closure step. The route provided sufficient 
amounts of material to carry out all initial experimental studies on the target pyridinol (vide 
infra). Fortunately, during the work on a pyridinolic isostere of α-TOH, a shorter and higher-
yielding sequence to 14 was found. This will be described in Section 5.3. 
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reflux, 18h, 83 %.  d) dibromodimethylhydantoin, DCM, -78 °C, 93 %.  e) 16a: HCOOH, 
H2CO(aq), i-PrOH, reflux, 77 %. 16b: aldehyde 5, NaBH(OAc)3, DCE, 30 min, r.t., 53 %. 
f) (1)  n-BuLi, THF, -78 °C (2) o-nitro-m-xylene, 25 % for 17a, 15% for 17b. 
 
Scheme 2.5: Synthesis of pyridinols containing an annelated aliphatic 6-membered ring. 
 
The bromination of 14 at -78 °C proceeded well, but care had to be taken that over-
bromination, presumably on the benzylic positions, did not take place.  A protocol, in which the 
reaction flask was regularly warmed to ∼0 °C after which it was quickly recooled to -78 °C, was 
found to work well. After the reaction, product 15 could simply be precipitated by adding aq. 
KOH and Na2S2O3. Up until the following alkylation stage, no chromatographic purifications 
were involved. The methyl derivative 16a was obtained by the usual Eschweiler-Clark 
methylation.  For phytyl-derivative 16b a reductive amination procedure21 with NaBH(OAc)3 
and aldehyde 5 was used. Both bromides were converted to the corresponding pyridinols by the 
usual hydroxylation sequence to obtain 17a and 17b in 25 and 15 % yield, respectively. Once 
again, substantial amounts of product were lost during column chromatography on a silica 
column. It should be pointed out that the yield for 17a was not optimized and it is expected it can 
be improved substantially by using similar non-chromatographic isolation procedures as for 1.  
 
2.3.2 Pyridinols with an annelated five-membered ring 
Bicyclic pyridinols with an annelated 5-membered ring (i.e. with a dihydro-
pyrrolopyridine system) synthetically represent the most challenging class of pyridinols. Simple 
dihydro-pyrrolopyridine structures have been prepared from chloride-precursors,22 by radical 
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cyclizations23 or by sluggish hydrogenations of difficult-to-prepare aza-indoles.24 All of these 
reactions required precursors that are not straightforward to synthesize given the desired 
substitution pattern of the pyridine product. After some unsuccessful attempts using 
intramolecular Friedel-Crafts steps, the method of Van der Plas was selected.25  It involves an 
intramolecular inverse electron-demand Diels-Alder reaction between an alkyne and pyrimidine 
ring as the key step (vide infra).  
The synthesis of 23, the precursor for this reaction, is depicted in Scheme 2.6. Compound 
20 is known but the literature procedures were lengthy26,27 or gave very low yields when 
repeated.28 The following alternative and shorter synthesis, that was very easy to scale up and 
provided crystalline 20, was designed. Acid 1829 was mixed with diphenylphosphorylazide30 in 
refluxing t-BuOH which induced a one-pot acid azidation, Curtius rearrangement and alcoholysis 
with t-BuOH. This crude Boc-protected amine 19 was deprotected with 1.0 M ethereal HCl and 
20 was isolated in good yield, simply by filtration. Coupling of this salt with triflate 21, prepared 
from 4,6-dimethyl-2-pyrimidinol and triflic anhydride,31 was achieved by a nucleophilic 
aromatic substitution in DMF in the presence of excess Et3N to afford amine 22. If the DMF was 
not distilled, traces of dimethylamine reacted to give the corresponding dimethylamino-
pyrimidine as a significant by-product. The two methyls on the pyrimidine ring reduced the 
coupling rate considerably compared to non-substituted pyrimidines25 and it was for this reason 
that the triflate proved superior over other activating groups, such as chloride25 and tosylate. 
Acetylation of 22 was difficult because of low nucleophilicity of the exocyclic amine, but could 
be accomplished by heating in acetic anhydride in the presence of DMAP, giving acetate 23.  
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Key: a) Ph2P(O)N3, Et3N, t-BuOH, reflux, 79 %. b) HCl, ether, r.t., 70 %. c) Et3N, DMF, 1 d, r.t., 93 %. d) 
Ac2O, DMAP, 100 °C, 20 h, 91 %.  
 
Scheme 2.6: Synthesis of the precursor for the inverse electron-demand Diels-Alder 
reaction. 
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The mechanism for the next step, formation of substrate 25, is depicted in Scheme 2.7.25 
It involves an inverse electron-demand Diels-Alder step of the alkyne and the pyrimidine moiety 
in 23 to give intermediate 24, which then undergoes a cycloreversion to give the product 25 and 
acetonitrile. As is evident from the mechanism, one of the methyls ending up on the pyridine ring 
in 25 comes from the alkyne side chain in 23. However, by starting with a pyrimidine ring with 
two ring methyls, it was made sure that there is no selectivity issue (elimination of MeCN vs 
HCN) as in the cycloreversion of an intermediate like 24 having only one ring methyl.  
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Scheme 2.7: Mechanism for the inverse electron-demand Diels-Alder reaction. 
 
After 3 d of reflux in nitrobenzene (210 °C), a common solvent for this type of reaction, 
25 was formed with good conversion.  However, purification was cumbersome because of the 
presence of residual nitrobenzene, giving rise to dark-colored oily material. It was found, 
however, that the reaction proceeded significantly faster and cleaner in refluxing diphenyl ether 
(250 °C), allowing easy work-up consisting of just an acid/base extraction to give a light-colored 
recrystallized product in 82 % yield. The TLC retention times for 23 and 25 were deceptively 
identical, yet 1H and 13C NMR analyses of 25 were informative since the chemical shifts of the 
two ring methyls are not the same anymore and an additional aromatic carbon is present in 25.  
In Scheme 2.8, the remaining part of the synthesis is shown. Acetate 25 was subjected to 
basic methanolysis which cleaved the acetate group and compound 26 was isolated after 
extraction of remaining solids. The rest of the synthesis was performed similarly to that of the 
annelated 6-membered analogue. Thus, 26 was brominated to give 27, which turned out to be 
virtually insoluble in many solvents or solvent mixtures even at somewhat elevated temperatures. 
The corresponding annelated 6-membered analogue 15 had not shown this surprising behavior. 
Upon substitution with either a methyl or a phytyl group, the compounds were soluble. It should 
be pointed out that the entire synthetic sequence, starting from acid 18, involved crystalline 
intermediates and the route was optimized so that no chromatographic purification was required 
up to this stage. The resulting bromides 28a,b were hydroxylated to give 29a,b in 27 and 17 % 
yield, respectively, after column chromatography.  
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Key: a) KOH, MeOH, reflux, 95 %. b) dibromodimethylhydantoin, DCM, -78 °C, 83 %. c) 28a: 
HCOOH, H2CO(aq), i-PrOH, reflux, 84 %. 28b: aldehyde 5, NaBH(OAc)3, DCE, 30 min, r.t., 33 %. 
d) (1) n-BuLi, THF,   -78 °C (2) o-nitro-m-xylene, 27 % for 29a, 17 % for 29b. 
 
Scheme 2.8: Synthesis of pyridinols having an annelated 5-membered aliphatic ring. 
 
2.4 Synthesis of “free” 6-amino-3-pyridinol 
In the course of the project, a short route to the non-N-alkylated free amino-pyridinol 32 
was also developed as part of a potential general route to any substituted analogue. Even though 
this route was ultimately not pursued, it does provide access to an otherwise difficult-to-
synthesize compound that could be useful in the future. The usual hydroxylation performed on 
amine 2 led to a range of unidentified and highly polar products. Thus, the key issue became the 
selection of an appropriate N-protecting group. The triphenylmethyl-group (trityl) was selected 
and this proved fruitful. In Scheme 2.9 the employed synthesis is shown. 
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Key: a) Ph3CCl, Et3N, CH2Cl2, 3h, r.t., 87 %. b) (1) s-BuLi (3.3 eq), THF, -78 
°C (2) o-nitro-m-xylene, 44 %. c) TFA, MeOH, 3 h, yield not determined. 
 
Scheme 2.9: Short synthesis of free amino-pyridinol. 
 
Tritylation of 2 proceeded well to give recrystallized product in 87 % yield. The 
subsequent hydroxylation was carried out in 44 % isolated yield under modified conditions 
already discussed for pyridinol 11 (Scheme 2.4). The resulting crystalline pyridinol 31 proved 
                              Synthesis of 6-amino-3-pyridinols 
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯ 
 
51
very stable and could be stored for long periods of time without any decomposition. Likely, the 
bulky trityl group helps in kinetically stabilizing the compound. During determination of its 
melting point 31 did not start to darken until ∼180 °C. Deprotection could be achieved by TFA in 
MeOH at room temperature or by AcOH at elevated temperatures. Pyridinol 32 was extremely 
polar and its purification was partially achieved but not optimized.  1H-NMR and 13C-NMR 
undoubtedly showed the presence of the typical 6-amino-3-pyridinol signals but the absence of 
any trityl-protons. In addition, HRMS confirmed the molecular composition of 32. 
 
2.5 Relevant physical properties of 6-amino-3-pyridinols 
2.5.1 Stability 
In Section 1.4, the calculated Ionization Potentials (IPs) for a range of 6-amino-3-
pyridinols, including the ones synthesized, were reported. It was reasoned that the air-stability of 
the pyridinols, a critical property in the design of novel antioxidants, is directly related to the IP 
value. This issue will be addressed in more detail in Chapter 3, but it is of interest to briefly 
mention here the relevant observations made during the synthesis and characterization of these 
compounds. Monocyclic pyridinols 1, 9 and 11 all were yellowish products after purification. 
They showed surprisingly good thermal stability. For example, the purity of crystalline 1 had not 
changed after storage under argon in the freezer for over a year! On the other hand, pyridinols 
with an annelated 5-membered ring (29a,b) both were orange to red compounds even 
immediately after purification by chromatography on silica gel. During these purifications, a red 
band developed just above the product band as the separation progressed, even when the pressure 
gas was nitrogen. This had not been observed at all for the monocyclic pyridinols and it was 
attributed to trace decomposition of these pyridinols 29a,b during separation. It was found that 
oily 29b decomposed slowly even upon storage at low temperatures, whereas solid 29a showed 
only few signs of decomposition under argon at -78 °C, at least for 2 months. The behavior of 6-
membered ring-annelated analogues 17a,b was intermediate. Oily 17b was usually red, but 17a 
could be obtained as a yellow solid. Occasionally, the development of a red band on silica gel 
during chromatography was also observed for these pyridinols. Solid 17a was reasonably stable 
upon storage under appropriate conditions. A comparison of all solid pyridinols revealed that 
monocyclic 1 had a real melting point (132 °C) to afford a clear yellow liquid, whereas 17a and 
29a melted in the same temperature range to give dark brown, evidently decomposed material. 
All of the above observations seem in agreement with the expected relationship between 
predicted IP and stability. However, it should be emphasized that all pyridinols could be 
synthesized in good to excellent purity under conditions that were dictated by common chemical 
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sense not requiring special equipment, such as a dry box. Thus, they could be handled easily and 
did not decompose instantaneously.  
 
2.5.2 Acidity and basicity 
3
4
5
6
7
8
9
10
11
12
HCl added (arbitrary)
p
H
A
B
 
 
Figure 2.2: pH titration curve of pyridinol 1 (8 mM in 13 mM aq. NaOH) with 13 mM 
aq. HCl. Solid line: pH curve. Dotted line: approximated first derivative curve. A=pKa for 
phenolic hydroxyl group. B=pKb for pyridine nitrogen. 
 
During the synthesis of the pyridinols, it was assumed that the phenolic hydroxyl group 
was weakly acidic (pKa > 10) and the work-up was adjusted accordingly. However, with the 
pyridine-rings being so electron rich, the question arose as to how basic the pyridine ring-
nitrogen was. This is quite relevant, both for any anticipated in vitro and especially in vivo 
studies of these compounds as well as for synthetic purposes (work-up). Pyridine itself has a pKb 
of 8.75 but it was expected that the electron-donating substituents in the pyridinols would lower 
this considerably towards physiological values (pH ∼ 7.4). A titration of the dibasic phenolate 
salt of 1 with dilute HCl was performed giving the titration curve depicted in Figure 2.2.32 
Clearly, a basic group was protonated between pH ∼8 and ∼6. The half-neutralization value 
between the two equivalence points matched up acceptably well with the minimum in the first 
derivative curve and amounted to pKb = 7.1. Likely, this corresponds to protonation on the 
pyridine ring analogously to DMAP, but it could also be on the exocyclic amine. From the initial 
part of the curve (pH 12 – 10), the pKa value for the phenolic hydroxyl group could be estimated 
(ca. 10.6).32 Preliminary results in the Porter group have indicated that for 17a the pyridine pKb 
value is lowered even more towards ca. 6.8. 
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2.6 NMR analysis of 6-amino-3-pyridinols  
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Figure 2.3: 1H NMR spectrum of 1 in (A) CDCl3 (B) CDCl3 / H2O (C) CDCl3 / D2O. 
 
Some interesting observations were made during the NMR analysis of the pyridinols. In 
CDCl3, all of the pyridinols with a tertiary exocyclic amine showed (extreme) broadening of 
some or all 1H-NMR signals.33 For N-Me derivatives (1, 9, 17a and 29a) all of the signals 
broadened and 13C spectra were hard to obtain. Figure 2.3 shows this effect: the 1H-NMR 
spectrum of 1 in DCl-free CDCl3 (A) exhibits broad peaks for the aromatic proton (6.2 ppm), 
four methyl groups (2.9, 2.3 and 2.1 ppm) and the phenolic hydroxyl (4 ppm). Addition of H2O 
did not have any effect (B), but addition of D2O led to sharpening of all peaks (C).  When the 
sample was then retreated with H2O, the peaks broadened again (not shown). Repeating these 
experiments with phosphate buffered H2O and D2O (pH 7.4) led to identical results, ruling out 
any effect due to pH differences of H2O and D2O. The broadening of the 
1H-NMR signals was 
variable but there seemed to be a certain correlation between peak broadening on one hand and 
electronic and especially steric properties of the substrate on the other. Bulkier substrates gave 
rise to increased broadening, with the most extensive broadening occurring for N-phytyl 
compounds. In Figure 2.4, the NMR spectra for 29b with and without D2O are shown. In Figure 
2.4A the broadening is extensive, in fact the peaks for the two methyl groups (2.3 and 2.1 ppm) 
are broad signals that were sharpened by D2O (Figure 2.4B). Interestingly, the signals for the 
phytyl chain protons that are at least one methylene group away from the pyridinol π-system (1.5 
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– 0.8 ppm) show no broadening at all. This clearly ruled out any broadening by paramagnetic 
species in solution.  
 
0.60.81.01.21.41.61.82.02.22.42.62.83.03.23.43.63.8
Chemical shift (ppm)
A
B
 
 
Figure 2.4: Part of the 1H-NMR spectrum of 29b in DCl-free CDCl3 (A) without and (B) 
with added D2O. 
 
None of the corresponding bromo-pyridines showed this behavior, indicating a key role 
for the phenolic hydroxyl group. No broadening was observed for 2,4,6-trimethyl-3-pyridinol 
and 2,4-dimethyl-3-pyridinol either,34 indicating that the amine substituent is also involved. 
When the 1H-NMR spectrum of 1 was recorded at various temperatures (300, 308, 318 and 328 
K) in CDCl3, a few changes were observed (Figure 2.5). First, the phenolic proton gradually 
shifted upfield (from 4.3 to 3.9 ppm) upon raising the temperature. More importantly, all broad 
peaks sharpened up slightly with increasing temperature, about 1.2 - 1.3 decrease in line width 
during 28 K temperature increase. Yet, even at 328 K the peaks were still surprisingly broad. A 
few 1H-NMR spectra of aminoalkoxy- or aminohydroxy-pyridines in CDCl3 have been reported, 
mostly because of their involvement in the metabolism of certain aminopyridine drugs.10,35,36 
However, no mention about the broadening of proton signals is made in any of these reports. 
Two papers on the broadening of 3,4-dihydroisoquinolines37 or carbolines38 by 14N quadrupolar 
coupling have been reported, but a careful comparison revealed that the present observations 
were not consistent with those reported in these papers.39 Thus, no precedence for this 
broadening phenomenon could be found. 
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Figure 2.5: 1H-NMR spectrum of pyridinol 1 in DCl-free CDCl3 at various temperatures. 
Traces of EtOAc are still visible. 
 
It is suggested that aggregate formation of the pyridinol in the relatively non-polar CDCl3 
could play a role. In the chloroform solution, the pyridinols could form aggregates by H-bonds 
involving the hydroxyl group as the H-bond donor and the quite basic tertiary amine and/or 
pyridine as the H-bond acceptor.40 It seemed that these proposed interactions are quite strong, 
probably due to multiple intermolecular hydrogen bonds, since only slight sharpening was 
observed upon 30 K increase in temperature and broadening occurred regardless of pyridinol 
concentration (not shown). This extensive hydrogen bonding gives rise to the broadening of the 
signals of all the protons close to the pyridine π-system, but not of signals for remote protons on 
the phytyl chain. In the more electron-rich 6- and 5-membered ring-annelated pyridinols, the 
basicity of the two nitrogen atoms is even more enhanced and hence they are better hydrogen 
bond acceptors leading to stronger H-bonds. The increase of broadening with bulkier substrates 
(phytyl derivatives) was likely the result of less efficient relaxation resulting in larger T1-values. 
  When the mixture was shaken with D2O, the OH groups will be exchanged for OD 
groups which by virtue of their stronger OD bonds are now weaker hydrogen bond donors.  
Indeed, Singh and Rao found that, for hydrogen bond complexes of phenols and amines in CCl4, 
the deuterium effect on the hydrogen bond equilibrium (KH/KD) for the phenol was substantially 
larger than 1.0 and increased with enhanced basicity of the amine.41 Thus, a D2O shake breaks up 
the proposed aggregates (at least partially42) and sharpens up signals, while a H2O shake 
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obviously will not have this effect.  Accordingly, 1 gave completely sharp signals in a good H-
bond acceptor solvent, such as CD3CN, while the phenolic proton was still clearly visible, the 
latter ruling out any effect by traces of D2O in the NMR solvent (not shown). This observation 
seemed to strongly support the H-bond hypothesis. However, no further detailed investigations 
of this unprecedented broadening effect were pursued as it is outside the general scope of the 
project. Therefore, the proposed mechanism remains speculative. 
 
2.7 Conclusion and outlook 
A series of 6-amino-3-pyridinols was synthesized and characterized using a common 
general strategy. The introduction of the reactive phenolic group in the final step allowed for 
easy scale up and storage of all intermediates up to the stable penultimate bromides. The 
hydroxylation step was a low-yielding step but proved reproducible and generally applicable for 
all substrates. Most pyridinols showed an unusual and unprecedented broadening of a number of 
signals with a large deuterium isotope effect in the 1H-NMR spectra. Preliminary NMR 
experiments suggested that strong intermolecular hydrogen bonds are key to this phenomenon. 
When large-scale syntheses of pyridinols will be desired in the future, it will probably be 
necessary to establish better hydroxylation conditions. Improvements could be obtained by using 
an alternative nitro-arene that does not give rise to the undesired reduction pathway (Scheme 
2.2).  Furthermore, the purification protocol can probably be optimized to minimize losses during 
column chromatography. For example, the use of alumina columns for purification has not yet 
been explored. In addition, for the ring-annelated pyridinols, lacking an ortho-substituent, the 
Elbs peroxidation should be re-examined.1,2 This reaction puts a sulfate-ester para to the amino 
group of an amino-pyridine, after which the pyridinol can be liberated by acid-hydrolysis of the 
ester. Despite the high temperatures for this hydrolysis (∼100 °C for 30 min), the acidic 
conditions will leave the final product protonated until work-up and it is expected that this 
greatly enhances its stability during isolation. 
 
2.8 Experimental section  
Materials and instruments. Unless indicated otherwise, all reactions were carried out under an 
inert atmosphere. Purifications by column chromatography were carried out with silica gel from Sorbent 
Technologies. In the case of amino-pyridinols, the silica gel was deactivated by packing the column with 
eluent containing 1 % Et3N followed by rinsing with Et3N-free eluent. Column purifications of pyridinols 
were carried out using nitrogen pressure. TLC plates were purchased from EM Science. Spots were 
visualized by UV light, treatment with I2 or treatment with phosphomolybdic acid. THF, ether and 
CH2Cl2 were dried using a Solvent Purification System from Solvtek. Hex-5-ynoic acid was purchased 
from TCI America, all other chemicals were purchased from Sigma-Aldrich Company. NMR spectra 
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were taken on 300 or 400 MHz Bruker NMR instruments. Peaks were calibrated on CDCl3 and are 
reported with respect to TMS. Since the phytyl side-chain contained three chiral centers that were all 
racemic, it gave rise to a complicated pattern of 13C signals in the alkyl region. If clearly visible, 1H-NMR 
shifts for phenolic protons are reported. In most cases, the spectrum for the compound in CDCl3/D2O is 
given (see Section 2.6). For 2D NMR spectra, only the indicative couplings are given. UV-spectra were 
recorded on a Hewlett Packard HP8452A spectrometer. IR spectra were measured with a Mattson 
Geneson Series FTIR. Melting points were taken on a Thomas Hoover melting point apparatus and are 
uncorrected. Elemental analyses were carried out by Atlantic Microlabs. Unless stated otherwise, all 
HRMS spectra were recorded using the electrospray technique. ES-HRMS measurements (positive ion 
mode) were performed at Ohio State University, FAB-HRMS at Duke University. HPLC purities are 
given in area % calculated by integration of all visible peaks, except the solvent front, using reverse phase 
conditions and UV detection at 330 nm (Section 4.8). Systematic names for molecules according to 
IUPAC rules were generated using the Beilstein AutoNom program version 2.02.118 and/or by using the 
ACD/I-Lab Web service (ACD/IUPAC Name Free 7.06) and adjusted where appropriate. 
pH Titration curve. Solution A was prepared by dissolving 14.6 mg of PyrOH 1 in 11 mL of 
0.013 M NaOH which gave a 8 mM solution of 1. To obtain a clear solution, sonication and vortexing 
were useful. Solution B was an aq. 0.013 M HCl solution. Solution A was stirred at room temperature and 
the pH was continuously recorded by a pH electrode that was immersed in the solution. Titration was 
performed by adding 200 µL of solution B, waiting for 5 s for full mixing and recording of the pH. This 
was repeated until the pH was approaching 3. Approximately 19 mL of solution B was needed. 
Compound 1 remained in solution at all stages of the titration. The approximated first derivative was 
obtained by plotting the slope between the two direct neighbors for a certain point.   
2-Amino-5-bromo-4,6-dimethyl-pyridine (2). This compound was prepared according to the 
literature6 (with 0.5 eq of 1,3-dibromo-5,5-dimethylhydantoin) in lower yield but higher purity, typically 
67 % yield after recrystallization from EtOAc. m.p. 136 °C (lit6: 108 – 110 °C). The literature yield was 
very likely incorrect since it reported 92 % of pure 2 after recrystallization while there was a reported 
1:10 ratio of regioisomers in the crude mixture.  
5-Bromo-4,6-dimethyl-2-(dimethylamino)-pyridine (3). Bromide 2 (1.2 g, 5.94 mmol) was 
heated at reflux overnight in a mixture of formic acid (20 mL) and 37 % formaline (20 mL). The reaction 
mixture was cooled and most volatiles were removed under reduced pressure. The residue was shaken 
with a mixture of 1.0 M aq. NaOH and CH2Cl2 (2x). The organic layers were collected, dried (MgSO4) 
and filtered. The filtrate was concentrated and purified by column chromatography (3 : 1 hexanes : 
EtOAc) to afford a yellowish semi-solid product (1.06 g, 78 %). It was a very low melting solid. 1H NMR 
(CDCl3, 300 MHz) δ 6.21 (s, 1H, Ar-H), 3.02 (s, 6H, N-Me), 2.53 (s, 3H, 6-Me), 2.29 (s, 3H, 4-Me); 13C 
NMR (CDCl3, 300 MHz) δ 157.9, 155.1, 147.9, 110.6, 105.6, 38.4, 26.0, 24.11; IR HRMS (FAB) for 
C9H13BrN2 [M – H] 227.0184, found 227.0174. 
2,4-Dimethyl-6-(dimethylamino)-3-hydroxy-pyridine (1). Bromide 3 (890 mg, 3.86 mmol) was 
dissolved in THF (10 mL) and the solution was cooled to –78 °C. To this was added n-BuLi (2.5 M in 
hexanes, 3.5 mL, 8.8 mmol) and the yellow reaction mixture was stirred at – 78 °C for 15 – 30 min (the 
Br/Li exchange was monitored by TLC and was quantitative). Then dry o-nitro-m-xylene (2.6 mL, 19.80 
mmol) was added, resulting in the solution coloring brown. After stirring for 2 h at –78 °C, the reaction 
mixture was warmed to room temperature and quenched with a satd. aq. Na2CO3-soln.  This mixture was 
extracted with ether (3x). The aqueous phase was cooled in an icebath and carefully neutralized dropwise 
by adding conc. HCl. The thus-obtained yellow mixture was extracted with EtOAc (3x). The organic 
extracts were dried (MgSO4), filtered, concentrated to give a yellow solid product (400 mg, 63 %). NMR 
and TLC analysis (one highly fluorescent spot) showed that this product was >95 % pure. The product 
could be recrystallized by dissolving it quickly in a minimum amount of hot ether/hexanes 1/1, cooling, 
storing at –30 °C, filtering, washing and drying. This protocol yielded yellow crystals which were stable 
under argon in the freezer for over a year. m.p. 132 °C; λmax (MeOH) = 328 nm; 1H NMR (CDCl3, 300 
MHz) δ 6.19 (br s, 1H, Ar-H), 4.75 (br s, OH), 2.96 (br s, 6H, N-Me), 2.29 (br s, 3H, 6-Me), 2.16 (br s, 
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3H, 4-Me); 1H NMR (CDCl3 + drop of D2O, 300 MHz): same shifts as without D2O, but sharp signals and 
no -OH signal; 13C NMR (CDCl3 + drop of D2O, 300 MHz) δ 154.8, 143.0, 141.1, 136.5, 106.3, 39.3, 
19.3, 16.8; 2D NOESY-NMR (CDCl3 + drop of D2O, 400 MHz) couplings: Ar-H x N-Me, Ar-H x 4-Me; 
IR (film) ν (cm-1) 3400, 3000, 2920, 1610, 1480, 1420, 1402, 1260; HRMS (FAB) for C9H14N2O [M] 
166.1106, found 116.1108; Anal. calc. for C9H14N2O (%): C 65.03, H 8.49, N 16.85 found: C 64.82, H 
8.71, N 16.59; Titration of this material dissolved in 0.013 M NaOH ([ArOH] = 8 mM) with 0.013 M HCl 
gave pKa(OH) ≈ 10.6,  pKa(NH+) = 6.99. 
3,7,11,15-Tetramethyl-hexadecanal (5). Dihydrophytol (3,7,11,15-tetramethyl-hexadecanol, 2.1 
g, 7.1 mmol)16 and TEMPO (0.010 g, 0.06 mmol) were dissolved in CH2Cl2 (50 mL). Water (1 mL) and 
KBr (0.08 g, 0.67 mmol) were added and the solution was cooled in an icebath. Commercial Chlorox 
bleach (5.25 %, 0.81 M, 12.3 mL, 9.9 mmol) was mixed with NaHCO3 (1.4 g) and this mixture was added 
to the reaction mixture at once. A red color developed, which disappeared after 2 – 5 min indicating 
completion of the oxidation. If necessary, more bleach was added to complete the reaction (TLC 
analysis). The layers were allowed to settle. The organic layer was separated, dried (MgSO4), filtered and 
concentrated to afford 1.9 g (90 %) of the aldehyde as a yellowish oil. For most reactions this crude 
aldehyde was suitable starting material. However, for the reaction with benzotriazole (see hereafter) more 
reproducible results were obtained when the aldehyde was purified by column chromatography (5 : 1 
hexanes : EtOAc). NMR spectra have been reported for the compound.43 
2-[(1-Benzotriazol-1-yl-3,7,11,15-tetramethyl-hexadecyl)-amino]-5-bromo-4,6-dimethyl-
pyridine (6). Bromide 2 (1.62 g, 8.1 mmol), benzotriazole (0.955 g, 8.1 mmol) and aldehyde 5 (2.62 g, 
8.8 mmol) were dissolved in EtOH (25 mL). The reaction mixture was heated at reflux for 30 min and 
then stirred at ambient temperature for 16 h. During this time, the product precipitated. The EtOH was 
evaporated and the resulting solid dried to give a white product (4.8 g) of sufficient purity for the next 
step. An analytical sample was reprecipitated from EtOH. m.p. 82 °C; 1H NMR (CDCl3, 300 MHz) δ 8.00 
(d, 1H, HBt, J=8.1 Hz), 7.89 (d, 1H, HBt, J=8.4 Hz), 7.45 (t, 1H, HBt, J=7.2 Hz), 7.32 (t, 1H, HBt, J=7.8 
Hz), 6.9 (m, 1H, NCHN), 6.18 (s, 1H, ArH), 5.73 (m, 1H, NH), 2.44 (s, 3H, 6-Me), 2.13 (s, 3H, 4-Me), 
1.28 – 0.9 (24H, alkyl), 0.85 (t, 15H, alkyl-CH3, J=6.6 Hz); 
13C NMR (CDCl3, 300 MHz) δ 155.5, 154.4, 
149.2, 127.5, 126.7, 124.3, 120.1, 118.7, 113.8, 111.3, 108.1, 65.2, 39.77, 37.79, 37.69, 37.57, 37.47, 
33.18, 33.06, 29.91, 29.64, 28.38, 25.52, 25.49, 25.22, 24.86, 24.54, 23.88, 23.76, 23.15, 23.05, 20.17, 
20.09, 19.96, 19.69; HRMS for C33H52BrN5B [M + H] 598.3479, found 479.2938 (complete cleavage of 
C-Bt bond: - 119.048 amu, found: - 119.054 amu). 
5-Bromo-4,6-dimethyl-2-[(3,7,11,15-tetramethyl-hexadecyl)-amino]-pyridine (7). The 
benzotriazole adduct 6 (4.7 g, ca. 7.83 mmol) was dissolved in THF (35 mL) and the solution was cooled 
in an icebath. Solid LAH (0.3 g, 7.9 mmol) was slowly added and the reaction mixture was warmed to 
room temperature and stirred for an additional 30 min. Subsequently were added 300 µL of water, 300 µL 
of 15 % NaOH and 600 µL of water. The mixture was filtered over Celite and the Celite cake was washed 
with ether. The filtrate was concentrated and the residue was purified by a column chromatography (9 : 1 
hexanes : EtOAc) to give the product as a yellow oil (3.3 g, 85 % starting from 2). 1H NMR (CDCl3, 300 
MHz) δ 6.13 (s, 1H, ArH), 4.35 (t, 1H, NH, J=5.4 Hz), 3.14 (m, 2H, NCH2), 2.46 (s, 3H, 6-Me), 2.19 (s, 
3H, 4-Me), 1.48 – 0.9 (24H, alkyl), 0.77 (t, 15H, alkyl-CH3, J=6.5 Hz); 
13C NMR (CDCl3, 300 MHz) δ 
157.2, 155.4, 148.3, 111.0, 105.2, 51.4, 40.86, 39.70, 37.80, 37.75, 37.64, 37.58, 37.04, 36.95, 33.0, 30.9, 
28.3, 25.65, 25.17, 24.88, 24.85, 24.82, 24.79, 24.74, 24.0, 23.13, 23.04, 20.12, 20.05, 20.00, 20.93; IR 
(film) ν (cm-1) 2900, 2450, 1580, 1510, 1100, 730; HRMS for C27H49BrN2 [M + H] 481.3152, found 
481.3155. 
5-Bromo-4,6-dimethyl-2-[N-methyl-N-(3,7,11,15-tetramethyl-hexadecyl)-amino]-pyridine 
(8). Amine 7 (1.0 g, 2.1 mmol) was heated at reflux overnight in a mixture of formic acid (10 mL), 37 % 
formaline (10 mL) and i-PrOH (20 mL). The reaction mixture was cooled and most volatiles were 
removed under reduced pressure. The residue was shaken in a mixture of 2.5 M aq. NaOH and CH2Cl2 
(2x). The organic layers were collected, dried (MgSO4) and filtered. The filtrate was concentrated in 
vacuo and dried under high vacuum to give a light orange oil in quantitative yield (1.0 g). 1H NMR 
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(CDCl3, 300 MHz) δ  6.14 (s, 1H, ArH),  3.45 (t, 2H, NCH2, J=7.2 Hz), 2.96 (s, 3H, N-Me), 2.49 (s, 3H, 
6-Me), 2.21 (s, 3H, 4-Me), 1.48 – 0.9 (24H, alkyl), 0.83 (t, 15H, alkyl-CH3, J=6.5 Hz); 
13C NMR (CDCl3, 
300 MHz) δ 157.0, 155.2, 147.7, 110.0, 105.3, 48.4, 39.78, 37.92, 37.87, 37.82, 37.71, 37.68, 34.21, 
34.11, 33.21, 31.14, 30.73, 26.00, 25.24, 24.91, 24.80, 24.18, 23.17, 23.07, 20.25,  20.22, 20.19, 20.15, 
20.12, 20.09; IR (film) ν (cm-1) 2900, 2450, 1580, 1510, 1100, 730; HRMS (FAB) for C28H51BrN2 [M] 
494.3236, found 494.3238. 
2,4-Dimethyl-3-hydroxy-6-[N-methyl-N-(3,7,11,15-tetramethyl-hexadecyl)-amino]-pyridine 
(9). Bromide 8 (304 mg, 0.62 mmol) was dissolved in THF (10 mL) and the solution was cooled to –78 
°C. Then n-BuLi (2.5 M in hexanes, 0.55 mL, 1.4 mmol) was added and the yellow reaction mixture was 
stirred at – 78 °C for 15 – 30 min (the Br/Li exchange was monitored by TLC and was quantitative). Then 
dry o-nitro-m-xylene (0.35 mL, 2.6 mmol) was added, resulting in a brown mixture. After stirring for 2 h 
at –78 °C, the reaction mixture was warmed up and quenched with satd. aq. NH4Cl-soln.  The THF layer 
was separated and the aqueous layer extracted once with EtOAc. The organic layers were dried (MgSO4), 
filtered and concentrated. The crude product was purified by column chromatography (6 : 1 hexanes : 
EtOAc) to afford a yellow oil (71 mg, 27 %). λmax (MeOH) = 328 nm;  1H NMR (CDCl3 + drop of D2O, 
300 MHz) δ  6.10 (s, 1H, ArH),  3.44 (t, 2H, NCH2, J=7.2 Hz), 2.93 (s, 3H, N-Me), 2.35 (s, 3H, 6-Me), 
2.18  (s, 3H, 4-Me), 1.48 – 0.9 (24H, alkyl), 0.83 (t, 15H, alkyl-CH3, J=6.5 Hz); 
13C NMR (CDCl3 + drop 
of D2O, 300 MHz) δ 153.4, 141.8, 140.0, 135.0, 105.2, 48.6, 39.77, 37.85, 37.78, 37.69, 36.59, 34.00, 
33.20, 31.22, 28.38, 25.41, 24.89, 24.78, 23.13, 23.04, 20.24, 20.16, 20.13, 20.09, 20.26, 19.61, 16.79; IR 
(film) ν (cm-1) 3400, 2930, 1610, 1480, 1420, 1220, 1050, 730; HRMS (FAB) for C28H52N2O [M] 
432.4080, found 432.4077; HPLC purity: 98.8 area %. 
2,4-Dimethyl-3-hydroxy-6-(3,7,11,15-tetramethyl-hexadecylamino)-pyridine (11). Bromide 7 
(790 mg, 1.7 mmol) was dissolved in THF (20 mL) and the solution was cooled to –78 °C. Then s-BuLi 
(1.3 M in pentane, 4.0 mL, 5.5 mmol) was added and the yellow mixture was stirred at – 78 °C for 15 – 
30 min (the Br/Li exchange was monitored by TLC and was quantitative). Subsequently dry o-nitro-m-
xylene (1.1 mL, 8.1 mmol) was added, resulting in a brown-green mixture. After stirring for 2 h at –78 
°C, the reaction mixture was warmed up and quenched with satd. aq. NH4Cl-soln.  The THF layer was 
separated and the aqueous layer extracted once with EtOAc. The organic layers were dried (MgSO4), 
filtered and concentrated. The crude product was purified by column chromatography (2 : 1 hexanes : 
EtOAc) to afford a yellow oil (200 mg, 28 %). λmax (MeOH) = 323 nm; 1H NMR (CDCl3, 300 MHz) δ  
6.06 (s, 1H, ArH),  4.10 (br s, 1H, NH and OH), 3.08 (m, 2H, NCH2), 2.28 (s, 3H, 6-Me), 2.19 (s, 3H, 4-
Me), 1.48 – 0.9 (24H, alkyl), 0.83 (t, 15H, alkyl-CH3, J=6.5 Hz); 
13C NMR (CDCl3, 300 MHz) δ 153.6, 
143.5, 141.7, 137.5, 105.3, 41.7, 39.8, 37.90, 37.85, 37.80, 37.69, 37.28, 37.19, 33.2, 31.1, 28.4, 25.2, 
24.87, 24.79, 23.11, 23.01, 20.15, 20.08, 20.05, 19.99, 18.98, 16.89; IR (film) ν (cm-1) 3400, 2930, 1610, 
1480, 1420, 1220, 1050, 730; HRMS (FAB) for C27H50N2O [M] 418.3931, found 418.3928; HPLC purity: 
93.8 area %. 
3-(4,6-Dimethyl-pyridin-2-ylamino)-propanoic acid (12). 2-Amino-4,6-lutidine (8.5 g, 70 
mmol) and acrylic acid (6 g, 84 mmol) were heated at reflux in pyridine (60 mL) overnight. The mixture 
was concentrated and dried thoroughly (to remove traces of pyridine and acrylic acid). Purification was 
cumbersome, but the following protocol gave good quality product albeit in low yield: the residue was 
dissolved in water containing NaOH (3.1 g, 77 mmol) and filtered through Celite. The filtrate was cooled 
in an icebath and slowly acidified with conc. H2SO4. Around pH 3-4 a precipitate formed, which was 
filtered and washed with water and acetone affording an off-white solid (4 g, 30 %) sufficiently pure for 
further reactions. An analytical sample was obtained by recrystallization from water and then from i-
PrOH followed by extensive drying. The product (as an i-PrOH-solvate) was obtained as white crystals. 
m.p. 84 °C; 1H NMR (d3-MeOD, 300 MHz) δ 6.87 (s, 1H, Ar-H), 6.77 (s, 1H, Ar-H), 3.86 (t, 2H, NCH2, 
J=5.0 Hz), 2.82 (t, 2H, CH2CO, J=5.0 Hz), 2.72 (s, 3H, 6-Me), 2.41 (s, 3H, 4-Me); 
13C NMR (d3-MeOD, 
300 MHz) δ 180.9, 157.7, 156.6, 150.1, 115.4, 109.0, 41.3, 38.5, 22.6, 20.2; HRMS for C10H14N2O2[M + 
H] 195.1128, found 195.1118. 
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5,7-Dimethyl-2,3-dihydro-1H-[1,8]naphthyridin-4-one (13). Polyphosphoric acid (25 g) was 
added to amino acid 12 (3.1 g, 16 mmol). The mixture was heated to 125 °C for 40 min. The mixture was 
cooled, and the PPA was slowly decomposed by addition of ice and solid NaOH (exothermic!!). 
Subsequently, the basic suspension was stored in the fridge for several hours and the precipitate filtered, 
washed with water and dried. This afforded the ring-closed product as an orange powder (2.1 g, 75 %).  
An analytical sample was obtained by column chromatography (5 % MeOH in CH2Cl2) to yield a yellow 
solid. m.p. 142 °C; 1H NMR (CDCl3, 400 MHz) δ 6.24 (s, 1H, Ar-H), 6.21 (br s, 1H, NH), 3.50 (t, 2H, 
NCH2, J=6.5 Hz), 2.61 (t, 2H, CH2CO, J=5.0 Hz), 2.49 (s, 3H, 6-Me), 2.27 (s, 3H, 4-Me); 
13C NMR 
(CDCl3, 300 MHz) δ 195.0, 162.6, 162.2, 152.8, 117.6, 110.3, 39.7, 39.0, 24.6, 22.6; HRMS for 
C10H12N2O[M + H] 177.1022, found 177.1013. 
5,7-Dimethyl-1,2,3,4-tetrahydro-[1,8]naphthyridine (14). Ketone 13 (2.1 g, 11.9 mmol) was 
dissolved in THF (10 mL). To this BH3
.THF (1.0 M in THF, 32 mL, 32.0 mmol) was added slowly. The 
reaction mixture was heated at reflux vigorously overnight. After cooling, conc. HCl was added to 
decompose the amine-borane complexes. After stirring for 10 min at room temperature, aq. 15 M KOH-
solution was added until basic pH was reached. The THF was removed under reduced pressure and the 
residue was cooled in ice. The solid was filtered, washed with water and dried. The product was obtained 
as a yellow solid (1.6 g, 83 %). An analytical sample was obtained by recrystallization from hexanes to 
give white needles. m.p. 114 °C; 1H NMR (CDCl3, 300 MHz)44 δ 6.25 (s, 1H, Ar-H), 5.02 (br s, 1H, NH), 
3.35 (m, 2H, NCH2), 2.58 (t, 2H, Ar-CH2, J=6.4 Hz), 2.27 (s, 3H, 6-Me), 2.09 (s, 3H, 4-Me), 1.94 (p, 2H, 
CH2, J=5.5 Hz); 
13C NMR (CDCl3, 300 MHz) δ 156.1, 153.8, 146.0, 114.7, 111.7, 41.7, 24.0, 23.5, 22.3, 
18.8; 2D NOESY-NMR (CDCl3, 400 MHz) couplings: Ar-H x 4-Me, Ar-H x 6-Me, Ar-CH2 x 4-Me, Ar-
CH2 x CH2CH2; HRMS for C10H14N2[M + H] 163.1230, found 163.1224. Anal. calc. for C10H14N2 (%): C 
74.03, H 8.70, N 17.27 found: C 73.94, H 8.71, N 17.20. For an improved synthesis, see Chapter 5. 
6-Bromo-5,7-dimethyl-1,2,3,4-tetrahydro-[1,8]naphthyridine (15). Amine 14 (1.6 g, 9.8 
mmol) was dissolved in CH2Cl2 (30 mL). The solution was cooled to –78 °C and 1,3-dibromo-5,5-
dimethylhydantoin (1.54 g, 5.4 mmol) was added portion wise. In order to avoid over-bromination of the 
electron-rich starting material, the following protocol worked best: the dry ice/acetone bath was removed 
for the duration of 1-1.5 min after which the reaction mixture was recooled to –78 °C and checked by 
TLC. Usually, after a few of these cycles, clean and full conversion was achieved. The cooling bath was 
removed, satd. aq. Na2S2O3-soln. (10 mL) was immediately added and the contents of the flask swirled 
thoroughly to destroy remaining 1,3-dibromo-5,5-dimethylhydantoin. After warming up to room 
temperature while stirring, water and excess solid KOH were added. The CH2Cl2 was removed under 
reduced pressure and the basic suspension was filtered. The precipitate was washed with water and dried. 
This gave the product as a yellow solid (2.2 g, 93 %). An analytical sample was obtained by 
recrystallization from MeOH/water to give yellow needles (the crystals retained 4.7 % MeOH in the 
lattice even after extensive drying). m.p. 146 °C; 1H NMR (CDCl3, 300 MHz) δ 4.95 (br s, 1H, NH), 3.32 
(m, 2H, NCH2), 2.65 (t, 2H, Ar-CH2, J=7.6 Hz), 2.44 (s, 3H, 6-Me), 2.24 (s, 3H, 4-Me), 1.91 (p, 2H, CH2, 
J=5.5 Hz); 13C NMR (CDCl3, 300 MHz) δ 154.6, 152.7, 145.2, 113.7, 111.9, 41.4, 25.7, 25.0, 22.1, 19.3; 
HRMS for C10H13BrN2[M + H] 241.0335, found 241.0340; Anal. calc. for C10H13BrN2.(MeOH)0.047 (%): 
C 49.73, H 5.48, N 11.55, found: C 49.46, H 5.46, N 11.01. 
6-Bromo-1,5,7-trimethyl-1,2,3,4-tetrahydro-[1,8]naphthyridine (16a). Bromide 15 (1.1 g, 
4.56 mmol) was heated at reflux overnight in a mixture of formic acid (10 mL) and 37 % formaline (10 
mL). The reaction mixture was cooled and most volatiles were removed by evaporation. Enough aq. 15 M 
KOH was added to make the solution basic and the suspension was then cooled in an icebath. The 
precipitate was filtered, washed with water and dried to give the product as a brown solid (0.9 g, 77 %) of 
satisfactory purity. An analytical sample was prepared by running the solid though a plug of silica gel 
using 3 : 1 hexanes : EtOAc as the eluent. This gave white needles. m.p. 75 °C;  1H NMR (CDCl3, 300 
MHz) δ 3.24 (t, 2H, NCH2, J=5.5 Hz), 3.06 (s, 3H, N-Me), 2.66 (t, 2H, Ar-CH2, J=6.5 Hz), 2.46 (s, 3H, 6-
Me), 2.22 (s, 3H, 4-Me), 1.95 (p, 2H, CH2, J=5.4 Hz); 
13C NMR (CDCl3, 300 MHz) δ 155.0, 152.3, 
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143.8, 114.9, 111.4, 50.0, 37.2, 26.2, 25.9, 22.2, 19.5; HRMS for C11H15BrN2[M + H] 255.0491, found 
255.0491. 
6-Bromo-5,7-dimethyl-1-(3,7,11,15-tetramethyl-hexadecyl)-1,2,3,4-tetrahydro-
[1,8]naphthyridine (16b). A mixture of aldehyde 5 (1.4 g, 4.7 mmol), bromide 15 (0.350 g, 1.44 mmol) 
and AcOH (272 µL, 4.7 mmol) was stirred in dichloroethane (10 mL). To this was added NaB(OAc)3H 
(1.0 g, 4.7 mmol) and the mixture was stirred at room temperature for 1 hr. Water and NaOH were added 
and the mixture was extracted with CH2Cl2 (2x). The organic layers were concentrated and redissolved in 
MeOH (10 mL). Excess NaBH4 (ca. 1 g, 29 mmol) was added and the mixture was stirred overnight (this 
served to completely reduce remaining aldehyde since it co-eluted with the product). The mixture was 
quenched with 1.0 M HCl (gas evolution), the MeOH was evaporated and the residue extracted with aq. 
1.0 M NaOH and CH2Cl2 (3x). The organic layers were dried (MgSO4), filtered and concentrated. The 
product was purified by column chromatography (40 : 1 hexanes : EtOAc) to afford the product as a 
colorless oil (0.4 g, 53 %). 1H NMR (CDCl3, 300 MHz) δ 3.59 (t, 2H, NCH2-ring, J=6.8 Hz), 3.27 (t, 2H, 
NCH2-chain, J=5.6), 2.64 (t, 2H, Ar-CH2, J=6.3 Hz), 2.47 (s, 3H, 6-Me), 2.21 (s, 3H, 4-Me), 1.90 (p, 2H, 
CH2-ring, J=5.6 Hz), 1.5 – 0.9 (24H, alkyl), 0.87 (t, 15H, alkyl-CH3, J=6.3 Hz); 
13C NMR (CDCl3, 300 
MHz) δ 154.0, 152.2, 143.6, 114.2, 110.7, 47.6, 47.1, 39.87, 37.98, 37.93, 37.86, 37.82, 37.79, 37.76, 
34.25, 34.15, 33.25, 33.19, 32.07, 31.20, 28.46, 26.20, 26.07, 25.28, 24.95, 24.83, 23.19, 23.10, 22.34, 
20.39, 20.36, 20.32, 20.26, 20.21, 20.15, 19.51; HRMS for C30H53BrN2 [M + H] 521.3465, found 
521.3476. 
2,4,8-Trimethyl-5,6,7,8-tetrahydro-[1,8]naphthyridin-3-ol (17a). This compound was prepared 
from bromide 16a (800 mg, 3.13 mmol), THF (20 mL), n-BuLi (2.5 M in hexanes, 2.88 mL, 7.2 mmol) 
and o-nitro-m-xylene (2.1 mL, 15.4 mmol) following the same procedure as for 9. The crude product was 
purified by column chromatography (1 : 1 hexanes : EtOAc) to afford a yellow solid (150 mg, 25 %) of 
sufficient purity for further experiments. λmax (MeOH) =331 nm; m.p. 126 °C – 132 °C (dec); 1H NMR 
(CDCl3 + drop of D2O, 300 MHz) δ 3.19 (br s, 2H, NCH2), 3.03 (br s, 3H, N-Me), 2.62 (br s, 2H, Ar-
CH2), 2.33 (br s, 3H, 6-Me), 2.06 (br s, 3H, 4-Me), 1.96 (s, 2H, CH2); After standing overnight in CDCl3 
and D2O under argon, the peaks sharpened: 
1H NMR (CDCl3 + D2O, 300 MHz) δ 3.19 (t, 2H, NCH2, 
J=5.6 Hz), 3.03 (s, 3H, N-Me), 2.62 (t, 2H, Ar-CH2, J=6.6 Hz), 2.33 (s, 3H, 6-Me), 2.06 (s, 3H, 4-Me), 
1.96 (p, 2H, CH2, J=6.4 Hz); 
13C NMR (CDCl3 + D2O, 300 MHz) δ 151.3, 140.1, 138.5, 132.4, 114.6, 
50.1, 37.4, 24.9, 22.1, 18.9, 11.5; HRMS for C11H16N2O [M + H] 193.1335, found 193.1345; The material 
was recrystallized from hot hexanes to give a light brown solid, although the following elemental analysis 
of this material actually suggested that the purity was diminished after this: Anal. calc. for C11H16N2O 
(%): C 68.72, H 8.39, N 14.57 found: C 67.78, H 8.41, N 13.92. 
2,4-Dimethyl-8-(3,7,11,15-tetramethyl-hexadecyl)-5,6,7,8-tetrahydro-[1,8]naphthyridin-3-ol 
(17b). This compound was prepared from bromide 16b (390 mg, 0.74 mmol), THF (10 mL), n-BuLi (2.5 
M in hexanes, 1.19 mL, 1.67 mmol) and o-nitro-m-xylene (0.5 mL, 3.7 mmol) following the same 
procedure as for 9. The crude product was purified by column chromatography (8 : 1 hexanes : EtOAc) to 
afford a red oil (50 mg, 15 %). An analytical sample was prepared by additional chromatography with 3 : 
1 hexanes : EtOAc yielding a yellow-orange oil. λmax (MeOH) =331 nm; 1H NMR (CDCl3, 300 MHz) δ 
only side-chain alkyl signals visible; 1H NMR (CDCl3 + drop of D2O, 300 MHz) δ 3.56 (br s, 2H, NCH2-
ring), 3.23 (br s, 2H, NCH2-chain), 2.60 (br s, 2H, Ar-CH2), 2.32 (br s, 3H, 6-Me), 2.06 (br s, 3H, 4-Me), 
1.92 (br  s, 2H, CH2-ring), 1.5 – 0.9 (24H, alkyl), 0.85 (. t, 15H, alkyl-CH3, J=6.3 Hz). Peaks could not be 
sharpened; 13C NMR (CDCl3 + drop of D2O, 300 MHz) δ 150.6, 139.9, 138.8, 132.6, 114.2, 47.6, 47.2, 
39.8, 37.91, 37.84, 37.78, 37.68, 34.14, 34.04, 33.19, 31.27, 28.37, 25.27, 25.19, 24.87, 24.78, 23.11, 
23.01, 22.51, 20.32, 20.26, 20.19, 20.14, 20.08, 19.35; HRMS for C30H54N2O [M + H] 459.4309, found 
459.4288; HPLC purity: 95.5 area %. 
Hex-4-ynoic acid (18). This compound was prepared according to the literature29 from hex-5-
ynoic acid,  m.p. 100 °C. NMR data have been reported.45  
tert-Butyl pent-3-ynyl-carbamate (19).  Acid 18 (7.7 g, 6.9 mmol) was dissolved in t-BuOH 
(100 mL). Diphenylphosphorylazide (16.3 mL, 7.6 mmol) and Et3N (9.57 mL, 6.9 mmol) were added and 
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the reaction mixture was heated at reflux for 30 h. The solvent was evaporated and the residue dissolved 
in EtOAc. This solution was extracted with 1 N aq. HCl, water, satd. aq. NaHCO3-soln. and brine. The 
organic layer was dried (MgSO4), concentrated in vacuo and dried. This afforded 9.97 g (79 %) of a crude 
yellow oil that was sufficiently pure for the next step.  1H NMR (CDCl3, 300 MHz) δ 4.82 (br s, 1H, NH), 
3.20 (m, 2H, NCH2), 2.30 (m, 2H, C≡CCH2), 1.76 (t, 3H, C≡CMe, J=2.5 Hz), 1.45 (s, 9H, t-Bu); 13C 
NMR (CDCl3, 300 MHz) δ 155.8, 79.3, 77.2, 76.3, 39.7, 28.4, 20.2, 3.5. HRMS for C10H17NO2 [M + Na] 
206.1151, found 206.1154. 
Pent-3-ynylamine hydrochloride (20). Crude BOC-protected amine 19 (16.34 g, 8.9 mmol) was 
dissolved in ethereal 2M HCl (50 mL). The solution was stirred for 24 h, during which a precipitate was 
formed. The crystals were filtered off, washed with ether and dried. This afforded the ammonium salt 
(7.46 g, 70 %) as white crystals. 1H NMR (D2O, 300 MHz) δ 3.07 (t, 2H, NCH2, J=6.5 Hz), 2.51 (m, 2H, 
CH2≡C), 1.73 (t, 3H, Me, J=2.1 Hz); 13C NMR (D2O, 300 MHz) δ 80.8, 74.1, 38.9, 17.3, 2.8.  NMR data 
were in agreement with literature report.26 
4,6-Dimethyl-pyrimidin-2-yl trifluoromethanesulfonate (21). This compound was prepared 
according to the literature procedure31 from 4,6-dimethyl-pyrimidin-2-ol. It was obtained as a brown oil 
which was >95 % pure. NMR data have been reported.31  
4,6-Dimethyl-2-(1-pent-3-ynyl-amino)-pyrimidine (22). Triflate 21 (19.18 g, 74.9 mmol), 
hydrochloride 20 (7.46 g, 62.4 mmol) and Et3N (34.7 mL, 250 mmol) were stirred in freshly distilled 
DMF (150 mL) at room temperature for 1 d. Water was added to decompose remaining triflate and the 
mixture was extracted with ether (3x) and water. To the organic layers was added MgSO4 and activated 
charcoal and the mixture was stirred for 10 min. After filtration, the filtrate was concentrated and dried 
under high-vacuum to afford a light brown solid of good purity (10.98 g, 93 %). The product could be 
recrystallized from water/acetone to afford white crystals (6.78 g, 57 %).  m.p. = 64 °C;  1H NMR 
(CDCl3, 300 MHz) δ 6.22 (s, 1H, ArH), 5.35 (br s, 1H, NH), 3.58 ( q, 2H, NCH2, J= 6.5 Hz), 2.42 (m, 2H, 
CH2C≡C), 2.27 (s, 6H, Ar-CH3), 1.77 (t, 3H, C≡CCH3, J=2.6 Hz); 13C NMR (CDCl3, 300 MHz) δ 167.8, 
162.5, 110.2, 77.6, 77.2, 40.9, 24.3, 20.1, 3.9; HRMS for C11H15N3 [M + Na] 212.1158, found 212.1177. 
Anal. calc. for C11H15N3 (%): C 69.81, H 7.99, N 22.20 found: C 69.92, H 8.10, N 22.38. 
2-[N-Acetyl-N-(1-pent-3-ynyl)-amino]-4,6-dimethyl-pyrimidine (23). Amine 22 (3.0 g, 15.87 
mmol) and DMAP (387 mg, 3.2 mmol) were heated overnight in Ac2O (30 mL) at ca. 100 °C. The 
reaction mixture was cooled and the solvent was removed in vacuo. The residue was dissolved in EtOAc 
and washed with satd. aq. NaHCO3-soln. and brine to remove the bulk of DMAP. The organic layer was 
dried (MgSO4), concentrated in vacuo and dried under high-vacuum to yield a brown-orange solid (3.33 
g, 91 %) of sufficient purity for further experiments. An analytical sample was obtained by column 
chromatography (2 : 1 hexanes : EtOAc) followed by recrystallization from hexanes to afford white 
crystals. m.p. = 63 °C; 1H NMR (CDCl3, 300 MHz) δ 6.78 (s, 1H, ArH), 4.12 (t, 2H, NCH2, J= 7.6 Hz), 
2.44 (m, 2H, CH2C≡C), 2.42 (s, 6H, Ar-CH3), 2.31 (s, 3H, COCH3), 1.65 (t, 3H, C≡CCH3, J=2.5 Hz); 13C 
NMR (CDCl3, 300 MHz) δ 172.5, 168.5, 161.5, 116.7, 77.6, 77.2, 46.3, 25.9, 24.6, 19.3, 4.1; HRMS for 
C13H17N3O [M + Na] 254.1264, found 254.1274. Anal. calc. for C13H17N3O (%): C 67.51, H 7.41, N 
18.17 found: C 67.13, H 7.35, N 18.06. 
1-Acetyl-4,6-dimethyl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine (25). Acetate 23 (4.0 g, 17.3 
mmol) was heated at reflux in diphenyl ether (50 mL) for 10 h. The solution was cooled and ether (25 
mL) was added.  The resulting solution was extracted with aq. 1 M HCl (3 x 25 mL). The aqueous layers 
were combined and carefully neutralized with solid NaHCO3 until the pH was slightly basic. The 
suspension was extracted 3x with CH2Cl2. MgSO4 and activated charcoal were added to the combined 
organic layers was added and the mixture was stirred for 10 min. After filtration, the filtrate was 
concentrated under reduced pressure and dried under high vacuum. The residue was recrystallized from 
hexanes/EtOAc to afford orange crystals (2.69 g, 82 %). m.p. = 105 °C; 1H NMR (CDCl3, 300 MHz) δ 
6.53 (s, 1H, Ar-H), 4.07 (t, 2H, NCH2, J=8.7 Hz), 2.86 (t, 2H, CH2, J=8.7 Hz), 2.65 (s, 3H, COMe), 2.36 
(s, 3H, 6-Me), 2.15 (s, 3H, 4-Me); 13C NMR (CDCl3, 300 MHz) δ 170.7, 155.7 (two overlapping C), 
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144.5, 121.7, 118.8, 45.9, 25.1, 24.4, 23.1, 18.6. HRMS for C11H14N2O [M + H] 191.1179, found 
191.1176. Anal. calc. for C11H14N2O (%): C 69.45, H 7.42, N 14.73 found: C 69.43, H 7.45, N 14.80. 
4,6-Dimethyl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine (26). Acetate 25 (2.69 g, 14.1 mmol) was 
dissolved in MeOH (100 mL).  Solid NaOH (2.27 g, 56.6 mmol) was added and the mixture was heated at 
reflux overnight. Solid NH4Cl (3.03 g, 56.5 mmol) was added to neutralize and then MeOH was removed 
by evaporation. The resulting solids were extracted with CH2Cl2 (3x). The combined organic extracts 
were concentrated in vacuo and dried under high vacuum. The product was obtained as an orange solid in 
quantitative yield with satisfactory purity. An analytically pure sample was obtained by recrystallization 
from EtOAc to give orange crystals which retained traces of CH3COOH. m.p. = 150 °C; 1H NMR 
(CDCl3, 300 MHz) δ 6.05 (s, 1H, Ar-H), 4.56 (br s, 1H, NH), 3.54 (t, 2H, NCH2, J=8.4 Hz), 2.91 (t, 2H, 
CH2, J=8.3 Hz), 2.28 (s, 3H, 6-Me), 2.09 (s, 3H, 4-Me); 
13C NMR (CDCl3, 300 MHz) δ 164.4, 154.3, 
142.4, 117.2, 114.2, 44.2, 26.2, 23.6, 18.2; HRMS for C9H12N2 [M + H] 149.1073, found 149.1077. Anal. 
calc. for C9H12N2 (%): C 72.94, H 8.16, N 18.90 found: C 72.37, H 8.13, N 18.81.  
5-Bromo-4,6-dimethyl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine (27). This compound was 
prepared from amine 26 (0.92 g, 6.2 mmol), CH2Cl2 (25 mL) and 1,3-dibromo-5,5-dimethylhydantoin 
(0.86 g,  3.1 mmol) following the same procedure as for 15.  After quenching with Na2S2O3 and KOH, the 
mixture was extracted with plenty of CH2Cl2 (3x). The organic layers were dried (MgSO4), concentrated 
in vacuo and dried under high vacuum to yield a yellow solid. This solid consisted of ∼90 % product and 
∼10 % remaining starting material (by NMR, 83 % corrected yield). Unexpectedly, this compound proved 
difficult to purify due to its extremely low solubility in any solvent. Therefore, it was used in the next step 
as the 90 % pure product. 1H NMR (d6-DMSO, 300 MHz) δ 4.60 (br s, 1H, NH), 3.61 (t, 2H, NCH2, 
J=6.3 Hz), 2.97 (t, 2H, CH2, J=6.3 Hz), 2.42 (s, 3H, 6-Me), 2.19 (s, 3H, 4-Me); 
13C NMR (d6-DMSO, 300 
MHz) δ  164.1, 153.0, 141.9 121.4, 111.0, 45.0, 27.7, 26.3, 20.5; HRMS for C9H11BrN2 [M + H] 
227.0178, found 227.0178. 
5-Bromo-1,4,6-trimethyl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine (28a). This compound was 
prepared from bromide 27 (1.8 g, 7.9 mmol) and a mixture of formic acid (40 mL), 37 % formaline (40 
mL) and i-PrOH (40 mL) following the same procedure as for 16a. The crude product was purified by 
column chromatography (CH2Cl2) to afford the product (1.7 g, 84 %) as a light-brown solid. 
Recrystallization from hexanes gave analytically pure product as beige crystals. m.p. = 64 °C; 1H NMR 
(CDCl3, 300 MHz) δ 3.42 (t, 2H, NCH2, J=7.9 Hz), 2.86 (s + t, 5H, NCH3 + ArCH2), 2.48 (s, 3H, 6-Me), 
2.22 (s, 3H, 4-Me); 13C NMR (CDCl3, 300 MHz) δ 162.0, 153.5, 141.6, 120.9, 111.8, 53.0, 33.6, 25.7, 
19.8; HRMS for C10H13BrN2 [M + H] 241.0334, found 241.0336.  
5-Bromo-4,6-dimethyl-1-(3,7,11,15-tetramethyl-hexadecyl)-2,3-dihydro-1H-pyrrolo[2,3-
b]pyridine (28b). This compound was prepared from aldehyde 5 (730 mg, 2.5 mmol), bromide 27 (380 
mg, 1.65 mmol), AcOH (94 µL, 1.6 mmol), dichloroethane (15 mL) and NaB(OAc)3H (525 mg, 2.5 
mmol) following the same procedure as for 16b. The product was purified by column chromatography 
(40 : 1 hexanes : EtOAc) to afford the product as a yellow oil (280 mg, 33 %). 1H NMR (CDCl3, 300 
MHz) δ 3.43 (m, NCH2-ring), 3.29 (m, NCH2-chain), 2.93 (t, 2H, Ar-CH2, J=8.4 Hz), 2.46 (s, 3H, 6-Me), 
2.14 (s, 3H, 4-Me), 1.5 – 0.9 (24H, alkyl), 0.80 ( t, 15H, alkyl-CH3, J=6.3 Hz); 
13C NMR (CDCl3, 300 
MHz) δ 161.6, 153.2, 141.2, 120.5, 111.0, 49.8, 44.0, 39.72, 37.87, 37.81, 37.75, 37.65, 34.81, 34.72, 
33.11, 31.07, 31.05, 28.32, 26.02, 25.49, 25.17, 24.84, 24.73, 23.10, 23.00, 20.13, 20.08, 20.05, 20.01, 
19.63; HRMS for C29H51BrN2 [M + H] 507.3308, found 507.3306. 
1,4,6-Trimethyl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-5-ol (29a). This compound was 
prepared from bromide 28a (1000 mg, 4.15 mmol), THF (30 mL), n-BuLi (2.5 M in hexanes, 3.8 mL, 9.5 
mmol) and o-nitro-m-xylene (2.26 mL, 16.6 mmol) following the same procedure as for 9. The crude 
product was purified by careful column chromatography (5 % MeOH in CH2Cl2) under N2 to afford an 
orange solid (200 mg, 27 %) with a purity > 96 % as judged from NMR. λmax (MeOH) =330 nm;  m.p. = 
115 °C (dec). 1H NMR (CDCl3, 300 MHz) δ 7.26 (br s, 1H, OH), 3.30 (t, NCH2-ring, J=7.1 Hz), 2.80 (s + 
t, 5H, NCH3 + ArCH2), 2.17 (s, 3H, 6-Me), 2.03 (s, 3H, 4-Me), D2O shake removed signal at 7.26 ppm 
but did not sharpen signals much. 13C NMR (CDCl3, 300 MHz) δ 158.1, 142.1, 140.8, 134.0, 121.1, 54.0, 
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34.8, 25.3, 18.9, 13.2, HRMS for C10H14N2O [M + H] 179.1179, found 179.1183. Anal. calc. for 
C10H14N2O (%): C 67.39, H 7.92, N 15.72 found: C 66.46, H 7.81, N 15.28. 
4,6-Dimethyl-1-(3,7,11,15-tetramethyl-hexadecyl)-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-5-
ol (29b). This compound was prepared from bromide 28b (95.2 mg, 0.187 mmol), THF (5 mL), n-BuLi 
(2.5 M in hexanes, 0.19 mL, 0.47 mmol) and o-nitro-m-xylene (0.16 mL, 1.2 mmol) following the same 
procedure as for 9.  The crude product was purified by column chromatography (6 : 1 hexanes : EtOAc) 
to afford a yellow oil (14 mg, 17 %). λmax (MeOH) =328 nm; 1H NMR (CDCl3, 300 MHz) δ 7.26 (v br s, 
1H, OH); 1H NMR (CDCl3 + drop of D2O, 300 MHz) δ 3.34 (m, NCH2-ring), 3.27 (m, NCH2-chain), 2.81 
(t, 2H, Ar-CH2, J=7.8 Hz), 2.29 (s, 3H, 6-Me), 2.09 (s, 3H, 4-Me), 1.5 – 0.9 (24H, alkyl), 0.86 ( t, 15H, 
alkyl-CH3, J=6.6 Hz);  HRMS for C29H52N2O [M + H] 445.4152, found 445.4114;  HPLC purity: 91.8 
area  %.  
5-Bromo-4,6-dimethyl-2-(triphenylmethylamino)-pyridine (30). A mixture of bromide 2 (2.5 
g, 12.5 mmol), trityl chloride (3.77 g, 13.5 mmol), Et3N (2.0 mL, 14.4 mmol) and CH2Cl2 (35 mL) was 
stirred at room temperature for 3 h. MeOH (5 mL) was added, stirring was continued for 5 min and satd. 
Na2CO3-solution (35 mL) was then added. The organic layer was separated and the aqueous layer was 
extracted twice with additional CH2Cl2. The combined organic layers were dried (MgSO4), filtered and 
concentrated. The residue was recrystallized from EtOAc/MeOH to afford the product as off white 
crystals (4.82 g in two crops, 87 %, m.p. 140 °C). A large, colorless, transparent crystal was obtained 
after very slow evaporation of solvent from a concentrated solution. m.p. 148 °C; 1H NMR (CDCl3, 300 
MHz) δ 7.34 – 7.20 (m, 15H, trityl), 6.02 (s, 1H, ArH), 5.54 (s, 1H, NH), 2.45 (s, 3H, 6-Me), 1.91 (s, 3H, 
4-Me); 13C NMR (CDCl3, 300 MHz)  δ 156.0, 155.0, 147.5, 145.3, 129.5, 128.4, 127.4, 109.4, 71.2, 25.5, 
23.8; HRMS for C26H23BrN2 [M + Na] 465.0937, found 465.0967. 
2,4-Dimethyl-3-hydroxy-6-(triphenylmethylamino)-pyridine (31). This compound was 
prepared from bromide 30 (4.0 g, 9.0 mmol), THF (50 mL), s-BuLi (1.3 M in pentane, 22.5 mL, 29.2 
mmol) and o-nitro-m-xylene (4.0 mL, 29.4 mmol) following the same procedure as for 11.  The crude 
product was purified by column chromatography (3 % -> 6 % MeOH in CH2Cl2) to give the product as a 
yellow solid (1.5 g, 44 %). A sample for elemental analysis was obtained by recrystallization from 
acetone to give white crystals that retained ∼0.5 eq of acetone even after extensive drying. λmax (MeOH) = 
316 nm; m.p. 210 °C (dec), darkening at 180 °C; 1H NMR (CDCl3, 400 MHz) δ 7.34 – 7.20 (m, 15H, 
trityl), 5.66 (s, 1H, NH), 5.45 (s, 1H, ArH), 2.28 (s, 3H, 6-Me), 1.80 (s, 3H, 4-Me); 13C NMR (CDCl3, 400 
MHz)  δ 151.7, 145.6, 142.7, 142.0, 129.5, 128.2, 127.1, 109.7, 71.2, 19.0, 16.5; 2D NOESY-NMR 
(CDCl3, 400 MHz) couplings: Ar-H x trityl, N-H x trityl, ArH x 4-Me; HRMS for C26H24N2O [M + H] 
403.1780, found 403.1767. Anal. calc. for C26H24N2O.½C3H6O (%): C 80.65, H 6.65, N 6.84 found: C 
80.49, H 6.47, N 6.86. 
6-Amino-2,4-dimethyl-3-hydroxy-pyridine (32). Tritylated pyridinol 31 (970 mg, 2.55 mmol) 
was suspended in MeOH (25 mL). The suspension was degassed with nitrogen for 15 min after which 
TFA (5 mL) was added. The resulting clear solution was stirred overnight and then extracted 3 x with 
hexanes (25 mL). The MeOH layer was concentrated and dried. The crude product was taken up in 
MeOH and treated with excess solid NaHCO3. After filtration and concentration, the crude product was 
purified by column chromatography (10 % -> 25 % MeOH in CH2Cl2) to give 590 mg of an oil which 
crystallized slowly. The oil contained only one product according to TLC analysis (extremely polar, 
fluorescent spot), but NMR analysis showed that besides product there was ca. 15 mole % of HEt3N
+-salts 
present. No attempts were made hereafter to improve this step. 1H NMR (d4-MeOH, 300 MHz) δ 6.45 (s, 
1H, ArH), 2.22 (s, 3H, 6-Me), 2.14 (s, 3H, 4-Me); 13C NMR (CDCl3, 400 MHz)  δ 151.7, 150.9, 143.3, 
134.3, 112.0, 17.9, 14.6. HRMS for C26H24N2O [M + H] 139.0866, found 139.0875. 
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 3 
 
 
3.1 Introduction† 
As explained in Section 1.2.2, the antioxidant activity of phenols relies on their ability to 
transfer an H-atom from the –OH group to peroxyl radicals LOO• at a rate constant kinh (Scheme 
3.1). By doing so, they break the propagating chain and prevent many more hydroperoxides from 
being formed. The pyridinols (PyrOHs), the synthesis of which was described in Chapter 2, are 
expected to possess high antioxidant activity based on calculations in which similar antioxidant 
mechanisms for the pyridinols as for phenols are assumed.  
 
N
NR1R2
OH
R3
+ LOO
kinh
N
NR1R2
O
R3
+ LOOH
PyrOH PyrO  
 
Scheme 3.1: Transfer of an H-atom by PyrOHs to propagating peroxyl radicals. 
 
                                                 
* Parts of the contents of this chapter are published: Wijtmans, M.; Pratt, D. A.; DiLabio, G. A.; Valgimigli, L.; Pedulli, G. F.; 
Porter, N. A. Angew. Chem. Int. Ed. 2003, 42, 4370. 
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The least complicated way to investigate antioxidant activity is in homogeneous solution. 
Dozens of kinh values in solution have been reported for phenols over the years.
1,2,3 It was 
therefore of great interest to establish this kinetic parameter for the PyrOHs. The techniques to 
measure kinh are limited. The most widely used technique involves inhibited autoxidations of 
styrene or cumene in the presence of antioxidants (Section 1.3). In these experiments, oxygen 
uptake is measured by EPR4 or a differential pressure transducer5 and this can be used to 
determine kinh after the appropriate calculations. Recently, the Porter group developed a novel 
peroxyl radical clock for highly active phenolic antioxidants based on the trapping of kinetic 
methyl linoleate oxidation products. The details for this clock6 have been explained in Section 
1.2.2. An investigation of the PyrOHs using both the radical and the oxygen uptake techniques 
was pursued. In addition, qualitative studies using the DPPH free radical (N,N-diphenyl-N’-
picryl-hydrazyl) as a peroxyl model were also performed. Except for the styrene autoxidations, 
all of the work described in this chapter was carried in the Porter labs. Styrene autoxidations 
were carried out at the University of Bologna (Italy).‡ The latter experiments were of such 
importance to the overall picture that they will be briefly discussed here as well. 
According to the criteria listed in Scheme 1.10, general stability is also an issue that 
matters in the design of new antioxidants. For example, some potentially very active phenolic 
antioxidants, such as 9-hydroxy-julolidine 8, have been reported to be unstable towards air.1,7,8,9 
Thus, the stability of the 6-amino-3-pyridinols towards oxygen was investigated. Lastly, the 
stability of PyrOHs in the presence of lipid hydroperoxides was studied. This is an issue usually 
not mentioned for phenolic compounds in the literature, but presumably it could matter because 
of the simultaneous presence of both species in typical autoxidations. More specifically, it was 
deemed important because of the presence of multiple (oxidizable) nitrogen atoms in the 
PyrOHs. 
N
OH
N
R1 R
1: R=R1=Me
4: R=C20H41, R1=Me
7: R=C20H41, R1=H
N
OH
N
R
N
OH
N
R
2: R=Me
5: R=C20H41
3: R=Me
6: R=C20H41
N
OH
8
 
 
                                                 
‡
 The collaborative work of Dr. Valgimigli and co-workers on styrene autoxidations, presented in Figures 3.1B and 
3.3A-B, and BDE studies of the pyridinols, which are not discussed here, is greatly appreciated. 
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Compounds 1-3 were the main subject of this investigation. In some cases the 
corresponding N-phytyl compounds 4-6 were used because of their better availability at that 
particular time. Even though 4-6 clearly possess the potential for amphiphilic behaviour (Chapter 
4), it was expected that their overall reactivity should not differ too much from the N-methyl 
derivatives 1-3 when investigated in a homogeneous organic medium. Compound 7 was 
structurally somewhat different as it contains a secondary exocyclic amine.  
 
3.2 Measurement of kinh using autoxidations 
3.2.1 Monocyclic pyridinols 
The peroxyl radical clock studies were carried out according to the published procedure.6 
Methyl linoleate (0.2 M) in benzene was allowed to undergo autoxidation in the presence of 10-
90 mM of 1. HPLC analysis afforded clean chromatograms of the oxidation mixtures indicating 
no unexpected oxidation pathways. Figure 3.1A shows the experimental correlation between the 
ratio of formed kinetic 11-OOH and thermodynamic 9, 13-OOH products vs the concentration of 
1, averaged over 4 different sets of oxidations. 
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Figure 3.1:  (A) Correlation between ratio of 11-OOH and 9 + 13-OOH products vs the 
concentration of antioxidant (1 or α-TOH) during methyl linoleate autoxidations (0.2 M) in 
aerated benzene at 37 °C for 4 h initiated by MeO-AMVN (10 mM). (B) Typical oxygen uptake 
during autoxidation of styrene (8.6 M) in the presence or absence of 1. In this case it was 
initiated by AMVN (2.5 mM) with 1 (1.25 µM) at 30 °C in chlorobenzene.  
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From the slope in Figure 3.1A it could be calculated that kinh = 1.16 ± 0.04 x 107 M-1s-1 in 
benzene at 37 ºC. Comparing this number with kinh for α-TOH (α-TOH, 3.5 x 106 M-1s-1)10 
revealed that 1 transfers an H-atom to peroxyl radicals 3.9 times faster than Nature’s best 
antioxidant.  Interestingly, the total amount of oxidation products (sum of 9, 11 and 13-OOH) 
under these standard conditions was ca. 8 times lower with 1 than with α-TOH under identical 
concentration. Under the conditions used for these autoxidations with highly active antioxidants, 
the radical derived from the antioxidant is usually the chain-carrying species since [AOX] x kinh 
>> [linoleate] x kp. Thus, the lower extent of oxidation in the presence of 1 implies that PyrO• 
had less tendency to initiate chains compared to α-TO•, resulting in less Antioxidant Mediated 
Peroxidation (AMP, see Section 1.2.2). 
Autoxidations were carried out with styrene in chlorobenzene in the presence of 1. Figure 
3.1B shows a typical oxygen uptake plot accompanied by a theoretical plot that would be 
obtained if 1 were to be omitted. It can be seen that 1 inhibited oxygen uptake in the first ca. 700 
s, after which the oxidation proceeded in an uninhibited fashion. Clearly, oxygen consumption 
was strongly suppressed by 1 which means that propagating chains were broken. From the 
inhibition time τ (in this case ca. 700 s) the stoichiometric factor n was calculated to be 2. This 
factor represents the number of chains broken per antioxidant and is usually 2 for phenolic 
antioxidants, corresponding to trapping of LOO• by ArOH and reaction of ArO• and LOO• to 
form non-radical products. From the slope of the inhibited part of the curve it was calculated that 
the inhibition constant kinh is 1.6 ± 0.6 x 107 M-1s-1 in chlorobenzene at 30 ºC, an average of 
several sets of oxidations. This number is in acceptable agreement with the number obtained by 
the peroxyl radical clock method. 
Lipophilic PyrOH 4 was also tested by the peroxyl radical clock. It afforded a very good 
linear correlation between trapped products and antioxidant concentration with a slope that gave 
kinh = 1.26 ± 0.11 x 107 M-1s-1 in benzene at 37 ºC. Not surprisingly, this number is very close to 
the one obtained for the N-methyl compound 1 under identical experimental conditions. One set 
of oxidations with desmethyl PyrOH 7 afforded kinh = 1.04 x 10
7 M-1s-1 in benzene at 37 ºC. The 
lower rate constant for this compound compared to the other PyrOHs tested was likely due to the 
less efficient electron-donating character of the –NH group. Interestingly, the total oxidation 
yield with 7 was about 1.5 times lower than in parallel oxidations with 4. When the autoxidations 
were repeated under ∼4 times lower radical flux, clear oxidation products could be detected for 
α-TOH but not for 7. This revealed an interesting observation: although kinh for 4 was somewhat 
lower than the one for 7, the total extent of oxidation was considerably higher with 7 than with 4. 
Given the fact that the difference in kinh values was only ∼20 %, the differences in oxidation 
amounts could likely be attributed to different fates of PyrO• resulting from 4 and 7. As shown 
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in Scheme 1.14, the presence of an abstractable N-H in 7-PyO• could allow for additional 
mechanistic pathways. Conceivably, quinone-imine formation offers a very fast and irreversible 
depletion pathway for 7-PyrO•, while for 4-PyrO•, the only depletion pathway available is 
radical-radical combination to give Non-Radical Products (NRP). Thus, the thermodynamically 
favorable quinone-imine formation seemed to help in reducing AMP by 7, but (obviously) not by 
4. As will be shown in Chapter 4, this interesting phenomenon extended to oxidations of LDL. It 
is noteworthy to mention that a similar structure-activity difference between N-Me and N-H 
substitution was observed for 2-amino-5-pyrimidinols by members of the Porter group.11 
 
3.2.2 Pyridinols with an annelated aliphatic ring 
The autoxidation studies with the more reactive annelated PyrOHs proved less 
straightforward. The peroxyl radical clock was attempted with substrates 2, 5 and 6. All 
compounds reproducibly failed to give HPLC chromatograms with detectable 9, 11 or 13 
hydroperoxides under standard conditions6 with concentrations of PyrOHs ranging from 15 to 90 
mM.  In fact, little to no oxidation products could be observed for autoxidations with 
antioxidants in this concentration range as illustrated in Figure 3.2. The use of different lipid 
substrates and more sensitive detection techniques (GC), as developed by the Porter group,11,12 
did not afford any improvement in detection. 
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Figure 3.2: Total amount of oxidation products in methyl linoleate autoxidations in the 
presence of various amounts of 6-membered annelated compound 5 under standard conditions 
(0.2 M methyl linoleate in benzene, 10 mM MeO-AMVN, 37 °C, 4 h).  
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At very low PyrOH concentrations (0.5 - 10 mM) and an oxidation time of 1 h, clean 
HPLC chromatograms with detectable hydroperoxide peaks could be obtained. However, the 
kinetic 11-OOH product could not be observed under these conditions. Furthermore, significant 
amounts of the thermodynamic trans, trans-hydroperoxides were observed under these 
conditions. Nevertheless, under these modified conditions an estimation of antioxidant activity 
could be made from the total amount of formed hydroperoxides (i.e. 9- and 13-OOH and 
corresponding trans, trans-compounds). The results revealed that in a 2 – 8 mM concentration 
range the extent of oxidation in the presence of 2 was at least 10 times lower than with α-TOH 
and at least 50 times lower than in an uninhibited oxidation. Similarly, oxidations in the presence 
of 6 in a 7 – 14 mM range also gave considerably less oxidation than with α-TOH (not shown). 
By definition, this dramatic inhibition of autoxidation over a wide concentration range implied 
very high antioxidant activity of these annelated pyridinols. However, no quantitative kinetic 
information could be obtained. Clearly, the limits of the peroxyl radical clock for these substrates 
had been reached: too high antioxidant concentrations led to complete inhibition, too low 
concentrations gave conditions under which the conjugated hydroperoxides but no 11-OOH 
could be detected.   
 
 
Figure 3.3: Typical oxygen uptake during styrene (8.6 M) autoxidations at 30 °C in 
chlorobenzene in the presence of annelated PyrOHs. (A) PyrOH 2 (1.1 µM), initiation by AMVN 
(1.25 mM). (B) PyrOH 3 (0.21 µM), initiation by AMVN (0.25 mM). Rate constants reported in 
the text are the average of several sets of oxidations.  
 
Fortunately, the considerably more sensitive styrene autoxidations could be carried out 
with much lower concentrations of antioxidant (µM range). 6-Membered annelated PyrOH 2 
behaved quite well and gave a very similar uptake plot as with 1 but with somewhat lower 
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initiation rates and PyrOH concentration (Figure 3.3A). Applying the usual calculations gave n = 
2 and kinh = 8.8 ± 3.2 x 107 M-1s-1. On the other hand, 5-membered annelated PyrOH 3 proved so 
inhibitory that extremely low initiation rates and PyrOH concentrations had to be used. The 
resulting extremely low oxygen uptake could be measured after repeated experiments but gave 
rise to relatively large errors due to scattering. Figure 3.3B shows an uptake plot obtained under 
those modified conditions. In this case dramatic inhibition was observed when only 210 nM of 3 
was present! From several series of oxidations it followed that n = 2 and kinh = 28.0 ± 18 x 107 
M-1s-1 for 3.   
Both annelated PyrOHs trapped two peroxyl radicals just like 1. However, their kinh were 
dramatically higher with relative rates compared to α-TOH being 28 and 88 for 2 and 3, 
respectively. Clearly, the incorporation of the annelated aliphatic ring had a beneficial effect on 
the antioxidant activity which was in accordance with incorporation of similar ring-systems in 
the phenol series.1 The relative effect of the annelated rings, though, was considerably larger in 
the PyrOH series. This can be attributed to a combination of improved orbital overlap and higher 
electron-donating character of amine substituents compared to oxygen substituents. The 
improved orbital overlap in the bicyclic structures can be visualized by the Newman projections 
of 1 and 2 (Figure 3.4) obtained from calculations.13 In 1, the N-methyl groups are positioned 
such that the N-lone pair has a substantial angle with the aromatic π-system. On the other hand, 
the substituents in 2 are positioned in a more symmetrical fashion leaving the lone pair orbital in 
better conjugation with the π-system. The explanation for the differences between 2 and 3 by this 
protocol falls beyond the scope of this thesis.  
 
N NC NC N
1 2
plane of ring
 
 
Figure 3.4: Newman projections of 1 and 2 according to calculations.13 The two bonds 
on the exocyclic amine represent the two alkyl substituents, either CH2R or CH3 groups. 
 
3.2.3 Consumption of antioxidants during autoxidations 
In all autoxidations described, the analysis was directed towards lipid oxidation products 
or consumed oxygen to extract the necessary information. Monitoring of the PyrOH 
consumption by normal phase HPLC analysis was attempted but proved very cumbersome due to 
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high polarity of these substrates. Therefore, modified small-scale oxidations were carried out and 
followed by fluorescence spectroscopy. Thus, ∼1 mM PyrOH was incubated at 37 °C with 
initiator MeO-AMVN14 under air. The consumption due to reaction of PyrOH with InOO• could 
be monitored by the typical PyrOH emission at 380 nm.  Figure 3.5 shows the consumption 
profiles for 1, 2 and 3. Clearly, the PyrOHs were consumed when exposed to a steady flux of 
peroxyl radicals. The appropriate blanks showed that degradation of the antioxidant by O2 played 
a very minor role, if any, under these conditions (vide infra). The qualitative trend in rate of 
disappearance matched with the trend in inhibition data obtained so far, but no quantitative data 
could be extracted from Figure 3.5. 
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Figure 3.5: Decay of [AOX] for 1-3 (1 mM) upon incubation in a cuvet at 37 °C in 
benzene with MeO-AMVN (10 mM). First 5 min was left out because it involved the 
temperature equilibration time. The data shown are from one of two sets of oxidations that 
yielded the same results. 
  
3.3 Reactivity of pyridinols under various conditions 
3.3.1 Electron transfer 
The extremely high rate constants measured for the PyrOHs lead to the question whether 
direct electron transfer from the PyrOH to a peroxyl radical or to molecular oxygen was involved 
in these reactions. This problem has been reported for very electron-rich phenols, such as 8,7,8 
and is outlined in Scheme 3.1. Especially electron-rich 5-membered annelated PyrOH 3 deserved 
attention regarding this issue. Several experiments were designed to establish the contribution of 
Eqs. 1 - 3 for the PyrOHs. 
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ArOH       +   LOO                  ArO          +    LOOH
ArOH       +   LOO                  ArOH        +    LOO
ArOH       +    O-O                  ArOH      +      O-O
Eq. 1   H-atom transfer
Eq. 2   Electron transfer
Eq. 3   Electron transfer 
 
Scheme 3.1: H-atom transfer vs electron transfer. 
 
Electron transfer to molecular oxygen (Eq. 3, reflecting air-stability) was measured 
qualitatively by incubating PyrOHs 1 - 3 in t-butylbenzene solution at 37 °C under air. The 
intensity of the typical absorption maxima at 330 nm or the fluorescence signal of the PyrOH 
was measured. It can be seen from Figure 3.6A that monocyclic PyrOH was indefinitely stable 
under air, even for 28 h (not shown). However, 2 and 3 disintegrated gradually with ca. 10 and 
20 % of UV signal lost after 3 h, respectively.   
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Figure 3.6: (A) UV intensities of PyrOHs 1, 2, 3 at 330 nm upon incubation in aerated t-
butylbenzene (300 µM) at 37 °C. Fluorescence measurements afforded similar profiles. (B) 
Disappearance of 3 and formation of several products after 0, 1, 2, 3, 4, 5, 6, 22, 25 and 28 h 
upon exposure to air in t-butylbenzene (300 µM) at 37 °C.  
 
As stated in Section 1.3, a higher electron density in the ring not only leads to the desired 
antioxidant activity but also to lower Ionization Potentials. This trend clearly correlates with the 
air stability of the compounds: 5-membered annelated PyrOH 3 was the least stable. Several 
products were formed from 3 upon exposure to air as is evident from the time-evolved UV-Vis 
spectra (Figure 3.6B). Features included a broad absorption centered at 420 nm and a relatively 
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sharp signal growing in at ∼310 nm. Graph 3.6A revealed that the air-stability for this type of 
PyrOH was not as poor as that reported for electron-rich aminophenols, such as 8,1,7,8 an 
observation also made during the synthesis of the compounds (Section 2.5.1). However, it did 
mean that 2, and especially 3, can readily give up an electron to a good acceptor. 
The stable free radical N,N-diphenyl-N’-picryl-hydrazyl (DPPH) can be used as a 
convenient radical probe.15 The reactivities of antioxidants can be probed by the consumption of 
DPPH upon mixing with excess antioxidant under pseudo-first order conditions. Wright et al. 
have reported that 8 reacted with DDPH in EtOAc ca. 3 orders of magnitude faster (105 M-1s-1) 
compared to α-TOH (102 M-1s-1).7,8  It was shown that this unexpectedly high rate was due to 
fast electron transfer (Eq. 2 with DPPH instead of LOO•), rather than relatively slow H-atom 
donation (Eq. 1). Similar DPPH experiments in EtOAc were performed with α-TOH, 
monocyclic PyrOH 1 and the 5-membered annelated PyrOH 3. Figure 3.7 shows the second-
order rate constant (k) obtained for the reaction of the antioxidant with DPPH. 
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Figure 3.7: The observed pseudo-first-order rate constant (kobs) for the reaction of α-
TOH, 1 and 3 with DPPH in EtOAc at room temperature plotted against antioxidant 
concentration. The data are from a single set. Reactions were performed at 25 °C with 2.4 µM 
DPPH and the plotted kobs-values were obtained after first-order fitting of the decay of DPPH UV 
signal at 518 nm. Second-order k-values were obtained by linear regression and are reported next 
to the corresponding trend line (in M-1s-1). The structure of DPPH is also shown. 
 
The rate constant for α-TOH with DPPH served as a reference and matched with 
literature values.8,15 Clearly, PyrOHs 1 and 3 reacted much faster with DPPH than α-TOH, 
which was not surprising given their known reactivity towards ROO• radicals. It should be 
N N
O2N
NO2
NO2
DPPH
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emphasized that 1 and especially 3 reacted so fast that the limits of a conventional UV 
spectrometer were nearly reached. Despite the good R2 values (0.98 and 0.97 for 1 and 3, 
respectively), it is strongly suggested to repeat these experiments with a stop-flow spectroscopy 
instrument. Nevertheless, it seemed fair to say that 3 seemed to react at least ∼10 times slower 
with DPPH than 8 (4.0 x 105 M-1s-1 in EtOAc). The calculated OH-BDE for 3 (72.4 kcal/mole, 
Section 1.4) is actually ∼3 kcal/mole lower than for 8.8 Thus, it would be expected that 3 would 
donate H-atoms faster than 8, yet it reacted slower with DPPH than 8. These obvious differences 
suggest that little electron transfer (Eq. 2) was occurring between 3 and DPPH and that the 
measured rate constant was (mostly) due to H-atom donation (Eq. 1). Calculations on Ionization 
Potentials (IP) support this observation.16 The order in IP values for 3 and 8 was actually 
reversed with respect to BDE values, namely 152.3 and 148.0 (estimated) kcal/mole, 
respectively. Thus, the lower IP for 8 (by ca. 4 kcal/mole) implies a considerably more facile 
electron transfer from 8 compared to 3. Again, additional experiments with more suitable 
equipment will be necessary to further substantiate the results with the DPPH probe.  
 
The experiments described in conjunction with observations made during synthesis 
(Section 2.5.1) strongly suggest that the tendency towards electron transfer of PyrOHs to oxygen 
was significant. Monocyclic PyrOH 1 was indefinitely stable towards air, whereas the most 
reactive member 3 did undergo reaction with oxygen to some extent over a period of hours. 
These observations strongly suggest the predicted beneficial effect of ring nitrogens on the 
properties of the antioxidants.  
 
3.3.2 Reactivity with hydroperoxides 
A critical assessment of the extremely low extent of oxidation in methyl linoleate 
autoxidations in the presence of 1, 2 and 3 leads to the question whether these PyrOHs were 
reacting with hydroperoxides. The reactivity of (synthetic) chain-breaking antioxidants with 
hydroperoxides or other non-radical peroxide products has received relatively little attention in 
the literature, because it obviously does not contribute to chain-breaking antioxidant efficiency. 
Some groups have synthesized α-TOH analogues which contain easily oxidizable atoms, such as 
sulfur, selenium or tellurium, para to the phenolic OH.17,18,19 It was shown that all these 
compounds were less efficient chain-breaking antioxidants than α-TOH since the heteroatom 
was oxidized rapidly by reactive oxygen species (ROS). However, in the presence of a 
stoichiometric reducing agent, such as glutathione, the Se- and Te-containing antioxidants were 
able to quench peroxyl radicals and decompose hydroperoxides by means of redox cycling.17 In 
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addition to chain-breaking antioxidant activity, this particular mode of action represents 
neutralizing antioxidant activity (Table 1.1) since it decomposes ROS into non-reactive alcohols. 
 
C5H9
OR
C5H9
C5H9
OR
C5H9
OR
C5H9
C5H9
9 (conjugated) 10 (conjugated) 11 (non-conjugated)Hydroperoxides (R=OH):
Alcohols (R=H): 12 (conjugated) 13 (conjugated) 14 (non-conjugated)  
 
Experiments were conducted in which several AOX were incubated in benzene under air 
at 37 °C with a mixture of freshly purified model linoleate (non)-conjugated hydroperoxides 9 – 
11 (LOOH) synthesized by the Porter group.11 In initial experiments, 6-membered ring annelated 
compound 5 (5 mM) was incubated with LOOH (31.5 mM) and it was found that LOOH fully 
decomposed over the course of 5 h leaving a brown solution. In a more systematic set of 
incubations, four different antioxidants (α-TOH, 4, 5 and 7) were incubated with LOOH in the 
presence and absence of radical quencher BHT (∼6 mM). The incubations were followed by 
HPLC and Figure 3.8 shows some representative HPLC chromatograms for t=3 h. The presented 
chromatograms looked identical when BHT was omitted. The hydroperoxides LOOH were 
perfectly stable for 3 h without antioxidant (not shown) or in the presence of α-TOH. However, 
LOOH decomposed in the presence of 6-membered ring annelated compound 5 or desmethyl 
PyrOH 7 giving rise to brown/black colored mixtures. Not shown are the data for N-methyl 
PyrOH 4, which did decompose LOOH but at a much slower rate than 5 and 7. Clearly, LOOH 
was not stable in the presence of PyrOHs.  
For the most reactive 5-membered annelated PyrOHs, an NMR experiment was devised. 
Compound 3 was mixed with a hydroperoxide and the progress of the reaction followed by 1H 
NMR spectroscopy. Rather than a mixture of 9-11, t-BuOOH was used as the hydroperoxide 
since it has no overlapping peaks in the region of interest (2 – 5 ppm). Of course, the reactivity 
of t-BuOOH and LOOH are not necessarily the same but it was felt that for preliminary stability 
tests their similarities were sufficient. Figure 3.9 shows that 3 clearly decomposed upon addition 
of t-BuOOH as can be seen from relative decreases of 1H NMR signal. The solution changed 
from yellow to dark orange in 2 h. The spectra looked rather complex and a reliable product 
assignment could not be performed, but an indicative feature was the formation of several 
multiplets between 3.6 - 4.3 ppm. Judging from experience in the Porter group on (bis)allylic 
systems, these peaks could be methine protons of benzylic hydroperoxides and alcohols. The 
latter can form after addition of oxygen to the corresponding benzylic radicals.  
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Figure 3.8: HPLC chromatograms after 3 h of aerobic incubation at 37 °C of (A) α-
TOH, (B) PyrOH 7 and (C) 6-membered annelated PyrOH 5 (all at 30 mM) and LOOH (5 mM) 
in benzene. *=overlapping peaks for 9 and 10. **=peak for 11. Time-scales (X-axis) are identical 
(10 – 20 min), offset for intensity-scale (Y-axis) is arbitrary and y-values are normalized.  
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Figure 3.9: Time evolved 1H-NMR spectra of an incubation mixture of 3 (∼2.5 mM) in 
CDCl3/D2O and t-BuOOH (in nonane, 5.5 M, 40 µL, ∼10 eq with respect to 3) at 25 °C.  
Presence of D2O was necessary for sharp peaks (see Section 2.6). The region below 2.0 ppm is 
not shown because of overlapping t-butyl and nonane peaks. The y-scales of the spectra are 
similar and are normalized to CDCl3.  
N
N
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Theoretically, several potential decomposition pathways are conceivable: 
 
(1) Dehydration of the hydroperoxide to ketones catalyzed by the moderately acidic PyrOH. 
(2) Fenton chemistry: PyrOH donates an electron to LOOH affording PyrOH•+, OH• and LO−. 
(3) Non-radical oxidation of PyrOH by LOOH to afford alcohols (LOH). 
 
Pathway (1) implied that the PyrOH would not be consumed since it is a catalyst. As can 
be seen from Figures 3.8 and 3.9, PyrOH 3 actually disappeared upon addition of an organic 
hydroperoxide. In addition, the more acidic 2-amino-5-pyrimidinols (with two ring N-atoms) 
were also tested but gave no decomposition of LOOH (not shown). Hence, pathway (1) was 
ruled out. As far as pathways (2) and (3) are concerned, they both would lead to the 
corresponding alcohols (LOH). When the HPLC chromatograms of incubation mixtures of 5 and 
7 after t=3 h are compared to authentic LOH (Figure 3.10), the peaks labeled with arrows could 
correspond to the conjugated alcohols 12 and 13. In addition, the peaks labeled with arrows 
displayed the characteristic UV spectrum for 12 and 13. In the case that any non-conjugated 
alcohol 14 was present, it will likely be buried under other peaks. Moreover, GC analysis 
qualitatively showed LOH to be present in incubation mixtures with 5 and 7 (not shown). Thus, 
the HPLC and GC data suggest that LOH is formed from LOOH in the presence of 5 or 7. 
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Figure 3.10: HPLC chromatograms after 3 h of aerobic incubation at 37 °C of AOX (30 
mM) and LOOH (5 mM) in benzene for PyrOHs 5 and 7. The reference chromatogram for LOH, 
which was recorded in a separate experiment, is also given.  
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It is not trivial to distinguish between pathways (2) and (3). One of the most likely 
pathways for a ‘non-radical’ oxidation would be N-oxidation at the pyridine ring (Figure 3.11A). 
A literature search revealed that electron-rich pyridines can undergo facile and clean N-oxidation 
(1-2 hrs, CH2Cl2, 0°C to room temperature, m-CPBA).
20,21 PyrOH 7, in addition to similar N-
oxidation, could also undergo quinone-imine formation (Figure 3.11B) in analogy to 
hydroquinones or p-aminophenols. Quinone formation from para- or ortho-dihydroxypyridines 
has been reported and can be accomplished by reagents, such as MnO2.
22,23 Fenton chemistry 
(Figure 3.11C), on the other hand, almost by definition would lead to complicated mixtures due 
to formation of extremely reactive OH•. The fact that BHT had no effect whatsoever on the 
product profile depicted in Figure 3.8 suggests that radical processes are likely not involved in 
the reaction. In any case, more detailed studies are needed to determine if and to what extent 
these two pathways contribute to the observed decomposition of the respective PyrOHs. 
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Figure 3.11: Potential pathways for reaction of lipid hydroperoxides with pyridinols. 
 
Despite the fact that not enough conclusive evidence has been gathered yet on the 
reaction of PyrOH with LOOH, the general implication on the kinetic experiments was 
considered. An important aspect is that reaction of LOOH with PyrOH would not actually break 
chains in autoxidations. Yet, the dramatically lower extent of methyl linoleate autoxidation in the 
presence of any PyrOH (Section 3.2) strongly suggests that propagating chains are still 
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effectively broken, i.e. the PyrOHs efficiently acted as H-atom donors. In addition, the other 
technique used for determination of kinh, viz. the styrene autoxidation, was carried out under 
conditions where both [PyrOH] and [LOOH] were extremely low (µM range). Thus, the rate for 
the reaction of LOOH with PyrOH would be greatly reduced. As an illustration of the validity of 
these interpretations, a comparison of the kinh-values for 1 obtained by the two different methods 
(1.16 ± 0.04 x 107 and = 1.6 ± 0.6 x 107, M-1s-1, respectively) shows that the two numbers are 
very similar within the limits of accuracy.  
 
3.4 Conclusion and outlook 
 
Antioxidant kinh  by clock 
(x 107 M-1s-1)a 
kinh by O2 uptake 
(x 107 M-1s-1)b 
 kinh/kinh(α-TOH) 
1 1.16 ± 0.04 1.6 ± 0.6 5 
2 - c 8.8 ± 3.2 28 
3 - c 28.0 ± 18c 88 
α-TOH 0.35 10 0.32 1  1.0 
(a) In benzene at 37 °C by methyl linoleate radical clock. (b) In chlorobenzene at 30 °C for 2, 
5, 6, 7; in benzene at 50 °C for 4. (c) Not determined, see text. 
 
Table 3.1: Collected Data for Experimentally Determined kinh for PyrOHs 1-3. 
 
The 6-amino-3-pyridinols, the synthesis of which was described in Chapter 2, were tested 
in homogeneous solution by several techniques. Methyl linoleate and styrene autoxidations 
showed that the PyrOHs were excellent H-atom donor towards peroxyl radicals (LOO•) and thus 
very good oxidation inhibitors.  Their kinh values are collected in Table 3.1. Pyridinols 1, 2 and 3 
were 5, 28 and 88 times faster (respectively) than Nature’s best antioxidant α-TOH. Detailed 
reactivity studies showed that electron transfer from PyrOHs to acceptors could occur as electron 
density in the ring increased, but the rates for these processes did not appear to be unacceptably 
high. For example, monocyclic 1 was stable for at least 24 h, whereas 5-membered annelated 
compound 3 decayed for ca. 20 % over 3 h, in solution under air at 37 °C. The PyrOHs could 
also react with LOOH directly at rates varying with the PyrOH structure. The involved 
mechanism has not been elucidated yet, but it was shown that the effect of this undesired 
reaction on the measured values for kinh was minimal. 
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In this chapter, the OH-BDE measurements that were carried out by Dr. Valgimigli et al. 
on compounds 1, 2 and 3 have not been discussed.  Increasingly lower BDEs were measured for 
1, 2 and 3; the respective values are 77.0, 76.3 and 75.4 kcal/mole. It is worth mentioning that 
the observed effect of the PyrOH structure on the experimental BDE matched very well with the 
calculated effect (Section 1.4). Furthermore, a very good linear correlation exists between 
log(kinh) and the experimental OH-BDE, thereby justifying the use of OH-BDE as a critical 
parameter in the design of novel antioxidants. 
 
The combination of measured rate constants and observed air-stability would lead one to 
believe that the upper limit for these PyrOH structures has been reached with 5-membered ring 
annelated compound 3. Increasing the electron density even more will probably lead to 
compounds that are too unstable to use. For practical purposes, 1 and 2 seem the most suitable 
compromise between reactivity and stability. It is strongly recommended to establish 
unambiguously their reaction with hydroperoxides LOOH as to get an insight in the effect of this 
pathway in various oxidation scenarios. Interestingly, if the oxidation products from PyrOHs and 
hydroperoxides are (partially) N-oxides, they can potentially be recycled in vivo by plasma 
reducing agents, such as glutathione or Vitamin C. Deoxygenation/reduction of N,N-
dimethylaniline-N-oxide by mercaptoethanol or Vitamin C, or a combination of both, has been 
described.24 In this way, the PyrOHs could simultaneously break chains and catalytically 
decompose lipid hydroperoxides. This combined action of redox-cycling and H-atom donation 
has been the basis for designing Se and Te based phenolic antioxidants.18 
 
3.5 Experimental section 
Materials and instruments. Benzene for oxidations was treated with neutral alumina prior to 
use. All other solvents were used as received. MeO-AMVN was purchased from Wako Chemicals USA 
Inc. All other chemicals were purchased from Sigma-Aldrich Company. The PyrOHs were synthesized 
and purified as described in Chapter 2, their purity being > 95 % judging from either HPLC with UV 
detection at 330 nm or 1H-NMR spectroscopy. NMR spectra were taken on 300 or 400 MHz Bruker NMR 
instruments. Signals were calibrated on CDCl3 and are reported with respect to TMS. UV-spectra were 
recorded on a Hewlett Packard HP8452A spectrometer. DPPH experiments were recorded on an Agilent 
8453 UV-Vis Spectrometer. Fluorescence measurements were recorded on an ISS PC1 Photon Counting 
Spectrometer using a thermostat to maintain a desired temperature in the sample holder (excitation slit: 
0.5, emission slit: 1.0 mm). HPLC analyses were carried out with a Waters 600 Controller, 717 
Autosampler and 996 Photodiode Array using a Beckman 5 µM Ultrasphere column (4.6 mm x 25 cm) 
normal phase column. GC was carried out using a Hewlett Packard 5980 Series II (30 m x 0.32 mm HP50 
column). 
Measurement of inhibition constant kinh. Rate constants for hydrogen atom transfer of the 
PyrOH to peroxyl radicals were measured with two different techniques. For the less reactive, monocyclic 
PyrOHs a recently published radical clock was used.6 A benzene solution which contained methyl 
linoleate (0.2 M) and the antioxidant in varying concentrations (0.001 – 0.1 M) was treated with MeO-
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AMVN initiator (final concentration = 10 mM). The oxidation was run at 37 °C for 4 h and then 
quenched by addition of BHT. The major oxidation products 9, 11 and 13-hydroperoxide were then 
quantified by normal-phase HPLC (0.5 % i-PrOH in hexanes) with UV detection (207 and 235 nm). For a 
given set of oxidations, the concentration of added antioxidant was plotted against the ratio of 11- vs 9- 
and 13- hydroperoxides. The slope of the obtained straight line gave the kinh value. In the case of the more 
reactive annelated PyrOHs, no reliable quantification could be performed. 
Alternative measurements were performed in the group of Luca Valgimigli and Gian-Franco 
Pedulli in Bologna, Italy, by studying oxygen uptake during inhibited styrene autooxidations.5  
Qualitative pyridinol consumption upon exposure to peroxyl radicals. In a quartz 200 µL 
fluorescence cuvet were mixed 20 µL of PyrOH solution (10 mM in benzene) and benzene (160 µL). The 
cuvet was prewarmed at 37 °C in the fluorometer. Then initiator (MeO-AMVN, 100 mM in benzene, 20 
µL) was added and the solution was left in the fluorometer at 37 °C. The decay of antioxidant was 
followed by measuring the PyrOH fluorescence (excitation at ca. 330 nm, emission at ca. 390 nm) every 
30 seconds. Between measurements the shutters were closed to prevent any photochemistry. Every time a 
blank, in which initiator solution was substituted with 20 µL of benzene, was run to correct for oxygen-
stability. 
DPPH experiments.8 A stock solution of the antioxidant (∼10 mM in EtOAc) was prepared. A 
varying amount of this stock (5 – 50 µL) was mixed with 1.5 mL EtOAc in a cuvet and placed in the 
cavity of the UV spectrometer. Recording of absorbance at 518 nm was started (every 0.5 sec) and 
quickly 1.0 mL of DPPH solution (2.4 µM in EtOAc) was injected into the cuvet. After initial scattering 
due to mixing, a clear decay of absorbance was observed. A first-order plot was fitted to this decay trace 
to obtain kobs using Sigmaplot software. For very reactive PyrOHs, the reaction was so fast that it reached 
the limit of the conventional spectrometer. The presence of molecular oxygen was shown to have no 
effect on the outcome. This was proven by repeating some of the experiments but with plain EtOAc (1.0 
mL) instead of DDPH solution in which case the absorbance at 330 nm (AOX signal) showed no 
significant change over a 1 min period.  
Measurement of reactivity of pyridinols with lipid hydroperoxides. A sample of 
hydroperoxides 9 – 11 had been synthesized in the Porter group.11 A solution of these hydroperoxide (17 
mM total in benzene, 50 µL) was mixed with PyrOH solution (ca. 50 mM in benzene, 120 µL). A BHT-
solution (120 mM in benzene, 10 µL) or benzene (10 µL) was then immediately added. Subsequently, the 
solution was incubated at 37 °C. At intervals, 30 µL aliquots were withdrawn and internal standard 
(benzylalcohol) was added. To block further reaction, 1.5 mL of hexanes was added and the mixture was 
stored at –78 °C until analysis. Product profiles were obtained by normal-phase HPLC (0.5 % i-PrOH in 
hexanes) with UV detection (207, 235 nm). 
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 4 
 
 
4.1 Introduction4  
In Chapter 3, the solution oxidation studies with 6-amino-3-pyridinols were described. As 
has been stated in Section 1.2.3, simple translation of antioxidant behavior in solution to 
behavior in micellar systems, such as LDL, proves to be erratic. The reason is that phenolic 
antioxidants, such as α-Tocopherol (α-TOH), have dual reactivity in LDL, namely as antioxidant 
as well as pro-oxidant.1 It is of interest to see how the pyridinols (PyrOHs) would behave in that 
respect. The theoretical and experimental data showed a lower OH-BDE yet reasonable IP for 
most of the PyrOHs (Sections 1.4 and 3.4) and therefore it can be speculated that in LDL these 
compounds could be better antioxidants but worse pro-oxidants than α-TOH by virtue of the 
stabilized ArO•. The isolation of LDL dispersions from human donors has been well 
documented and supplementation of LDL with additional compounds has been described.2,3,4  
This provides an excellent opportunity to study the antioxidants in this more biological setting. 
In this chapter, the supplementations of LDL with various synthetic lipophilic 6-amino-3-
pyridinols will be described. Supplemented LDL was subjected to oxidations induced by water-
soluble peroxyl radicals and the profiles of antioxidants and cholesteryl esters oxidation products 
were studied. It will also be shown that fluorescence spectroscopy can sometimes be a valuable 
tool in the analysis of LDL and its oxidation behavior. 
                                                 
* Parts of the contents of this chapter will be published: Milne, G. L.; Seal, J. R.; Havrilla, C. M.; Wijtmans, M.; Porter, N. A. 
Submitted to J. Biol. Chem.  
The antioxidant activity 
of 6-amino-3-pyridinols 
in human Low Density 
Lipoprotein *  
Chapter 4      
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯                    
 
88
4.2 Fluorescence assay as a quick approximation of protein content 
Purified LDL dispersions were obtained from human blood after two density gradient 
sequential floatations at 14ºC and two consecutive isolations by Size Exclusion Chromatography 
(PD10) columns. The concentrations of purified LDL dispersions were determined by a Lowry 
UV assay.5 This assay gave the Apo B100-content (in mg protein / mL) and, since one LDL 
particle contains exactly one protein, this also represented the LDL concentration. However, 
these Lowry assays tend to be quite time-consuming. It would be advantageous to have an 
alternative quick way to confirm the Lowry value since the LDL concentration is a crucial 
parameter in all oxidation studies. Esterbauer et al. reported that LDL fluoresces at 330 nm when 
excited at 280 nm and that this signal resulted mostly from the 37 tryptophan (Trp) residues in 
Apo B1006 but also from α-TOH (ca. 2.7 % of signal).7 In agreement with this, it was found that, 
upon excitation at 280 nm, 1 eq. of Apo B100 (37 Trp-residues) fluoresces almost 400 times 
stronger at 326 nm than 1 eq. of α-TOH, all in SDS buffer pH 7.4. This meant that at an average 
of ca. 6 molecules of α-TOH in LDL, its contribution to the observed fluorescence would be 
insignificant. Calculations showed that other fluorescent constituents in purified LDL 
dispersions, such as ubiquinol-108 or bilirubin,9 do not contribute significantly to this signal 
either. Thus, it was anticipated that the Apo B100 content could be derived directly from the 
fluorescence signal at 326 nm upon excitation with 280 nm. 
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Figure 4.1: Protein concentration of native LDL (mg/mL) by the Lowry assay and the 
fluorescence assay. Each different symbol represents a different blood donor. For a given donor, 
each data point represents a different batch of blood. Measurements were performed at 37 °C 
after shaking 100 – 200 µL LDL with 3 mM SDS buffer for 30 s.  
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Figure 4.1 shows the protein concentrations, as determined by this fluorescence assay (y-
axis) and by the standard Lowry assay (x-axis), of several LDL batches. It reveals that there is a 
good linear correlation between the two assays, even for different blood donors. The fact that the 
slope is not equal to 1 means that commercial Apo B100 in SDS buffer, used to obtain Trp 
fluorescent responses, does not accurately mimic Apo B100 in de-aggregated LDL in SDS 
buffer. Nevertheless, with the corrected slope from Figure 4.1, the LDL concentration can now 
be determined quickly. Furthermore, the chances of experimental errors were much less with this 
method as compared to the Lowry method since there is considerably less handling involved in 
the fluorescence experiment than in the Lowry assay. In practice, both methods were used to 
determine the LDL concentration and it was made sure that the values were consistent. 
 
4.3 Supplementation of LDL 
A few protocols for supplementation of LDL with external compounds have been 
reported. In the present study, purified LDL4 rather than crude plasma2,3 was supplemented with 
PyrOHs 1-4. 
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Supplementation of purified LDL followed by Size Exclusion Chromatography (SEC) 
using Sephadex PD10 columns has been successfully demonstrated for β-carotene10,11 and for 
both hydrophilic and hydrophobic pyrene compounds.4 In addition, there was evidence from 
previous research in the Porter labs that this method works well.12 Thus, a concentrated solution 
of synthetic PyrOH 1 – 4 in DMSO was slowly added to aqueous LDL dispersions in PBS buffer 
(ca. 1 mg/mL, final DMSO content < 3 vol %) and the resulting mixture was allowed to stir 
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slowly for 15 – 30 min.13 Non-incorporated PyrOH was removed by SEC and extracts of the 
resulting LDL were analyzed by HPLC to establish the extent of incorporation. ‘Blank’ 
supplementations, with only buffer rather than LDL dispersion, gave ca. 5-10 % recovery of 
PyrOH after SEC, indicating efficient retention of unincorporated PyrOHs. In addition, the 
chosen concentrations of inhibitors were well below the intrinsic critical micelle concentration of 
the PyrOHs14 in order to exclude the possible recovery of PyrOH-micelles after SEC. All this 
underscores that the supplementation numbers presented in this chapter are attributable to actual 
PyrOH incorporation in the LDL particles. Additional experiments are currently ongoing to 
assess plasma supplementation of antioxidants to LDL in order to use the LDL dispersion more 
efficiently.  Only one chromatographic step in this method, instead of the two used in 
supplementation of purified LDL, will presumably lead to reduced loss of LDL in the sequence. 
Studies on small-scale supplementations were carried out with 1, 2 and 3. During the 
supplementations, aliquots were taken which were immediately subjected to SEC and then 
analyzed for PyrOH and α-TOH. A typical time course is shown in Figure 4.2.  The 
supplementation seemed complete within 5 min at 37 °C. Additional experiments showed that 
supplementation was reproducibly fast, regardless of the temperature (37 °C or 4 °C) or structure 
of PyrOH (not shown). Thus, the incorporation of the PyrOHs in LDL was unexpectedly fast. 
Presumably, this was driven by the highly lipophilic nature of the compounds. Another important 
observation was that the concentration of α-TOH was not affected by the incorporation of 
PyrOH, i.e. LDL was not ‘saturated’ with antioxidants. 
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Figure 4.2: Typical time course for incorporation of 1 into LDL at 37 °C. This particular 
LDL batch had 12-13 molecules of α-TOH/LDL. The time course looked very similar when 
carried out at 4° C (not shown). 
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Additional evidence for this was obtained by supplementing a fixed amount of LDL with 
varying amounts of PyrOH. The supplementation efficiency was defined as the amount of 
PyrOH recovered in LDL divided by the amount of PyrOH initially added. The results of this 
study indicated that the efficiency of supplementation was similar in every equal-scale run (for 
example, ∼12 % for 3 under the conditions shown in Figure 4.3). Taking all data into account, it 
was concluded that LDL supplementation under these conditions was a rapid equilibrium and 
that there was no ‘saturation’ limit for antioxidants in LDL in the range of the measurement, viz. 
5 – 30 PyrOHs per LDL.  
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Figure 4.3: Incorporated AOX as a function of added AOX. Carried out with PyrOH 3 at 
25°C for 30 min on a 300 µL scale. Values given are per LDL particle. 
 
In practice, the supplementation seemed to depend on the volume scale at which it was 
carried out and on the LDL batch. Efficiencies were usually in the 50 – 90 % range for the larger 
scale (3-4 mL) experiments that will be discussed in the next sections. After every 
supplementation, the efficiency was determined by HPLC for each batch of supplemented LDL.  
On one occasion, native LDL and LDL supplemented with 2 were compared by UV-Vis 
spectroscopy (Figure 4.4). Characteristic features of the spectrum for native LDL are the peaks at 
280 nm (Trp) and 460 nm (bilirubin and carotene). Upon supplementation with 2 followed by 
SEC, a broad absorption from 300-400 nm appeared. Subtraction of the two spectra afforded the 
difference graph shown in the inset. This graph has a maximum at 318 nm, which is very close to 
the UV-maximum of 2 in methanol. The incorporation of 2 in LDL could also be confirmed by 
fluorescence spectroscopy. During their synthesis and characterization, it was noticed that the 
PyrOHs show moderate fluorescence in the 380 nm region upon excitation at 320-330 nm (see 
also Section 3.2.3). In Figure 4.5A, the excitation spectra with detection at 388 nm for native 
LDL and LDL supplemented with 2 are shown. Native LDL shows a signal at 280 nm which is 
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likely due to the emission shoulder of the 37 Trp residues.7 In supplemented LDL, an additional 
excitation peak at ∼329 nm was clearly visible and this was attributed to incorporated 2.  
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Figure 4.4: Absorption spectra of native LDL and LDL supplemented with 2, both with 
[LDL]= 0.75 mg/mL. Inset shows the difference curve of the two spectra. 
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Figure 4.5:  (A) Excitation spectra of native LDL and LDL supplemented with 2, 
detection at 388 nm. (B) Emission spectra of 2 in methanol or hexanes and incorporated in LDL, 
excitation with 330 nm. The spectrum of native LDL, which lacked any signal in the 350-450 nm 
region, is not shown. 
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It should be pointed out here that it is not exactly known where the PyrOHs reside in the 
LDL particles (core, surface, or both). It has been suggested that α-TOH resides mostly on the 
surface of the LDL particle.15,16,17  On the basis of a simple structural comparison, one might 
expect this to be the case for the PyrOHs as well since the polarity and hydrogen-bonding 
capacity of the PyrOH head group appear to be comparable to that of α-TOH. Fluorescence 
spectroscopy may provide useful information addressing this issue. Figure 4.5B shows the 
emission spectra of LDL supplemented with 2 together with the spectra for 2 in methanol or 
hexanes. These spectra reveal that in the more polar solvent methanol the emission maximum is 
at lower energy due to increased stabilization of the excited state. The spectrum of supplemented 
LDL shows that the emission maximum of 2 in LDL is on the ‘polar end’ of the emission range. 
This suggests that the PyrOH head group of 2 in LDL resides mostly in a very polar 
environment, possibly the negatively charged surface. An additional feature of Figure 4.5B is the 
increased broadness of the emission peak of 2 in LDL, indicating that the environment in which 
2 resides is less homogeneous than in simple solution. Conceivably, the non-uniform surface of a 
LDL particle could cause this broadening. In fact, emission broadening has been observed before 
upon incorporation of hydrophilic pyrene substrates.4 Although only investigated briefly, it is 
believed that the described fluorescence measurements, after optimization, could potentially be a 
powerful tool for future investigations into the dynamics of PyrOHs in LDL (for an example, see 
Section 4.5). Moreover, measurements of the relative fluorescence intensities of the PyrOHs in 
LDL, compared to hexane or methanol solution, might provide additional evidence for their 
location. 
 
4.4 Oxidation studies – results  
4.4.1 General procedure  
Oxidation studies were carried out with supplemented LDL (0.48 – 0.75 mg/mL) in PBS 
buffer pH 7.4 at 37 °C under air. The oxidations were initiated by water-soluble peroxyl radicals 
using 0.5 – 1.0 mM azoinitiator C-0 (Scheme 4.1).  
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Scheme 4.1: Structure of the C-0 initiator and the mechanism of its decomposition. 
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Any oxidation of supplemented LDL was accompanied by a reference oxidation of native 
LDL that had been supplemented with a DMSO-blank instead of PyrOH-DMSO solution 
(Section 4.3). The LDL oxidations were only analyzed for the core lipids, because established 
analytical techniques were available for that. During the oxidations aliquots were withdrawn and 
successively treated with methanol to break up the LDL particles, PPh3 to reduce all 
hydroperoxides to alcohols, and BHT to stabilize the mixture. Subsequently, the mixture was 
extracted with hexanes/methanol/buffer 5:3:1.18 The hexanes phase was analyzed by normal 
phase HPLC with UV detection for oxidized cholesteryl linoleate esters (CE) and by reverse 
phase HPLC with electrochemical detection for antioxidants PyrOHs and α-TOH.  
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Figure 4.6: Typical HPLC chromatograms of an oxidation of LDL (0.75 mg/mL). In this 
case, LDL was supplemented with 2. (A) Antioxidant profile after 3 h (2, α-TOH, γ-TOH, 
**=internal standard δ-TOH). (B) Lipid profile after 7 h. CE 5-8=cholesteryl linoleate alcohols 
obtained by PPh3 reduction of corresponding hydroperoxides 5-8 (vide infra), *=arachidonate 
esters. 
 
Figure 4.6 shows typical HPLC chromatograms for oxidations of LDL, in this case LDL 
supplemented with 2. This particular batch of LDL also contained 2 molecules of γ-TOH per 
LDL, the analysis of which will not be discussed in this chapter. Under the general conditions 
used, the major lipid oxidation products were cholesteryl linoleate hydroperoxides 5-8 (Figure 
4.6B), the structures of which are shown in Figure 4.7. The sum of 5-8 provided a number for 
total oxidation products while (5+6) / (7+8) provided a cis/trans ratio. The sum is simply a 
measure for the total extent of LDL oxidation that had occurred. On the other hand, the cis/trans 
ratio is a measure for antioxidant capacity of the LDL core, since rearrangement of cis to trans 
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isomer is known to depend on the H-atom donating capacity of the medium.19 Under the usual 
oxidative conditions used, the bis-allylic hydroperoxide was never observed (Scheme 1.6). 
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Figure 4.7: Major oxidation products formed in LDL. 
 
Four successful sets of oxidations (A - D) with varying batches of LDL from different 
blood donors were carried out. Given the very limited amount of available LDL, no exact 
duplicates were carried out for a given batch. Rather, the results will be presented separately for 
each set followed by a general discussion of the results. 
 
4.4.2 Oxidation Set A 
LDL was supplemented with PyrOHs 1 and 2. The resulting purified LDL stock solutions 
were diluted to a concentration of 0.76 mg/mL. This particular batch of LDL contained 7-8 
molecules of α-TOH/LDL. Initiation was performed by adding aq. C-0 to a final [C-0] = 1.0 
mM. HPLC analysis of PyrOH by electrochemical or UV detection could not be performed 
reliably, because of analytical problems.20 However, reliable α-TOH and lipid-profiles could be 
obtained.  
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Figure 4.8: Relative consumption of α-TOH during LDL oxidations of Set A (LDL=0.75 
mg/mL, 1.0 mM C-0). 
 
In native LDL, α-TOH was consumed within 2 h (Figure 4.8), whereas in LDL 
supplemented with 1 or 2 this consumption time was at least 3 h. Furthermore, some initial 
sparing of α-TOH (first 30 min) in supplemented LDL was observed, most notably in LDL 
supplemented with 2.  
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Figure 4.9: (A) Number of cholesteryl linoleate hydroperoxides (LOOH) per LDL 
particle and (B) cis/trans ratio of LOOH in LDL particle during oxidations of Set A (LDL=0.75 
mg/mL, 1.0 mM C-0). 
 
The formation of lipid hydroperoxides was about 2/3 times less prevalent in 
supplemented LDL than in native LDL (Figure 4.9A). After α-TOH was consumed (∼2 h), 
peroxidation continued. For native LDL this rate seemed similar, but for supplemented LDL a 
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decrease in peroxidation rate was observed after consumption of α-TOH. Cis/trans ratios were 
highest in LDL supplemented with 2 indicating high antioxidant capacity in the core (Figure 
4.9B). 
 
4.4.3 Oxidation Set B 
LDL was supplemented with PyrOHs 1, 2 and 4 (37, 22, and 31 molecules per LDL and 
supplementation efficiencies of 100, 62 and 90 %, respectively). The resulting purified LDL 
stock solutions were diluted to a concentration of 0.46 mg/mL.21 This particular batch of LDL 
contained 12-13 molecules of α-TOH/LDL. Initiation was performed by adding aq. C-0 to a 
final [C-0] = 1.0 mM.  
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Figure 4.10: Relative consumption of (A) α-TOH and (B) PyrOH during LDL oxidations 
of Set B (LDL=0.46 mg/mL, 1.0 mM C-0). 
 
The α-TOH profile of these oxidations looked similar to the one in Set A, but the features 
were more pronounced (Figure 4.10A). Clearly, the initial sparing of α-TOH by 4 and especially 
2 was visible. In all cases, the time for consumption of α-TOH was prolonged with 1 h with 
respect to native LDL. Striking differences were observed in the consumption of the PyrOHs. 
Whereas 1 and 2 showed similar consumption patterns and were still present after 6-7 h, 4 
disappeared dramatically faster and was completely consumed in 4 h (Figure 4.10B). The lipid 
profiles also looked similar to the ones in Set A. Thus, all PyrOHs prevented oxidation in the 
LDL core at comparable efficiencies (Figure 4.11) with 2 performing overall best. In all cases 
peroxidation continued after consumption of α-TOH, with oxidations of supplemented LDL 
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continuing at lower rates. Most strikingly, 4 did not seem to have any clear antioxidant benefit 
over 1 or 2 even though it reacted much faster (Figure 4.10B). 
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Figure 4.11: (A) Number of cholesteryl linoleate hydroperoxides (LOOH) per LDL 
particle and (B) cis/trans ratio of LOOH in LDL particle during oxidations of Set B (LDL=0.46 
mg/mL, 1.0 mM C-0).  
 
4.4.4 Oxidation Set C 
LDL was supplemented with PyrOHs 2 and 3 to afford 12 and 7 molecules per LDL and 
supplementation efficiencies of 80 and 50 %, respectively. The amount of supplemented 
antioxidant was purposely lowered in order to get almost a 1:1 stoichiometry of PyrOH and α-
TOH. The investigations of 1 or 4 were not continued because 2 showed more promise overall. 
The resulting purified LDL stock solutions were diluted to a concentration of 0.75 mg/mL. This 
particular batch of LDL contained 8-9 molecules of α-TOH/LDL. Initiation was performed by 
adding aq. C-0 to a final [C-0] = 1.0 mM.  
With lower amounts of PyrOH in the LDL particle, the sparing effect actually became 
less obvious than in the previous Sets (Figure 4.12A). Nevertheless, a slight increase in the 
lifetime for α-TOH was observed and it appeared that PyrOHs 2 and 3 were about equally 
effective in this respect. However, the latter disappeared much faster, indicating a higher overall 
reactivity (Figure 4.12B). Figures 4.13A,B show that there is reduced antioxidant effect with the 
lower amount of PyrOH in the LDL particle as compared to previous Sets. Yet, both PyrOHs do 
inhibit oxidation to a certain extent and 3 seemed somewhat more effective than 2. 
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Figure 4.12: Relative consumption of (A) α-TOH and (B) PyrOH during LDL oxidations 
of Set C (LDL=0.75 mg/mL, 1.0 mM C-0). For clarity, x-scale shows 0 – 3 h, no α-TOH was 
detected after this point. 
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Figure 4.13: (A) Number of cholesteryl linoleate hydroperoxides (LOOH) per LDL 
particle and (B) cis/trans ratio of LOOH in LDL particle during oxidations of Set C (LDL=0.75 
mg/mL, 1.0 mM C-0). 
 
4.4.5 Oxidation Set D 
The same batches of supplemented LDL as in Set C were used. Initiation was performed 
by adding aq. C-0 to a final [C-0] = 0.5 mM. The amount of initiator was lowered in order to 
increase the lifetime of the antioxidants by lowering the extent of their reaction with water-
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soluble peroxyl radicals at the LDL surface. It was hoped that this would lead to a better picture 
of the synergistic action of all antioxidants in the LDL particle. 
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Figure 4.14: Relative consumption of (A) α-TOH and (B) PyrOH during LDL oxidations 
of Set D (LDL=0.75 mg/mL, 0.5 mM C-0). 
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Figure 4.15: (A) Number of cholesteryl linoleate hydroperoxides (LOOH) per LDL 
particle and (B) cis/trans ratio of LOOH in LDL particle during oxidations of Set D (LDL=0.75 
mg/mL, 0.5 mM C-0). 
 
Indeed, sparing of α-TOH was more pronounced again with lower initiator 
concentrations (Figure 4.14A). Both 2 and 3 were able to initially spare α-TOH for 1 h. The 
relative consumption pattern of 2 vs 3 was quite similar as in Set C, but absolute consumptions 
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were lower by about a factor 1.5. Once again, 3 was consumed much faster than 2 (Figure 
4.14B). Oxidation profiles looked somewhat better for supplemented LDL as compared to native 
LDL, with 2 and 3 having similar overall effect (Figure 4.15).  
 
4.5 Oxidation studies – in situ fluorescence assay 
Inspired by the clear and resolved emission signals from PyrOHs incorporated in LDL 
(Figure 4.5), the LDL oxidations were followed by fluorescence spectroscopy on two occasions. 
In addition to being much less time-consuming than HPLC analysis, this in situ method could 
provide detailed information about the dynamics of the antioxidants during oxidation. Figure 
4.16 shows the graphs obtained from the oxidation of native LDL and LDL supplemented with 1. 
The appropriate blanks showed that consumption of PyrOHs was not due to photodecomposition. 
A similar graph was obtained for LDL supplemented with 2.  
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Figure 4.16: Disappearance of absolute emission counts during oxidation of LDL (0.75 
mg/mL) initiated by C-0 (0.5 mM). Signal for PyrOHs: excitation at 330, emission at 380 nm. 
Signal for Trp residues: excitation at 295 nm, emission at 326 nm.22 (A) LDL supplemented with 
1 (B) Native LDL.  
 
Exposure of supplemented LDL to C-0 led to consumption of the incorporated PyrOH 1 
(Figure 4.16A) which is in full agreement with the HPLC analysis. A signal in native LDL at the 
same wavelengths was insignificantly small and did not change during the course of the 
oxidation (Figure 4.16B). Simultaneously, the fluorescence of the Trp residues in Apo B100 was 
also measured. It is known that Trp residues are amongst the most easily oxidized protein 
residues in Apo B100.7,23,24,26 Fluorescence spectroscopy has been used before to follow the 
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destruction of Trp residues during copper(II)7 or HClO-induced23 LDL oxidation, and during 
AAPH induced oxidation of Apo B100-Apo(a) complexes.24 Thus, the Trp destruction can serve 
as an early oxidation marker. 
Clearly, oxidation of native LDL induced by water-soluble peroxyl radicals also led to 
immediate destruction of Trp residues of Apo B100 (Figure 4.16B). Interestingly, there seems to 
be a lag time in protein damage in an analogous oxidation of supplemented LDL (Figure 4.16A). 
The signal only started to decay after 1 had been consumed. Theoretically, quenching (re-
absorption) of the Trp emission light (326 nm) by time-dependent amounts of 1 (λmax = 330 nm) 
could occur. However, the absolute Trp counts in native LDL at t=0 (Figure 4.16B) are very 
similar to the value for supplemented LDL at t=0 (Figure 4.16A). This is supported by the fact 
that the rest absorbance due to PyrOHs in supplemented LDL was only ∼0.05 after a typical 
supplementation (Figure 4.4).25 Thus, virtually no absorption of emission light should occur and 
the lag time in Figure 4.16A looked relevant. 
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Figure 4.17: Consumption of Trp residues in Apo B100 during oxidations with native 
LDL or LDL supplemented with 1, 2 or 4 (0.48 mg/mL) initiated by C-0 (1.0 mM). Signal for 
Trp residues: excitation at 295 nm, emission at 326 nm.22 PyrOH emission signals (not shown) 
had disappeared after 60, 60 and 30 min for LDL supplemented with 1, 2 and 4, respectively. 
 
This in situ fluorescence protocol was repeated with a different batch of LDL that had 
been supplemented with 1, 2 or 4 (Figure 4.17). The batch of blood used gave rise to lower 
absolute emission signals for the PyrOHs and therefore lower sensitivity for PyrOH detection. 
Possibly this is due to the different constitution of the purified plasma.  Yet, PyrOH signals could 
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still be clearly detected and were found to rapidly disappear upon oxidation (not shown, see 
footnotes Figure 4.17). This shorter PyrOH lifetime compared to Figure 4.16 is the result of the 
∼3 x higher radical flux employed. Again, lag times were present for all three PyrOHs but they 
were shorter which is consistent with a faster PyrOH decay. Overall, 2 seems to be better in 
protecting Trp residues than the other two PyrOHs in terms of lag time and overall Trp 
fluorescence. It is anticipated that this in situ assay, if so desired, can be optimized in terms of 
higher signal sensitivity, for example, by changing slit widths or selecting more appropriate 
wavelength-couples. 
 
Thus, the interesting observation was that the PyrOHs, but not α-TOH, seem to 
effectively prevent oxidative damage of Trp residues in Apo B100. The lack of α-TOH to protect 
these residues to oxidation is known.7 It has been proposed that damage of Trp residues in Cu2+ 
mediated oxidations occurs by initial formation of Trp carbon-centered radicals by electron 
transfer from Trp to Cu2+. These radicals can subsequently add oxygen to give peroxyl radicals 
and further decomposition products.26 Some of these decomposition products, such as 
kinurenine, can be detected readily by HPLC.26 Likely, the first step can also occur with water 
soluble peroxyl radicals in the form of simple H-atom abstraction from surface-accessible Trp-
residues by InOO•. Maybe the PyrOHs are better in sparing the Trp residues because of their 
ability, both in terms of reactivity and location, to prevent formation of the Trp radicals. It should 
be noted, however, that not enough data have been collected to be more specific on this issue. 
Yet, protein damage is what can ultimately cause the LDL particles to be recognized by 
scavenger receptors in the artery wall27 and therefore the antioxidant activity of PyrOHs on Apo 
B100 deserves further investigation.  The dynamic and non-destructive nature of the in situ 
fluorescence assay is certainly attractive for this purpose.  
Owing to the speculative nature of the results described in this section, they are not 
included in the discussion in the next section.   
 
4.6 Oxidation studies – discussion 
4.6.1 Lipid oxidation profiles  
Exposure to water-soluble peroxyl radicals led to peroxidation of lipids in LDL particles. 
In all oxidations of native LDL, peroxidation continued at a comparable or higher rate even after 
the phase- and radical-transfer agent α-TOH was completely consumed. This has been reported 
for native LDL by Stocker et al.28 under similar oxidation conditions as described in this 
chapter.29 They reported that the rate of inhibited peroxidation Rp
inh, with α-TOH still present, is 
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virtually independent on the initiator concentration. The lipid oxidation profiles for native LDL 
(Figure 4.9A, 4.11A, 4.13A, 4.15A) matched with this, Rp
inh being very similar in Sets A-D. 
However, the rate of the subsequent uninhibited peroxidation Rp
uninh, after consumption of α-
TOH, depended on initiator/LDL ratio. This is also in agreement with Stocker’s results28 and can 
be rationalized by taking into account that TMP is the major oxidation mechanism during 
inhibited peroxidation, with initiation by α-TO• being the slow and rate-determining step. 
However, when α-TOH is consumed, another mechanism must be operative. For example, 
water-soluble peroxyl radicals can react with lipid hydroperoxides located on the surface which 
can then initiate chains in LDL. The reaction of linoleate esters with LOO• is much faster than 
with α-TO• (62 vs 0.03 M-1s-1 in solution, respectively)30,31 resulting in a dependence of Rpuninh, 
but not Rp
inh on initiator/LDL ratio. 
In all lipid oxidation profiles of supplemented LDL (Figure 4.9A, 4.11A, 4.13A, 4.15A), 
the peroxidation rate until full consumption of α-TOH, Rp1, was slightly lower compared to Rpinh 
(native LDL). This shows that the PyrOHs are able to reduce the overall effect of exposure of 
LDL to radical species. For LDL containing just α-TOH, Stocker has shown an almost linear 
effect of Rp
inh on α-TOH content.3 In the present case, supplemented LDL showed reduced 
peroxidation compared to native LDL despite the presence of a higher total amount of phenolic 
antioxidants in the former. This indicated that PyrO• radicals show considerably less tendency 
towards AMP (Antioxidant Mediated Peroxidation), i.e. PyrO• radicals are less efficient radical 
transfer agents than α-TO•. This result is in agreement with the solution oxidations described in 
Section 3.2 where the extent of methyl linoleate oxidations was much lower with added PyrOH 
than with added α-TOH. The shapes for the cis/trans curves for supplemented LDL looked very 
similar as for native LDL (Figure 4.9B, 4.11B, 4.13B, 4.15B), but the cis/trans ratios were 
consistently higher in supplemented LDL. This indicates that the H-atom donating capacity in 
the core of supplemented LDL is higher than in native LDL.  
A general comparison of all lipid oxidation profiles revealed that 2 and 3 are the most 
effective PyrOHs in preventing oxidation in the LDL core.  
 
4.6.2 α-TOH consumption profile 
Exposure of LDL particles to water-soluble peroxyl radicals led to the consumption of 
the antioxidants. The simultaneous analysis of the two classes of antioxidants (α-TOH and 
PyrOH) provided information about their mutual interaction. Generally, in all oxidations with 
supplemented LDL, α-TOH remained present for somewhat longer times compared to native 
LDL. This longer lifetime of α-TOH is consistent with the presence of a larger amount of 
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antioxidants in the LDL particle. A more pronounced sparing effect was observed for LDL 
supplemented with 2 (Figure 4.10A, 4.12A, 4.14A) or 3 (Figure 4.14A) under mild radical flux 
conditions. For the first 30-60 min the α-TOH content remained nearly constant, while the 
PyrOH content decreased.32 Similar sparing effects have been observed for liposomal 
membranes or LDL containing α-TOH and the lipophilic antioxidant ubiquinol-10.33,34,35 In 
those cases, ubiquinol-10 quenched α-TO• and thereby regenerated α-TOH, i.e. α-TOH did not 
disappear until almost all of ubiquinol-10 had been consumed. In oxidations of LDL 
supplemented with 2 or 3, however, α-TOH started to disappear rapidly after 30-60 min while 
there was still considerable PyrOH left. Likely, this meant that α-TO• was formed after 30-60 
min despite the presence of residual, more active PyrOH. A difference in location and mobility 
of α-TOH and PyrOH in the LDL particle may explain this observation. Apparently, during the 
first 30-60 min the locations of the antioxidants are such that PyrOH can very effectively spare 
α-TOH. However, the sparing capability drops drastically after that point. A comparison of the 
slopes of α-TOH consumption in supplemented LDL starting at t=30-60 min and in native LDL 
from t=0 min suggests that the sparing efficiency was more or less reduced to zero after t=30-60 
min. This is an intriguing observation. It is suggested that, during the initial 30-60 min of the 
oxidation, the structure of the LDL particle might change such that it restricts the mobility of the 
PyrOHs or causes them to reside in alternative locations. Prassl et al. performed LDL oxidations 
under similar conditions as described in this chapter (1 mg/mL of LDL, similar initiating radical 
flux) and followed the relative destructions of Apo B100 by its denaturation profile, and the lipid 
core by its characteristic transition temperature.36 They found that during the early stages of 
oxidation (∼1 h), the protein at the surface was the main target for structural damage, while the 
lipid core components preserved their structural integrity.  In other words, the LDL surface was 
much more prone to structural changes than the lipid core in the early stages of oxidation. It 
might be speculated that this will have an effect on the mobility of the various antioxidants, 
obviously more so on the surface than in the lipid core. 
In general, it seems fair to say that all PyrOHs studied did prolong the lifetime of α-TOH. 
In addition, PyrOHs 2 and 3 completely inhibited α-TOH consumption for the first 30-60 min 
under mild radical flux conditions. 
 
4.6.3 Pyridinol consumption profile 
The different reactivities of the various PyrOHs upon oxidative conditions are evident. 
PyrOH 2 was tested in all Sets of oxidations and therefore provided a convenient reference for 
the relative reactivities. Thus, the consumption times of 1-4 (Sets B and C) per initial PyrOH, all 
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relative to 2, could be estimated for a given set of oxidations. The values are collected in Table 
4.1.  
 
PyrOH Relative consumption time a Estimated from Set 
1 0.60  B 
2 1.00 - 
3 0.49 C 
4 0.35 C 
(a) Defined as the time needed for the total PyrOH consumption per initial 
PyrOH molecule present divided by the corresponding value for 2 in a parallel 
oxidation in the same Set.  
 
Table 4.1: Estimated relative consumption times for PyrOHs during oxidations. 
 
The trend seems to reflect the solution reactivities of the respective PyrOHs with the 
notable exception of 2. Thus, the order of reactivity 1 < 3 < 4 is the same as in solution 
autoxidation studies with their non-lipophilic counterparts (Section 3.2.3). It should be 
emphasized that the consumption of the PyrOHs in LDL may reflect several pathways, such as 
the reaction with LOO• but also with O2 and LOOH (Section 3.3.2, vide infra). Despite the fact 
that 2 had the lowest relative rate of consumption in LDL oxidations, it actually competed with 3 
for being the best PyrOH studied in LDL as shown by lipid oxidation profiles and α-TOH 
sparing. This is an interesting point, because it brings up the issue whether 2 is showing the dual 
antioxidant action for which it was initially designed (Scheme 1.14) After quenching one LOO•, 
the resulting PyrO• theoretically could donate another H-atom to LOO• or react with O2 to 
export superoxide out of the particle. Either scenario will enhance the per mole antioxidant 
activity of 2 in LDL. At this point there is no conclusive evidence if and which of such 
mechanisms is operative.  
PyrOH 4 was consumed very fast and it is clear that this can only be partially attributed 
to an excellent antioxidant activity (Figure 4.10, 4.11). PyrOHs 1 and 4 were present in similar 
amounts yet 4 disappeared ca. twice as fast without noticeable improvement in lipid oxidation 
profile. It is suggested that 4, in addition to acting as an antioxidant, decomposes readily in the 
LDL particle by independent pathways. The stability issue of these 5-membered ring-annelated 
PyrOHs has already been noticed during their synthesis. Given the results of the stability 
experiments described in Section 3.3.1, it seems reasonable to suggest that electron transfer from 
4 to O2 was one of these pathways. This process would yield superoxide and thus render 4 a pro-
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oxidant. Other pathways may include oxidation of the pyridine moiety by the lipid 
hydroperoxide products yielding inactive oxygenated PyrOHs (Section 3.3.2). On the basis of 
solution stability studies, it may be expected that 6-membered ring-annelated PyrOH 3 can also 
suffer from instability problems in LDL oxidations. However, from Sets C and D it is clear that 3 
actually has a comparable antioxidant efficiency as 2 while being present in a lower 
concentration. A delicate balance between activity and stability might be the crucial factor in the 
case of these more reactive ring-annelated PyrOHs. It was concluded that 3 has sufficient 
promise to justify further study. On the other hand, 4 is deemed not to be useful as an in vivo 
antioxidant.  
 
4.7 Conclusion and outlook 
An assay was developed to determine the concentration of LDL by using the fluorescence 
of Trp residues in Apo B100. This assay was less time-consuming and less prone to introduction 
of experimental errors than the standard Lowry assay. 
Pyridinols 1-4 were successfully incorporated in human LDL. All prevented oxidation of 
LDL lipids when LDL was exposed to water soluble peroxyl radicals. This was deduced from 
their sparing of α-TOH and the reduced amount of oxidation products.32 Careful analysis of the 
results indicated that the pyridinols have reduced radical-transfer activity, which is in accordance 
with the solution studies on BDE and kinh. Compounds 2 and 3 look most promising as 
antioxidants. 5-Membered ring-annelated pyridinol 4 is too unstable to be useful, whereas 1 
shows lower activity than 2 and 3.  
 
It is recommended to continue studies with pyridinols 2 and 3. Investigation of the 
oxidation behavior of the LDL surface, both phospholipids and Apo B100, could provide crucial 
additional information that complement/refine the results presented in this chapter. However, it 
should be mentioned that techniques to follow phospholipids oxidation in detail became 
available only recently.37,38 Therefore, when this project was continued, experiments were 
planned to look at the relative extents of oxidation of both the lipids in the LDL core (cholesteryl 
esters) as well as the surface (phospholipids, possibly Apo B100) in an effort to obtain 
information on the PyrOHs location in LDL and its overall antioxidant effect on the whole LDL 
particle. Ultimately, this could lead to a defined model of the action of synthetic pyridinol 
antioxidants in human LDL. An issue that should not be overlooked is that the pKb-values of the 
pyridinols, upon incorporation of the annelated ring (Section 2.5.2), seem to approach the pH of 
the buffer utilized in the LDL experiments. Potential protonation of the pyridinol headgroups at 
pH 7.4 and its effect on overall PyrOH activity therefore needs to be investigated.  
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A very important point, only briefly mentioned here, is the reaction of PyrOH with 
LOOH described earlier in Section 3.3.2. It is very likely that this may occur in LDL particles as 
well. Since this phenomenon was not discovered until very late in the project, no experimental 
data have been collected that can shed light on its contribution to the overall performance of 
PyrOHs in LDL.  
Finally, some interesting speculations can be made concerning the action of some current 
drugs by taking into account the results reported in this chapter.  Certain 2-amino-pyridine drugs 
are metabolized quite efficiently to the corresponding 3-hydroxy-6-amino-pyridines or the 3-O-
sulfate esters39,40,41 and this raises the question whether the metabolites, which are PyrOHs, 
actually contribute to the beneficial drug effect. For example, the pharmacophore in the diabetes 
drug BRL 49653, which is currently marketed under the name rosiglitazone, is the 
thiazolidinedione unit (Figure 4.18). It is known that this compound is a potent and selective 
ligand for peroxisome proliferator-activated receptors (PPAR), which are transcription factors 
that regulate expression of genes involved in lipid metabolism.42 Alternatively, a naturally 
occurring group of ligands for these PPARs are actually simple unsaturated fatty acids as well as 
certain prostaglandins.42 Interestingly, 3-hydroxy metabolites of the drug have been detected 
abundantly in rats and dogs41 and in incubations of human liver microsomes.43  It is suggested 
that these metabolites, having a PyrOH-type structure, may contribute to the in vivo drug effect 
by changing the overall lipid profile through antioxidant activity. 
 
N
N
O
NH
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O
O
3-position thiazolidinedione unit
 
 
Figure 4.18: Structure of BRL 49653 (or Rosiglitazone), a drug used for treatment of 
non-insulin dependent diabetes mellitis. The relevant structural features are shown. 
 
4.8 Experimental section 
Materials and methods. All chemicals and Apo B100 were purchased from Sigma-Aldrich 
Chemicals and used without further purification, unless stated otherwise. The azo-initiator C-0 (15) was 
generously donated by Wako Chemicals USA Inc. All reusable glassware contaminated with blood 
products was soaked in a solution of full strength bleach for 15 min and then washed with Envirocide® 
(Metrex Research Corp; Parker, CO) and finally rinsed with deionized water three times.  Phosphate-
buffered saline (PBS, pH 7.4, 50 mM) was prepared from NaCl (32.0 g), Na2HPO4 (20.0 g) and NaH2PO4 
(7.85 g) in deionized water (4L) followed by adjustment of the pH to 7.4 with NaOH. It was stored over 
Chelex-100 resin (ca. 3 g/L, purchased from BioRad) for 24 h. The resin was removed and 
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diethylenetriaminepentaacetic acid (DETAPAC) was added to a final concentration of 100 µM in order to 
remove trace metal contaminants. The standards, α-TOH and δ-TOH, were purified by column 
chromatography. The PyrOHs were synthesized and purified prior to use as described in Chapter 2, their 
purity being > 95 % judging from HPLC with UV detection at 330 nm. Biorad DC Protein Assay was 
purchased from BioRad. PD10 columns were obtained from Supelco. Solvents were HPLC quality and 
purchased from commercial sources. UV-spectra were recorded on a Hewlett Packard HP8452A 
spectrometer. Fluorescence measurements were recorded on a ISS PC1 Photon Counting Spectrometer 
(excitation slit: 0.5, emission slit: 1.0 mm). HPLC analysis was performed with a Waters 600 Controller, 
717 Autosampler and 996 Photodiode Array. HPLC analysis of antioxidants was carried out on a single 
Supelco 5 µm Discovery C-18 column (4.6 mm x 25 cm) using reverse phase conditions (1.5 mL/min, 
eluent: 4 L of MeOH mixed with 8.85 g LiClO4, 200 mL HPLC grade water and 8.0 mL of distilled 
pyridine) and electrochemical detection (LC-4C, from BAS) according to a published procedure.44 The 
electrode was polished regularly and response factors were measured frequently, as the response tended to 
decrease with increased use. HPLC analyses of lipids were carried out on two tandem Beckman 5 µm 
Ultrasphere columns (4.6 mm x 25 cm) using normal phase conditions (1.0 mL/min, eluent: 0.4 % or 0.5 
% i-PrOH/hexanes) and UV detection (235 nm) which provided separation of the four isomeric 
cholesteryl linoleate alcohols resulting from hydroperoxides 5 - 8. Centrifugations for the LDL-isolations 
were performed with a Beckman Optima LE-80K centrifuge and a Ti 70 rotor. Centrifugations for work-
up of oxidation samples were performed on an Adams analytical benchtop centrifuge. 
LDL Isolation. This work involves the use of lipoproteins isolated from human blood. Blood 
donations were conducted in accordance with guidelines established by the Institutional Review Board 
(IRB) at Vanderbilt University; the procedures are outlined by the Vanderbilt University IRB Study 
Protocol 905, “Free Radicals, Membranes, and Enzyme Photoactivation,” PI: Ned A. Porter, Ph.D.  
Guidelines regarding occupational exposure to blood borne pathogens, as presented by the office of 
Vanderbilt Environmental Health and Safety, were followed when blood products were manipulated.45,46 
Blood donations were conducted in the Clinical Research Center (Vanderbilt University Medical Center, 
Medical Center North, AA-3200).  Whole blood was isolated from fasting, normolipidemic healthy 
subjects in two Baxter 250 mL blood collection bags containing 35 mL of an anticoagulant citrate 
phosphate dextrose solution.  This anticoagulant solution contained 921 mg of sodium citrate (dihydrate), 
893 mg of dextrose (monohydrate), 105 mg of citric acid (anhydrous), and 78 mg of monobasic sodium 
phosphate (monohydrate).  To collect the plasma, the bags containing the blood were then centrifuged at 
4200 rpm for 10 min at 22ºC at the Vanderbilt University Hospital Blood Bank (Room 3115).  Plasma 
was transferred into a second blood bag and the red blood cells were discarded. 
LDL (1.019 < density < 1.063 g/mL) was isolated from the plasma over 24-30 h by density 
gradient sequential floatation at 14ºC.47 One spin, to remove chylomicrons, VLDL, and IDL (density < 
1.019 g/mL), was performed at 70,000 rpm for 5.5h. A second spin, which isolated LDL from the HDL, 
was performed using the same spin conditions.  Optima Optiseal polyallomer tubes were used for the first 
spin, while Beckman polycarbonate tubes were used for the second spin.  The isolated LDL was passed 
through two consecutive PD-10 columns, which had been equilibrated with 25 mL of PBS, to remove 
KBr leftover from the centrifugation.  The following procedure was used for this desalting technique: 2.5 
mL of LDL was loaded onto each column, 0.4 mL of PBS was then loaded onto the columns, and LDL 
was then eluted with 2.7 mL of PBS.  The elution was monitored by observing the orange-yellow color of 
LDL move from the column.  The 2.7 mL of LDL collected from each column was then loaded onto a 
second equilibrated PD-10 column, 0.2 mL of PBS was loaded onto the column, and LDL was eluted 
with 2.9 mL of PBS.  The LDL dispersion was then stored at 4ºC under argon in the dark until further use, 
usually no longer than 1 week from isolation. 
Protein concentration. Protein concentrations were determined by the Trp fluorescence assay 
(vide infra) and by the UV-Vis method of Lowry48 as modified by Evans5 or, more recently, the BioRad 
DC Protein assay.  
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Fluorescence assay. An aliquot (100 – 200 µL) of LDL was withdrawn from the stock LDL 
dispersion and diluted with 2 – 3 mL of SDS solution (3 mM in PBS buffer). The solution was vortexed 
for 30 sec and equilibrated in the fluorometer at 37 °C prior to analysis. The fluorescence signal was 
measured at 37 °C (excitation at 280 nm, emission at 326 nm, excitation slit 0.5, emission slit 1.0 mm). 
The uncorrected protein concentration was calculated using the response of plain Apo B100 in SDS 
buffer at 37 °C (2571 counts per µM Trp residue = 95127 counts per µM Apo B100). As explained in the 
text, a correction factor of 1.62 has to be applied hereafter to correct for the differences in Apo B100 
environment in SDS buffer vs. average disaggregated LDL particle. Alternatively, the corrected response 
factors can be used directly (4165 counts per µM Trp residue = 154105 counts per µM Apo B100. 
 
 
Figure 4.19:  Representative SDS-PAGE gel comparing the protein content of the some isolated 
lipoprotein fractions.Taken from ref 49. 
 
Apoprotein Mr Lipoprotein Fraction 
A-I 29,016 HDL 
A-II 17,400 HDL 
B-100 515,000 VLDL, LDL 
B-48 241,000  
C-I 7,000 VLDL, HDL 
C-II 9,000 VLDL, HDL 
C-III 9,300 VLDL, HDL 
D 19,000 HDL 
E 33,000 VLDL, HDL 
Albumin 66,000 Found in plasma 
 
Table 4.2: Lipoprotein fractions, associated apoproteins and their masses. Taken from ref 49. 
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LDL purity.  Care had to be taken not to contaminate the LDL fraction with other lipoproteins 
(HDL, IDL, VLDL, chylomycrons). SDS-PAGE gels, run on a Ciba-Corning electrophoresis system, and 
LipoGels, run on a Beckman Instruments Paragon LipoGel system, were used to determine the purity of 
LDL.  Each lipoprotein class has a specific set of associated apoproteins which can be detected by the 
gels.  A typical SDS Page gel is shown in Figure 4.19. A list of lipoprotein fractions and the associated 
apoproteins is presented in Table 4.2. 
Large-scale supplementation of LDL.  Purified LDL (2.46 – 2.48 mL) was equilibrated by 
gentle stirring at room temperature for 5 min. A concentrated solution of the antioxidant in DMSO (2 – 4 
mM, 20 – 70 µL) was added dropwise over a period of 20-30 sec. Gentle stirring was then continued at 
room temperature.13 After 30 min, free antioxidant was removed by passage through two consecutive PD-
10 columns under elution conditions already described for desalting LDL (see ‘LDL isolation’). Control 
experiments showed that ca. 90 – 95 % of the free antioxidant was retained by this protocol. Protein 
concentrations of supplemented LDL were then determined by the Lowry assay or BioRad DC Protein 
assay. 
Kinetic supplementation studies. Purified LDL (∼150 µL) was equilibrated by gentle stirring at 
room temperature for 5 min in a vial. A concentrated solution of PyrOH in DMSO (2 – 4 mM, 2 – 4 µL) 
was added after which the vial was slowly rotated manually for a few seconds to ensure efficient mixing 
of the two liquids. Gentle stirring was then continued at room temperature. Aliquots (30 µL) were 
withdrawn at intervals, diluted with 1.0 mL of PBS buffer and immediately passed through two PD10 
columns under the following elution conditions: the whole 1.03 mL was loaded on a PD10 column 
followed by 1.0 + 1.0 mL buffer and LDL was then eluted with 1.2 mL PBS.  This 1.2 mL was then 
loaded onto a second equilibrated PD-10 column, followed by 0.8 + 1.0 mL buffer and LDL was then 
eluted with 1.4 mL PBS. Subsequently, internal standard was added and extraction was performed with 5 
mL of methanol and 7 mL of hexanes. The hexane phase was analyzed for antioxidants as described in 
the next paragraph. Blanks without added PyrOH were conducted to determine the loss of LDL on the 
PD10 columns. This efficiency number was used throughout when the PyrOH incorporation number was 
calculated.  
Oxidation of LDL. The LDL concentration was adjusted with PBS to give final concentrations 
of 0.46 or 0.75 mg/mL and allowed to equilibrate to 37 °C for 5 min in a vial. In two sets of experiments, 
a quartz cuvet equipped with a 2.0 mm stirring bar was used. To the stirred solution was added the 
requisite amount of C-0 initiator in water (50 mM). The solution was then gently stirred at 37 °C. In two 
sets of experiments, the oxidation mixture was analyzed frequently by fluorescence spectroscopy 
(wavelength couples: 295/326 nm and 330/380 nm). In all experiments, two aliquots (one for antioxidant, 
AOX, analysis and one for lipids, LIP, analysis) were removed at various intervals and treated as 
described below. Aliquots taken were usually 140 or 150 µL each.  To the AOX aliquot was added BHT 
(25 µL of 3 mM solution in MeOH)50, to the LIP sample BHT and Ph3P (25 µL of 25 mM solution in 
MeOH). Aliquots were then worked up or stored at -78 °C until work-up. To the aliquots was added a 
known amount of internal standard in hexanes (δ- or γ-TOH for AOX sample, methyl 13-
hydroxyoctadecane-trans-9-trans-11-dienoate for LIP samples). Extraction of all aliquots was performed 
with 1 mL of methanol, 1 mL of PBS buffer18 and 5 mL of hexanes. After vortexing and centrifugation, 
the hexanes phase was removed and concentrated by a dry N2-stream or by using a speed-vac. The residue 
was redissolved in the mobile phase used for HPLC analysis. HPLC conditions including solvent system 
for antioxidant and lipid analysis are given in the ‘Materials and methods’ section. The following general 
retention times for antioxidants were found when the specified reverse phase solvent system was used: 
compound 1 @ 14.7 min, compound 2 @ 9.5 min, compound 3 @ 18.0 min, compound 4 @ 13.5 min, α-
TOH @ 18.0 min, δ-TOH @ 12.0 min, γ-TOH @ 15.0 min. The following general retention times were 
found for the lipid alcohols when the specified normal phase solvent system was used: CE 6 @ 19 min, 
CE 8 @ 21 min, CE 5 at 28.0 min, CE 7 at 30.0 min, standard @ 50 min. 
Analysis for aggregation behavior of PyrOH by fluorescence. To 2.0 mL of PBS buffer was 
added  0 – 25 µL of PyrOH (3.3 mM in DMSO) followed by 1 µL of a diphenyl-hexatriene solution (18.1 
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mM in THF).14 The solutions were stirred in the dark at room temperature for 1 h and then analyzed by 
fluorescence spectroscopy (excitation at 385, emission at 430 nm). Absence of fluorescence signal meant 
that no aggregation had occurred, i.e. concentration of PyrOH was lower than the CMC. 
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 5 
 
 
5.1 Introduction 
The N-methyl substituted 6-amino-3-pyridinols described in Chapter 2 and 3 were 
designed such that these molecules would be suitable for simple solution oxidation studies. The 
N-phytyl derivatives described in Chapters 2 and 4 were prepared to afford similar model 
compounds but with lipophilic properties suitable for use in LDL oxidations. However, when 
one thinks of an expanded scope, such as investigation of these pyridinols in vivo, a look at 
Nature is necessary. For example, all 8 possible stereoisomers of α-Tocopherol (α-TOH) are 
equally strong antioxidants in solution. However, (R,R,R)-α-TOH is apparently Nature’s 
antioxidant of choice since it is the isomer that is most efficiently incorporated in lipoproteins.1 
This preference can be directly related to preferential binding of the R,R,R-isomer to the hepatic 
tocopherol binding protein.2 Thus, it would be of great interest to synthesize a 6-amino-3-
pyridinol with the greatest possible structural resemblance to (R,R,R)-α-TOH. This structural 
protocol calls for target 1, a 6-amino-3-pyridinol isostere of (R,R,R)-α-TOH. The most striking 
feature of 1 is that the lipophilic tail is no longer connected to the N-atom, as in the phytyl 
derivatives described in Chapters 2 and 4, but on the aliphatic ring thereby introducing an extra 
stereogenic center. It should be pointed out that the phytyl chain, as used in Chapter 2, is actually 
a C20 chain rather than the C16 chain of α-TOH. The reason for this is the better commercial 
availability of the C20 precursor while the structural resemblance is still acceptable. For the same 
reason, preliminary syntheses of compounds related to 1 were performed with this C20 precursor, 
obtained as a racemic diastereomeric mixture from Aldrich Chemical Co. It was assumed that in 
a later stage, after optimization of the synthesis, the appropriate enantiopure (R,R)-C16 precursor 
synthesis of 6-amino-3-
pyridinol isosteres of 
Vitamin E  
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could be prepared by an established 5-step literature method3 and used in the same way as the 
C20 precursor. 
 
HO
O
(R,R,R)-α-Tocopherol (α-TOH)
N
HO
N
H
(R,R,R)-1  
 
Thus, the initial objective was to develop a synthetic methodology for the preparation of 
target 2. In addition, the preparation of des-methyl derivative 3 was investigated since the 
absence of a quaternary center could render its synthesis less problematic than that of 2. This 
target 3 still has a reasonable structural similarity to α-TOH. Having established the synthetic 
routes to the targets 2 and 3, the attention will be focused to the introduction of the correct 
stereochemistry, both in the side chain and in the ring, and the right chain length of the side 
chains. Thus, this chapter will not describe optimized syntheses, but rather will outline a short 
synthetic strategy that has the potential to achieve the goals described above. 
 
N
HO
N
H
2: (all-rac), R=Me
3: (all-rac), R=H
R
 
 
5.2 Synthesis of an isostere having a quaternary carbon α to the nitrogen 
atom 
5.2.1 Approaches from monocyclic precursors 
The same general strategy as outlined in Chapter 2 was used. Thus, the preparation of the 
appropriate bicyclic structure was to be followed by bromination and hydroxylation. A critical 
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look at the structure of 2 reveals that a possible bottleneck could be the construction of the 
quaternary carbon α to the nitrogen atom.  Indeed, there is virtually no precedence for structures 
such as 2 or even the non-hydroxylated derivatives. Only one paper reports the synthesis of a 
similar structure by a palladium-mediated Hegedus-coupling between a 2-amino-pyridine and a 
vinylic side-chain.4 Despite the smooth coupling, it was expected that the specific vinylic 
precursor, required for the present study, may not be straightforward to prepare. Therefore, it was 
decided to use precursors that have the pyridine skeleton already in place. 
 
N NH2
+
4 5
5
+
TFA
reflux
OH
O
N NH2OH
N N
H
OH
O
N N
H
 
 
Scheme 5.1: Attempted reactions of 2-amino-4,6-dimethylpyridine. 
 
In the first attempts the same Michael-approach, as described in Section 2.4.1 for the 
simple bicyclic structures, was used although more difficulties were to be expected (Scheme 
5.1).5 Preliminary experiments were carried out with dimethyl-acrylic acid (4) as the model 
reactant. It was subjected to reactions with 2-amino-4,6-dimethylpyridine (5) under a variety of 
conditions. Attempted conditions include: pyridine / heating at reflux, pyridine / 220 °C / 
pressure, N-methylmorpholine / heating at reflux, 2,4,6-collidine / heating at reflux, n-BuLi / 
THF, AcOH / heating at reflux, TFA / heating at reflux or neat / 100 °C. In all cases the starting 
materials were recovered. Even though the addition of benzylamine to 4 has been described,6 the 
combination of the steric hindrance of 4 and low nucleophilicity of 5 rendered this coupling 
completely unsuccessful. Replacing 4 with its ethyl or tert-butyl ester led to predominant amide 
formation. Similar problems were encountered by Robillard et al. in their attempts to add 
aromatic thiols to polysubstituted acrylates.7 Acidic coupling of 2-methylbut-3-en-2-ol and 5 
unfortunately gave migration of the double bond (Scheme 5.1). Approaches using isoprene8 or 
chlorinated alkynes9 also failed. It was concluded that annelation reactions, to construct the 
desired bicyclic structures from precursors already containing the quaternary carbon, are not 
viable. 
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5.2.2 Naphthyridine approach  
 
N
HO
N
H
R
N N
H
R
N N
a [1,8]-naphthyridine 
 
Scheme 5.2: Retrosynthetic analysis leading to the use of [1,8]-naphthyridines. 
 
In the structures of 2 and 3, a partially reduced [1,8]-naphthyridine structure can be 
recognized. It is known that [1,8]-naphthyridines without α-substituent can be alkylated adjacent 
to the nitrogen atom using alkyl- or aryllithiums.10,11,12 Acknowledging this as a good synthetic 
opportunity for the present study, a retrosynthetic strategy was designed leading to the use of 
[1,8]-naphthyridines (Scheme 5.2). The advantage of this route is the construction of the bicyclic 
unit prior to later-stage quaternization. The question remained whether the addition of R could be 
performed on α,α’-disubstituted [1,8]-naphthyridines. So far, this particular transformation has 
not been described. Therefore, its viability needed to be investigated. The required trimethyl-
substituted [1,8]-naphthyridine 6 was prepared by the Skraup reaction following a literature 
procedure (Scheme 5.3).13 
 
N N
+
5 6
a)
N NH2
O
 
Key: a) H2SO4, H2O, FeSO4, H3BO3, sodium 3-nitrobenzenesulfonate, 
150 °C, 10 h, 36 %. 
 
Scheme 5.3: Skraup synthesis of [1,8]-naphthyridine 6. 
 
It was found that adding more H2SO4 to the reaction mixture drove the reaction to 100 % 
conversion. Nevertheless, the reported yield of 82 %13 could not be reproduced. Instead, a 
modest 36 % yield of clean product was obtained. The low yield undoubtedly is the result of the 
very cumbersome isolation procedure. The reaction involves an initial Michael addition of the 
amine to crotonaldehyde, followed by nucleophilic attack of the ring on the aldehyde unit, 
subsequent dehydration and oxidation by sodium 3-nitrobenzenesulfonate. Apparently, FeSO4 
and H3BO3 are added to moderate the potential violent behavior of this reaction.
14,15 Interestingly, 
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when the Skraup reaction was tried with 3,3-dimethyl-acrolein, the initial Michael addition again 
failed to proceed (Section 5.2.1), even under these forcing conditions. 
 
N N
6
n-BuLi
N N
H
NN
H
7 (desired) 8
+
 
 
Scheme 5.4: Addition of n-BuLi on trisubstituted [1,8]-naphthyridine 6. 
 
The desired alkyllithium addition was extensively investigated with compound 6 and n-
BuLi (Scheme 5.4). A regioselectivity problem, leading to compounds 7 and 8, was expected, 
although it was hoped that the slightly less electron-rich ring would be the preferred site of 
attack. Upon addition of n-BuLi to 6 in THF at -78 °C, a deep-red color developed but very little 
conversion was observed. The deep-red color was attributed to the anions 9a,b formed by 
deprotonation of the acidic α-methyl groups in 6. It was suspected that there is competition 
between deprotonation, leading ultimately back to starting material 6, and alkyl addition to 
afford 7 and 8. In scheme 5.5, all intermediates and products involved in the proposed 
mechanism are depicted. Alkyl addition (pathway B), to give nitrogen centered anions 10a,b, 
does not proceed readily at -78 °C, because 6 is an α-substituted naphthyridine. However, at 
higher temperatures, deprotonation (pathway A) dominated in THF and consumed most or all 
starting material, leading to anions 9a,b which are inactive and result in recovery of starting 
material 6 after aqueous quenching.  
Anion 10 is more shielded from solvent interaction because of steric bulk by neighboring 
groups, whereas 9 is readily accessible for interaction with solvent. In addition, one would 
expect that 9 is inherently less stable than 10 since its charge resides on a more electropositive 
atom. Thus, it was reasoned that lowering the solvent polarity should have a more profound 
destabilizing effect on anion 9 than on 10. This is clearly demonstrated by the higher conversions 
in entries 3, 4 and 5 (Table 5.1). The opposite is also true: in the very polar solvent DMPU an 
intense red color was formed immediately but all starting material was recovered unchanged 
(entry 1). In all cases except in entry 6, compounds 6, 7 and 8 were the only significant products 
and no 1,4-addition products could be detected.   
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Scheme 5.5: Reaction of 6 with n-BuLi: competition between deprotonation and 
addition.  
 
# Solvent Temp Color Conversion (%)c Ratio 7 : 8d 
1 DMPUa 0 °C Intense red < 3  - 
2 THF -78 °C -> r.t. Brown-red 5  - 
3 ether 0 °C -> r.t. Red 62 0.86 
4b hexanes / ether 2 / 1 0 °C  Orange 87 0.83 
5b hexanes / ether 6 / 1 0 °C Orange 84 0.78 
6 hexanes 0 °C -> r.t. Brown ∼40 n.d.e 
(a) N,N-dimethylpropyleneurea, a safe alternative for HMPA. (b) Carried out by Tae-gyu Nam of the 
Porter group. (c) Established by integrating aromatic peaks in 1H-NMR. (d) Established by integration 
of aromatic and vinyl peaks in 1H-NMR. (e) Reaction gave large amounts of unidentified by-products. 
 
Table 5.1: Product profiles for addition of 3 – 4 eq of n-BuLi to substituted 
naphthyridine 6 under various conditions. 
 
The use of 100 % hexanes (entry 6) solvent led to low conversion and formation of a 
multitude of products. This is due to the insolubility of 6 in hexanes and more lipophilic 
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naphthyridines may not suffer from this problem. A variety of reagent combinations, such as n-
BuLi / BF3, n-BuLi / CeCl3 or n-BuLi / CuI in ether, led to similar or lower conversions than in 
entry 3. In conclusion, the use of hexanes / ether solvent mixture in the ratio 2 / 1 seemed to be 
the optimal medium for good and clean conversion of this particular type of α-substituted 
naphthyridine. Counter-intuitively, there was always a slight preference for the undesired isomer 
8 over 7. The reason for this is not understood.  Nevertheless, it was decided to continue with 
this route because it established the quaternary carbon with acceptable conversion and relative 
ease and had the potential for being a short and straightforward route. 
 
5.2.3 The naphthyridine approach in the synthesis of the isostere 
In order to construct the core skeleton of isostere 2, the attacking alkyllithium species 
must be the unknown ‘phytyllithium’ reagent, instead of n-butyllithium. This reagent was 
prepared in situ by iodine/lithium exchange of phytyl iodide 12 and t-BuLi.16 The iodide in turn 
was prepared in two steps from commercially available starting material by hydrogenation and 
subsequent iodination.17 In situ prepared phytyllithium was then subjected to reaction with 6 in 
ether (Scheme 5.6). The optimized conditions with 33 % ethereal hexanes (Table 5.1) had not 
been found yet at the time that this reaction was carried out. A mixture of starting material 6, 
isomers 13 and 14, phytol 11 (vide infra) and phytane was obtained. The latter compound 
resulted from aqueous quenching of unreacted phytyllithium. Without separation, this whole 
mixture was immediately hydrogenated over Raney/Ni. After column chromatography, a mixture 
was obtained consisting of desired product 15 in a low 5 % yield (NMR) based on 6, its isomer 
16 and large amounts of inseparable 11. The presence of the latter was unexpected. First, it was 
thought that the iodine/lithium exchange was incomplete and that remaining iodide 12 was 
hydrolyzed upon quenching the reaction mixture with satd. aq. NH4Cl-solution. However, 
quenching with methanol still afforded large amounts of 11. Iodide 12 was always stored in a 
closed vial at -30 °C, so it was unlikely that it had been hydrolyzed. Most likely, the stock 
solution of t-BuLi had partially hydrolyzed to give significant amounts of LiOH which in turn 
reacted with the iodide 12 to give alcohol 11.  
 
Summarizing, the low yield in this addition and reduction sequence can be accounted for 
as follows:  
(i)  Non-optimized conditions for addition, i.e. less polar solvents should be used.   
(ii)  Inefficient Li/I exchange giving by-product 11, complicating the column separation. 
(iii)  Regioselectivity of the alkylation leaving a mixture of 13 and 14  
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(iv) Relatively large amounts of Raney/Ni had to be used due to partial poisoning of the 
catalyst by starting material and/or product, similarly to the poisoning of Lindlar’s 
catalyst by quinoline. 
 
N N
H
HO HO
I
11
12
Phyt
NN
H
Phyt+
N N
H
Phyt
NN
H
Phyt+
13 14
15 16
a)
b)
e
N N
6
+ PhytLi
c)
d)
 
Key: a) H2, Raney/Ni, EtOH, 24 h, r.t., quantitative. b) Ph3P, imidazole, I2, CH2Cl2, 1 h, 0°C, 41 
%. c) t-BuLi, ether, -78 °C, 1 h. d) Ether, -78° to 0°C, 3 h, ratio of 13 / 14 =  1 / 1.1. e) H2, 
Raney/Ni, EtOH, 24 h, r.t., yield of 15: 5 % based on 6, yield of 16: 5.5 % based on 6 (after 
column chromatography). 
 
Scheme 5.6: Reaction of naphthyridine 6 with phytyllithium. 
 
It was expected that problems i, ii and iv could easily be solved by using n-hexane 
solvent, fresh t-BuLi and alternative non-metal hydrogenation reagents (such as diimide18). In 
view of the limited timeframe, the small amount of obtained product was carried further to 
demonstrate the general applicability of the whole route. Bromination was carried out according 
to established procedures (Sections 2.3 and 2.4) to give bromide 17 in 65 % yield (Scheme 
5.7).19 The purity of the material obtained was sufficient to perform a reliable 2D NOESY-NMR 
experiment (Figure 5.1) in order to confirm the structure, especially the quaternary center. The 
chemical shifts for both the methyl (H3) and phytyl-CH2 group (H4) and their cross-peaks with 
the amine-H7 indicated that they were located in the aliphatic ring adjacent to the amine. 
Diastereomeric methylene hydrogens H2 were present as two signals, group H4 was buried 
under the bulk phytyl protons. 
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N N
H
Phyt
N N
H
Phyt
Br HO
17 2
N N
H
Phyt
15
a) b)
 
Key: a) Dibromodimethylhydantoin (DBDMH), CH2Cl2, -78 °C, 10 – 30 min, 65 %. (b) 1) t-BuLi, 
THF,    -78 °C, 20 min. 2) o-nitro-m-xylene, -78 °C, 2 h, 20 %. 
 
Scheme 5.7: Bromination and hydroxylation of aminopyridine 15. 
 
  
Figure 5.1: The 5 – 1 ppm region of the 2D NOESY spectrum of bromide 17 in CDCl3. 
Phasing was applied extensively but some noise could not be removed. Proton peaks are labeled 
with numbers. Indicative coupling are listed.  
 
Hydroxylation of bromide 17 was carried out once under the usual conditions but with a 
slightly different Br/Li exchange procedure. Treatment with s-BuLi proved inefficient and t-
BuLi was necessary to give a full Br/Li exchange. Quenching with o-nitro-m-xylene afforded 
target compound 2 in ∼20 % isolated yield. This low yield is consistent with those of the 
preparation of all other phytylated pyridinols (Sections 2.3 and 2.4). Preliminary analyses of 
compound 2 using chiral HPLC showed multiple peaks, indicating that the different 
stereoisomers might be separable by this technique. No antioxidant studies were performed with 
compound 2 due to time restrictions. 
N
H
N
17
Br
5
6
1
2
3
4
7
 
 
H7 x H4, H7 x H3 
H3 x H2 
H1 x H6, H1 x H2 
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5.3 Synthesis of an isostere having a tertiary carbon α to the nitrogen atom 
The synthesis of des-methyl isostere 3 was achieved by the same strategy as reported for 
2 in the previous paragraph (Scheme 5.8). In the Skraup reaction, to obtain dimethyl-
naphthyridine 18, glycerol was used as an acrolein source.13 The subsequent alkyllithium 
addition did not suffer from deprotonation or regioselectivity problems, as the non-substituted 
ring in naphthyridine 18 was smoothly alkylated with excess phytyllithium at -78 °C in 42 % 
isolated yield after subsequent hydrogenation. The dihydro-intermediate 19 had to be purified, to 
remove traces of material that poisoned the Ni catalyst in the next step, and hydrogenated 
immediately since it proved to be prone to oxidation by air. Interestingly, a diastereomeric shift 
of 0.6 ppm was observed for the ring-methylene group adjacent to the chiral enter in product 20. 
2D NOESY NMR was used to unequivocally assign all peaks in the 1H-NMR spectra. 
Subsequent bromination proceeded smoothly to give 21 in 73 % yield. 
 
N N
H
Phyt
HO
3
N N
H
Phyt
Phyt-I 12
N N
H
Phyt
19
N N
N NH2
+
5 18
HO
OH
OH
20
N N
H
Phyt
21
Br
N N Phyt
HO
22
+
a) d)
e) f)
PhytLi
c)
b)
 
Key: a) H2SO4, H3BO3, glycerol, sodium 3-nitrobenzenesulfonate, water, FeSO4, 150 °C, 4 h, 35 %. b) t-BuLi, 
ether, -78 °C, 1 h. c) Ether, -78° C, 2 h. d) H2, Raney/Ni, EtOH, 24 h, r.t., 42 % based on 18. e) DBDMH, 
CH2Cl2, -78 °C, 10 – 30 min, 73 %. (f) 1) n-BuLi, then t-BuLi, THF, -78 °C, 20 min. 2) o-nitro-m-xylene, -78 
°C, 2 h, varying yield. 
 
Scheme 5.8: Synthesis of isostere 3, with tertiary carbon adjacent to the nitrogen atom. 
 
In the hydroxylation step, 1 eq of n-BuLi followed by 2 eq of t-BuLi had to be used to 
accomplish smooth Li/Br exchange. Unfortunately, pyridinol 3 proved to be quite unstable and 
was rapidly oxidized to naphthyridinol 22. Nevertheless, on one occasion a small amount of ∼80 
% pure product was obtained after a careful purification procedure and this material was used for 
analytical purposes. No further antioxidant studies were carried out with this compound due to 
its observed instability. 
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N N N N
H
a)
18 23  
Key: a) H2, 10 % Pd/C, EtOH, 
overnight, r.t., 97 % (crude), 74 % 
(recrystallized). 
 
Scheme 5.9:  Selective hydrogenation of naphthyridine. 
 
Concomitantly, in the search for better synthetic procedures for some other key 6-amino-
3-pyridinols, it was found that simple hydrogenation of 18 selectively reduced the less 
substituted ring and thereby gave compound 23 in a very high yield without any need for 
chromatographic purification (Scheme 5.9). Pyridine 23 has already been described in Section 
2.3.1 where it was used for the synthesis of the unsubstituted 6-membered annelated pyridinols. 
Implementation of this hydrogenation step provided a two-step sequence that is clearly superior 
over the irreproducible three-step procedure described in Section 2.3.1.  
 
5.4 Conclusion and outlook 
The addition of alkyllithiums to α,α’-substituted [1,8]-naphthyridines, a reaction that has 
not been reported so far, was successfully accomplished whereby the outcome critically 
depended on the solvent used. In non-polar solvents, competing deprotonation was minimal and 
high conversions were obtained. The lack of regioselectivity in this step is compensated by the 
overall ease and short length of the naphthyridine route. This route was demonstrated for target 
2. After some optimizations mentioned in the text, the sequence is expected to be a useful 
strategy to arrive at the 6-amino-3-pyridinol isostere of Vitamin E, i.e. compound 1.  Target 3, 
having a tertiary carbon α to the nitrogen atom, could also be prepared by this route but was 
unstable and therefore not of further interest for the indicated purposes. 
   
A few recommendations for the preparation of the individual enantiomers of 1:  
 
-  One of the options could be to perform a stereoselective addition of alkyllithium to the 
naphthyridine, using a chiral organometallic catalyst. For quinoline, such an approach has 
been reported.20 Perhaps, a closer look at enantioselective additions of organometallics to 
imines can provide some ideas.21 
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-   Eventually, the desired C16 chain will be a single enantiomer
3 and it may be possible that 
the diastereomers, formed after addition of this chain to the naphthyridine nucleus 6, can 
be separated without any auxiliary.  
-   Resolution of racemic amines can be performed at any stage in the synthesis by 
enzymatic22 or chemical resolution, for example, by reaction with chiral auxiliaries, such 
as Mosher chloride. 
 
5.5 Experimental 
Materials and instruments. Unless indicated otherwise, all reactions were carried out under an 
inert atmosphere. All purifications by column chromatography were carried out with silica gel from 
Sorbent Technologies. In the case of amino-pyridinols, the silica gel was deactivated by packing the 
column with eluent containing 1 % Et3N followed by rinsing with Et3N-free eluent. Column purifications 
of pyridinols were carried out under nitrogen pressure, except for 22. TLC plates were from EM Science. 
Spots were visualized by UV light, treatment with I2 or treatment with phosphomolybdic acid. THF, ether 
and CH2Cl2 were dried using a Solvent Purification System from Solvtek. All other solvents were used as 
received. All chemicals were purchased from Aldrich Company. NMR spectra were taken on 300 or 400 
MHz Bruker NMR instruments. Signals were calibrated on CDCl3 and are reported with respect to TMS. 
Since the phytyl side-chain contained three chiral centers that were all racemic, it gave rise to a 
complicated pattern of 13C signals in the alkyl region. If visible, 1H-NMR shifts for phenolic protons are 
reported. For 2D NMR spectra, only the indicative couplings are given. UV-spectra were recorded on a 
Hewlett Packard HP8452A. Fluorescence measurements were recorded on a ISS PC1 Photon Counting 
Spectrometer. Melting points were taken on a Thomas Hoover melting point apparatus and are 
uncorrected. Elemental analyses were carried out by Atlantic Microlabs. ES-HRMS measurements 
(positive ion mode) were performed at Ohio State University. HPLC purities for the PyrOHs are given in 
area % calculated by integration of all visible peaks, except the solvent front, using reverse phase 
conditions and UV detection at 330 nm as described in Section 4.8. Chiral HPLC analysis was performed 
using the setup described in Section 3.5 and a Chiralcel OJ column from Chiral Technologies. Systematic 
names for molecules according to IUPAC rules were generated using the Beilstein AutoNom program 
version 2.02.118 and/or by using the ACD/I-Lab Web service (ACD/IUPAC Name Free 7.06) and 
adjusted where appropriate. 
n-Butyllithium addition to substituted naphthyridines (Table 5.1).  Naphthyridine 6 (0.4 – 0.5 
mmol) was dissolved / suspended in the solvent (∼5 mL). The flask was cooled to the indicated 
temperature and n-BuLi (2.5 M in hexanes, 1.2 – 1.6 mmol, 3.5 – 4.5 eq) was added dropwise. The 
reaction mixture was stirred at the indicated temperature for 3-4 h (overnight for entry 6). Satd. aq. 
NH4Cl-soln. was added (10 mL) and the mixture was extracted twice with EtOAc. The organic layers 
were combined, dried (MgSO4), filtered and concentrated to yield an oil. This oil was analyzed by 
1H-
NMR, showing that in all cases 6, 7 and 8 were the only products (except entry 6). Therefore, the 
conversion and regioselectivity could be determined by integration of the clearly resolved peaks in the 
vinylic-aromatic region. Indicative signals in CDCl3 for 6: δ 8.14 (d), 7.26 (d), 7.10 (s) ppm. For 7: 6.38 
(dd), 6.12 (s), 5.30 (dd) ppm. For 8: 7.03 (d), 6.29 (d), 5.09 (s) ppm. 
3,7,11,15-Tetramethyl-hexadecan-1-ol (11). This compound was prepared in quantitative yield 
according to a literature procedure.23  
3,7,11,15-Tetramethyl-hexadecyl iodide (12). Alcohol 11 (5.0 g, 16.8 mmol), imidazole (1.4 g, 
20.5 mmol) and Ph3P (5.0 g, 19.1 mmol) were dissolved in CH2Cl2 (50 mL) and the solution was cooled 
to 0°C. Iodine (5.0 g, 19.8 mmol) was added resulting in the formation of a suspension. The yellow-
brown mixture was stirred in the icebath for 1 h, after which it was filtered. The filtrate was washed 
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successively with 1.0 M HCl, 5 % H2O2 and finally satd. aq. Na2S2O3-soln. The colorless organic layer 
was dried (MgSO4), filtered and concentrated. The residue was taken up in hexanes, stirred vigorously 
and filtered to remove Ph3PO. The filtrate was concentrated and the resulting oil was run through cotton 
wool (using air pressure) to remove the last traces of precipitated solids. This afforded a yellowish oil (2.8 
g, 41 %) which was sufficiently pure for further reactions. NMR data were in agreement with the 
literature.24 
2,4,7-Trimethyl-[1,8]-naphthyridine (6). This compound was prepared according to the 
literature procedure13 in 36 % yield after column chromatography, m.p. 96 °C (lit: 98 °C).13  
2,5,7-Trimethyl-2-(3,7,11,15-tetramethyl-hexadecyl)-1,2,3,4-tetrahydro-[1,8]naphthyridine 
(15). A solution of phytyl iodide 12 (2.3 g, 5.6 mmol) in ether (30 mL) was cooled to –78 °C. To this was 
added slowly t-BuLi (1.7 M in pentane, 7.5 mL, 12.9 mmol) resulting in a yellow suspension. After 45 
min at the same temperature, the solution was warmed to room temperature to decompose excess t-BuLi. 
A solution of 6 (0.85 g, 5.0 mmol) in ether (saturated, about 30 mL needed) was cooled to –78 °C. To this 
the phytyllithium solution was slowly added. The mixture was stirred for 2 h at –78 °C, then overnight at 
room temperature. MeOH was added to quench the reaction mixture and after stirring for 15 min, satd. aq. 
NH4Cl-soln. and EtOAc were added. The organic layer was separated and the aqueous layer re-extracted 
with additional EtOAc. The organic layers were combined, dried (MgSO4), filtered and concentrated 
yielding to yield an orange. Quick column chromatography (3 : 1 hexanes : EtOAc) to remove unreacted 
starting naphthyridine yielded 1.8 g of a mixture of phytol 11, the desired product 13 and its regioisomer 
14. Product and regioisomer were obtained in a 1 / 1.1 ratio.  
Data dihydro-intermediate (13): 1H-NMR (CDCl3, 300 MHz) δ 6.44 (d, 1H, Ar-CH=C, J=10.0 
Hz), 6.16 (s, 1H, ArH), 5.33 (dd, 1H, Ar-CH=CH, J1=10.0 Hz), 4.44 (br s, 1H, NH), 2.25 (s, 3H, 6-Me), 
2.14 (s, 3H, 4-Me), 1.55 – 0.9 (26H, alkyl), 0.85 (app. t, 15H, alkyl-CH3, J=6.3 Hz); HRMS for C31H54N2 
[M + Na] 477.4179, found 477.4202.  
This crude mixture (1.8 g) was dissolved in EtOH (30 mL) and Raney/Ni (50 % water wet, 2.7 g) 
was added. The solution was stirred overnight under an H2 atmosphere. The catalyst was removed by 
filtration over Celite and the filtrate was concentrated. Column chromatography (2 : 1 hexanes : EtOAc) 
gave a mixture of the desired product 15 (0.11 g, 5 % yield based on 6), the regioisomer 16 (0.06 g, 2.7 % 
yield based on 6) and phytol 11 (0.13 g). This mixture was used as such since a reasonable separation 
could be achieved in the next step. 1H-NMR (CDCl3, 300 MHz) δ 6.24 (s, 1H, ArH), 4.74 (s, 1H, NH), 
2.57 (t, 2H, Ar-CH2, J=6.7 Hz), 2.27 (s, 3H, 6-Me), 2.09 (s, 3H, 4-Me), 1.7 (m, 2H, ArCH2CH2), 1.3 – 1.0 
(26H, alkyl), 1.13 (s, 3H, NCCH3), 0.85 (app. t, 15H, phytyl-CH3, J=6.3 Hz); HRMS for C31H56N2 [M + 
Na] 479.4336, found 479.4365. 
6-Bromo-2,5,7-trimethyl-2-(3,7,11,15-tetramethyl-hexadecyl)-1,2,3,4-tetrahydro-
[1,8]naphthyridine (17). Amine 15 (0.25 mmol + 0.14 mmol of isomer 16) was dissolved in CH2Cl2 (10 
mL). The solution was cooled to –78 °C and 1,3-dibromo-5,5-dimethylhydantoin (60 mg, 0.22 mmol) was 
added portion wise. The dry ice/acetone bath was removed for the duration of 1-1.5 min after which the 
solution was recooled to –78 °C and analyzed by TLC. After a couple of these cycles clean and full 
conversion was achieved. The cooling bath was removed, satd. aq. Na2S2O3-soln. (10 mL) was 
immediately added and the contents of the flask swirled thoroughly as to destroy remaining 1,3-dibromo-
5,5-dimethylhydantoin. After warming up to room temperature while stirring, water and excess aq. 1.0 M 
NaOH were added and the basic mixture was extracted with CH2Cl2 (2x). The organic layers were dried 
(MgSO4) and filtered. To the organic layers was added DMAP (50 mg) and octanoyl chloride (160 µL). 
After stirring for 30 min (to esterify remaining phytol 11), satd. aq. Na2CO3-soln. was added and 
extraction with CH2Cl2 was performed twice. The organic layers were dried (MgSO4), filtered and 
concentrated. The crude product was purified by column chromatography (10 : 1 hexanes : EtOAc) to 
give bromide 17 (100 mg, 0.19 mmol, 75 %) as a colorless oil which contained 20 % of the brominated 
regioisomer. 1H-NMR (CDCl3, 300 MHz) δ 4.58 (s, 1H, NH), 2.64 (t, 2H, Ar-CH2, J=6.6 Hz), 2.45 (s, 
3H, 6-Me), 2.27 (s, 3H, 4-Me), 1.9 – 1.6 (m, 2H, ArCH2CH2), 1.3 – 1.0 (26H, alkyl), 1.14 (s, 3H, 
NCCH3), 0.85 (app. t, 15H, phytyl-CH3, J=6.3 Hz); 2D NOESY-NMR
 (CDCl3, 300 MHz) couplings: NH 
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x R3CCH3, NH x R3CCH2Phytyl, R3CCH3 x R3CCH2Phytyl, Ar-CH2CH2 x R3CCH3, Ar-CH2CH2 x 
R3CCH2Phytyl, Ar-CH2CH2 x Ar-CH2, Ar-CH2 x 4-Me; 
13C NMR (CDCl3, 300 MHz) δ 153.8, 153.0, 
145.3, 112.6, 111.7, 51.8, 39.38, 38.99, 37.46, 37.40, 37.29, 37.17, 33.27, 32.77, 32.05, 31.99, 29.31, 
27.98, 26.19, 25.43, 24.81, 24.47, 24.39, 24.03, 22.73, 22.64, 21.76, 19.77, 19.70, 19.66, 19.07; HRMS 
for C31H55BrN2 [M + Na] 557.3441, found 557.3414. 
2,4,7-Trimethyl-7-(3,7,11,15-tetramethyl-hexadecyl)-5,6,7,8-tetrahydro-[1,8]naphthyridin-3-
ol (2). Bromide 17 (45.0 mg, 0.11 mmol) was dissolved in THF (5 mL) and the solution was cooled to -78 
°C. To this was added s-BuLi (1.4 M in hexanes, 245 µL, 0.35 mmol) and the yellow solution was stirred 
at -78 °C for 20 min (TLC showed no exchange). To this solution was added t-BuLi (1.7 M in 
cyclohexane, 200 µL, 0.35 mmol) and the dark yellow solution was stirred at -78 °C for ca. 30 min (the 
Br/Li exchange was followed by TLC and was quantitative). Subsequently, dry o-nitro-m-xylene (130 µL, 
0.94 mmol) was added. After stirring for 2 h at –78 °C, the solution was quenched with satd. aq. NH4Cl-
soln. and then warmed up.  The greenish THF layer was separated and the aqueous layer extracted once 
with EtOAc. The organic extracts were dried (MgSO4), filtered and concentrated. The crude product was 
purified by column chromatography (3 : 2 EtOAc : hexanes) to afford a yellow oil (7 mg, 20 %). λmax 
(MeOH) = 330 nm;  1H-NMR (CDCl3, 300 MHz) δ 2.60 (t, 2H, Ar-CH2, J=6.6 Hz), 2.30 (s, 3H, 6-Me), 
2.13 (s, 3H, 4-Me), 1.8 – 1.0 (m, 28H, alkyl), 1.14 (s, 3H, NCCH3), 0.85 (app. t, 15H, phytyl-CH3, J=6.3 
Hz. HRMS for C31H56N2O [M + H] 473.4465, found 473.4430; HPLC purity: 93.0 area %. 
2,4-Dimethyl-[1,8]-naphthyridine (18). This compound was prepared according to the literature 
procedure13 and purified by column chromatography. NMR data were in agreement with literature data.25  
5,7-Dimethyl-2-(3,7,11,15-tetramethyl-hexadecyl)-1,2,3,4-tetrahydro-[1,8]naphthyridine 
(20). A solution of phytyl iodide 12 (1.8 g, 4.43 mmol) in ether (15 mL) was cooled to –78 °C. To this 
was added slowly t-BuLi (1.7 M in pentane, 6 mL, 10.05 mmol) resulting in a yellow suspension. After 
45 min at the same temperature, the solution was warmed to room temperature to decompose excess t-
BuLi, after which the mixture was recooled to –78 °C. A solution of 18 (0.56 g, 3.55 mmol) in ether 
(saturated, about 30 mL needed) was slowly added resulting in a persistent deep-red color. The mixture 
was stirred for 2 h at –78 °C, then 2 h at room temperature. Satd. aq. NH4Cl-soln. was added and the 
solution was extracted with EtOAc (3x). The organic layers were dried (MgSO4), filtered and 
concentrated yielding an orange oil. This oil had to be purified by column chromatography, since 
impurities in the mixture poisoned the catalyst in the next step. However, the NMR spectrum showed that 
during the purification some product was oxidized to the naphthyridine. After column chromatography (3 
: 1 hexanes : EtOAc), an orange oil (0.95 g, 61 % corrected) was obtained which contained substantial 
amounts of air-oxidized material.  
Dihydro-intermediate (19): 1H-NMR (CDCl3, 300 MHz) δ 6.41 (d, 1H, Ar-CH=C, J=9.9 Hz), 
6.16 (s, 1H, ArH), 5.50 (m, 1H, Ar-CH=CH), 4.6 (br s, 1H, NH), 4.4 (m, 1H, CH), 2.23 (s, 3H, 6-Me), 
2.12 (s, 3H, 4-Me), 1.55 – 0.9 (26H, alkyl), 0.85 (app. t, 15H, alkyl-CH3, J=6.3 Hz); HRMS for C30H52N2 
[M + H] 441.4203, found 441.4218.  
Without delay, this impure material was subjected to hydrogenation in EtOH (50 mL) in the 
presence of Raney/Ni (50 % water wet, 2 g). After 24 h, the mixture was filtered over Celite and the cake 
was washed with MeOH. The filtrate was concentrated and dried, giving a thick yellowish oil (0.81 g, 42 
% from 18) which was sufficiently pure for further reactions. An analytical sample was prepared by 
column chromatography (2 : 1 hexanes : EtOAc) yielding a thick colorless oil. 1H-NMR (CDCl3, 300 
MHz) δ 6.26 (s, 1H, ArH), 4.53 (s, 1H, NH), 3.27 (m, 1H, CH), 2.7 – 2.62 (m, 1H, Ar-CHA2), 2.56 – 2.48 
(m, 1H, Ar-CHB2), 2.27 (s, 3H, 6-Me), 2.09 (s, 3H, 4-Me), 1.97 (m, 1H, ArCH2CH
A
2), 1.38 (m, 1H, 
ArCH2CH
B
2), 1.28 – 1.0 (26H, alkyl), 0.85 (app. t, 15H, alkyl-CH3, J=6.3 Hz); 
13C NMR (CDCl3, 300 
MHz) δ 155.9, 154.0, 146.0, 114.8, 111.6, 51.9, 40.17, 38.24, 38.18, 38.13, 38.08, 34.77, 33.72, 33.69, 
33.57, 28.8, 25.06, 25.29, 24.47, 23.52, 23.43, 23.20, 20.55, 20.52, 20.49, 20.46, 19.29 ; 2D NOESY-
NMR (CDCl3, 400 MHz) couplings: NH x 6-Me, NH x CH, Ar-CH
A
2 x Ar-CH
B
2, Ar-CH
AB
2 x 4-Me, 
ArCH2CH
A
2 x ArCH2CH
B
2, ArCH2CH
AB
2 x CH, ArH x 4-Me, ArH x 6-Me; HRMS for C30H54N2 [M + H] 
443.4360, found 443.4394. 
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6-Bromo-5,7-dimethyl-2-(3,7,11,15-tetramethyl-hexadecyl)-1,2,3,4-tetrahydro-
[1,8]naphthyridine (21). This compound was prepared according to the procedure described for 17 
starting from amine 20 (500 mg, 1.13 mmol), CH2Cl2 (10 mL) and 1,3-dibromo-5,5-dimethylhydantoin 
(162.5 mg, 0.57 mmol). The crude product was purified by column chromatography (20 : 1 hexanes : 
EtOAc) yielding the product as an orange oil (430 mg, 73 %). 1H-NMR (CDCl3, 300 MHz) δ 4.76 (s, 1H, 
NH), 3.23 (m, 1H, CH), 2.74 – 2.65 (m, 1H, Ar-CHA2), 2.61 – 2.51 (m, 1H, Ar-CH
B
2), 2.44 (s, 3H, 6-Me), 
2.22 (s, 3H, 4-Me), 1.96 (m, 1H, ArCH2CH
A
2), 1.6 (m, 1H, ArCH2CH
B
2), 1.5 – 1.0 (26H, alkyl), 0.85 
(app. t, 15H, alkyl-CH3, J=6.3 Hz); 
13C NMR (CDCl3, 300 MHz) δ 154.2, 152.4, 145.1, 113.5, 111.8, 
51.6, 39.7, 34.05, 33.20, 33.17, 33.08, 33.06, 28.27, 28.04, 27.91, 25.56, 25.11, 24.79, 24.77, 24.71, 
24.17, 24.14, 23.05, 22.95, 20.10, 20.07, 20.04, 20.01, 19.98, 19.95, 19.87, 19.29; HRMS for C30H53BrN2 
[M + H] 521.3485, found 521.3471. 
2,4-Dimethyl-7-(3,7,11,15-tetramethyl-hexadecyl)-5,6,7,8-tetrahydro-[1,8]naphthyridin-3-ol 
(3), only successful attempt. Bromide 21 (65.5 mg, 0.13 mmol) was dissolved in THF (5 mL) and the 
solution was cooled to 0 °C. To this was added dropwise n-BuLi (2.5 M in hexanes, 60 µL, 0.15 mmol) 
and the red solution was stirred at 0 °C for 20 - 25 min. This solution of the lithium amide was then 
cooled to -78 °C. To this t-BuLi (1.7 M in cyclohexane, 250 µL, 0.43 mmol) was added dropwise and the 
dark red solution was stirred at -78 °C for ca. 30 min (the Br/Li exchange was followed by TLC and was 
quantitative). Subsequently, dry o-nitro-m-xylene (85 µL, 0.63 mmol) was added. After stirring for 2 h at 
–78 °C, the solution was quenched with satd. aq. NH4Cl-soln. and then warmed up.  The THF layer was 
separated and the aqueous layer extracted once with EtOAc. The organic extracts were dried (MgSO4), 
filtered and concentrated. The product proved very prone to double (air) oxidation to give naphthyridinol 
22 (data for this are given in the next section). On one occasion, careful purification by column 
chromatography (no Et3N deactivation, eluting with 3 : 2 EtOAc : hexanes) gave desired 3 as a yellow oil 
(6 mg). According to NMR, this oil was contaminated with 15 % of 22. λmax (MeOH) = 335 nm; 1H NMR 
(CDCl3, 300 MHz) δ 4.44 (s, 1H, NH), 3.21 (m, 1H, CH), 2.73 – 2.53 (m, 2H, Ar-CH2), 2.30 (s, 3H, 6-
Me), 2.17 (s, 3H, 4-Me), 1.96 (m, 1H, ArCH2CH
A
2), 1.55 (m, 1H, ArCH2CH
B
2), 1.5 – 0.95 (26H, alkyl), 
0.85 (app. t, 15H, alkyl-CH3, J=6.3 Hz); 
1H NMR (CDCl3 + drop of D2O, 300 MHz): peaks the same, 
except peak @ 4.44 is gone; HRMS for C30H54N2O [M + H] 459.4309, found 459.4288. 
Oxidized product: 2,4-Dimethyl-7-(3,7,11,15-tetramethyl-hexadecyl)-[1,8]naphthyridin-3-ol 
(22). Failed hydroxylations afforded fully oxidized product. 1H NMR (CDCl3, 300 MHz) δ 8.12 (d, 1H, 
Ar-CH=CH, J=8.7 Hz), 7.28 (d, 1H, Ar-CH=CH, J=8.7 Hz), 2.95 (m, 2H, Ar-CH2), 2.69 (s, 3H, 6-Me), 
2.49 (s, 3H, 4-Me), 1.90 – 0.95 (24H, alkyl), 0.85 (app. t, 15H, alkyl-CH3, J=6.3 Hz); HRMS for 
C30H50N2O [M + H] 455.4001, found 455.4010. 
5,7-Dimethyl-1,2,3,4-tetrahydro-[1,8]naphthyridine (23). Naphthyridine 18 (6.8 g, 43.0 mmol) 
and 10 % Pd/C (0.5 g) were stirred in EtOH (70 mL) overnight under H2 atmosphere. The catalyst was 
removed by filtration over Celite and the solvent removed by concentration giving an off white solid 
(6.96 g, 42.9 mmol) in near quantitative yield. The product was recrystallized from hexanes to afford 5.2 
g of yellow needles (74 %). Analytical data have already been described in Section 2.9. 
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Part B 
 
 
 
Photochemistry of CdSe nanocrystals 
covered with functionalized cinnamates 
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 6 
 
 
6.1 History 
Nanocrystals (NC) are well-defined particles in the nanometer range. The very first 
example of a nanocrystal was reported in the 19th century by Faraday, who prepared 
monodispersed colloidal gold particles. Over the last decades, the focus of research has shifted 
from relatively large particles (>100 nm) to nanocrystals with diameters of 1 – 20 nm. Especially 
semiconductor nanocrystals in this size range, also called quantum dots, have attracted 
considerable interest.1 This is because their unique optical, electronic and mechanical properties 
differ substantially from the properties of the corresponding bulk material. Modern quantum dot 
technology has its origins, in part, in the mid-1970s quest for new answers to meet the worldwide 
energy crisis. Research in photo-electrochemistry (e.g., solar energy conversion) was tapping the 
semiconductor/liquid interface to exploit the advantageous surface area-to-volume ratio of 
nanocrystal particles for energy generation. Seminal developments arose in the early 1980s from 
two labs, worlds apart: Dr. Louis Brus at Bell Laboratories,2,3 and Drs. Alexander Efros and A.I. 
Ekimov of the Yoffe Institute in St. Petersburg (Leningrad at that time) in the former Soviet 
Union.4,5 Dr. Brus and his collaborators experimented with nanocrystal semiconductor materials 
and observed solutions of strikingly different colors made from the same substance.6 As a result, 
in the beginning of the 80s, the first reports on plain nanocrystalline CdS particles appeared.5,7,8 
It was found that these particles, as a colloidal dispersion in water, exhibit interesting 
fluorescence properties. It took about another decade before work on the closely related CdSe 
nanocrystallites really made a start. This is, in part, attributable to a convenient synthesis for 
monodisperse CdSe NC that was published by Bawendi et al.9 After that, publications on CdSe 
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NC have probably multiplied ten-fold every year. This makes them the most widely studied 
semiconductor NC,10 and accordingly they will be the focus of this introduction. 
  
6.2 General physical properties 
 
 
   A                 B 
 
Figure 6.1: (A) HOMO-LUMO energy separations for CdSe NC as a function of size 
(diamonds) compared to the prediction of the effective mass approximation (solid line). (B) UV-
Vis absorption spectra for different sizes CdSe NC. Taken from ref. 9. 
 
The interesting properties of semiconductor NC in general stem from the quantum 
confinement phenomenon. Photo-excitation of a semiconductor leaves an electron and a hole. 
These two charge carriers form a bound pair, also known as a Wannier exciton, which is 
delocalized over the crystal lattice. The ideal distance between the two carriers is defined by the 
net Coulomb interaction between them and is known as the Bohr radius. In the bulk 
semiconductor material, the dimensions of the crystals are sufficiently large to allow the carriers 
to achieve this Bohr Radius. However, in the 1 – 20 nm size area, the dimensions of the 
nanocrystal are actually lower than the Bohr radius leaving the charge carriers confined within 
the boundaries of the nanocrystal. This three-dimensional confinement collapses the continuous 
density of energy levels, typical for a bulk semiconductor solid, and leads to strongly confined 
electron excitations11. As the size of the nanocrystal becomes smaller, the confinement becomes 
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increasingly prevalent and the HOMO-LUMO energy levels of the nanocrystal separate 
accordingly. Figure 6.1A shows the experimentally determined separation of the HOMO and 
LUMO levels of semiconductor CdSe NC as a function of size.9 The energy separation increases 
with decreasing particle size, clearly illustrating the quantum confinement. The solid line 
represents the values predicted by theory. It is the quantum confinement effect that leads to very 
interesting size-dependent properties of semiconductor NC.12,13 Once again: this introduction 
will focus on the optical properties of CdSe NC, but it should be pointed out that the size-
dependence holds for a range of properties, such as electronic,14,15 magnetic16 and 
photoconductive17, for a variety of semiconductor NC.  
The size-dependence of the optical properties of CdSe NC can be illustrated by 
comparing the UV-Vis absorption spectra of different sizes NC (Figure 6.1B).9 The peak at the 
red end of the absorption spectrum is the first excitation peak. A continuous absorption up to the 
first excitation is visible, a result of the multitude of energy levels of the NC. On the basis of the 
increasing energy separation with smaller size NC, a blue-shift of the first-excitation peak is to 
be expected when the size of the NC decreases. This is indeed the case. The 115 Å NC (peak at 
ca. 705 nm) closely resembles the situation of the bulk solid (bulk band gap of 716 nm) with 
little quantum confinement effect. However, a gradual blue-shift of about 300 nm is observed 
when the size of the NC is lowered to 12 Å.  
 
 
Emission  wavelength (nm) 
 
Figure 6.2: Sharp and size-dependent emission signals of different sizes of CdSe NC. 
Excitation is at 360 nm. The emission counts are normalized. Taken from ref. 18. 
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CdSe NC are also highly fluorescent, emitting light when an electron and hole 
recombine. The wavelength of the fluorescent light is red-shifted, usually about 30 nm from the 
first excitation peak. Thus, the fluorescence of the NC is also size-dependent. An interesting 
feature of the fluorescence emission peaks is the small peak width and this will be touched upon 
again later. Figure 6.2 shows the emission peaks for a range of different sizes of CdSe NC 
including 1 size of CdTe NC.18 
 
6.3 Synthesis and structure  
The classical synthesis of CdSe involves a high-temperature procedure.9,19  Me2Cd and Se 
are added to trioctylphosphineoxide (TOPO) at 300 °C. As soon as the reagents are added, 
nucleation starts as indicated by an immediate orange coloring. Growth of the existing nuclei is 
then continued at ca. 250 °C until the desired size is reached as judged by UV analysis of 
aliquots. The mixture is cooled and the NC precipitated by and washed with MeOH to remove 
unreacted materials and excess TOPO. This synthesis has obvious drawbacks in terms of ease of 
use and toxicity of reagents. Thus, in the light of potential industrial applications, better 
syntheses were desired. In the past years, major improvements have been made in terms of 
nucleation media, Cd- and Se-sources and temperature.20,21 Recently, syntheses starting from 
CdO22 or Cd(OAc)2 
23 have been developed as “green”, scalable alternatives. It should be pointed 
out that even remarkable biosyntheses of closely related CdS NC have been reported. The first 
example is the discovery of the biosynthesis of CdS NC in the yeasts Candida glabrata and 
Schizosaccharomyces pombe, cultured in the presence of cadmium salts.24 More recently, an 
enzyme mediated extra cellular synthesis of CdS NC by the fungus, Fusarium oxysporum, 
starting from aqueous CdSO4 was developed. 
25
  In any synthesis, the crude NC usually do not 
consist of only one size. Rather, they have a certain size distribution as is expected on statistical 
basis. A broad UV signal for the first excitation peak is indicative hereof. Narrower size 
distributions and thus sharper UV signals can be obtained by size-selective precipitation, a 
technique in which the largest NC are selectively precipitated.9  
 
P O Trioctylphosphine oxide (TOPO)
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The surface Cd and Se atoms have free coordination sites available, so-called dangling 
bonds, which can be occupied by Lewis-bases. The NC obtained after the high-temperature 
syntheses are covered by TOPO surface ligands via coordination of the P=O moiety with Cd. If 
no such stabilizing surface ligands are present, the NC are unstable and can easily aggregate into 
larger undefined clusters. In addition, the TOPO ligands enhance solubility of the NC in organic 
solvents. TOPO-coated CdSe NC prepared by any of the methods discussed above were shown 
to be Wurtzite crystals with C3v symmetry as established by high resolution transmission electron 
microscopy imaging26 (Figure 6.3). Most crystals facets contain alternating Cd and Se, but the 
poles of the crystal consist of just Cd or Se, leading to a large permanent dipole moment. 
Interestingly, Rutherford Back Scattering experiments showed that the overall Cd-Se 
stoichiometry is actually 1.2:1 rather than the expected 1:1, with the excess Cd residing on the 
surface27. This observation was explained in terms of the superior passivating ability of TOPO as 
compared to Se, since it was established that exactly one TOPO was binding to each surface Cd 
atom. 
 
 
 
Figure 6.3: Model of a Wurtzite CdSe nanocrystal obtained by high-resolution 
transmission electron microscopy imaging. Taken from ref. 26. 
 
The interaction of NC and TOPO is reversible in nature and procedures have been 
developed to exchange TOPO for other simple organic ligands, such as alkylamines28 or 
pyrimidines.29 Thus, the organic surface ligands not only stabilize and solubilize the NC,30  they 
also offer a potential handle for further chemistry. Usually a ligand is desired that binds strongly 
and irreversibly to the surface. Thiols have found extensive use as irreversibly bound ligands by 
virtue of the very strong Cd-S bond.31 
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6.4 The stability issue 
The size-dependent optical and fluorescence properties of CdSe NC in conjunction with 
the sharp emission peaks have led to investigations of potential biological applications of these 
species. For example, the potential use of NC as biomarkers has received considerable 
attention.32,33 The basis for this interest is that a mixture of different sizes of NC can be excited 
by one single wavelength (see Figure 6.2) giving rise to a range of sharp and distinguishable 
fluorescent responses. For example, this would enable the simultaneous use of a range of 
different sizes NC within one biological system.  This makes NC superior over conventional 
organic dyes, since the latter suffer from compromised photostability and usually only can be 
excited with one particular wavelength. Much progress has been made in the field of NC as 
biomarkers. One issue that had to be addressed was that, despite the attractive fluorescence 
properties, the luminescence quantum yields of plain CdSe NC are rather low. The reason for 
this is that some charge carriers, formed upon excitation of NC, leak out of the NC instead of 
recombining to give luminescence. In the presence of oxygen, this process can lead to photo-
oxidation, a problem encountered with various NC.  
An important contribution came from Peng et al. who conducted a clear and systematic 
study on the aerobic photostability of thiol coated CdSe NC.34 Their results revealed that the 
photochemical instability of the NC actually is attributable to three distinguishable processes, 
namely the photocatalytic oxidation of the thiol ligands on the surface of nanocrystals, the photo-
oxidation of the nanocrystals, and the precipitation of the NC. At first, the thiol ligands on the 
surface of a nanocrystal were gradually oxidized by molecular oxygen, with the CdSe NC core 
acting as a photocatalyst for this process. The photogenerated holes in a NC were trapped by the 
thiol ligands bound on the surface of the nanocrystal, which initiated the photo-oxidation of the 
ligands and protected the NC from any photo-oxidation. However, after nearly all thiol ligands 
on the surface of the NC were converted into disulfides, all these disulfides went into the 
solution (if soluble). Subsequently, the unprotected NC underwent photo-oxidation and 
precipitated from the solution as undefined particles. Systematic changes in structure of the 
surface thiols showed the following trends:34  
1)  The longer the thiol-carbon chain, the slower is the photodecomposition. This is 
attributed to slower diffusion of oxygen to the core. 
2) Aromatic thiols and bidentate thiols actually give faster decomposition than monodentate 
aliphatic thiols. 
3) Excess free ligand in solution retards the photodecomposition by quenching surface sites. 
 
No chemical mechanism was formulated. However, it is presumed that a similar 
oxidation mechanism holds for both CdSe and CdS NC. Various reports indicate that this is 
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indeed the case.34,20 Upon irradiation in the presence of oxygen, CdS NC degrade according to 
the general mechanism depicted in Scheme 6.1.35,36  
 
CdS  +  hν → CdS (e¯ + h+)     e¯=electron, h+=hole 
e− + O2 → O2−  
h+ + CdS → Cd2+S− 
Cd2+S− + O2− + O2→ Cd2+ + SO42− 
Overall: CdS + 2O2 → Cd2+ + SO42− 
 
Scheme 6.1: Mechanism for aerobic photodecomposition of CdS NC. 
 
 The photo-oxidation issue was tackled by coating the surface with an additional shell of 
inorganic semiconductor, such as ZnSe,37,38 ZnS39,40 or CdS.41,42 These core-shell 
semiconductors had larger bandgaps than the CdSe core material making it less favorable for 
charge carriers to leak out from the core through the shell material. Recently, coating with 
organic dendrimers has been used to stabilize the NC and this will be discussed in Section 6.5.4. 
 
6.5 The status quo of CdSe/ligand conjugates 
It is evident that the use for biological applications calls for further chemical refinement 
and functionalization of NC. This is because the ligands will largely determine the interaction of 
the NC with their environment, especially in a complex biological system, such as a cell. 
Compared to the research on NC from a physical point of view, the field of surface modification 
of the CdSe NC took longer to emerge. As mentioned above, procedures were developed to 
cover the NC surface with simple commercially available amines or thiols. Several groups have 
now taken this further and have conjugated NC with more functionalized ligands for biological 
purposes. A brief overview of this development will be given.43 It should be pointed out that 
almost all of the following examples make use of core-shell NC rather than CdSe cores. 
However, the chemistry of the surface derivatization is likely to be very similar for both. 
 
6.5.1 Covalent conjugates by chemical coupling of NC and biomolecules  
Approaches have been developed in which the NC and biomolecules were coupled by a 
standard organic reaction. Nie et al. coated NC with mercaptoacetic acid and coupled some of 
the carboxylic acid groups to amine groups of the proteins Immunoglobulin G and transferrin 
using ethyl-3-(dimethylaminopropyl)carbodiimide (EDCI) as the coupling reagent.44 It was 
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shown that the resulting NC-protein conjugates were water-soluble and well-defined, and that no 
aggregation had occurred. The NC retained their highly fluorescent properties. Figure 6.4A 
shows how cultured HeLa cells, which have an affinity for the transferrin protein, show nothing 
when incubated with just mercaptoacetic acid-coated NC. However, when the cells were treated 
with NC-transferrin conjugates, the conjugates were encapsulated by the cells leaving 
luminescent dots inside the cell (Figure 6.4B). 
 
 
 
Figure 6.4: Cultured HeLa cells incubated with (A) just mercaptoacetic acid-coated NC 
and (B) NC-transferrin conjugates. Bright white spots represent luminescence from NC. Taken 
from ref. 44. 
 
Nie et al. later showed the same approach using a different protein, namely trichosanthin 
which is an inhibitor of HIV infection.45 The obtained NC-trichosanthin conjugates were used to 
study the location of the protein within human choriocarcinoma cells (JAR cells).  This particular 
approach, in which functional groups on the NC surface were further derivatized by organic 
transformations, was also utilized by Thompson et al.46 They coated NC with DTT, after which 
amine termini of oligonucleotides were coupled to the hydroxyl groups by a standard carbonyl-
bis-imidazole coupling. The resulting DNA-derived NC were shown to undergo hybridization 
with human sperm cells. Very recently, Wu et al. used immunoglobulin G and streptavidin, 
linked to carboxylic acid groups on the NC surface by EDCI coupling (see above), to label the 
breast cancer marker Her2 on the surface of fixed and living cancer cells. Their goal was to stain 
actin and microtubule fibers in the cytoplasm and to detect nuclear antigens inside the nucleus. 
Interestingly, they were able to simultaneously detect these different cellular targets with one 
excitation beam using two different sizes of CdSe/ZnS NC.47 
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6.5.2 Covalent conjugates by prior thiolization of biomolecules 
A strategy, which is essentially the reverse of the approach outlined in Section 6.5.1, has 
also been reported. The biomolecule of interest was first derivatized with a certain reagent such 
that it leaves a free thiol on the molecule, after which this thiol-functionalized biomolecule 
served as the NC ligand. For example, 3’-propylthiol or 5’-hexylthiol-terminated 22mer DNA 
was exchanged onto CdSe/ZnS NC by Mirkin et al.48 These species were then used to create 
hybrid assemblies. Ruoslahti et al. used the same protocol to couple CdSe/ZnS NC with three 
different oligopeptides which had been treated with iminothiolane (3-
mercaptopropionimidate.HCl) to incorporate thiol groups.49 Based on the peptide sequence, the 
resulting NC colored specific areas in mice, such as blood or lymphatic vessels or lung cells. For 
example, lung endothelial cells of mice contain membrane dipeptidases for which a certain 
oligopeptide, called GFE, is a substrate. Upon treating LE cells with fluorescing NC-GFE 
conjugates, pictures were obtained that showed the luminescent NC decorating the LE cells 
(Figure 6.5A). When treated with excess of free GFE, the NC-GFE conjugates were displaced 
and no luminescence was observed anymore (Figure 6.5B). 
 
 
 
Figure 6.5: Fluorescence microscopy pictures of (A) LE cells treated with NC-GFE 
conjugates followed by (B) treatment with excess of free GFE. Bright white spots represent 
luminescence from NC. Taken from ref. 49. 
 
6.5.3 Non-covalent bioconjugates by electrostatic interaction 
In some examples, purely non-covalent interactions are used to conjugate biomolecules to 
the NC, rather than covalent bonding. Alivisatos et al. reported on the use of the non-covalent 
avidin-biotin interactions to compose bioconjugates.50 They synthesized water-soluble CdSe/CdS 
NC by coating them with a layer of trimethoxy-silyl groups and then derivatized the surface with 
biotin. The resulting NC were used to selectively color mouse fibroblasts that had been incubated 
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with streptavidin. As can be deduced from Figure 6.6, the luminescent NC were able to penetrate 
the mouse fibroblasts and bind to streptavidin residues. 
 
 
 
Figure 6.6: Coloring of streptavidin residues in mouse fibroblasts. Bright white spots 
represent luminescence from NC. Taken from ref. 50. 
 
The use of non-covalent interactions to couple a protein and NC was also demonstrated 
by Goldman et al. Engineered recombinant proteins with positively charged domains were 
conjugated with dihydrolipoic acid coated NC through purely electrostatic interactions.51 No loss 
of biological activity was noted. The same protocol was repeated with avidin and biotinylated 
antibodies could be conjugated to the resulting NC-avidin clusters.52 Van Orden et al. used the 
inverse strategy, i.e. they coupled thiolated Bovine Serum Albumin to CdSe/ZnS and 
subsequently conjugated rhodamine-derivatized streptavidin to the NC.53 They observed 
enhanced rhodamine fluorescence upon BSA-streptavidin conjugation and attributed this to 
FRET processes (Fluorescence Resonance Energy Transfer). 
 
6.5.4 Conjugates from NC and functionalized purely organic ligands 
In none of the cases discussed so far, multi-step organic transformations were used. A 
few groups have described the preparation of ligands for CdSe NCs by multiple organic 
transformations. Peng et al. have described organic ligands on three different occasions. In one 
report, aromatic bis-acylhydrazide 1 was prepared and used as a crosslinking agent between two 
CdSe NCs.54  
Later, the use of dendritic thiols, such as 2, to stabilize the NC surface was reported.55 
These spacious thiols gave rise to thicker surface layers, hence diminishing oxygen migration to 
the NC surface and thereby photolytic decomposition of NC. Increased stability of CdSe NC 
with dendrimer-amino ligands was reported by others around the same time.56 Taking the 
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dendritic thiols one step further, Peng et al. arrived at a new type of ligands (3). In a very recent 
paper, they show that NC coated with this ligand can be successfully transformed into so-called 
‘NC in dendron boxes’ by performing cross-metathesis on the surface allyl groups using Grubbs’ 
catalyst.57 The resulting ‘box-NC’ were extremely stable towards photodegradation and even 
towards chemical etching by corrosive reagents, such as H2O2 and aq. HCl. It should be pointed 
out that Grubbs metathesis had already been performed on a CdSe NC surface once before, 
namely to make linear polyolefin-NC composites.58  
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A simple non-thiol ligand was prepared and tested by Emrick and Skaff.59 They used a 
PEG-ylated pyridine derivative 4 to coat plain CdSe NC. The resulting PEG-ylated NC were 
water-soluble and considerably more stable than their thiol-analogues. More elaborated organic 
thiols have been designed and prepared by Rosenthal et al. They have reported on the synthesis 
and use of the serotonin derivative 5.60 CdSe NC, coated with this ligand and HSCH2COOH as 
co-ligand, were found to inhibit Drosophila serotonin transporters (hSERT) and illuminate the 
locations where this interaction took place. Figure 6.7 shows this interaction: luminescence upon 
binding of NC to hSERT-containg cells (Figure 6.7A), but no luminescence in hSERT-free cells 
(Figure 6.7B).  
Experiments with a variety of other biologically interesting organic ligands are currently 
underway in the Rosenthal lab. For example, NC coated with derivatives of known Dopamine 
Transporter Protein (DAT) antagonists (6) were shown to have some affinity for DAT with a 
moderate IC50 value of 6 µM.61  
 
Chapter 6 
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯ 
 
144
HS
O
O
O
H
N
NH2
4
O
N
N
H
N O
O
O
O
SH
5
N O
O
O
O
6
n
 
 
 
      A             B 
 
Figure 6.7:  Luminescence upon treatment of (A) hSERT-rich cells (B) hSERT-free cells 
with NC coated with hSERT-inhibitor 5. Bright white spots represent luminescence from NC. 
Taken from ref. 60. 
 
 
6.6 CdSe/ligand conjugates – remaining questions 
From the mini-review in Section 6.5, it becomes clear that a substantial amount of work 
has been done in the area of CdSe coverage with functionalized organic ligands, for quite a 
variety of very interesting and exciting applications. However, little attention has been given to 
fundamental questions regarding the mutual interactions of the ligands and the NC itself. This is 
of particular importance for photo-interactions, as, without exception, all the studies discussed in 
Section 6.5 make use of its interesting photoactive properties. A better knowledge about the 
photo-interaction between CdSe NC and its ligands can lead to more efficient and robust 
applications of NC in biology.  
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In addition, the actual coverage process with ligands, such as thiols, is not well defined 
yet. The nature and quantity of the surface ligands remain properties that are not always trivial to 
determine. Various techniques, such as UV spectroscopy62, Rutherford Back Scattering60 and 1H-
NMR spectroscopy,63 have been used for this purpose.  The surface area of NC is quite large and 
therefore it is not surprising that in all cases several to many organic ligands are present on the 
surface. One report showed the preparation and purification of homo-dimers of CdSe NC, but it 
was not unambiguously proven how many bonds participated in the dimer-linkage.54 It would be 
of great interest, for a variety of reasons, to prepare NC that have exactly one of a particular 
functional group on the surface. This can be envisaged as mixing, on the NC surface, of standard 
surface ligands, such as mercaptoacetic acid, with exactly one molecule of a functionalized 
organic ligand. In this way stoichiometric surface chemistry could be carried out, even under 
biologically relevant conditions and with large biomolecules or other species leading to better 
defined surfaces. Further potential applications include aligning of the NC surface for electronic 
purposes, the importance of which for CdSe nanorods has been recently touched upon by 
Alivisatos et al.64  Thus, a study aimed at finding ways to prepare monofunctionalized CdSe 
nanocrystals would be of interest. So far, this has not been reported for CdSe or any other 
nanocrystal type, such as gold nanoparticles. In order to achieve monofunctionalization, the use 
of an extremely bulky auxiliary, that will block parts of the remaining available NC surface, can 
be envisaged.  Two approaches, which follow this general protocol, were initiated at different 
time points. 
 
The first approach involves linking the NC to a solid support. The general outline for this 
is depicted in Scheme 6.2. The solid support can be a silica surface that has been functionalized 
by standard methods with a very small amount of a thiol connected by a cleavable linker X. The 
average distance RS between two thiols must be considerably larger than the diameter of the NC 
(RNC) to ensure monocoupling of NC to the support. NC, coated with an exchangeable ligand A, 
such as phosphine oxide or amine, can interact with the support to complex one thiol to one NC. 
Subsequently, the rest of exchangeable ligands A are replaced by an inert thiol B. The final step 
involves cleavage of the group X in the linker arm leaving a group Z on the ligand and a group Y 
on the surface of the silica. By this protocol, it should be possible to arrive at NC that have 
exactly one molecule of a specific functional group Z on the surface.  
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Scheme 6.2: Monofunctionalization of NC using a solid support as a bulky auxiliary. 
 
A second approach for NC monofunctionalization, perceived during the course of this 
work, makes use of an enzyme as the bulky auxiliary (Scheme 6.3). A brief description of this 
idea will be given. Only preliminary work on the structure of suitable ligands has been 
performed so far. An inhibited enzyme was considered as the actual bulky auxiliary.  The 
enzyme, after inhibition by a molecule that possesses a free thiol group, will be brought into 
reaction with NC covered with some labile ligand A. Depending on the size of the enzyme, one 
would expect 1 to ca. 5 inhibited enzymes to be bound per NC. However, presumably the size 
difference of these various aggregates is such that they can be separated by Size Exclusion 
Chromatography. Then, the remaining ligands A are replaced by an inert thiol B, after which the 
free enzyme is released by an activation step.  
 
In either approach, it was deemed critical to first develop a suitable linker X (for the solid 
support approach) and an enzyme inhibitor that could be removed from the enzyme (for the 
enzyme approach). These studies for suitable ligands would also allow simultaneously studying 
of fundamental interactions between NC and the ligands, the importance of which has been 
pointed out in the beginning of this section. 
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Scheme 6.3: Monofunctionalization of NC using an enzyme as a bulky auxiliary. 
 
6.7 Research objectives 
For reasons stated in Section 6.6, the most important interaction between NC and ligands 
is the photo-interaction. A group X was chosen that would be photocleavable (Scheme 6.2). This, 
in principle, will render the cleavage to be clean and free of co-reagents. In addition, this strategy 
allows some fundamental studies on the photo-interaction of NC/ligand conjugates. 
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Scheme 6.4: o-Hydroxy-cinnamate groups and the mechanism for their photocleavage. 
 
For several reasons, the ligand of choice became a substituted o-hydroxy cinnamoyl unit 
(Scheme 6.4). In the Porter group there is considerable experience with these compounds, in 
particular as photocleavable serine protease inhibitors.65,66 The chromophore is an o-hydroxy E-
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cinnamate ester unit (λmax ≈ 370 nm) which upon irradiation with near-visible light yields the Z 
isomer. The latter consequently lactonizes to release a coumarin derivative and an alcohol or 
phenol.67,68 The p-diethylamino substituted hydroxy-cinnamate proved to be the most efficient 
substrate, giving 7-diethylaminocoumarin (hereafter denoted as ‘coumarin’) as the product.69  
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Scheme 6.5: Use of a cinnamate cleavable linker in monofunctionalization of NC. 
 
It is important to note that the formation of coumarin, which is highly fluorescent, 
provides an ideal handle for in situ measurements of the progress of the photocleavage without 
actually having to separate the NC first. Potential application of the above methodology is 
depicted in Scheme 6.5. The cinnamate ester group can be linked to the NC by a terminal SH 
group and to the support by either substitution on the ring or by alkylation of the amine. After 
cleavage, NC with exactly one alcohol functionality will be formed and coumarin will be left 
behind on the silicon support. 
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Scheme 6.6: Activation of NC-Enzyme conjugates by light. 
 
As the cinnamates are enzyme inhibitors, it seemed very logical to utilize the same 
photocleavable unit for the enzyme approach. This idea is depicted in Scheme 6.6. Enzymes of 
choice could be Factor Xa, Chymotrypsin or Thrombin.70 Of course, the largest enzyme will be 
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the best candidate. After SEC, the free enzyme is released by irradiation leaving one coumarin 
molecule on the NC surface. For further practical refinement of this method, a functional group 
must be present in the coumarin moiety, as coumarin itself is quite unreactive towards a variety 
of reagents. A secondary exocyclic amine, rather than a tertiary one like in Scheme 6.6, may 
serve this purpose leaving an -NH group on the surface that can be further functionalized. Note 
that the two approaches require two structurally different cinnamate linkers, one with the thiol 
connected to the aromatic ring (Scheme 6.6) and one with the thiol connected to the ester part 
(Scheme 6.5). 
 
The targets formulated for this project are: 
 
1) Design and synthesis of cinnamate ligands for both the solid support and enzyme 
approach. 
2) Assemblage of all appropriate ligand/NC conjugates and thorough investigation of their 
photochemical properties. 
3) Optimization of the cleavage conditions for model aggregates. 
 
6.8 Outlines of the chapters 
In Chapter 7, the results concerning the development and behavior of photocleavable 
ligands for NC will be described. Topics include the synthesis of the appropriate cinnamate-
thiols and derivatives thereof, exchange of these thiols onto NC surface and characterization of 
the resulting NC. Extensive studies were carried out regarding the interaction between the 
ligands and NC and a mechanism for this interaction will be presented. Furthermore, as a spin-
off of this mechanistic study, some interesting behavior of the surface cinnamates under 
irradiation with visible light will be discussed. 
Chapter 8 deals with the development of ligands for the enzyme-approach depicted in 
Scheme 6.6. These ligands were synthesized and exchanged onto the NC. Some mechanistic 
studies will be reported that demonstrate the potential feasibility of the enzyme-approach. 
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7.1 Introduction 
Surface ligands constitute a vital part of CdSe nanocrystals (NC). They provide enhanced 
solubility and stability1 of the NC and, very importantly, they determine the interaction of the 
NC with the outside environment in more complex systems. This has been clearly demonstrated 
for biological systems in the mini-review given in Section 6.5. However, little is known about 
the intrinsic interaction of CdSe NC with the surface ligands. It is evident that with increasing 
complexity of NC-ligand aggregates, understanding of the NC-ligand interaction becomes 
increasingly important. It is therefore of great interest to study the photo-interaction of NC with 
the ligands, since many important applications of CdSe NC make use of its unique 
photoproperties.  
 
N
O
O
OH
R
N OH
O
O R
N O O
+   R-OHR = alkyl, aryl, Ser-enzyme
350 - 380 nm
1
 
Scheme 7.1:   Mechanism of photocleavage of cinnamate esters. 
 
As explained in Section 6.7, the cinnamate unit depicted in Scheme 7.1 has interesting 
photochemical properties.2,3 These cinnamates undergo a photo-induced cis-trans isomerization 
and the cis isomer can subsequently lactonize releasing an alcohol fragment. The resulting 
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product (coumarin, 1) is highly fluorescent whereas the cinnamate precursors are not. This 
means that the formation of coumarin can be conveniently monitored in situ by fluorescence 
spectroscopy. Inspired by this, attaching a photoactive thiol, having the same chromophore as the 
inhibitors, on the NC surface was considered. The convenient in situ analysis for coumarin is 
quite attractive since it circumvents the need for the time-consuming NC separation for every 
sample aliquot. In this chapter, the synthesis of various functionalized thiols and their exchange 
onto the NC surface will be described. Extended photolytic studies were carried out with the 
resulting NC to determine any potential interaction between NC and ligand. 
 
7.2 Design, synthesis and photochemistry of cinnamate thiols  
7.2.1 Design and synthesis 
A suitable ligand, such as thiol 2, consists of a group that attaches to the CdSe surface 
(i.e. a thiol), a spacer to provide steric flexibility and the photoactive cinnamate unit.  
 
N
O
O(CH2)nSH
OR
2: R = H, n = 11
3: R = H, n = 6
4: R = Me, n = 11
5: R = 4-I-PhCH2, n = 11  
 
Initial attempts towards the synthesis of 2 involved coupling an S-protected 11-mercapto-
undecanol derivative with the cinnamic acid part using reagents like DCC or carbonyl 
diimidazole. All these attempts failed, presumably due to the presence of the o-phenolic group. 
Since a protecting group for the thiol group already had to be used, an additional protecting 
group for the phenol was not desirable. Therefore, a different approach, in which 2 was prepared 
from a substituted aldehyde and a functionalized Wittig reagent in a 5-step sequence (Scheme 
7.2), was used.  The Wittig salts were prepared by reacting the desired alcohol with BrCH2COBr, 
followed by an SN2 reaction with PPh3. These salts proved remarkably stable and therefore the 
ylid was always prepared in situ by addition of 1 eq. of Et3N to the salt prior to adding the 
aldehyde. The Wittig reaction proceeded very well in the presence of the free phenol, in fact the 
phenolic OH group accelerated the reaction by intermolecular H-bonding to the aldehyde and the 
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reaction was completed within a few hours at room temperature. Initially, this synthesis was 
successfully carried out until the last step using the p-methoxybenzyl (PMB) group as the sulfur 
protecting group. However, no deprotection conditions could be found that left the rest of the 
molecule intact (TFA / heating at reflux, Hg(OAc)2 / TFA, Ag(NO3)2, DDQ). The thiol 
protecting group of choice then became the SAc (thioacetate) group. The entire synthesis could 
be successfully carried out with this protecting group, including delivery of the penultimate 
compound 12a as a stable, crystalline solid. Subsequently, 12a was selectively deprotected, 
without affecting the ester unit, using NaSMe.4 For reasons discussed later, a shorter-chain 
analogue 3, methoxy derivative 4 and 4-iodobenzyloxy derivative 5 were also prepared using an 
analogous synthetic sequence. It should be pointed out that the Wittig reaction proceeded much 
more sluggishly (3 d at 60 °C) when the o-phenol was replaced by an o-alkoxy group. Two 
additional ligands 6 and 7 (vide infra), which lacked a cinnamate group, were commercially 
available or were prepared according to literature procedures. 
N
O
O(CH2)nSAc
OR
2, 3, 4, 5
(70 - 90 %)
HO(CH2)nBr
a) b)
O(CH2)nSAc
O
Br c)
O(CH2)nSAc
O
Ph3P
Br
d)
e)
8a: n = 11 (93 %)
  b: n = 6   (93 %) 9a, b  (85 %, 77 %)
10a, b (85 %, 89 %)
N OR
O
11a: R = H
    c: R = Me
    d: R = 4-I-PhCH2
12a: R = H, n = 11                (75 %)
    b: R = H, n = 6                  (65 %)
    c: R = Me, n = 11              (41 %)
    d: R = 4-I-PhCH2, n = 11  (45 %)
HO(CH2)nSAc
 
Key: a) KSAc, DMF, mol. sieves, 24 h, r.t. b) BrCH2COBr, DMAP, py, 15 min, 0 ºC. c) PPh3, EtOAc, 3 d, 
r.t. d) 1) Et3N, PhH, 15 min. 2) aldehyde, PhH, r.t. or ∆, 1 –3 d.  e) NaSMe, MeOH, 0 ºC, 2 h. Yields are 
given within parentheses. 
 
Scheme 7.2:  Synthesis of thiol-containing cinnamate ligands. 
 
Chapter 7 
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯ 
 
156
Using the same synthetic strategy, cinnamate models 13 and 14a,b were prepared starting 
from commercially available ylids (Scheme 7.3). 
 
N
O
OEt
ORN OR
O
13  : R = H    (78 %)
14a: R = Me  (60 %)
N OR
O
OEt
+
   14b: R = Me     (6 %)
a)
 
Key: a) Ph3P=CHCO2Et, PhH, r.t. or ∆, 1 –3 d.  Yields are given within parentheses. 
 
Scheme 7.3: Synthesis of model cinnamates. 
 
7.2.2 Photochemistry  
All cinnamates synthesized had UV absorption maxima at 374 - 376 nm. Several 
photolyses at 374 nm with model 13 were carried out and followed by recording the fluorescence 
of coumarin 1 (excitation at 374 nm, emission at 438 nm). Upon irradiation, 13 underwent 
photoisomerization and lactonized as expected on the basis of previous results obtained in the 
Porter group with these types of compounds (Scheme 7.1).2,3  
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Figure 7.1: Irradiation of 13 with 374 nm in various media. The relative coumarin 
formation is calculated from its fluorescence increase. Note that the DMF curve is on the x-axis. 
 
It was found that the lactonization step is the rate-determining step. Coumarin formation 
was extremely slow in DMF, but it was dramatically accelerated by base and protic solvents 
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(Figure 7.1). Base acted by assisting in the removal of the phenolic proton. In fact, with K2CO3 
as the base, substantial phenolate formation occurred as was deduced from an additional UV 
signal at 420 nm. Since DMF and EtOH are both polar solvents, the acceleration by EtOH and 
aq. EtOH must be attributed to hydrogen bonding with the carbonyl and/or phenol groups.  
 
7.3 Exchange onto NC and characterization of the resulting aggregates 
7.3.1 Exchange procedure 
All synthesized thiols were exchanged onto the CdSe surface. For this, pyridine coated 
CdSe nanocrystals (py-NC) were used. Two different sizes of NC were employed, the diameters 
being 31 Å and 72 Å. Py-NC were obtained by heating the corresponding TOPO CdSe NC in 
pyridine for 20 h, followed by precipitation by and washing twice with hexanes. 1H-NMR 
analysis of the isolated py-NC revealed that ca. 35 % of the surface TOPO ligands were replaced 
by this one pyridine treatment as shown by broad proton-peaks for bound pyridine in the 7 – 8 
ppm range.5 An exchange procedure was selected that would ensure high dilution of the 
cinnamates on the surface, so that direct interaction between two cinnamates could reliably be 
ruled out. Thus, cinnamate thiols were exchanged onto NC by stirring in deoxygenated HCl-free 
chloroform with hexane-wet py-NC in the presence of 2 - 3 eq. of inert co-ligand 6 at room 
temperature for several days. The exchange procedure was followed by precipitation, extensive 
washing to remove any free ligand (confirmation by GC and UV analysis) and drying. Without 
the use of co-ligand 6, the resulting isolated proved insoluble in DMF. NC coated with just 6 or 
11-mercapto-undecanol (7) were prepared for reference purposes.   
 
O
O
O
SH
6
SH
7
HO
 
 
Table 7.1 shows all types of NC that were prepared. All types were soluble in DMF. Yet, 
it is interesting to point out that the relatively small number of cinnamates on the NC surface 
rendered the NC difficult to dissolve compared to NC without cinnamates. Thus, type V NC 
dissolved in DMF within seconds, whereas for types I-III dissolution took hours to days. 
Subsequently, stock solutions were prepared by filtration through Celite to remove any 
undissolved material. The UV maximum at the first excitation peak of the resulting DMF 
solution (see below) served as a measure for the NC concentration. All solutions were visibly 
clear and were stored at -78 °C to mimimize decomposition. Usually the 31 Å NC did not 
precipitate significantly during storage, whereas the 72 Å NC tended to precipitate. 
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NC type Size NC (Å) Ligand(s)a 
I 31 2 ,  6 
II 31 3 ,  6 
III 31 4 ,  6 
IV 31 5 ,  6 
V 31 6 
VI 31 7 
VII 72 2 ,  6 
VIII 72 6 
(a) Although 2 to 3 molar excess of 6, with respect to 
the cinnamate ligand, was used, this did not necessarily 
reflect the exact composition on the NC surface. 
 
Table 7.1: Different types of nanocrystals prepared. 
 
7.3.2 Characterization of NC 
All NC show continuous optical absorption far into the visible region (Figure 7.2), a 
property typical for CdSe NC.6 The 31 Å NC have a first excitation absorption peak at 560 nm 
(A), for the 72 Å NC this is 630 nm (B). Type V NC, lacking cinnamate ligands, had identical 
UV features as the original TOPO coated NC (not shown), showing that the exchange and 
dissolution procedures did not compromise the structural features of the NC. A key feature in 
Figure 7.2 is the observation that types I and VII have a significantly increased absorption 
centered around 374 nm as compared to types V and VIII. This is because of the presence of the 
bound cinnamates and can be better visualized by subtraction of the two respective spectra, as 
shown in the inset of Figure 7.2A. The subtracted absorbance at 374 nm allows for a molar 
quantification of the amount of cinnamates for a given sample which. After quantification of the 
molar amount of NC from the absorbance at its first excitation peak, this leads to an 
approximated number of cinnamates per NC surface.7 Approximated ε-values for NC from 
earlier literature reports were used, namely 500,000 M-1cm-1 for 31 Å NC and 1,100,000 M-1cm-1 
for 72 Å NC, all at their first excitation peak.8,9,10 For cinnamates 2-4 and iodo-ligand 5, ε was 
found to be 35,000 and 27,000 cm-1M-1, respectively, in DMF at 374 nm. Using these numbers, it 
was estimated that around 20-30 cinnamate molecules were on the surface of types I - IV NC, 
whereas the much larger type VII NC had around 250 associated cinnamate molecules. These 
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numbers were rather low when compared to the total amount of available coordination sites, 11 an 
observation which was in agreement with the expectation. 
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Figure 7.2: Representative UV-Vis absorption spectra for cinnamate-coated CdSe 
nanocrystals sizes (A)  31 Å and (B) 72 Å. Inset in A: spectrum obtained after subtraction of 
spectrum of type V from spectrum of type I. Inset in B: expansion of 580 – 680 nm region for 
type VIII. 
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Figure 7.3: 1H-NMR of type V NC with integration of key signals. Signals marked with 
X are residual solvent signals.  
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For NC covered with iodinated ligand (type IV), representative studies were performed 
using fluorescence spectroscopy. 1H NMR spectroscopy and Rutherford Backscattering. The 1H-
NMR spectra of purified type IV NC in CDCl3 (Figure 7.3) showed proton resonances for the 
cinnamate downfield protons (vinylic and aromatic, 6.0 – 8.0 ppm) and the alkyl protons (around 
3.5 ppm) of the glycol co-ligand (6). Some interesting features of the NMR spectrum are 
noteworthy. None of the protons of the cinnamate π-system (6.0 – 8.0 ppm) broadened 
extensively, which indicated that the NC surface was reasonably homogeneous. Secondly, a 
signal for the free cinnamate thiol (5), apparent from a sharp quartet A for CH2SH group, was 
clearly visible. A qualitative comparison shows that this signal contributed only for roughly 30 
% to the ‘total’ amount of 5 as was deduced by comparison of its integration with that of other 
signals of 5, viz. B and C. The same was true for co-ligand (6, quartet D). Evidently, upon 
dissolution of the NC, part of the surface thiols was released and migrated into solution. The 
CH2S signals for the corresponding bound thiols were most likely buried under the peaks at 2.8 – 
4.0 ppm.12 Interestingly, when the NC from this “NMR solution” were reprecipitated and 
washed, less than 0.5 % of 5 (with respect to the total calculated amount in the “NMR-solution” 
using signals B and C) was recovered and the 1H-NMR spectrum of the resulting NC looked 
similar to the first one. This all suggests that, upon dissolution of NC, an equilibrium between 
free and bound thiol ligand is established and that upon distortion of this equilibrium, by adding 
an anti-solvent, the thiols re-bind to the NC. Later in this thesis, additional evidence supporting 
this hypothesis will be presented (Sections 7.5.2 and 8.3.2). 
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Figure 7.4: Emission spectra of types IV and V NC and the original TOPO-NC in DMF, 
excitation at (A) 374 and (B) 425 nm. NC-concentrations for type IV and V were identical. 
TOPO-NC are less soluble in DMF and their emission counts are normalized for the sake of 
comparison. 
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Emission spectra of NC types IV and V and the original TOPO-covered NC were taken 
(Figure 7.4). Upon excitation at 425 nm, clear emission peaks centered at 590 nm were observed 
(B). The shape and position were unchanged with respect to the original TOPO-coated NC. The 
absolute counts were higher for type IV NC than for type V NC. Most likely, this is the result of 
some random absorption of molecular O2 on the NC surface, which is known to enhance the 
emission. Upon excitation at 374 nm, the emission of type IV NC was reduced due to partial 
absorption of the excitation light by the surface cinnamates. Type V NC showed very similar 
emission spectra at both wavelengths. In conclusion, the ligand exchange procedure and the 
nature of the ligand did not alter the emission properties and thus the structural integrity of the 
NC. In addition, RBS experiments with type IV NC were carried out.11 Using this technique it 
was possible to show that the bulk (ca. 65 %) of surface ligands still consisted of original TOPO 
ligands (see also Section 7.3.1). This was in agreement with the low coverage numbers for the 
cinnamates as determined by UV Spectroscopy. The lack of pyridine to displace all TOPO 
ligands from CdSe NC, even after repeated cycles, has been known.5 
 
7.4 Photolysis studies – photostability of NC 
7.4.1 General photolysis procedure 
Photolysis studies were performed on all types of NC in DMF solution. All studies were 
performed at similar NC concentrations as deduced from their absorbance at the first excitation 
peak. Initial studies involved irradiating DMF solutions of type I NC at 374 nm. This wavelength 
was selected because it was of interest to see whether coumarin could be formed on the surface 
in the manner shown in Scheme 7.1. Aliquots were taken and analyzed afterwards for formation 
of coumarin 1 by fluorescence spectroscopy. These irradiations were always accompanied by 
formation of insoluble material that complicated the analysis. It turned out that this insoluble 
material is the result of photo-oxidation of NC. It is known that aerobic photolysis of CdSe NC 
results in decomposition (see Section 6.4).13,14 Peng et al. performed a systematic study on this 
phenomenon using UV analysis and CdSe NC, coated with various hydrophilic thiols, irradiated 
at 254 nm in water.14  
 
Peng’s photolysis procedure was adopted, with minor modifications, for further 
experiments in the present study. Thus, NC solutions were irradiated at a certain wavelength and 
analyzed in situ by UV and fluorescence spectroscopy. First, the photostability of NC, with 
emphasis on the 31 Å NC, will be discussed. The photo-induced chemistry of the surface ligands 
will be treated in the Section 7.5.  
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7.4.2 Effect of cinnamate unit 
 Figure 7.5A shows the evolution of the UV-Vis spectrum of type 1 NC upon aerobic 
irradiation at 374 nm. A distinct trend can be observed. After an incubation period (ca. 1 hr) the 
first excitation peak shifted from 560 nm to 542 nm over 6 h accompanied by general fading of 
absorption features. This indicates surface decomposition of the NC by photo-oxidation of 
surface Cd and Se atoms.15 Figure 7.5B shows a graphic representation of this phenomenon with 
the position of the first excitation peak plotted against irradiation time.  After 5 h a precipitate 
was clearly visible in the solution. Interestingly, type I NC decomposed dramatically faster than 
type V NC under identical conditions (Figure 7.5B). The latter only started to decompose after > 
15 h of irradiation. It was thought that type V NC shows the same moderate photoinstability of 
NC coated with long-chain thiols as observed by Peng14 and that type I NC actually shows an 
abnormally high instability. Both type I and V NC had mostly trisethyleneglycol ligand (6) on 
the surface and the only difference between them was the additional cinnamate ligands present 
on the surface of type I.  Therefore, the large difference in photostability indicated that the 
surface cinnamate thiols in some way accelerated decomposition.  This observation was 
investigated in more detail 
 
 
 
Figure 7.5: Evolution of absorption spectra during aerobic irradiation of (A, B) type I 
NC and (B) type V NC in DMF at 374 nm. 
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7.4.3 Involvement of reactive oxygen species 
Some photolyses were performed in deoxygenated solutions, obtained using the freeze-
pump-thaw technique. Not surprisingly, irradiation of type I NC in the absence of oxygen did not 
lead to decomposition (Figure 7.6B).16 Experiments were performed to find out which reactive 
form(s) of oxygen play(s) a role. Involvement of singlet oxygen, resulting from energy transfer 
from NC* to O2, was ruled out since addition of excess NaN3 (a singlet oxygen quencher
17) did 
not inhibit photodecomposition of type I NC (not shown).  Next, epinephrine18 was added to the 
irradiation solution to analyze for superoxide anion (O2
−), which could result from electron 
transfer from NC to oxygen.19 Epinephrine reacts with O2
− to give adrenochrome that absorbs at 
486 nm. Figure 7.6A shows that addition of type I NC led to increased oxidation of epinephrine 
during 374 nm air irradiation relative to reference samples without NC. Anaerobic irradiation of 
NC and epinephrine did not lead to any adrenochrome, ruling out any direct interaction between 
NC* and epinephrine. All this indicates that superoxide was formed during aerobic irradiation of 
type I NC.   
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Figure 7.6: (A) Formation of adrenochrome during irradiations of 100 uM epinephrine in 
DMF at 374 nm with and without NC and/or air present. When NC were present, the absorbance 
of adrenochrome was corrected for NC absorbance. (B) Irradiations of type I NC at 374 nm with 
and without 2.2 mM KO2-crownether complex and/or air present. The arrow indicates the point 
at which air was let in after initial air free conditions (dotted line). 
 
Experiments were performed in which external superoxide (KO2 as crownether complex) 
was added. It turned out that anaerobic irradiation of type I NC in the presence of KO2 did not 
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lead to degradation (Figure 7.6B). The NC began to decompose only when air was allowed into 
the system (dotted line). Type V NC did not decompose significantly in the presence of both air 
and KO2 (not shown). 
So far all observations, except for the abnormal behavior of the cinnamate ligands, are in 
agreement with the decomposition mechanism proposed for CdS NC in the literature19,20 
(Scheme 7.4). Thus, oxygen is required for decomposition and superoxide plays a passive rather 
than an active role. Furthermore, during aerobic irradiation with epinephrine (Figure 7.6A) no 
NC degradation seemed to take place even though superoxide was clearly formed. Likely, step 4 
could not take place in those cases because the superoxide formed (Step 2) was immediately 
trapped and the Cd and Se species could not dissolve leaving just an oxidized layer. The 
interesting observation is that the cinnamate ligands seem to accelerate the NC decomposition 
dramatically. 
 
(1) CdS  +  hν → CdS (e¯ + h+)     e=electron, h=hole 
(2) e− + O2 → O2−  
(3) h+ + CdS → Cd2+S− 
(4) Cd2+S− + O2− + O2→ Cd2+ + SO42− 
Overall: CdS + 2O2 → Cd2+ + SO42− 
 
Scheme 7.4: Proposed mechanism for aerobic photodecomposition of CdS NC. Taken 
from ref. 20. 
 
7.4.4 Effect of the wavelength of  irradiation 
In trying to find the reason for the accelerated decomposition, a series of basic issues 
needed to be addressed. The first one is the fact that upon irradiation of type I NC with 374 nm 
light, both the NC as well as the surface cinnamate ligands can be promoted to their excited 
states (Figure 7.2). Therefore, air-exposed solutions of type I NC were irradiated at 4 different 
wavelengths, including 494 and 560 nm where the NC still absorbs but the cinnamates do not. 
These experiments showed that the type I NC degraded regardless of the wavelength (Figure 
7.7). The minor differences in rates of decomposition were attributed mostly to the spectral 
intensities of the Mercury Lamp that was used. It should be pointed out, again, that none of these 
photodegradations took place if oxygen was omitted from the system. Thus, type I NC 
decomposes aerobically regardless of the irradiation wavelength, i.e. excited cinnamate units do 
not play an inductive role in the decomposition mechanism.  
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Figure 7.7:  Decomposition of type I NC during irradiation at different wavelengths. 
 
Furthermore, it is important to note that it was shown early on that type I NC upon 374 
nm irradiation slowly releases coumarin 1, a potential photo bleacher with λmax = 380 nm, into 
solution (see Section 7.5). Any effect of this molecule in the decomposition of the NC had to be 
addressed. However, aerobic irradiations at 374 nm with type V NC in the presence of mM 
concentrations of coumarin showed that it did not induce photodegradation of the NC nor did it 
decompose itself (not shown). Further evidence for the former observation was obtained by 
replacing the o-hydroxy group of the ligand with an o-methoxy group in order to block coumarin 
formation. Irradiation of the resulting NC (type III) at 374 nm still led to photodegradation. 
Similar results were obtained upon irradiation at 560 nm (not shown). It appeared that a variety 
of surface cinnamates is able to induce NC photodegradation upon irradiation with any 
wavelength within the NC absorption range. 
 
7.4.5 Effect of electron donors and acceptors in solution 
On the basis of the observation that superoxide was formed during decomposition as well 
as on the literature reports that the formation of NC holes is the event that triggers 
decompositon,19 it may be speculated that electron transfer from the NC* to oxygen, via the 
cinnamate unit, is the key step in the decomposition mechanism. In order to test this hypothesis, 
the effect of an externally added electron donor or acceptor was investigated. The following 
compounds were tested: C(NO2)4 (TNM) and CBr4 as acceptors and N,N,N’,N’-tetramethyl-
phenylenediamine (TMPD) as donor. Dramatic effects were observed during aerobic irradiation 
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of type I NC (Figure 7.8A). In the presence of the good electron acceptor TNM, the nanocrystals 
degraded considerably faster than with just air. In the former case, no clear excitation peak could 
be detected anymore beyond 20 min of photolysis time, indicating extensive decomposition.  
Similar results were observed for type II NC when CBr4 (1.0 mM) was used (not shown). On the 
other hand, 1 mM of the excellent donor TMPD completely inhibited aerobic degradation of type 
I NC, even after 24 h of irradiation.  Moreover, type V NC degraded very fast under 374 nm light 
in the presence of 100 uM TNM in sharp contrast to their very slow degradation with just air 
(Figure 7.8B). An experiment in which light and air were introduced stepwise showed that only 
light and not air was necessary for type V NC to degrade with TNM, i.e. the excited NC* reacted 
directly with TNM (or CBr4). Thus, it may be concluded that a good electron acceptor in solution 
induced photodegradation of all types of NC in the presence but also absence of air21, whereas an 
electron donor inhibited decomposition, presumably by quenching the NC+ cation. 
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Figure 7.8: (A) Aerobic 560 nm irradiation of type I NC in the presence of additives. The 
photolysis in the presence of TNM was performed at 374 nm, but this should not have a large 
effect (see Figure 7.7).  (B) 374 nm irradiation of type V NC in the presence and absence of 0.1 
mM TNM. Figure B also shows a ‘stepwise’ irradiation in the presence of TNM where first light 
and then air were introduced, the arrows indicate the corresponding time points.  
 
7.4.6 Effect of chain length 
Electron transfer from type I NC to the cinnamate was proposed as a possible mechanism 
for the NC degradation. Two pathways for this process can be envisioned, viz. (i) through space 
electron transfer from the excited nanocrystal (NC*) to the cinnamate (bending of the cinnamate 
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moiety to the NC surface) and/or (ii) through bond electron transfer. Electron tunneling through 
4 and up to 16 carbon alkyl chains has been reported for alkylthiol-coated Au-clusters.22 As a 
dependence of electron transfer on the chain length has been observed previously,22 replacement 
of the 11 carbon atom spacer by a 6 carbon atom spacer might provide insight into the validity of 
the aforementioned electron transfer process in the present case. However, as can be seen from 
Figure 7.9, no dramatic differences were observed in aerobic photodegradation at 560 nm of NC 
coated with either C6 (type II) or C11 (type I) spacers. Neither type degraded in the absence of 
oxygen.  
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Figure 7.9: Effect of chain length irradiations at 560 nm. 
 
7.4.7 Irradiations of 72 Å NC – general results 
The large size NC (72 Å) are very insoluble in DMF. During irradiation close to their 
first excitation peaks (560 and 620 nm, respectively), type I NC began to decompose after 1 h 
and precipitated after 5 h, whereas type VII NC showed no signs of any decomposition even 
after 24 h. This difference can not be fully accounted for by the ca. 3 fold lower intensity of the 
Mercury Lamp at 620 nm. Therefore, it was concluded that the large size NC are more stable 
against photodegradation. This is a deceptive conclusion, though, as the ‘oxidizable’ surface area 
of these 72 Å NC is much larger and hence incubation times for decomposition may have 
increased proportionally. Nevertheless, their properties were not investigated further because of 
the compromised solubility and stability of these NC and the resulting increased tendency to 
precipitate on standing. 
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7.5 Photolysis studies - (Photo)chemistry of surface ligands 
7.5.1 Formation of coumarin from NC during irradiation with 374 nm light 
At the beginning of the project, the prime interest was in the potential interaction of the 
surface ligands with NC. Investigating the behavior of the cinnamate ligands provided insight in 
the decomposition phenomenon, which was described in Section 7.4. In the simplest scenario, it 
may be expected that the cinnamate thiols at the NC surface will show the typical photochemical 
behavior (Scheme 7.1) when subjected to irradiation at 374 nm. Thus, this will lead to formation 
of coumarin in solution. This compound is highly fluorescent (emission maximum at 438 nm) 
and can be conveniently detected by in situ fluorescence spectroscopy. Indeed, photolysis of type 
I NC at 374 nm gave rise to the formation of coumarin (Figure 7.10A).  
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Figure 7.10:  Formation of coumarin (1) from type I NC upon (A) (an)aerobic irradiation 
at 374 nm. (B) Effect of 2.2 mM KO2 on coumarin formation. In Figure B, light was switched on 
after 60 min. 
 
The absolute fluorescence counts for coumarin could not be used for quantitative 
measurements because part of the coumarin emission light was shown to be quenched by the NC. 
The notion that coumarin was formed faster during aerobic photolysis of type I NC (Figure 
7.10A) may be explained by looking in more detail into the mechanism of its formation (Scheme 
7.1). It was shown that the second, non-photochemical lactonization step of the cis-cinnamate on 
the NC surface is the rate-determining step23 which is in agreement with studies with model 
compound 13 (Figure 7.1). Reasoning that O2
−, a strong base, was formed during aerobic 
photolyses, it was found that superoxide is able to accelerate the formation of coumarin. As can 
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be deduced from Figure 7.10B, mixing type I NC with KO2 did not give any coumarin (first 60 
min) but as soon as the irradiation with 374 nm light was started, coumarin formed much faster 
as compared to photolysis without external KO2. It was also found that during the aerobic 
photolyses in the presence of superoxide quencher epinephrine, the rate of coumarin formation 
decreased (not shown).  It is known that the superoxide anion has reasonable stability in DMF24 
and therefore it was speculated that superoxide formed during aerobic irradiations of NC 
catalyzes the lactonization step of the cis-cinnamates.  
 
7.5.2 Formation of coumarin from NC by exposure to visible light 
Coumarin was formed upon irradiation of type I NC at a variety of wavelengths, i.e. from 
374 nm to 560 nm, with 374 nm being the most efficient wavelength (Figure 7.11A). The 
observation that the rate of coumarin formation, during the irradiation with 560 nm light, 
depends on the presence of air, as in the case of irradiation with 374 nm light (Figure 7.10A), is 
not shown.  
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Figure 7.11: Coumarin formation during aerobic irradiation of (A) type I NC at various 
wavelengths and (B) types II and VII NC at their first excitation peak.  
 
The coumarin formation with visible light was reproducible for all types of NC that 
possessed a free o-phenol group in the cinnamate ligand. Thus, type II and type VII showed an 
increase of fluorescence during irradiations with light of 560 nm and 620 nm, respectively 
(Figure 7.11B), whereas all other NC (types III, IV, V, VI and VIII) showed no fluorescence 
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evolution at all. It is important to realize that the cinnamate unit has no absorption > 440 nm and, 
thus, this necessarily means that the isomerization of the surface cinnamates at 494, 560 or 620 
nm proceeds by an alternative mechanism as the photochemical isomerization depicted in 
Scheme 7.1.  It is interesting to point out that now there seems to be a pronounced effect of the 
spacer length (type I versus II). Even though the decomposition rate of the NC at 560 nm looks 
similar to those shown in the previous Section (Figure 7.9), the concurrent coumarin formation in 
the case of the shorter chain type II NC was considerably faster. The same trend was observed 
when these photolyses were repeated in the absence of air, either at 560 nm or at 374 nm (not 
shown). Clearly, coumarin formation seems faster when the cinnamate is connected to the NC by 
a shorter chain. 
 
Quantitative photolyses were carried out to confirm the formation of coumarin by visible 
light, taking care that the fluorescence and UV beams, used for intermediate in situ analyses, did 
not contribute significantly to the isomerization. NC solutions that were free of O2 and Me2NH, a 
common contaminant of DMF, were irradiated at their first excitation peak (i.e. 560 or 620 nm) 
for 24 h without any exposure to other light sources. The NC were separated by size-exclusion 
membrane centrifugation and the filtrate analyzed by fluorescence and GC for the presence of 
coumarin. Identical blanks were left in the dark and worked up in the same manner.  
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Figure 7.12: Typical UV-Vis spectrum of (A) filtrate and (B) reconstituted NC, after 
irradiation and subsequent separation of types I, II or VII NC. For reference, Figure B also shows 
the normalized UV spectra of non-photolyzed NC types II and V. 
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Figure 7.12A shows a typical UV spectrum of a filtrate after photolysis of types I, II or 
VII NC. The major UV absorption around 374 – 380 nm (for coumarin) is clearly visible. The 
absorption patterns typical for NC are lacking, indicating that the separation of NC was efficient. 
In some instances it was possible to redissolve the NC that remained on the membrane filter. 
Figure 7.12B shows the UV spectrum of reconstituted type II NC; for reference also the 
normalized spectra of non-photolyzed type II and V NC are given. This figure reveals that the 
NC had not decomposed during the photolysis and that the initial absorption at 374 nm in type II 
NC had disappeared upon photolysis. In fact, the UV spectrum of photolyzed type II NC strongly 
resembles the spectrum of type V NC.  In addition, the solutions of reconstituted NC did not 
show any fluorescence resulting from coumarin.  
 
Type NC Abs of NC
a Coumarin in the filtrate (nmol)b 
          A (light)               B (dark) 
I 0.27 20.9 (34.0)            0.9 
II 0.20 29.4 (28.0)            3.4 
VII 0.02  12.9 (14.3)            3.45 
(a) Absorbance at first excitation peak [560 nm for entries 1 and 2, 630 nm for 
entry 3] (b) Numbers by fluorescence, numbers between brackets are by GC.  
 
Table 7.2:  Quantification of coumarin formed during anaerobic photolyses. 
 
The data in Table 7.2 show that much more coumarin is present in the filtrates of the 
photolyzed NC (filtrate A) as compared to the filtrates of NC solutions left in the dark (filtrate 
B). This clearly shows that coumarin is formed during irradiations of NC even at 560 and 620 
nm! Additional information was obtained by exhaustively photolyzing both filtrate A and B at 
374 nm in order to convert any remaining cinnamate into coumarin.25 Filtrate B gave substantial 
coumarin formation, indicating that there had been free ligands in the NC solution. This was also 
suggested by the GC-detection of the co-ligand 6 in the filtrate. It was calculated that the 
percentage of free ligand in the initial NC solution was ca. 40 % for both types I and II. This 
observation was confirmed by subjecting freshly dissolved type IV NC, which cannot release 
coumarin, to an identical centrifugation/filtration procedure without prior photolysis. This 
resulted in the recovery of about half of the surface cinnamate ligands in the filtrate, as 
established by UV spectroscopy. All of these percentages are in the same range as the percentage 
of 30 % approximated by NMR (Figure 7.3).26 Filtrate A did not give significant coumarin 
formation, which indicates that the aforementioned free cinnamates underwent coumarin 
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formation during the irradiation of NC at 560 or 620 nm. This somewhat surprising observation 
will be confirmed later by independent experiments (Section 7.5.4). It should be mentioned that 
fluorescence analysis is the most sensitive and reliable method for coumarin detection. GC 
detection (values between brackets in Table 7.2) usually gave similar numbers as for the 
fluorescence detection, but the very low amounts of coumarin were approaching the detection 
limits of the GC. Nevertheless, the combined fluorescence and GC data convincingly show that 
cinnamates are indeed forming coumarin on the NC surface and in solution upon irradiation with 
visible light. It should be pointed out that (non)-irradiated solutions of type VII NC always had 
relatively more co-ligand 6 in solution as compared to types I and II. This suggests that extensive 
spontaneous ligand-cleavage had occurred even without photolysis, once again demonstrating 
the low stability of these extremely large NC. 
 
7.5.3 Electrochemistry with model cinnamates 
A clue for a pathway for the isomerization of surface trans-cinnamates to cis-cinnamates 
during irradiation at 560 nm was obtained from the photostability experiments discussed in 
Section 7.4. It was proposed that the surface cinnamate transfers an electron to electron acceptors 
in solution during the NC decomposition. It is this intermediate cinnamate radical anion that was 
speculated to be the actual species that underwent substantial trans-cis isomerization. Several 
experiments have been performed to obtain evidence for this.  
 
0
10
20
30
40
50
60
70
0 300 600 900 1200 1500
Irradiation time (min)
F
lu
o
re
sc
en
ce
 c
o
u
n
ts
 (
x1
00
0) TMPD
no TMPD
 
 
Figure 7.13:  Coumarin formation during aerobic irradiation of type I NC with 560 nm 
light with and without 1 mM TMPD present. 
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As mentioned earlier, the NC decomposition is completely inhibited (Figure 7.8A) during 
aerobic photolyses of type I NC at 560 nm with the good electron donor TMPD in solution. 
Clearly, electron loss from the NC via the cinnamate is inhibited by TMPD. Furthermore, the 
coumarin formation in the presence of TMPD was ca. 12 times slower than in its absence, both 
under aerobic (Figure 7.13) and anaerobic (not shown) conditions.  It is suggested that TMPD 
first quenches a hole of the excited NC* by donating an electron and then the loosely associated 
TMPD•+ acts as an electron acceptor to either the NC¯ or to the cinnamate radical anion, thus 
preventing cinnamate isomerization.  
To gain more insight in the isomerization mechanism, some electrochemical experiments 
were carried out. Reports on electrochemical isomerizations of cis-alkenes via radical anions are 
scarce and all refer to very electron-poor alkenes, such as dimethyl maleate and 1,2-
diarylsulfonylethenes.27,28 Simple cinnamates 13 and 14a,b were used as models. Cyclic 
voltammograms of 13 and 14a,b were recorded in dry, deoxygenated DMF to identify their 
oxidation/reduction peaks. All three compounds (13, 14a,b) showed similar electrochemical 
characteristics: an oxidation peak around 0.8 – 0.9 V and a reduction peak around –1.3 to –1.5 V 
(Figure 7.14A). Thus, the cinnamate radical cation as well as the anion could be studied in DMF. 
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Figure 7.14: (A) Cyclic voltammograms of cinnamates 13 and 14a in DMF. 
SE=Supporting electrolyte. Not shown is CV for 14b, which was very similar to that for 14a. 
Concentrations of substrate and supporting electrolyte were 0.4 – 0.75 mM and 50 mM, 
respectively; scan rate=100 mV/s ; initial scan direction: negative; platinum electrodes as 
working and counter electrode; silver electrode as reference electrode; n-Bu4N
+PF6
− as 
supporting electrolyte. (B) Trans-cinnamate formed (%) and total concentration of (trans and 
cis) cinnamate (mM), during bulk electrolysis of 0.5 mM 14b in DMF at –1.5 V. 
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Bulk electrolysis was performed using the same solvent and electrode set up in 
conjunction with HPLC analysis. Electrolysis of 13 at –1.5 V gave no significant formation of 
coumarin 1 in 3 h, which was expected since the trans isomer was probably the strongly favored 
isomer and the lactonization of any cis isomer is extremely slow in DMF. Important to note here 
is that no decomposition of the radical anion was observed. On the other hand, electrolysis of 13 
at +0.9 V was accompanied by rapid decomposition of the radical cation, possibly by an 
intramolecular reaction of the phenol group (not shown). Decomposition of this radical cation 
was confirmed by reacting 13 and catalytic FeCl3 as an electron acceptor in CH2Cl2. According 
to NMR analysis, various products had formed, which could not be identified. Reductive 
electrolysis of cis-cinnamate 14b should give a clearer picture for radical anion isomerization, 
since the trans isomer is the favored isomer and thus a changing cis/trans ratio due to 
isomerization should be, at least, detectable. In addition, no complicating lactonization step was 
involved. Figure 7.14B shows the electrolysis of compound 14b at –1.5 V in DMF in the dark. 
The diamonds show the percentage of trans isomer (14a) formed, while the circles show the total 
concentration of trans + cis (14a + 14b). The data show that 4% trans isomer had been formed 
after 3 h while there was no decomposition of either 14a or 14b.  A second attempt (not shown) 
gave ca. 10 % isomerization after 20 h without any decomposition. This less efficient 
isomerization was likely the result of deterioration of the electrode surface during long 
electrolysis times (20 h). It should be pointed out that without applied voltage no isomerization 
was observed when the solution was left in the cell, i.e. the Pt-metal did not induce the 
isomerization. From all the above experiments, it was concluded that the structurally related 
cinnamates 13 and 14a,b were able to isomerize around the double bond in the radical anion 
form without decomposition. However, the radical cation of 13 decomposes rapidly making its 
involvement in explaining the behavior of the NC quite unlikely. It was attempted to record 
cyclic voltammograms of type I NC as well, but this did not look promising and was not pursued 
further. Likely, the inherent low solubility of NC was the cause for absence of any peak. Bard et 
al. reported similar observations with CdSe NC.29 
 
7.5.4 Behavior of  cinnamates in solution and on the NC surface 
In order to gain more insight in the proximity effect on the interactions of NC and the 
cinnamate unit, systematic irradiations with model cinnamate 13 in DMF solution (Figure 7.15) 
were performed. When 13 was irradiated under air in DMF at 374 nm, fast formation of the cis 
isomer was observed30 by UV analysis as the cis isomer has a lower UV absorption than the 
trans isomer. However, little coumarin formation was observed even after 20 h. This clearly 
shows that the lactonization step is very slow in DMF. Not unexpectedly, irradiation of 13 at 560 
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nm did not lead to any formation of cis isomer or coumarin since 13 does not absorb at 560 nm. 
However, when a small amount of type V NC was added, coumarin formation was observed 
during irradiation at 560 nm without decomposition or precipitation of the nanocrystals. This was 
in agreement with the results from the quantitative NC photolyses listed in Table 7.2. This 
necessarily implies that the isomerization of cinnamate in solution was mediated by the NC 
surface, possibly by a mechanism similar to that by which surface cinnamates isomerize at the 
NC. The same result was observed for the larger size nanocrystals. Thus, irradiating 13 at 620 
nm in the presence of type VIII NC gave substantial coumarin formation (not shown). In general, 
as is deduced from the increase in coumarin fluorescence, NC mediated coumarin formation 
from solution cinnamate 13 is much slower than coumarin formation from NC-bound cinnamates 
2 and 3 for irradiations at wavelengths > 500 nm. Also, NC decomposition is accelerated much 
more by NC-bound than by solution cinnamates. It is suggested that in all cases a similar 
mechanism is operating (i.e. electron transfer from NC* to cinnamate) and that the limiting 
factor in the case of solution cinnamates is the availability of (temporary) NC surface area. Thus, 
a large proximity effect on the interaction between NC and cinnamates has been established. 
 
0
5
10
15
20
25
30
35
0 100 200 300
Irradiation time (min)
F
lu
o
re
sc
en
ce
 c
o
u
n
ts
 (
x1
00
0) 560 nm, no NC
560 nm, NC
374 nm, no NC
 
 
Figure 7.15:  Irradiation of model compound 13 (6.0 uM) under air at two different 
wavelengths. The initial fluorescence value was lower in the NC-containing solution due to 
quenching of emission. 
 
It should be noted that two groups31,32 have reported the isomerization of cis-alkenes to 
trans-alkenes by suspended CdS bulk powder and visible light in CH2Cl2. In such dynamic 
equilibria there will be a steady amount of cis isomer present at any time, just as in the case of 
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the direct photo-isomerization depicted in Scheme 7.1. De Mayo et al. describe isomerization by 
alkene radical cation intermediates.31 In the present study, compound 13 was irradiated at 470 
nm in the presence of suspended CdSe powder following their procedure but no significant 
consumption of 13 or formation of coumarin 1 was observed. This means that the radical cation 
of 13 was not formed at all under these particular conditions as it already has been shown by the 
electrochemical experiments to be unstable. On the other hand, one example of CdS mediated 
photo-isomerization of electron-deficient alkenes by a radical anion intermediate has been 
reported (Yanagida et al).32 Using this protocol with CdSe powder, which was essentially the 
same as that of De Mayo except for the presence of a large amount of donor Et3N, less than 2 % 
coumarin was formed after 24 h of irradiation at 470 nm. This very low conversion was in sharp 
contrast with the 16 % conversion obtained after 6 h with type V NC and 6.0 µM of 13 dissolved 
in DMF. This implies that photocatalysis of alkene isomerization by soluble CdSe NC is much 
faster than mediation by suspended CdSe powder.  
 
7.6 Proposed mechanism for the photochemistry of cinnamate-NC 
aggregates 
7.6.1 Proposed mechanism 
The following general mechanism is proposed to explain both the enhanced 
photodecomposition of the NC and the behavior of the surface ligands during irradiations at 
wavelengths >425 nm. In irradiations at wavelengths < 425 nm, the same proposed mechanism is 
valid but now isomerization can also occur by direct absorption of the light by the surface 
cinnamates. The latter pathway is predictable and not of great interest and, therefore, will not be 
included in this Section. 
 It is important to realize that the bound ligands are in equilibrium with solution ligands 
(Eq. 1), judging from the evidence presented earlier (Sections 7.3.2 and 7.5.2). Yet, this does not 
change the overall picture too much, as it was expected that all relevant steps essentially take 
place with bound ligands (Scheme 7.5). Upon irradiation of any type of nanocrystal, an electron 
and a hole are formed in the excited state of the NC (Eq. 2). It is conceivable that part of the time 
these two will recombine to emit fluorescence light (Eq. 2). If an excellent electron acceptor A is 
present in the solution (TNM or CBr4, however not O2) an electron can be transferred from the 
NC* to A leaving an unpaired hole in the NC (Eq. 3). This NC cation (NC+) induces ligand 
oxidation and cleavage and subsequently decomposes (Eq. 4).15   
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NC    S----R NC*  S----R
NC+  S----R
hv
NC*  S----R
NC+   S----R NC degradation.
Eq. 2
Eq. 3
Eq. 4
NC    S----R NC     +    HS----R (sol) Eq. 1
recombination
__ A
 
 
Scheme 7.5: Photodegradation of all types of NC in the presence of electron acceptors. R 
can be any ligand. 
 
If cinnamate ligands cover the NC surface, an additional decomposition mechanism can 
take place even without the presence of excellent electron acceptors in the solution. This 
mechanism (Schemes 7.6 and 7.7) also explains the coumarin formation. After absorption of 
light (Eq. 5), the excited NC can transfer an electron to the nearby cinnamate π-system (Eq. 6) 
but not directly to O2. The resulting cinnamate radical anion ([cinn]
−) has several pathways fur 
further reactions. Most importantly, it can isomerize around its double bond during its lifetime 
(Eq. 7). Furthermore, it can transfer its electron, either back to the NC (Eq. 8) or into solution 
provided a reasonable electron acceptor, such as O2, is present (Eq. 9). In the first scenario, the 
NC hole and electron will recombine and there is no net loss of electrons or atoms. However, in 
the second case a NC hole is left unpaired and this will eventually lead to degradation (Eq. 4). 
Most of the evidence presented so far points to this involvement of electron transfer processes in 
the cinnamate isomerization step. Most notable is the intimate relation between electron-transfer 
induced NC decomposition and coumarin formation and also the fact that electron donors inhibit 
coumarin formation (for additional examples of this, see Section 8.3.2). However, it cannot be 
excluded that transfer of excited energy between NC and ligand (Eq. 10) is occurring. This 
would leave the cinnamate ligand in the excited state, at which point it can isomerize as well (Eq. 
11). It is not known to what extent this energy transfer may take place. 
Irrespective of the exact isomerization mechanism, non-photochemical lactonization of 
the cis-cinnamate to give coumarin 1 can take place at several stages (Scheme 7.7). Most likely, 
this occurs when the cinnamate moiety is not negatively charged (Eqs. 12-14). As shown earlier, 
this lactonization may be catalyzed by the superoxide ion if the irradiation is performed under 
aerobic conditions. Coumarin will go into solution and 11-mercapto-undecanol ligands are left 
Chapter 7 
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯ 
 
178
on the NC. It is expected that these ligands do not actively participate in any electron transfer, in 
analogy to type VI NC which did not undergo any decomposition. 
 
NC    S----cinn NC*  S----cinn
hv
Eq. 5
NC*  S----cinn NC+  S----[cinn]
-
Eq. 6
NC+  S----cinnNC+  S----[cinn]
- O2
Eq. 7NC+  S----[cinn]
- alkene
isomerization
NC+  S----[cinn]
-
Eq. 9
NC* S----cinn NC   S----[cinn]* Eq. 10
e  transfer
E transfer
Eq. 11
alkene
isomerization
NC   S----[cinn]* NC   S----[cinn]*
_   O2
NC+  S----[cinn]
-
NC    S----cinn Eq. 8
back  transfer
recombination
 
 
Scheme 7.6: Decomposition of NC covered with cinnamate ligands and possible 
mechanism for NC-induced isomerization of the cinnamate ligands upon irradiation with 
wavelengths > 450 nm. ‘Cinn’ represents both cis and trans isomers. 
 
NC    S----cinn Eq. 12
NC*  S----cinn Eq. 13
Eq. 14NC    S----[cinn]*
(cat.         )
NC    S----OH
NC*  S----OH
NC    S----OH
+  1
+  1
+  1
O2
(cat.         )O2
(cat.         )O2
 
 
Scheme 7.7: Lactonization of cis-cinnamate to release coumarin 1 in solution. 
 
                                                    Synthesis and photochemical properties of CdSe nanocrystals … 
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯ 
 
179
A few remarks regarding this mechanism are in place. First, it was noticed that coumarin 
formation upon aerobic irradiation of types I, II and VII NC at >400 nm (7.10A) continued at a 
comparable rate even when the NC were degrading. It is speculated that the disulfides, that are 
formed from surface thiols upon NC degradation,14 still can weakly coordinate to the NC surface 
during decomposition and thus undergo similar chemistry as their thiol counterparts (as long as 
the decomposing NC still absorb at the photolysis wavelength). Secondly, taking into account 
that the spacer length has little effect on the rate of NC decomposition, it is unlikely that 
hindered diffusion of O2 to the NC surface
14 is a rate-determining factor in the present case. 
Indeed, it has to be assumed that larger molecules, such as C(NO2)4  or CBr4, are perfectly able to 
approach the surface since they readily induce anaerobic degradation of type V NC. Instead, 
electrochemical arguments can be used to rationalize the differences. A literature survey shows 
that the approximate reduction peak potentials for C(NO2)4 and O2 in DMF are +0.31 and –0.72 
V (versus NHE), respectively.33,34 Even though TNM was present in a ca. 10-fold lower 
concentration than oxygen in the photolysis mixtures (0.1 mM versus 1.3 mM of O2 in air-
saturated DMF35), the large difference in reduction potentials means that O2 is a less effective 
electron acceptor under the conditions employed. Thus, type V / VIII NC are quite unreactive 
towards O2. The cinnamates, used in the present study, are less efficient electron acceptors than 
O2 (Ered for 13 is -1.2 V versus NHE).  It is suggested that, despite this difference, the close 
proximity of the cinnamate and its covalent bonding to the NC surface in types I / II / III / VII 
NC enables it to actively mediate electron transfer to O2 in solution, thereby rendering these 
types more reactive towards O2 than types V and VIII. 
 
7.6.2 Yield of coumarin formation by visible light 
It is of interest to determine the efficiency of the process, thus how many surface 
cinnamates release coumarin. An estimate can be obtained by comparing the data of Table 7.2 
with the coverage estimates obtained from UV spectra, such as the one shown in Figure 7.2. 
Usage of the ε-values mentioned in Section 7.3.2 allows for comparison of the initial cinnamate 
coverage (Figure 7.2) and total retrieved coumarin (Table 7.2), per NC unit. Dividing these two 
numbers defines an approximate photolysis efficiency, i.e. percentage of coumarin molecules 
recovered from the filtrate per initial cinnamate ligand. In Table 7.3, these numbers for the 
different batches of NC are listed. The data reveal that the photolysis of all cinnamate-covered 
NC with visible light under anaerobic conditions for 24 h proceeds with quite efficient coumarin 
formation and without (not shown) significant NC decomposition. The high efficiency numbers 
match with the almost complete disappearance of 374 nm absorption depicted in Figure 7.12B. 
In complete agreement with the electrochemistry experiments, the chemistry of the cinnamate 
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radical anion is very clean judging from the high efficiency: it either isomerizes or lactonizes 
when present in the cis form.  
 
Type NC Photolysis wavelengtha Photolysis efficiency (%) 
I 560 nm 93 ±  5b 
II 560 nm 83 ±  3 b 
VII 620 nm 84 c 
(a) Under air free conditions for 24 - 40 h in oxygen- and HNMe2-free 
DMF (b) Average of two photolyses. (c) Only performed once. 
 
Table 7.3:  Estimated efficiencies of coumarin formation after airfree irradiation for 24 h. 
 
 7.7 Conclusion & Outlook 
In this chapter, the synthesis and characterization of 31 and 72 Å CdSe nanocrystals, with 
trans-cinnamate ligands bound to the NC surface by thiol groups, is described. Upon dissolution 
of these NC in organic solvents, some surface thiols are released into solution. The NC show a 
dramatically increased aerobic photo-instability as compared to NC without cinnamate ligands. It 
is proposed that the surface cinnamates facilitate electron transfer from excited NC* to O2 in 
solution by acting as an electron carrier. Even in the absence of air, this reversible electron 
transfer between NC* and cinnamate occurs. While in its radical anion form, the double bond of 
the cinnamate unit can isomerize to give small amounts of the cis isomer. This cis isomer 
undergoes lactonization and releases coumarin into solution. Thus, using visible light and 
anaerobic conditions, organic compounds were efficiently released from ligands on a CdSe 
nanocrystal carrier without decomposition of the NC core. The cleavage is less clean for 72 Å 
NC due to the inherent instability of these large species. 
 
For any practical applications of this system, further optimization will be necessary. For 
example, the rather low rate of coumarin release can be considerably improved by either adding 
base to the DMF solution or by switching to aqueous or alcoholic media (Figure 7.1). These 
experimental modifications will speed up the rate-determining lactonization step. Furthermore, 
the NC photostability in the presence of air, a given parameter in biological systems, needs to be 
addressed. This may be improved by switching to ZnS or CdS coated CdSe NC36 which are less 
prone to leakage of electron carriers and hence photo-oxidation. Of course, this very same 
property may make them less suitable for the present purposes as they are less efficient electron 
                                                    Synthesis and photochemical properties of CdSe nanocrystals … 
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯ 
 
181
donors. Other options include incorporating Peng’s dendron-like structures.37,38 Such 
optimizations could lead to useful new concepts. For example, given the size-dependent optical 
properties of the NC, combinatorial protocols can be envisaged in which compounds are released 
selectively and stepwise from a mixture of different sizes of NC by increasing the energy of the 
beam stepwise.  The scope of these concepts may be expanded by looking at NC, such as PbSe,39 
that have lower-energetic absorption properties (in the IR region). Furthermore, simultaneous use 
of NC as biomarker (dye) and carrier (drug delivery agent) can be envisaged. As a start to these 
approaches, the topic of the next chapter will be ligands from which alcohols, rather than 
coumarin, can be released into solution upon photolysis with visible light. 
 
7.8 Experimental section 
Materials and instruments. TOPO-coated CdSe Nanocrystals were a generous gift from the labs 
of Prof. Rosenthal at Vanderbilt University. Unless indicated otherwise, all reactions were carried out 
under an inert atmosphere. All handling of cinnamates and nanocrystals was performed in a darkroom 
illuminated by red light. All purifications by column chromatography were carried out with silica gel 
from Sorbent Technologies. TLC plates were purchased from EM Science. Spots were visualized by UV 
light, treatment with I2 or treatment with phosphomolybdic acid. THF, ether and CH2Cl2 were dried using 
a Solvent Purification System from Solvtek. MeCN and H2O for HPLC analysis were of HPLC quality. 
All other solvents were used as received. All chemicals were purchased from Aldrich Company. All 
centrifugations were performed with a Fisher Scientific Centrific Model 228. Membrane size-exclusion 
centrifugations utilized Centriplus 50 centrifuge tubes (Millipore). NMR spectra were taken on a Bruker 
300 or 400 MHz NMR instruments. Signals were calibrated on CDCl3 and are reported with respect to 
TMS. 31P shifts are reported with respect to 80 % H3PO4. In the 
13C spectra, some alkyl carbons 
overlapped. If visible, 1H-NMR shifts for phenolic protons are reported. UV-spectra were recorded on a 
Hewlett Packard 8452A spectrometer. Fluorescence measurements were recorded on an ISS PC1 Photon 
Counting Spectrometer (excitation and emission slit: 0.5 mm). Elemental analyzes were carried out by 
Atlantic Microlabs. Unless stated otherwise, all HRMS spectra were recorded using the electrospray 
technique. ES-HRMS measurements (positive ion mode) were performed at Ohio State University, FAB-
HRMS at Duke University. GC was carried out using a Hewlett Packard 5980 Series II chromatograph 
(30 m x 0.32 mm HP50 column, Tinit=100 °C, tinit=1 min, rate=20 °C/min, Tfinal=250 °C). Melting points 
were taken on a Thomas Hoover melting point apparatus and are uncorrected. HPLC analyses for bulk 
electrolysis were performed with a Waters 600 Controller, 717 Autosampler and 996 Photodiode Array 
using a Supelco 5 µM LC-18-DB column (4.6 mm x 25 cm) reverse phase column. Electrochemistry 
experiments were performed on a CH Instruments CHI660A Electrochemical Workstation. Platinum 
electrodes (1.57 mm2 effective area) were purchased from CH instruments, platinum wires from VWR. 
Systematic names for molecules according to IUPAC rules were generated using the Beilstein AutoNom 
program version 2.02.118 and/or by using the ACD/I-Lab Web service (ACD/IUPAC Name Free 7.06) 
and adjusted where appropriate. 
General photolysis procedure. Irradiations were carried out in circular quartz tubes (diameter 
0.9 mm, height 13 cm), equipped with a vacuum-adapter side-arm, that were left open to air or degassed 
by the freeze-pump-thaw technique to remove air and traces of HNMe2 (no significant leaking of the 
vacuum was observed after 24 h). All UV and fluorescence analyses for photolyses were recorded in this 
tube. All photolysis solutions with the 31 Å nanocrystals showed an absorbance of 0.10 – 0.20 at the first 
excitation peak of the nanocrystal, for the 72 Å nanocrystals this was 0.02 - 0.07. For irradiation, a high 
pressure mercury lamp (1000 W, Hanovia 528B-1) in conjunction with a Spectral Energy GM 252 high 
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intensity grating monochromator was used. The metal sample chamber was at ca. 40 cm distance from the 
source. Irradiation was performed at ambient temperature and care was taken to prevent any exposure to 
incidental ambient light. At intervals the tube was removed from the beam and submitted to UV (300 nm 
– 700 nm) and fluorescence spectroscopy (excitation at 374 nm/ emission at 438 nm) for no longer than a 
few seconds. Although they were shown to have very little effect on the outcome of the photolysis, these 
intermediate analyses were not conducted during quantitative photolysis experiments (see below). In 
some cases, the nanocrystals were separated from the solution after photolysis, as described below. 
Quantitative analysis of photolysis mixtures. NC solutions were freeze-pump-thawed (3 
cycles) to remove air and HNMe2. After >24 h irradiation time without any intermediate analysis, 
irradiation was stopped and the solution was analyzed by UV and fluorescence spectroscopy. The 
photolysis tube was then opened, internal standard (biphenyl, 1 mM) in DMF was added and the contents 
of the tube were transferred (incl. 1 wash with DMF) into a Millipore centrifuge tube. The tube was spun 
at 3300 rpm  for 1 h and the filtrate collected. More DMF was then added to the Millipore tube and it was 
spun again. The two filtrates were combined and adjusted to exactly 10.0 mL DMF. This solution was 
analyzed by UV (374 nm), to determine the combined amount of coumarin and cinnamates, and by 
fluorescence (excitation at 374 nm/ emission at 438 nm) spectroscopy to quantify the amount of coumarin 
formed. Subsequently, the solution was poured into a vial containing ether (20 mL) and water (20 mL), 
the vial was shaken and the ether layer was separated. After drying with MgSO4, the ether was removed. 
The residue was redissolved in a very small amount of DMF (50-100 µL) and analyzed by GC for formed 
coumarin (confirmed by spiking with authentic material). In all cases, a blank solution (with composition 
and volume equal to the solution that had been photolyzed) was left in the dark for the duration of the 
photolysis and subsequently was worked up exactly as described above. The blank numbers thus obtained 
were used as correction, since some thiols tend to go into solution upon prolonged storage of the 
nanocrystals. 
Cyclic voltammetry measurements. All handling was conducted in the dark. An 
electrochemical cell equipped with a vacuum-adapter side-arm was used. The cell utilized a platinum 
working- and counter-electrode and a silver-reference electrode. The signal for the Fc/Fc+ couple (set at 
0.47 V versus HNE) served as the calibration signal for the cell. The supporting electrolyte (tetra-n-
butylammonium hexafluorophosphate (TBAHP) was dissolved in freshly distilled DMF (5 mL, 
[TBAHP]=50 mM), the solution was degassed (three freeze-pump-thaw cycles) and the background CV 
measured. Then the cell was opened, a concentrated solution of the analyte added (to about 1 mM) and 
the solution was degassed again. Substrate CV’s were then measured and compared to the obtained 
background signals.  
Bulk electrolysis. All handling was conducted in the dark. The working- and counter-electrode 
for the cell were coiled long platinum wires (471 mm2 surface area each). The reference electrode was an 
Ag/AgBF4 (15 mM) couple in DMF. The signal for the Fc/Fc+ couple (set at 0.47 V versus HNE) served 
as the calibration signal for the cell. Nitrogen was bubbled through the electrolysis solution at all times, 
except during the recording of a CV. The supporting electrolyte TBAHP was dissolved in freshly distilled 
DMF (5 mL, [TBAHP]=50 mM). Cyclic voltammograms were recorded for the background signal. A 
concentrated solution of the analyte was added (to give a final concentration of about 0.5 – 1.0 mM) and 
cyclic voltammograms were recorded to establish reduction/oxidation peaks. Bulk electrolysis was 
performed (at either +0.9 V or –1.5 V) with continuous measurement of the current and with continuous 
stirring. At intervals, 50 µL aliquots were taken. Internal standard (benzophenone) was added and without 
any further manipulation the DMF aliquots were analyzed by reverse phase HPLC using 40 % aq. CH3CN 
(flow rate = 1.0 mL/min) and UV detection (374 and 254 nm). A vial containing a solution, identical to 
the solution that was electrolyzed, was placed next to the electrochemical cell and aliquots from this blank 
were analyzed as to correct for any isomerization due to incidental light.  
Pyridine coated nanocrystals (py-NC). In a centrifuge tube, TOPO coated NC (ca. 40 mg) were 
heated at 90 ºC in distilled pyridine (2 mL) overnight in a glove box. After cooling, excess hexanes were 
added and the vial was shaken and centrifuged. The supernatant liquid was decanted. Hexanes were added 
to the residue and the process was repeated once more. The resulting hexane-wet nanocrystals were used 
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as such, as extensive drying led to loss of ligands and formation of insoluble material. The py-NC (as a 
solution in pyridine) could be stored for months in the glove box. On one occasion, pentane was used as 
the washing solvent (3x) and after brief air-drying the pyridine coated nanocrystals were dissolved in 
CDCl3 for NMR analysis; 
1H NMR (CDCl3, 300 MHz) δ 8.61 (br m, 2H, pyr-H2), 7.83 (br m, 1H, pyr-
H4), 7.30 (br m, 2H, pyr-H3), 2.17 (br s, 12H, TOPO-C1,2H2), 1.61 (br s, 30H, TOPO-C
3-8H2), 0.86 (br m, 
9H, TOPO-CH3), NMR shifts for unbound TOPO: δ 1.6, 1.21, 0.82. Comparing the integration of the 
pyridine and TOPO NMR peaks indicated that roughly 60 % of the original TOPO ligands had been 
replaced by pyridine. 
Ligand exchange procedure. Hexane-wet, pyridine coated NC were dissolved in CHCl3 or 
CDCl3 (treated with neutral alumina just before use) and degassed with nitrogen. To this was added a 
concentrated solution of the synthetic thiol(s) (typically 0.5 – 1.0 M) in degassed CHCl3 or CDCl3 (treated 
with neutral alumina just before use). The mixture was stirred in the dark under an inert atmosphere for 2-
3 d. After the indicated time, excess solvent was added (ether for all cinnamate-coated NC, hexanes for all 
others) to precipitate the NC. The vial was then shaken and centrifuged. The supernatant liquid was 
decanted.  More solvent was added to the residue and the process was repeated 4 times. The washings 
were concentrated and analyzed by GC to make sure all free ligand had been washed out. The washed NC 
were dried under high-vacuum and stored at –78 ºC. Alternatively, they were dissolved in DMF by 
stirring for a couple of days, followed by filtering through Celite. These solutions were stored at lower 
temperatures to avoid decomposition. 
S-(11-Hydroxy-undecyl) thioacetate (8a). 11-Bromoundecanol (7.8 g, 31 mmol), potassium 
thioacetate (7.1 g, 60 mmol) and dry DMF (70 mL) were stirred at room temperature for 20 h in the 
presence of molecular sieves (4Å). The brown suspension was diluted with ether and water, the organic 
layer was collected and the aqueous layer was extracted with ether. The combined organic layers were 
dried (MgSO4), filtered and concentrated. The resulting solid was recrystallized from hexanes to give off 
white crystals (7.2 g, 93 %). m.p. 49 °C; 1H NMR (CDCl3, 400 MHz)40 δ 3.55 (t, 2H, OCH2, J=6.6 Hz), 
2.79 (t, 2H, SCH2, J=7.2 Hz), 2.25 (s, 3H, COCH3), 2.17 (s, 1H, OH), 1.49 – 1.45 (m, 4H, SCH2CH2 + 
OCH2CH2), 1.35 – 1.15 (m, 14H, alkyl); 
13C NMR (CDCl3, 400 MHz) δ 196.5, 63.1, 33.1, 30.92, 29.88, 
29.80, 29.76, 29.46, 29.41, 29.11, 26.1; HRMS for C13H26O2S [M+H] 247.1732, found 247.1727. 
S-(6-Hydroxy-hexyl) thioacetate (8b). This compound was prepared from 6-bromohexanol (2.5 
g, 13.8 mmol), potassium thioacetate (3.16 g, 27.8 mmol) and dry DMF (20 mL) using the same 
procedure as for 8a. The product was obtained as an orange oil (2.17 g, 93 %). 1H NMR (CDCl3, 300 
MHz)41 δ 3.54 (t, 2H, OCH2, J=6.6 Hz), 2.82 (t, 2H, SCH2, J=7.5 Hz), 2.46 (s, 1H, OH), 2.26 (s, 3H, 
COCH3), 1.57 – 1.45 (m, 4H, alkyl), 1.33 – 1.29 (m, 4H, alkyl); 
13C NMR (CDCl3, 300 MHz) δ 196.5, 
62.9, 32.8, 30.9, 29.84, 29.33, 28.84, 25,66.  
 11-Acetylsulfanyl-undecyl bromoacetate (9a). A mixture of alcohol 8a (6.97 g, 28.3 mmol), 
pyridine (2.95 mL, 36.5 mmol) and DMAP (1.7 g, 14 mmol) in CH2Cl2 (50 mL) was stirred at 0 °C. 
Bromoacetyl bromide (2.95 mL, 33.6 mmol) was added dropwise, after which the mixture was stirred for 
30 min at 0 °C. The yellow suspension was diluted with CH2Cl2 and extracted successively with water, 
1.0 M aq. HCl, satd. aq. NaHCO3-soln. and water. The organic layer was dried with MgSO4, filtered and 
concentrated to give an orange oil (8.86 g, 85 %) which was sufficiently pure for the next step. An 
analytical sample was obtained by column chromatography (4:1 hexanes:EtOAc) to afford a colorless oil. 
1H NMR (CDCl3, 400 MHz) δ 4.09 (t, 2H, OCH2, J=6.7 Hz), 3.77 (s, 2H, BrCH2), 2.79 (t, 2H, SCH2, 
J=7.2 Hz), 2.24 (s, 3H, COCH3), 1.59 (p, 2H, OCH2CH2, J=6.8 Hz), 1.50 (p, 2H, SCH2CH2, J=7.5 Hz, 
1.28 – 1.20 (m, 14H, alkyl); 13C NMR (CDCl3, 400 MHz) δ 196.2, 167.6, 66.7, 31.0, 29.84, 29.75, 29.45, 
29.41, 29.13, 28.98, 28.75, 26.2, 26.1; HRMS for C13H26BrO3S [M+H] 367.0943, found 367.0933. 
6-Acetylsulfanyl-hexyl bromoacetate (9b). This compound was prepared from alcohol 8b (1.0 
g, 5.7 mmol), pyridine (0.6 mL, 7.4 mmol), DMAP (0.34 g, 2.78 mmol, CH2Cl2 (15 mL) and bromoacetyl 
bromide (0.6 mL, 6.8 mmol) using the same procedure as for 9a. The product was obtained as a brown oil 
(1.3 g, 77 %). 1H NMR (CDCl3, 300 MHz) δ 4.09 (t, 2H, OCH2, J=6.6 Hz), 3.75 (s, 2H, BrCH2), 2.80 (t, 
2H, SCH2, J=7.5 Hz), 2.25 (s, 3H, COCH3), 1.57 (p, 2H, OCH2CH2, J=6.6 Hz), 1.51 (p, 2H, SCH2CH2, 
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J=6.9 Hz), 1.37 (m, 4H, alkyl); 13C NMR (CDCl3, 300 MHz) δ 196.1, 167.6, 66.5, 30.9, 29.70, 29.25, 
28.78, 28.59, 26.28, 25.62; HRMS for C10H17BrO3S [M+Na] 318.9974, found 318.9954. 
(11-Acetylsulfanyl-undecyloxycarbonymethyl)-triphenylphosphonium bromide (10a). A 
mixture of crude bromide 9a (8.36 g, 22.7 mmol) and PPh3 (12.2 g, 45 mmol) in EtOAc (70 mL) was 
stirred for 3 d at room temperature. The solvent was evaporated to give a red oil and this was redissolved 
in EtOAc (30 mL). To this ether (250 mL) was added dropwise at 0 °C. The solid was filtered, washed 
with plenty of ether and dried. The resulting light-brown solid (12.5 g, 85 %) was sufficiently pure for 
further reactions and proved stable for at least 2 years at room temperature. An analytical sample was 
obtained by column chromatography (9 : 1 CH2Cl2 : MeOH) to afford a colorless glass. m.p. 90 °C; 1H 
NMR (CDCl3, 400 MHz) δ 7.86 – 7.61 (m, 15H, -PPh3), 5.43 (d, 2H, PCH2, J=14 Hz), 3.89 (t, 2H, OCH2, 
J=6.4 Hz), 2.79 (t, 2H, SCH2, J=7.2 Hz), 2.24 (s, 3H, COCH3), 1.49 (p, 2H, OCH2CH2, J=7.2 Hz), 1.34 – 
1.03 (m, 16H, alkyl); 13C NMR (CDCl3, 400 MHz) δ 196.3, 164.6, 135.7 – 130.3 (multiple carbons), 
118.0 (J=352 Hz), 67.2, 33.0, 31.0, 29.68, 29.60, 29.53, 29.31, 29.25, 28.95, 28.30, 25.8; 31P NMR 
(CDCl3, 400 MHz) δ 21.82; HRMS for C33H42O3PS [M] 549.2592, found 549.2592.  
The corresponding ylid, 11-Acetylsulfanyl-undecyl (triphenyl-λ5-phosphanylidene)-acetate, was 
always prepared in situ (see next reaction), but it could be obtained quantitatively by dissolving the salt in 
CH2Cl2 and washing 3 x with satd. aq. Na2CO3-soln. followed by drying and concentrating the organic 
layer to give a yellow solid. 1H NMR (CDCl3, 300 MHz) δ 7.58 – 7.22 (m, 15H, -PPh3), 3.80 (t, 2H, 
OCH2, J=6.3 Hz), 2.77 (t, 2H, SCH2, J=7.5 Hz),  2.18 (s, 3H, COCH3), 1.48 (p, 2H, OCH2CH2), 1.34 – 
1.08 (m, 16H, alkyl), the vinylic proton (pKa usually around 7.5) was sometimes observed as a broad peak 
around 2.0 ppm. 
(6-Acetylsulfanyl-hexyloxycarbonymethyl)-triphenylphosphonium bromide (10b). Crude 
bromide 9b (1.15 g, 3.88 mmol) and PPh3 (2.1 g, 7.76 mmol) were stirred in EtOAc (20 mL) for 3 d at 
room temperature. The solvent was evaporated to give a thick oil. This oil was stirred vigorously with 
ether and then allowed to settle after which the ether was decanted. This process was repeated 4 more 
times to wash away all the excess PPh3. The resulting crude product was a very thick oil (1.95 g, 89 %) 
that could not be crystallized but that was sufficiently pure for further reactions. An analytical sample was 
obtained by column chromatography (5 % -> 15 % MeOH in CH2Cl2) to afford a colorless thick oil. 
1H 
NMR (CDCl3, 300 MHz) δ 7.86 – 7.61 (m, 15H, -PPh3), 5.40 (br d, 2H, PCH2, J=14 Hz), 3.89 (t, 2H, 
OCH2, J=6.8 Hz), 2.73 (t, 2H, SCH2, J=7.4 Hz), 2.23 (s, 3H, COCH3), 1.42 – 1.31 (m, 4H, alkyl), 1.20 –
1.1 (m, 4H, alkyl); 13C NMR (CDCl3, 300 MHz) δ 196.2, 164.6, 135.5, 134.35, 130.72, 128.88, 118.0 
(J=384 Hz), 66.9, 33.3, 31.01, 29.40, 28.98, 28.24, 25.25; 31P NMR (CDCl3, 300 MHz) δ 21.94; HRMS 
for C28H32O3PS [M] 479.1804, found 479.1838. 
4-Diethylamino-2-(4-iodo-phenylmethyloxy)benzaldehyde (11d). 4-Diethylamino-salicyl-
aldehyde (1.5 g, 7.77 mmol) was dissolved in DMF (20 mL) and cooled in an ice bath. To this solid KOt-
Bu (0.91 g, 8.1 mmol) was added. After stirring in the ice bath for 15 min, a clear brown solution was 
obtained. A solution of 4-iodobenzyl bromide (2.8 g, 9.43 mmol) in DMF (20 mL) was slowly added and 
stirring was continued for 3 h after which TLC indicated completion of the reaction. Excess water was 
added and the crude product was filtered and dried. Further purification was achieved by column 
chromatography (3:1 hexanes:EtOAc) to afford the product as a pink solid (1.3 g, 41 %). m.p. 130 °C; 1H 
NMR (CDCl3, 300 MHz) δ 10.2 (s, 1H, CHO), 7.73 (d, 2H, ICH, J=6.9 Hz), 7.73 (1H, Ar-H6, J=8.8 Hz), 
7.20 (d, 2H, ICHCH, L=6.9 Hz), 6.28 (d, 1H, Ar-H5, J1=8.7 Hz), 6.00 (app. s, 1H, Ar-H3), 5.09 (s, 2H, 
OCH2Ar), 3.37 (q, 4H, NCH2, J=6.9 Hz), 1.16 (t, 6H, NCH2CH3, J=6.9 Hz); 
13C NMR (CDCl3, 300 MHz) 
δ 187.3, 163.3, 154.1, 138.2, 136.8, 131.0, 129.3, 114.8, 105.1, 94.4, 94.0, 69.9, 45.2, 12.9; HRMS for 
C18H20INO2 [M+Na] 432.0431, found 432.0427. 
11-Acetylsulfanyl-undecyl E-3-(4-diethylamino-2-hydroxy-phenyl)propenoate (12a). Salt 
10a (1.02 g, 1.5 mmol) was dissolved in benzene (3 mL) and the solution was stirred until almost 
homogeneous. Then Et3N (230 µL, 1.65 mmol) was added and stirring was continued for 15 min, 
resulting in a solution of the ylid and a precipitate of Et3N.HBr. To this suspension was added 4-
diethylaminosalicylaldehyde (0.26 g, 1.3mmol) and the mixture was stirred in the dark at room 
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temperature for 18 h. The benzene was removed by concentration and the resulting oil was applied to a 
silica column. All colored bands (mostly product, but also traces of coumarin and aldehyde) were eluted 
as one fraction with 2:1 hexanes:EtOAc to give an orange oil. This oil was dissolved in hexanes (30 mL) 
and minimal EtOAc at reflux and then cooled to room temperature while stirring vigorously. After 
reaching room temperature, the mixture was left at –30 °C for 15 h. The yellow precipitate was filtered, 
washed with hexanes and dried yielding a yellow powder (0.45 g, 75 %) of very good purity. If an orange 
color was present in the solid, a second crystallization using the above protocol was employed. m.p. 58 
°C; λmax (DMF) 374 nm; 1H NMR (CDCl3, 400 MHz) δ 7.96 (d, 2H, ArCH=C, J=16.0 Hz), 7.30 (d, 2H, 
Ar-H6, J=8.8 Hz), 7.10 (br s, 1H, OH), 6.40 (d, 2H, ArC=CH, J=16.0 Hz), 6.22 (d, 2H, Ar-H5, J=8.8 Hz), 
6.11 (app. s, 1H, Ar-H3), 4.18 (t, 2H, OCH2, J=6.3 Hz), 3.33 (q, 4H, NCH2, J=6.9 Hz), 2.86 (t, 2H, SCH2, 
J=7.2 Hz), 2.32 (s, 3H, COCH3), 1.67 (p, 2H, OCH2CH2, J=7.1 Hz), 1.54 (p, 2H, SCH2CH2, J=7.2 Hz), 
1.4 – 1.20 (m, 14H, alkyl), 1.15 (t, 6H, NCH2CH3, J=6.9 Hz); 
13C NMR (CDCl3, 400 MHz) δ 197.0, 
167.0, 158.0, 151.1, 141.7, 131.2, 112.0, 110.1, 105.1, 98.5, 64.8, 44.8, 31.0, 29.86, 29.82, 29.65, 29.61, 
29.49, 29.23, 29.19, 26.4, 13.1; HRMS (FAB) for C26H41NO4S [M] 463.2756, found 463.2765; Anal. 
calc. for C26H41NO4S (%): C 67.35, H 8.91, N 3.02, found: C 67.26, H 8.96, N 3.00. 
6-Acetylsulfanyl-hexyl E-3-(4-diethylamino-2-hydroxy-phenyl)propenoate (12b). This 
compound was prepared from phosphonium salt 10b (500 mg, 1.1 mmol), benzene (3 mL), Et3N (175 µL, 
1.26 mmol) and 4-diethylaminosalicylaldehyde (174 mg, 0.9 mmol) using the same procedure as for 12a. 
The crude oil was purified by column chromatography (3:1 hexanes:EtOAc) to give the product as an 
orange oil (275 mg, 65 %). λmax (DMF) 374 nm; 1H NMR (CDCl3, 300 MHz) δ 7.90 (d, 1H, ArCH=C, 
J=16.0 Hz), 7.46 (br s, 1H, OH), 7.22 (d, 1H, Ar-H6, J=9 Hz), 6.30 (d, 1H, ArC=CH, J=16.0 Hz), 6.13 
(dd, 1H, Ar-H5, J1=8.8 Hz, J2=2.2 Hz), 6.05 (d, 1H, Ar-H3, J=2.3 Hz), 4.10 (t, 2H, OCH2, J=6.6 Hz), 3.24 
(q, 4H, NCH2, J=7.0 Hz), 2.79 (t, 2H, SCH2, J=7.1 Hz), 2.24 (s, 3H, COCH3), 1.61 (p, 2H, OCH2CH2, 
J=6.5 Hz, 1.50 (p, 2H, SCH2CH2, J=6.5 Hz), 1.34 – 1.30 (m, 4H, alkyl), 1.06 (t, 6H, NCH2CH3, J=7.0 
Hz); 13C NMR (CDCl3, 300 MHz) δ 197.0, 170.1, 158.6, 151.1, 142.2, 131.2, 111.4, 110.1, 104.9, 98.5, 
64.6, 44.9, 31.0, 29.7, 29.4, 29.0, 28.8, 25.8, 12.9; HRMS for C21H31NO4S [M+Na] 416.1866, found 
416.1832. 
11-Acetylsulfanyl-undecyl E-3-(4-diethylamino-2-methoxy-phenyl)propenoate (12c).  Salt 
10a (760 mg, 1.2 mmol) was dissolved in benzene (3 mL) and the mixture was stirred until almost 
homogeneous. Then Et3N (190 µL, 1.34 mmol) was added and stirring was continued for 15 min, 
resulting in a solution of the ylid and a precipitate of Et3N.HBr. To this suspension was added 4-
diethylamino-2-methoxy-benzaldehyde (207 mg, 1.0 mmol) and the mixture was heated in the dark at 55 
°C for 3 d. The benzene was removed by concentration and the resulting oil was applied onto a silica 
column. The product was eluted with 2:1 hexanes:EtOAc to give an orange oil (198 mg, 41 %) having an 
E/Z ratio of  13/1 (by NMR). Clearly distinguishable peaks for the Z isomer will be reported. E isomer:  
λmax (DMF) 376 nm; 1H NMR (CDCl3, 300 MHz) δ 7.92 (d, 1H, ArCH=C, J=15.9 Hz), 7.36 (d, 1H, Ar-
H6, J=8.7 Hz), 6.32 (d, 1H, ArC=CH, J=15.9 Hz), 6.25 (dd, 1H, Ar-H5, J1=8.7 Hz, J2=1.8 Hz), 6.12 (d, 
1H, Ar-H3, J=1.5 Hz), 4.18 (t, 2H, OCH2, J=6.6 Hz), 3.86 (s, 3H, OMe), 3.37 (q, 4H, NCH2, J=6.9 Hz), 
2.86 (t, 2H, SCH2, J=7.2 Hz), 2.32 (s, 3H, COCH3), 1.72 (p, 2H, OCH2CH2, J=6.9 Hz), 1.56 (p, 2H, 
SCH2CH2, J=7.2 Hz), 1.3 – 1.20 (m, 14H, alkyl), 1.19 (t, 6H, NCH2CH3, J=6.9 Hz); 
13C NMR (CDCl3, 
300 MHz) δ 196.2, 169.0, 160.7, 151.0, 141.0, 131.1, 112.4, 111.4, 104.5, 94.1, 64.3, 55.5, 44.9, 30.9, 
29.62, 29.59, 29.56, 29.41, 29.20, 29.00, 28.90, 26.3, 13.0; HRMS for C27H43NO4S [M + Na] 500.2805, 
found 500.2772; Z isomer:  λmax (DMF) 374 nm; 1H NMR (CDCl3, 300 MHz) δ 7.99 (d, 1H, Ar-H6, 
J=8.9 Hz), 7.20 (d, 1H, ArCH=C, J=12.7 Hz), 5.56 (d, 1H, ArC=CH, J=12.7 Hz), 4.11 (t, 2H, OCH2), 
3.83 (s, 3H, OMe) ; 13C NMR (CDCl3, 300 MHz) δ 196.2, 167.6, 160.0, 150.8, 139.3, 133.1, 128.7, 
112.5, 103.7, 93.6, 64.9, 55.6. 
11-Acetylsulfanyl-undecyl E-3-(4-diethylamino-2-(4-iodo-phenylmethyloxy)-phenyl)-
propenoate (12d). This compound was prepared from phosphonium salt 10a (1.5 g, 2.4 mmol), benzene 
(12 mL), Et3N (350 µL, 2.5 mmol) and iodo-aldehyde 11d (0.8 g, 1.95 mmol) using the same procedure 
as for 12c. The crude product was purified by column chromatography (5:1 hexanes:EtOAc) to give an 
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orange solid (0.6 g, 45 %) having an E/Z ratio of  11/1 (by NMR). Clearly distinguishable peaks for the Z 
isomer will be reported. m.p. 64 °C; λmax (DMF) 374 nm (ε= 27,349 cm-1M-1); E isomer:  1H NMR 
(CDCl3, 300 MHz) δ 7.96 (d, 1H, ArCH=C, J=15.9 Hz), 7.69 (d, 2H, ICH, J=8.2 Hz), 7.37 (d, 1H, Ar-H6, 
J=8.8 Hz), 7.18 (d, 2H, ICHCH, L=8.2 Hz), 6.30 (d, 1H, ArC=CH, J=15.9 Hz), 6.25 (dd, 1H, Ar-H5, 
J1=8.8 Hz, J2=2.0 Hz), 6.05 (d, 1H, Ar-H3, J=2.3 Hz), 5.08 (s, 2H, OCH2Ar), 4.16 (t, 2H, OCH2, J=6.7 
Hz), 3.33 (q, 4H, NCH2, J=6.9 Hz), 2.84 (t, 2H, SCH2, J=7.2 Hz), 2.32 (s, 3H, COCH3), 1.66 (m, 2H, 
OCH2CH2), 1.56 (m, 2H, SCH2CH2), 1.3 – 1.20 (m, 14H, alkyl), 1.15 (t, 6H, NCH2CH3, J=6.9 Hz); 
13C 
NMR (CDCl3, 300 MHz) δ 196.4, 168.9, 159.3, 150.9, 140.5, 138.1, 137.2, 130.8, 129.3, 112.8, 111.8, 
105.1, 96.1, 93.7, 70.0, 64.5, 45.0, 31.0, 29.90, 29.86, 29.71, 29.63, 29.57, 29.27, 29.22, 26.4, 13.0; 
HRMS C33H46INO4S [M+Na] 702.2085, found 702.2096. Z isomer: 
1H NMR (CDCl3, 300 MHz) δ 7.96 
(d, 1H, ArCH=C, J=12.7 Hz), 5.65 (d, 1H, ArC=CH, J=12.7 Hz), 5.01 (s, 2H, OCH2Ar), 4.05 (q, 2H, 
OCH2, J=6.7 Hz). 
11-Mercapto-undecyl E-3-(4-diethylamino-2-hydroxy-phenyl)propenoate (2). Cinnamate 12a 
(230 mg, 0.498 mmol) was dissolved in MeOH (2.5 mL) and this solution was deoxygenated with 
nitrogen. The solution was cooled to 0 °C and NaSMe (70 mg, 0.99 mmol) was added. Stirring at 0 °C 
was continued for 1 – 2 h and then the mixture was quenched with satd. aq. NH4Cl-soln. This mixture was 
extracted 4 x with CH2Cl2 and the combined organic layers were dried (MgSO4), filtered and concentrated 
to give a yellow solid (140 mg, ~67 %). This crude material was of good purity but may contain traces of 
the disulfide. A careful column (2:1 hexanes:EtOAc, N2 as pressure gas) gave virtually disulfide-free 
product as a yellow solid. m.p. 78 °; λmax (DMF) 374 nm (ε= 35,191 cm-1M-1); 1H NMR (CDCl3, 400 
MHz) δ 7.96 (d, 2H, ArCH=C, J=16.0 Hz), 7.30 (d, 2H, Ar-H6, J=8.8 Hz), 7.0 (br s, 1H, OH), 6.40 (d, 
2H, ArC=CH, J=16.0 Hz), 6.22 (d, 2H, Ar-H5, J=8.8 Hz), 6.11 (s, 1H, Ar-H3), 4.19 (t, 2H, OCH2, J=6.3 
Hz), 3.33 (q, 4H, NCH2, J=6.9 Hz), 2.51 (app. q, 2H, HSCH2, J=7.2 Hz), 1.67 (p, 2H, OCH2CH2, J=7.6 
Hz), 1.54 (p, 2H, SCH2CH2, J=6.8 Hz), 1.4 – 1.2 (m, 14H, alkyl), 1.15 (t, 6H, NCH2CH3, J=6.88 Hz); 
13C 
NMR (CDCl3, 400 MHz) δ 170.2, 158.1, 151.1, 141.7, 131.2, 112.0, 110.1, 105.1, 98.5, 64.8, 44.8, 34.4, 
29.88, 29.67, 29.46, 29.22, 28.77, 26.4, 25.0, 13.1; HRMS (FAB) for C24H39NO3S [M] 421.2651, found 
421.2635. 
6-Mercapto-hexyl E-3-(4-diethylamino-2-hydroxy-phenyl)propenoate (3). This compound 
was prepared from cinnamate 12b (260 mg, 0.64 mmol), MeOH (5 mL) and NaSMe (90 mg, 1.3 mmol) 
using the same procedure as for 1. The crude oil was purified by column chromatography (3 : 1 hexanes : 
EtOAc) affording 150 mg of a yellow oil. The compound seemed rather unstable and always contained 
(in addition to unreacted starting material) amounts of coumarin, cis isomer and disulfides, all of which 
could not be removed on two different occasions. λmax (DMF) 374 nm (ε= 35,191 cm-1M-1);  1H NMR 
(CDCl3, 300 MHz) δ 7.93 (d, 1H, ArCH=C, J= 16Hz), 7.30 (d, 1H, Ar-H6, J=8.9 Hz), 6.63 (br s, 1H, 
OH), 6.37 (d, 1H, ArC=CH, J= 16 Hz), 6.22 (dd, 1H, Ar-H5, J1=8.9 Hz, J2=1.9 Hz), 6.07 (d, 1H, Ar-H3, 
J=2.0 Hz), 4.17 (t, 2H, OCH2, J=5.8 Hz), 3.34 (q, 4H, NCH2, J=6.88 Hz), 2.50 (app. q, 2H, HSCH2, J=7.4 
Hz), 1.7 – 1.55 (m, 4H, alkyl), 1.4 – 1.2 (m, 4H, alkyl), 1.15 (t, 6H, NCH2CH3, J=7.0 Hz);  
13C NMR 
(CDCl3, 300 MHz) δ 170.0, 158.0, 151.2, 141.7, 131.3, 112.1, 110.2, 105.4, 98.6, 64.7, 45.0.9, 34.4, 29.2, 
28.6, 26.1, 25.1, 13.2  HRMS for C19H29NO3S [M+Na] 374.1766, found 374.1781. 
11-Mercapto-undecyl E-3-(4-diethylamino-2-methoxy-phenyl)propenoate (4). This 
compound was prepared from cinnamate 12c (198 mg, 0.407 mmol, E/Z 13/1), MeOH (5 mL) and 
NaSMe (57 mg, 0.82 mmol) using the same procedure as for 1. The resulting yellow oil (173 mg, 95 %) 
had satisfactory purity. The E/Z ratio of the product was 11/1 by NMR. Clearly distinguishable 1H peaks 
for the Z isomer will be reported. E isomer:  λmax (DMF) 376 nm; 1H NMR (CDCl3, 300 MHz) δ 7.92 (1, 
2H, ArCH=C, J=15.9 Hz), 7.36 (d, 1H, Ar-H6, J=8.7 Hz), 6.32 (d, 1H, ArC=CH, J=15.9 Hz), 6.25 (dd, 
1H, Ar-H5, J1=8.7 Hz, J2=2.3 Hz), 6.12 (d, 1H, Ar-H3, J=2.3 Hz), 4.18 (t, 2H, OCH2, J=6.6 Hz), 3.84 (s, 
3H, OMe), 3.37 (q, 4H, NCH2, J=6.9 Hz), 2.48 (app q, 2H, SCH2, J=7.0 Hz), 1.72 (p, 2H, OCH2CH2, 
J=7.4 Hz), 1.56 (p, 2H, SCH2CH2, J=6.3 Hz), 1.3 – 1.20 (m, 14H, alkyl), 1.19 (t, 6H, NCH2CH3, J=6.9 
Hz); 13C NMR (CDCl3, 300 MHz) δ 169.0, 160.7, 151.0, 141.0, 131.1, 112.4, 111.4, 104.5, 94.1, 64.3, 
55.5, 45.0, 34.5, 29.75, 29.56, 29.33, 29.13, 28.64, 26.3, 13.0; HRMS for C25H41NO3S [M + Na] 
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458.2699, found 458.2658.  Z isomer: λmax (DMF) 374 nm; 1H NMR (CDCl3, 300 MHz) δ 7.99 (d, 1H, 
Ar-H6, J=8.9 Hz), 7.20 (d, 1H, ArCH=C, J=12.7 Hz), 5.66 (d, 1H, ArC=CH, J=12.7 Hz), 4.11 (t, 2H, 
OCH2), 3.83 (s, 3H, OMe). 
11-Mercapto-undecyl E-3-(4-diethylamino-2-(4-iodo-phenylmethyloxy)-phenyl)propenoate  
(5). Cinnamate 12d (270 mg, 0.4 mmol) was suspended in MeOH (20 mL) and this mixture was 
deoxygenated with nitrogen. Then NaSMe (87 mg, 1.2 mmol) was added. Stirring was continued for 3 h 
and then the mixture was quenched with satd. aq. NH4Cl-soln. This mixture was extracted with CH2Cl2 (3 
x) and the combined organic layers were dried (MgSO4), filtered and concentrated to give a yellow oil. 
NMR analysis revealed that the reaction had only proceeded halfway, presumably because of the very low 
solubility of the starting material. Therefore this material was resubjected to the same conditions as 
described above with 2:1 MeOH : i-PrOH as solvent. This led to a quick reaction and after usual work-up 
and column chromatography (6:1 hexanes:EtOAc) the product was obtained as a yellow oily solid (200 
mg, 79 %) of satisfactory purity. The E/Z ratio of the product was 11/1. Clearly distinguishable 1H peaks 
for the Z isomer will be reported. λmax (DMF) 374 nm; E isomer:  1H NMR (CDCl3, 300 MHz) δ 7.96 (d, 
1H, ArCH=C, J=15.9 Hz), 7.69 (d, 2H, ICH, J=8.2 Hz), 7.37 (d, 1H, Ar-H6, J=8.8 Hz), 7.18 (d, 2H, 
ICHCH, J=8.2 Hz), 6.30 (d, 1H, ArC=CH, J=15.9 Hz), 6.25 (dd, 1H, Ar-H5, J1=8.8 Hz, J2=2.2 Hz), 6.05 
(d, 1H, Ar-H3, J=2.2 Hz), 5.08 (s, 2H, OCH2Ar), 4.16 (t, 2H, OCH2, J=6.7 Hz), 3.33 (q, 4H, NCH2, J=6.9 
Hz), 2.51 (q, 2H, HSCH2, J=7.2 Hz), 1.66 (m, 2H, OCH2CH2), 1.56 (m, 2H, SCH2CH2), 1.3 – 1.20 (m, 
14H, alkyl), 1.15 (t, 6H, NCH2CH3, J=6.9 Hz); 
13C NMR (CDCl3, 300 MHz) δ 168.9, 159.3, 150.9, 140.6, 
138.1, 137.2, 130.8, 129.3, 112.8, 111.8, 105.2, 96.1, 93.7, 70.0, 64.5, 45.0, 34.4, 29.89, 29.69, 29.46, 
29.24, 28.78, 26.4, 25.0, 13.0; HRMS C31H44INO3S [M+Na] 660.1979, found 660.2013. Z isomer: 
1H 
NMR (CDCl3, 300 MHz) δ 7.96 (d, 1H, ArCH=C, J=12.7 Hz), 5.65 (d, 1H, ArC=CH, J=12.7 Hz), 5.01 (s, 
2H, OCH2Ar), 4.05 (q, 2H, OCH2, J=6.7 Hz). 
Ethyl E-3-(4-diethylamino-2-hydroxy-phenyl)propenoate (13). Ethyl (triphenyl-λ5-
phosphanylidene)acetate (2.09 g, 5.5 mmol) and 4-diethylaminosalicaldehyde (1 g, 5 mmol) were stirred 
in benzene (5 mL) in the dark at room temperature for 20 h. Benzene was removed by concentration and 
the residue applied to a silica column. The product was eluted with 2:1 EtOAc:hexanes and then 
recrystallized from a hexanes/EtOAc mixture to afford the product as a yellow solid (1.01 g, 78 %). m.p. 
154 °C; λmax (DMF) 376 nm (ε= 35,191 cm-1M-1); 1H NMR (CDCl3, 300 MHz) δ 7.93 (d, 1H, ArCH=C, 
J=15.7 Hz), 7.31 (d, 1H, Ar-H6, J=8.9 Hz), 6.4 (br s, 1H, OH), 6.38 (d, 1H, ArC=CH, J=15.7 Hz), 6.24 
(dd, 1H, Ar-H5, J1=8.9 Hz, J2=2.4 Hz), 6.06 (d, 1H, Ar-H3, J=2.4 Hz), 4.25 (q, 2H, OCH2, J=7.1 Hz), 
3.34 (q, 4H, NCH2, J=7.1 Hz), 1.32 (t, 2H, OCH2CH2, J=7.1 Hz), 1.16 (t, 6H, NCH2CH3, J=7.1 Hz); 
13C 
NMR (CDCl3 / d
6-DMSO, 300 MHz) δ 167.6, 158.0, 149.8, 140.4, 129.7, 110.3, 108.7, 103.3, 97.1, 58.7, 
43.6, 13.8, 12.0; HRMS for C15H21NO3 [M + Na] 286.1436, found 286.1420; Anal. calc. for C15H21NO3 
(%): C 68.42, H 8.04, N 5.32, found: C 68.36, H 7.98, N 5.27. 
7-Diethylamino-chromen-2-one (1). Ethyl (triphenyl-λ5-phosphanylidene)acetate (3.45 g, 9.9 
mmol) and 4-diethylaminosalicaldehyde (1.5 g, 7.75 mmol) were heated at 180 ºC for 1 h. The mixture 
was cooled and then purified by column chromatography (2:1 hexanes:EtOAc). The product was 
collected and recrystallized from i-Pr2O to give an orange solid (0.88 g, 52 %). m.p. 84 °C; λmax (DMF) 
380 nm (ε= 25,339 cm-1M-1); 1H NMR (CDCl3, 300 MHz) δ 7.50 (d, 1H, ArCH=C, J=10.6 Hz), 7.24 (d, 
1H, Ar-H6, J=8.8 Hz), 6.55 (dd, 1H, Ar-H5, J1=8.8 Hz, J2=2.5 Hz), 6.48 (d, 1H, Ar-H3, J=2.5 Hz), 6.00 
(d, 1H, ArC=CH, J=10.6 Hz), 3.38 (q, 4H, NCH2, J=7.1 Hz), 1.22 (t, 6H, NCH2CH3, J=7.1 Hz); 
13C NMR 
(CDCl3, 300 MHz) δ 162.6, 157.1, 151.1, 144.1, 129.2, 109.4, 109.1, 108.6, 97.8, 45.2, 12.8; HRMS for 
C13H15NO2 [M+Na] 240.0995, found 240.0981. NMR data matched with previously reported literature 
data.42 
2-[2-(2-Methoxy-ethoxy)-ethoxy]-ethanethiol (6). This compound was prepared from 
tris(ethyleneglycol)monomethyl ether according to a 3-step patent procedure.43  The crude orange oil was 
subjected to vacuum-distillation and the lowest boiling fraction was collected to give the product as a 
clear colorless liquid. No NMR or MS data for this compound were reported in the patent.  1H NMR 
(CDCl3, 300 MHz) δ 3.66 – 3.53 (m, 10H), 3.37 (s, 3H, OMe), 2.7 (q, 2H, SCH2), 1.62 (t, 1H, SH, J=8.4 
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Hz); 13C NMR (CDCl3, 300 MHz) δ 73.1, 72.2, 70.8-70.4, 59.2, 24.5; HRMS (as disulfide) for 
C14H30O6S2 [M+Na] 381.1376, found 381.1376. 
Ethyl 3-(4-Diethylamino-2-methoxy-phenyl)propenoate (14a,b). A mixture of ethyl (triphenyl-
λ5-phosphanylidene)acetate (470 mg, 1.24 mmol) and 4-diethylamino-2-methoxy-benzaldehyde (230 mg, 
1.1 mmol) were heated at 160 °C for 1 h. The mixture was then cooled and subjected to careful column 
chromatography (2:1 hexanes:EtOAc) to give the E isomer (200 mg, 60 %) and the Z isomer (10 mg, 6 %, 
contained ca. 10% of the E isomer) as yellow oils. E isomer 14a:  λmax (DMF) 376 nm; 1H NMR (CDCl3, 
300 MHz) δ 7.92 (d, 1H, ArCH=C, J=15.9 Hz), 7.34 (d, 1H, Ar-H6, J=9 Hz), 6.32 (d, 1H, ArC=CH, 
J=15.9 Hz), 6.25 (dd, 1H, Ar-H5, J1=9 Hz, J2=2.3 Hz), 6.10 (d, 1H, Ar-H3, J=2.3 Hz), 4.21 (q, 2H, OCH2, 
J=7.2 Hz), 3.84 (s, 3H, OMe), 3.36 (q, 4H, NCH2, J=7.2 Hz), 1.31 (t, 3H, OCH2CH3, J=7.2 Hz), 1.18 (t, 
6H, NCH2CH3, J=7.2 Hz); 
13C NMR (CDCl3, 300 MHz) δ 157.9, 159.7, 150.1, 140.1, 130.3, 111.8, 110.7, 
103.9, 93.6, 59.8, 55.2, 44.7, 14.8, 12.9; HRMS for C16H23NO3 [M+Na] 300.1570, found 300.1565. Z 
isomer 14b: λmax (DMF) 374 nm; 1H NMR (CDCl3, 300 MHz) δ 7.96 (d, 1H, Ar-H6, J=8.8 Hz), 7.17 (d, 
1H, ArCH=C, J=12.7 Hz), 6.25 (dd, 1H, Ar-H5, J1=8.8 Hz, J2=2.4 Hz), 6.08 (d, 1H, Ar-H3, J=2.4 Hz), 
5.58 (d, 1H, ArC=CH, J=12.7 Hz), 4.16 (q, 2H, OCH2, J=7.1 Hz), 3.82 (s, 3H, OMe), 3.39 (q, 4H, NCH2, 
J=7.2 Hz), 1.31 (t, 3H, OCH2CH3, J=7.1 Hz), 1.18 (t, 6H, NCH2CH3, J=7.2 Hz); 
13C NMR (CDCl3, 300 
MHz) δ 167.5, 159.9, 150.8, 139.3, 133.1, 113.8, 111.7, 103.8, 93.9, 60.0, 55.7, 44.9, 14.7, 13.1; HRMS 
for C16H23NO3 [M+Na] 300.1570, found 300.1576. 
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8.1 Introduction  
Mono-functionalized CdSe nanocrystals are attractive for a variety of reasons. One of the 
approaches to these inherently difficult-to-make species is to use a bulky auxiliary in the 
preparation of these NC, so that only a few ligands will bind to the NC surface. As outlined in 
Section 6.6, enzymes can serve this purpose of auxiliary quite well by virtue of their large size 
and mass. A convenient and efficient procedure for the cleavage of the enzyme needs to be 
developed, however.  
hv
NR2
NC
Enz SOH
OO
NR2
O
HO
NC
Enz
S
O
+
 
 
Scheme 8.1: Sequence for synthesis of monofunctionalized NC using enzyme auxiliary. 
 
Inspired by the results described in Chapter 7, a cinnamate linker seemed attractive as it can be 
cleaved by visible light. There is considerable experience in the Porter group with enzymes, such 
as chymotrypsin, and their inhibition by p-diethylamino-o-hydroxy-cinnamate structures.1,2 
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Hence, the idea was born to couple one or two enzymes, inhibited by a cinnamate molecule, to 
one NC by means of a thiol group and then separate the resulting aggregates by Size Exclusion 
Chromatography. Subsequently, the free enzyme could be cleaved from the surface by visible 
light mediated by the NC surface (Scheme 8.1). The thiol groups of the cinnamates in Scheme 
8.1 must be connected to the aromatic part rather than to the ester part, because the latter is a 
required part of the enzyme-acyl complex. Thus, the location of the thiol-linker in the cinnamates 
in Scheme 8.1 is on the other side of the molecule compared to the cinnamate structures utilized 
in Chapter 7. In this chapter, the synthesis of these structurally different cinnamates, their 
exchange onto CdSe NC and the photochemical properties of the resulting aggregates will be 
described. The use of an enzyme as auxiliary, as outlined earlier, has not been evaluated due to 
time constraints. 
 
8.2 Design, synthesis and photochemistry of N-substituted cinnamates 
8.2.1 Design and synthesis 
 
 
Figure 8.1: X-Ray structure of acyl-enzyme complex resulting from inhibition of 
Chymotrypsin by N,N-diethylamino-cinnamate 1. The sterically less restricted N-ethyl group is 
indicated with an arrow. Taken from Ref. 4. 
 
In the design of a thiol containing cinnamate, which fulfills the criteria outlined in the 
introductory section, the experience with N,N-diethylamino-cinnamates in the Porter group3 was 
used as a guideline. For the connection of a long thiol-containing spacer to the cinnamate 
O
O
OHN
1
NO2
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aromatic ring (Scheme 8.1), two ways could be envisioned for an amino-cinnamate, viz. 
alkylation directly onto the aromatic ring or alkylation of the amine substituent. An X-ray 
structure of chymotrypsin, inhibited by N,N-diethylamino-cinnamate 1, has been obtained 
previously.4 Inspection of this structure reveals that replacing one N-ethyl by an N-undecyl group 
may be viable without compromising the inhibitor activity (Figure 8.1). Therefore, alkylation of 
the amine substituent with a thiol containing agent was preferred. This strategy has the additional 
advantage that the electronic and photochemical properties should not differ too much from the 
original cinnamate structure used in Chapter 7.  
The aim of these preliminary studies is primarily to validate the photochemistry of N-
substituted cinnamates on the NC surface. Therefore, there is no need for a specific ester group 
that will be recognized by the enzyme and neither for the α-methyl group on the double bond as 
in 1.  As far as the ester part is concerned, the n-octyl ester was selected since this would leave a 
non-volatile (b.p. ∼ 200 °C) and GC-detectable alcohol (n-octanol) after isomerization and 
lactonization. Thus, the target for these initial studies became compound 2 (Scheme 8.2). 
The general strategy for the synthesis of 2 was based, for the major part, on the thiol-
compatible routes developed for the O-substituted cinnamates (Section 7.2.1) with the difference 
being that the required salicylaldehyde had to be synthesized first. Scheme 8.2 shows the nine–
step sequence that was successfully conducted. 3-Aminophenol was acylated selectively at the 
amine group with 11-bromoundecanoyl chloride and this was followed by selective reduction of 
the amide group using borane. This sequence of acylation and reduction was then repeated with 
acetyl chloride to install the N-ethyl group. It should be pointed out that this sequence could be 
carried out without chromatographic purification of intermediates, affording phenol 3 in 54 % 
overall yield. Reductive amination procedures on 3-aminophenol with 11-bromo-
undecylaldehyde were attempted but these proceeded in unacceptable yields or not at all. 
Therefore, the presented alkylation sequence proved superior despite the larger number of steps. 
The bromide was then substituted with a thioacetate group following a standard procedure and 
the DMF-wet product was carried on without purification. Vilsmeier-Haack formylation 
followed by aqueous work-up proceeded well and left the thioacetate group intact. Crystalline 
Wittig salt 7 was prepared from n-octanol in two steps by bromoacetylation and an SN2 reaction 
with PPh3. The key Wittig step involved mixing of 7 and Et3N to produce the corresponding ylid, 
followed by addition of salicylaldehyde 5. Once again, the o-phenol group accelerated the Wittig 
reaction and it could be conducted at room temperature despite the electron-rich aromatic ring. 
Selective deprotection of ester 6 using NaSMe5 gave target 2 as a yellow oil in ∼90 % purity. A 
small amount of S-deprotected 4, resulting from incomplete formylation, remained and could not 
be removed by column chromatography. 
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Synthesis phosphonium salt
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Key: a) SOCl2, 24 h, r.t., quant. b) 3-amino-phenol (2 eq), THF, 3 h, r.t. c) 1) BH3
.THF, THF, 24 h, 
r.t. 2) HCl, MeOH, r.t. d) AcCl, pyr, THF, 0.5 h, r.t. e) 1) BH3
.THF, THF, 24 h, r.t. 2) HCl, MeOH, 
r.t., 54 % based on 11-bromoundecanoic acid. f) KSAc, DMF, mol. sieves, 24 h, r.t. g) 1) POCl3, 
DMF, 24 h, r.t. 2) H2O, 2 h, r.t., 80 % based on 3. h) 1) Salt 7, Et3N, PhH, 0.5 h, r.t. 2) Aldehyde 5, 
PhH, 24 h, 70 %. i) NaSMe, MeOH, 0 °C, 2 h, varying yield. j) BrCH2COBr, pyr, CH2Cl2, cat. 
DMAP, 0 °C, 0.5 h. k) PPh3, EtOAc, 2 d, r.t., 84 % based on n-octanol. 
 
Scheme 8.2: Synthesis of N-substituted cinnamate. 
 
The same sequence was carried out with Wittig-ylid 8 containing an additional methyl 
group and a tert-butyl ester (Scheme 8.3).6 In this way, the tert-butyl cinnamate 9 was prepared 
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which, after acidic cleavage of the tert-butyl ester with TFA, gave acid 10 in good yield without 
touching of the -SAc group. Acid 10 was envisaged to be useful for the preparation of enzyme-
specific phenolic esters. However, this was not pursued further at this stage. 
 
O
O
OH
(a)
5 NAcS(H2C)10
(b)
9
O
OH
OHNAcS(H2C)10
10  
Key: (a) Ph3P=CMeCO2tert-Bu (8), PhH, 2 d, r.t., 95 %. (b) TFA/CH2Cl2 1/1, 2 h, 86 %. 
 
Scheme 8.3: Synthesis of free cinnamic acid as a potential precursor for phenolic esters. 
 
8.2.2 Photochemistry  
A basic requirement for the project is that the N-substituted cinnamates undergo photo-
induced cis-trans isomerization and subsequent lactonization similar to the O-substituted 
cinnamates described in Chapter 7 (Scheme 8.4). Even though this is to be expected based on 
structural similarity, a few qualitative spectroscopic and NMR studies with thiol-protected 
cinnamate 6 were carried out to confirm this. It was decided to leave the thiol protected as the 
acetate, as the thiols will be ‘protected’ as well once exchanged onto the NC surface.  
 
O
OC8H17
OH
6 (trans)
NR
OC8H17OH
6b (cis)
NR
O
hν
11
NR O O
+ C8H17OHR=(CH2)10SAc  
 
Scheme 8.4: Expected photo-isomerization and lactonization of compound 6. 
 
Irradiation at 374 nm of ∼15 µM 6 in DMF containing traces of NaOAc, to accelerate the 
lactonization step, gave rise to a rapid formation of a compound that fluoresced at 438 nm upon 
excitation at 374 nm (not shown). This emission signal was attributed to coumarin 11. The initial 
build-up of cis isomer could be deduced from the initial decrease in UV absorbance at 374 nm, 
as the cis isomer has a lower ε than the trans isomer. Unambiguous information about the 
complete product pattern was obtained by irradiating ∼40 mM 6 in CD3OD. Figure 8.2 shows 
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parts of the 1H-NMR spectrum after 6 h of irradiation at 374 nm. Signals were assigned on the 
basis of comparison of spectra reported in Section 7.8. Indicative characteristics are the triplet at 
3.45 ppm (n-octanol), the two ester signals for 6 and 6b (∼4.05 ppm) and several well resolved 
aromatic protons for 11 (6.4 and 6.6 ppm). The spectrum clearly shows the simultaneous 
presence of 6 (trans), 6b (cis), coumarin 11 and n-octanol in an approximate ratio 1: 0.3 : 0.9 : 
0.9. As is evident from the peak integrations, the protected thiol group is completely stable under 
the irradiation conditions (2.7 ppm). 13C-NMR confirmed the formation of n-octanol by an 
increasing α-oxygen signal at 63 ppm (6 was at 66 ppm). Exhaustive photolysis led to full 
conversion of 6 to 11 and n-octanol (not shown). Thus, the photochemistry of 6 in DMF or 
MeOH solution followed the expected pathway and cleanly gave coumarin 11 without 
interference of the protected sulfur moiety. 
5.65.86.06.26.46.66.87.07.27.47.67.8
2.803.003.203.403.603.804.004.20
6
6b
11
11
6
6b
11
11
6
11
6b
6, 6b
6
6b
6
6b n-octanol 6
-CH2-SH peak6,6b, 11
Chemical shift (ppm)  
 
Figure 8.2: Diagnostic parts of the NMR spectrum of a solution of 6 in d4-MeOD after 6 
h of irradiation at 374 nm. Signals are labeled with the corresponding structure: trans isomer 6, 
cis isomer 6b, coumarin 11 and n-octanol. The signal labeled with ‘–CH2-SH’ corresponds to the 
methylene group next to the sulfur atoms of 6, 6b and 11. 
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8.3 Ligand exchange and photolysis studies 
8.3.1 Ligand exchange onto NC 
The thiol 2 was exchanged onto CdSe NC in the same manner as described in Section 
7.3. Thus, pyridine-coated NC were stirred in deoxygenated and alumina-treated chloroform with 
2 and co-ligand 12, followed by precipitation of the NC and extensive washing with hexanes. GC 
and UV analyses were conducted on the washings to ensure complete removal of free ligands. 
Two different sizes of NC were used, the diameters being 31 Å and 72 Å. Table 8.1 shows the 
types of NC prepared and studied. Occasionally, the types I – VIII that were described in Chapter 
7 will be included in this Chapter as well. 
 
O
O
O
SH
12  
NC type Size NC (Å) Ligand(s)a 
IX 31 2 ,  12 
V 31 12b 
X 72 2 ,  12 
VIII 72 12b 
 (a) Although 2 to 3 molar excess of 12, with 
respect to 2, was used, this did not necessarily 
reflect the exact composition on NC surface. (b) 
These batches are the same ones used as in 
Chapter 7, therefore the same type code is used 
as in Chapter 7. 
 
Table 8.1: Different types of nanocrystals prepared. 
 
All NC were soluble in DMF, albeit less than NC covered with O-substituted cinnamates. 
Presumably the outer n-octyl chains rendered the NC more hydrophobic. UV analysis was used 
to check the integrity of the NC covered with N-substituted cinnamates.  Figure 8.3 shows the 
UV spectra of all four types NC listed in Table 8.1. The 31 Å NC have the first excitation peak 
absorption at 560 nm (Figure 8.3A), for the 72 Å NC this is at 630 nm (Figure 8.3B). From the 
differences in absorbance at 374 nm, it is clear that cinnamate ligands were bound to the NC 
surface. Using the same protocol and ε-values7,8,9 as discussed in Section 7.3.2, it was estimated 
that types IX and X contain 30 and 40 molecules of ligand 2 per NC, respectively.10 No further 
characterization studies were carried out on these NC. 
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Figure 8.3: UV spectra of NC in DMF: (A) Types IX and V (B) Types X and VIII. 
 
8.3.2 Photolysis studies 
Several photolysis studies were performed, using both UV and fluorescence spectroscopy 
to monitor the progress of the reactions. It was expected that the mechanism for the NC 
decomposition as well as for the coumarin formation, proposed for NC covered with O-
substituted NC in Section 7.6, is the same for NC covered with N-substituted cinnamates. Some 
experiments were carried out to confirm this assumption (Figure 8.4).  
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Figure 8.4: Irradiation of type IX NC in DMF at 560 nm under airfree and under aerobic 
conditions, with and without ∼1 mM TMPD. 
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Type IX NC rapidly decomposed upon aerobic irradiation at 560 nm, but not when air 
was omitted. Furthermore, the excellent electron donor TMPD (N,N,N’,N’-
tetramethylphenylenediamine) fully inhibited aerobic photodecomposition. The same results 
were obtained for the larger type X NC, although the incubation time for degradation was much 
longer (not shown). This issue has been addressed in Section 7.4.7. 
It was not clear which coumarin fluorescence profile could be expected, because upon 
photolysis these N-substituted cinnamates presumably leave the coumarin portion (ligand 14, 
hereafter denoted as ‘coumarin’) on the NC surface, while n-octanol migrates into solution. The 
NC and coumarin being so close together, extensive quenching of coumarin fluorescence may 
occur. However, a clear increase of the fluorescence signal at 374/438 nm was observed upon 
irradiation of type IX NC at 560 nm (Figure 8.5). On the basis of structural resemblance with 
simpler coumarins, this signal was attributed to coumarin 14. Detectable fluorescence due to 
coumarin species bound to CdS or Au NC has been reported before.11,12 In the present case, 
confirmation that the observed fluorescence was mainly due to surface-bound coumarin, rather 
than solution species, will be given in the next section. The presence of air somewhat accelerated 
the coumarin formation, whereas the electron donor TMPD completely inhibited its formation. 
The larger size NC (Type X) showed the same trends, but they were less stable upon storage and 
had the tendency to precipitate randomly. In summary, all key results described in this Section 
are in excellent agreement with the proposed mechanism described in Section 7.6. Thus, types X 
and IX NC seemed to behave entirely analogously to the corresponding NC covered with O-
substituted cinnamates. 
 
 
 
Figure 8.5: Irradiation of type IX NC at 560 nm, with and without air, in the presence of 
∼1 mM TMPD.  
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Quantitative photolyses were conducted as described in Section 7.5.2. Thus, types IX or 
X NC were irradiated at their first excitation peak under airfree conditions for >24 h without any 
exposure to other light sources. A blank was left in the dark for the same duration. The NC were 
isolated by SEC membrane centrifugation and reconstituted in DMF. The filtrate was analyzed 
for n-octanol and also for any free ligand 2, 12 or 14 by GC analysis, UV and fluorescence 
spectroscopy. Table 8.2 shows the estimated photolysis efficiencies for both types NC, defined 
by the amount of n-octanol recovered from the filtrate divided by the initial amount of cinnamate 
ligands present.  
 
Type NC Photolysis wavelengtha Photolysis recovery (%) 
IX 560 nm 103 % b 
X 630  nm 116 ±  9 % c 
(a) Under air free conditions for 24 - 40 h in oxygen- and HNMe2-
free DMF. (b) Only performed once. (c) Average of two photolyses. 
 
Table 8.2:  Estimated efficiencies of coumarin formation after airfree irradiation for 24 h. 
 
Photolysis with freshly prepared type IX NC at 560 nm was performed. GC analysis 
revealed large amounts of n-octanol in the filtrate, ∼7 times more than in the corresponding 
blank. These results clearly indicate that a photochemical reaction had occurred upon irradiation 
at 560 nm, presumably following the mechanism depicted in Scheme 8.4. The photolysis 
efficiency amounted to 100 %. Figure 8.6A shows a UV spectrum of the reconstituted NC 
together with a spectrum of the original NC. The UV spectrum of the filtrate is plotted in Figure 
8.6B. Both phases showed the typical absorbance for 14 around 374 nm. In addition, the filtrate 
as well as the reconstituted NC showed high fluorescence coumarin counts (not shown). Thus, in 
addition to 14 bound to the NC, the filtrate also contained substantial amounts of unbound 14. Its 
quantity was estimated to be ca. 40 % with respect to n-octanol. This indicates the cleavage of 
Cd-S bonds at the NC surface, a phenomenon already observed and addressed in Section 7.6. 
The numbers suggest that at least ∼60 % of recovered n-octanol was released from the NC 
surface by isomerization and subsequent lactonization of the cinnamate ligands. Separate 
experiments confirmed that unbound cinnamate molecules in solution could also be isomerized 
by the NC, albeit slower (see also Section 7.5.4). 
The photolysis of type X NC at 630 nm gave large amounts of recovered n-octanol and 
the efficiency numbers were somewhat higher than 100 %, which was attributed to an error. 
However, in these cases also large amounts of co-ligand 12 were detected, even in the blank. 
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This is indicative, again, of the inherent instability of ligands on these very large nanoparticles 
(72 Å), a phenomenon already discussed in Section 7.4.7. 
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Figure 8.6: (A) Non-normalized UV Spectra of type IX NC before and after photolysis at 
560 nm, SEC centrifugation and reconstitution. (B) UV Spectrum of the filtrate after SEC 
centrifugation.   
 
8.4 Conclusion and outlook 
N-Substituted cinnamates with a thiol linker were synthesized and underwent the same 
photo-induced isomerization in solution as O-substituted cinnamates. Photolysis of NC, covered 
with either ligand, showed identical trends and results. Thus, the NC covered with N-substituted 
cinnamates were prone to rapid aerobic photo-oxidation. They released n-octanol into solution 
upon irradiation with visible light (560 or 630 nm) in the absence or presence of air, with 
concomitant formation of a coumarin. Fresh batches of 31 Å NC (Type IX) gave high anaerobic 
photolysis efficiencies, accompanied by some cleavage of surface thiols. However, the large size 
NC (72 Å) gave large amounts of free ligand in solution and therefore were not useful for 
practical applications due to inherent instability of the ligand-Cd bond. In summary, the 
photochemistry of the NC covered with N-substituted cinnamates can be fully explained by the 
mechanism proposed in Section 7.6. 
 
The significance of the results presented in this chapter relates to the potential use of 
CdSe NC in biological systems. One can envisage that the release of organic compounds from 
NC with visible light may find application in areas such as drug delivery, imaging, etc. (see 
Section 7.7). A few critical hurdles are obvious, such as air-stability and the nature of released 
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compounds. No attempts were made to improve the (air)-stability of the NC, since other research 
teams are addressing this issue elegantly and valuable lessons can be drawn from their 
results.13,14,15 However, in the present study the ligand structure was successfully adjusted to 
allow the release of a biologically important functional group, namely an alcohol. It may be 
speculated that the same protocol can be used for the release of amines, in which case the ligand 
must contain an amide bond rather than an ester unit. This would broaden the range of potential 
molecules to be photo-released even more.  
 
8.5 Experimental section 
Materials and instruments. TOPO-coated CdSe Nanocrystals were a generous gift from the labs 
of Prof. Rosenthal at Vanderbilt University. Unless indicated otherwise, all reactions were carried out 
under an inert atmosphere. All handling of cinnamates and nanocrystals was performed in a darkroom 
illuminated by red light. All purifications by column chromatography were carried out with silica gel 
from Sorbent Technologies. TLC plates were purchased from EM Science. Spots were visualized by UV 
light, treatment with I2 or treatment with phosphomolybdic acid. THF, ether and CH2Cl2 were dried using 
a Solvent Purification System from Solvtek. All other solvents were used as received. All chemicals were 
purchased from Aldrich Company. All centrifugations were performed with a Fisher Scientific Centrific 
Model 228. Membrane size-exclusion centrifugations utilized Centriplus 50 centrifuge tubes (Millipore). 
NMR spectra were taken on Bruker 300 or 400 MHz NMR instruments. Signals were calibrated on 
CDCl3 and are reported with respect to TMS. 
31P shifts are reported with respect to 80 % H3PO4. In the 
13C spectra, some alkyl carbons overlapped. If visible, 1H-NMR shifts for phenolic protons are reported. 
UV-spectra were recorded on a Hewlett Packard 8452A spectrometer. Fluorescence measurements were 
recorded on an ISS PC1 Photon Counting Spectrometer (excitation and emission slit: 0.5 mm). Melting 
points were taken on a Thomas Hoover melting point apparatus and are uncorrected. ES-HRMS 
measurements (positive ion mode) were performed at Ohio State University. GC was carried out using a 
Hewlett Packard 5980 Series II chromatograph (30 m x 0.32 mm HP50 column, Tinit=100 °C, tinit=1 min, 
rate=20 °C/min, Tfinal=250 °C). Systematic names for molecules according to IUPAC rules were 
generated using the Beilstein AutoNom program version 2.02.118 and/or by using the ACD/I-Lab Web 
service (ACD/IUPAC Name Free 7.06) and adjusted where appropriate. 
General photolysis procedure. Irradiations were carried out in circular quartz tubes (diameter 
0.9 mm, height 13 cm), equipped with a vacuum-adapter side-arm, that were left open to air or degassed 
by the freeze-pump-thaw technique to remove air and traces of HNMe2 (no significant leaking of the 
vacuum was observed after 24 h). All UV and fluorescence analyses for photolyses were recorded in this 
tube. All photolysis solutions with the 31 Å nanocrystals showed an absorbance of 0.10 – 0.20 at the first 
excitation peak of the nanocrystal, for the 72 Å nanocrystals this was 0.02 - 0.07. For irradiation, a high 
pressure mercury lamp (1000 W, Hanovia 528B-1) in conjunction with a Spectral Energy GM 252 high 
intensity grating monochromator was used. The metal sample chamber was at ca. 40 cm distance from the 
source. Irradiation was performed at ambient temperature and care was taken to prevent any exposure to 
incidental ambient light. At intervals the tube was removed from the beam and submitted to UV (300 nm 
– 700 nm) and fluorescence spectroscopy (excitation at 374 nm/ emission at 438 nm) for no longer than a 
few seconds. Although they were shown to have very little effect on the outcome of the photolysis, these 
intermediate analyses were not conducted during quantitative photolysis experiments (see below). In 
some cases, the nanocrystals were separated from the solution after photolysis, as described below. 
Quantitative analysis of photolysis mixtures. NC solutions were freeze-pump-thawed (3 
cycles) to remove air  and HNMe2. After >24 h irradiation time without any intermediate analysis, 
irradiation was stopped and the solution was analyzed by UV and fluorescence spectroscopy. The 
Synthesis and photochemical properties of CdSe nanocrystals … 
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯ 
 
203
photolysis tube was then opened, internal standard (biphenyl, 1 mM) in DMF was added and the contents 
of the tube were transferred (incl. 1 wash with DMF) into a Millipore centrifuge tube. The tube was spun 
at 3300 rpm for 1 h and the filtrate collected. More DMF was then added to the Millipore tube and it was 
spun again. The two filtrates were combined and adjusted to exactly 10.0 mL DMF. This solution was 
analyzed by UV (374 nm), to determine the combined amount of coumarin and cinnamates, and by 
fluorescence (excitation at 374 nm/ emission at 438 nm) spectroscopy to quantify the amount of coumarin 
formed. Subsequently, the solution was poured into a vial containing ether (20 mL) and water (20 mL), 
the vial was shaken and the ether layer was separated. After drying with MgSO4, the ether was removed. 
The residue was redissolved in a very small amount of DMF (50-100 µL) and analyzed by GC for n-
octanol (confirmed by spiking with authentic material). In all cases, a blank solution (with composition 
and volume equal to the solution that had been photolyzed) was left in the dark for the duration of the 
photolysis and subsequently was worked up exactly as described above. The blank numbers thus obtained 
were used as correction, since some thiols tend to go into solution upon prolonged storage of the 
nanocrystals. 
Pyridine coated nanocrystals (py-NC). In a centrifuge tube, TOPO coated NC (ca. 40 mg) were 
heated at 90 ºC in distilled pyridine (2 mL) overnight in a glove box. After cooling, excess hexanes was 
added and the vial was shaken and centrifuged. The supernatant liquid was decanted. Hexanes were added 
to the residue and the process was repeated once more. The resulting hexane-wet nanocrystals were used 
as such, as extensive drying led to loss of ligands and formation of insoluble material. The py-NC (as a 
solution in pyridine) could be stored for months in the glove box. On one occasion, pentane was used as 
the washing solvent (3x) and after brief air-drying the pyridine coated nanocrystals were dissolved in 
CDCl3 for NMR analysis. 
1H NMR (CDCl3, 300 MHz) δ 8.61 (br m, 2H, pyr-H2), 7.83 (br m, 1H, pyr-
H4), 7.30 (br m, 2H, pyr-H3), 2.17 (br s, 12H, TOPO-C1,2H2), 1.61 (br s, 30H, TOPO-C
3-8H2), 0.86 (br m, 
9H, TOPO-CH3), NMR shifts for unbound TOPO: δ 1.6, 1.21, 0.82. Comparing the integration of the 
pyridine and TOPO NMR peaks indicated that roughly 60 % of the original TOPO ligands had been 
replaced by pyridine in this particular batch. 
Ligand exchange procedure. Hexane-wet, pyridine coated NC were dissolved in CHCl3 or 
CDCl3 (treated with neutral alumina just before use) and degassed with nitrogen. To this was added a 
concentrated solution of the synthetic thiol(s) (typically 0.5 – 1.0 M) in degassed CHCl3 or CDCl3 (treated 
with neutral alumina just before use). The mixture was stirred in the dark under an inert atmosphere for 2-
3 d. After the indicated time, excess solvent was added (ether for all cinnamate-coated NC, hexanes for all 
others) to precipitate the NC. The vial was then shaken and centrifuged. The supernatant liquid was 
decanted.  More solvent was added to the residue and the process was repeated 4 times. The washings 
were concentrated and analyzed by GC to make sure all free ligand had been washed out. The washed NC 
were dried under high-vacuum and stored at –78 ºC. Alternatively, they were dissolved in DMF by 
stirring for a couple of days, followed by filtering through Celite. These solutions were stored at lower 
temperatures to avoid decomposition. 
3-[N-(11-Bromo-undecyl)-N-ethylamino]-phenol (3). 11-Bromo-undecanoic acid (6.6 g, 24.8 
mmol) in SOCl2 (30 mL) was stirred at room temperature overnight. The mixture was concentrated and 
dried to give the acid chloride as an oil. This was redissolved in THF (100 mL) and 3-amino-phenol (5.4 
g, 49.6 mmol) was added. The reaction mixture was stirred at room temperature for 3 h. The precipitated 
3-amino-phenol hydrochloride was filtered off and washed with ether. The filtrate was concentrated, dried 
and redissolved in THF (50 mL). BH3
.THF (1.0 M, 90 mL, 90 mmol) was slowly added (gas evolution !!) 
and the mixture was stirred overnight at room temperature. The reaction was carefully quenched with 
MeOH and after 15 min of stirring, conc. HCl was added to decompose the amine-borane complex. After 
5 min of stirring, volatiles were removed by concentration in vacuo and the residue was taken up in 
CH2Cl2 and satd. aq. NaHCO3-soln. The organic layer was separated and the aqueous layer was extracted 
2x with CH2Cl2. The combined organic layers were dried (MgSO4), filtered and concentrated to give 
crude 3-(N-(11-bromo-undecyl)amino)-phenol as a yellow oil (8 g, 100 %). The THF wet product was 
taken up in THF (100 mL) and treated with pyridine (2.2 mL, 27 mmol) and acetyl chloride (1.7 mL, 24 
mmol). After 0.5 h at room temperature, the pyridine-hydrochloride was filtered and washed with ether. 
Chapter 8 
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯ 
 
204
The filtrate was concentrated and redissolved in THF (40 mL). BH3
.THF (1.0 M, 93 mL, 93 mmol) was 
slowly added (gas evolution !!) and the mixture was stirred overnight at room temperature. The reaction 
was carefully quenched with MeOH and after 15 min of stirring, conc. HCl was added to decompose the 
amine-borane complex. After 5 min of stirring, volatiles were removed by concentration in vacuo and the 
residue was taken up in CH2Cl2 and satd. aq. NaHCO3-soln. The organic layer was separated and the 
aqueous layer was extracted 2x with CH2Cl2. The combined organic layers were dried (MgSO4), filtered 
and concentrated. The crude product was purified by column chromatography (5 : 1 hexanes : EtOAc) to 
give the product as a yellowish oil (4.5 g, 59 % calculated from the amount of 11-bromo-undecanoic 
acid). 1H NMR (CDCl3, 400 MHz) δ 7.06 (t, 1H, Ar-H5, J=8.0 Hz), 6.28 (dd, 1H, Ar-H4, J1=8.3 Hz, 
J2=2.3 Hz), 6.20 (d, 1H, Ar-H2, J=2.2 Hz), 6.15 (dd, 1H, Ar-H6, J1=7.8 Hz, J2=2.2 Hz), 4.5 (br s, 1H, 
OH), 3.43 (t, 2H, CH2Br, J=6.8), 3.33 (q, 2H, NCH2CH3, J=7.1 Hz), 3.22 (t, 2H, NCH2CH2, J=6.8 Hz), 
1.89 (m, 2H, BrCH2CH2), 1.67 – 1.23 (16H, alkyl), 1.15 (t, 3H, CH3, J=7.0 Hz); 
13C NMR (CDCl3, 300 
MHz) δ 157.4, 149.4, 130.5, 105.2, 103.2, 99.7, 51.0, 44.7, 34.6, 33.3, 30.10, 29.97, 29.93, 29.87, 29.21, 
28.62, 27.91, 27.64, 12.7; HRMS for C19H32BrNO [M + H] 370.1740, found 370.1733. 
4-[N-(11-acetylsulfanyl-undecyl)-N-ethyl-amino]-2-hydroxy-benzaldehyde (5). A mixture of 
bromo-phenol 3 (2.0 g, 5.4 mmol), potassium thioacetate (1.3 g, 11.4 mmol) and molecular sieves in 
DMF (20 mL) was stirred overnight at room temperature.  The reaction mixture was decanted from the 
molecular sieves, ether and water were added, the whole was stirred briefly, the ether layer was collected 
and the aqueous layer back-extracted with ether (2 x). The combined organic layers were extracted with 
water, dried (MgSO4), filtered and concentrated to give a brown oil. This DMF-wet oil was dissolved in 
dry DMF (10 mL). In a separate flask, DMF (50 mL) was cooled to 0 ºC after which POCl3 (0.63 mL, 6.7 
mmol) was added dropwise. The mixture was stirred at room temperature for 30 min during which it 
turned orange. To this solution of Vielsmeier-Haack reagent was added the DMF-product solution (10 
mL). The clear solution was stirred overnight at room temperature, after which it was quenched with ice. 
The DMF-ice mixture was allowed to stir for 1.5 h (turning from green to yellow), after which solid 
NaHCO3 was added to neutralize. The solution was extracted with ether (3x) and the combined organic 
layers were extracted 1x with water. The organic layer was dried (MgSO4), filtered and concentrated to 
give the crude aldehyde as a red oil (1.8 g). This product proved to be sufficiently pure for the next step, 
but always some DMF remained even after extensive drying. Purification was performed by column 
chromatography (6 : 1 hexanes : EtOAc) to afford an orange oil. This oil contained 10 % of unformylated 
material.  1H NMR (CDCl3, 300 MHz) δ 11.64 (s, 1H, CHO), 9.47 (s, 1H, OH), 7.24 (d, 1H, Ar-H5, J=9.0 
Hz), 6.24 (dd, 1H, Ar-H6, J1=9.0 Hz, J2=2.1 Hz), 6.04 (d, 1H, Ar-H2, J=2.0 Hz), 3.40 (q, 2H, NCH2CH3, 
J=7.1 Hz), 3.29 (t, 2H, NCH2CH2, J=6.8 Hz), 2.85 (t, 2H, CH2S, J=7.2 Hz), 2.31 (s, 3H, COCH3),  1.70 – 
1.20 (18H, alkyl), 1.19 (t, 3H, NCH2CH3, J=7.1 Hz); 
13C NMR (CDCl3, 300 MHz) δ 196.4, 192.2, 164.7, 
154.7, 135.7, 111.7, 104.8, 97.0, 50.1, 45.7, 30.1, 29.84, 29.81, 29.75, 29.72, 29.44, 29.38, 29.10, 27.8, 
27.4, 12.7; HRMS for C22H35NO3S [M + Na] 416.2235, found 416.2248. 
n-Octyloxycarbonymethyl-triphenylphosphonium bromide (7). A mixture of n-octanol (7.0 g, 
53.9 mmol), pyridine (4.8 mL, 59.3 mmol) and DMAP (3.28 g, 26.9 mmol) in CH2Cl2 (100 mL) was 
stirred at 0 °C. Bromoacetyl bromide (5.2 mL, 59.3 mmol) was added dropwise, after which the mixture 
was stirred for 30 min at 0 °C. The yellow suspension was diluted with CH2Cl2 and extracted with water, 
1.0 M aq. HCl, satd. aq. NaHCO3-soln. and finally water. The organic layer was dried with MgSO4, 
filtered and concentrated to give crude bromo-ester (12.2 g, 90 %) which was stirred in EtOAc (150 mL) 
with Ph3P (19.5 g, 74.13 mmol) at room temperature for 2 d. Excess ether was then slowly added to 
induce precipitation. The salt was filtered and dried affording a white solid (23.27 g, 84 % based on n-
octanol). An analytical sample was recrystallized form EtOAc to afford a white solid. m.p. 122 °C; 1H 
NMR (CDCl3, 300 MHz) δ 7.86 – 7.61 (m, 15H, -PPh3), 5.52 (d, 2H, PCH2, 13.8 Hz), 3.87 (t, 2H, OCH2, 
J=6.7 Hz), 1.39 (p, 2H, OCH2CH2, J=7.1 Hz), 1.15 (m, 10H, alkyl), 0.85 (t, 3H, Me, J=6.7 Hz); 
13C NMR 
(CDCl3, 300 MHz) δ 164.8, 135.6, 134.2, 133.6, 130.7, 118.2 (d, J=384 Hz), 67.3, 31.9, 29.3, 28.4, 25.9, 
22.9, 14.4; 31P NMR (CDCl3, 300 MHz) δ 22.11; HRMS for C28H34BrO2P [M] 433.2291, found 433.2286. 
Synthesis and photochemical properties of CdSe nanocrystals … 
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n-Octyl E-3-{4-[N-(11-acetylsulfanyl-undecyl)-N-ethyl-amino]-2-hydroxy-phenyl}-
propenoate (6). Salt 7 (288 mg, 0.56 mmol) was dissolved in benzene (3 mL) and stirred until almost 
homogeneous. Then Et3N (85 µL, 0.61 mmol) was added and stirring was continued for 15 min, resulting 
in a solution of the ylid and a precipitate of Et3N.HBr. To this suspension was added the salicylaldehyde 5 
(170 mg, DMF-wet, ca. 0.4 mmol) and the reaction mixture was stirred in the dark at room temperature 
for 2 d. The benzene was evaporated and the residue was purified by column chromatography (1 : 1 
hexanes : EtOAc) to afford a yellow oil (138 mg, ca. 70 %). An analytical sample was obtained by 
dissolving some of the oil in a minimum amount of MeOH, storing at –30 °C, filtering off the precipitated 
yellow solid and washing with precooled MeOH (all at –30 °C with a dry-ice cooled filter). Upon 
warming to room temperature the solid melted affording the product as a yellow oil. λmax (DMF) 374 nm; 
1H NMR (CDCl3, 300 MHz) δ 7.95 (d, 1H, ArCH=C, J=15.9 Hz), 7.29 (d, 1H, Ar-H6, J=8.8 Hz), 7.09 (br 
s, 1H, OH), 6.39 (d, 1H, ArC=CH, J=15.9 Hz), 6.19 (dd, 1H, Ar-H5, J1=8.8 Hz, J2=2.0 Hz), 6.09 (d, 1H, 
Ar-H3, J=2.1 Hz), 4.17 (t, 2H, OCH2, J=6.7 Hz), 3.32 (q, 2H, NCH2CH3, J=7.0 Hz), 3.21 (t, 2H, 
NCH2CH2, J=7.7 Hz),  2.84 (t, 2H, CH2S, J=7.4 Hz), 2.31 (s, 3H, COCH3), 1.67 (p, 2H, OCH2CH2, J=7.2 
Hz), 1.50 – 1.15 (28H, alkyl), 1.13 (t, 3H, NCH2CH3, J=6.9 Hz), 0.87 (t, 3H, alkyl-CH3, J=5.5 Hz); 
13C 
NMR (CDCl3, 300 MHz) δ 196.6, 169.6, 157.6, 150.9, 141.3, 130.7, 111.5, 109.6, 104.7, 98.1, 64.4, 50.4, 
45.0, 31.8, 30.6, 29.61, 29.50, 29.35, 29.26, 29.21, 29.12, 28.90, 28.81, 22.6, 14.1, 12.4; HRMS for 
C32H53NO4S [M + Na] 570.3587, found 570.3639. 
n-Octyl E-3-{4-[N-ethyl-N-(11-mercapto-undecyl)-amino]-2-hydroxy-phenyl}-propenoate 
(2). Protected cinnamate 6 (180 mg, 0.37 mmol) was dissolved in MeOH (5 mL) and this solution was 
deoxygenated with nitrogen gas. The solution was cooled to 0 °C and stirred. Then NaSMe (51 mg, 0.72 
mmol) was added. Stirring at 0 °C was continued for 1 – 2 h and then the mixture was quenched with 
satd. aq. NH4Cl-soln. This mixture was extracted 4x with CH2Cl2 (4 x 5 mL) and the combined organic 
layers were dried (MgSO4), filtered, concentrated and dried to give the product as a yellow oil (100 mg). 
Careful NMR analysis showed that the product contained material that had not been formylated and 
therefore had not reacted in the Wittig reaction (15 mole %) and Ph3PO (0.6 mole %). The unformylated 
material could not be separated by column chromatography. This material was used as the 84 % pure 
product. λmax (DMF) 374 nm; 1H NMR (CDCl3, 300 MHz) δ 7.95 (d, 1H, ArCH=C, J=15.9 Hz), 7.29 (d, 
1H, Ar-H6, J=8.8 Hz), 6.39 (d, 1H, ArC=CH, J=15.9 Hz), 6.19 (dd, 1H, Ar-H5, J1=8.8 Hz, J2=2.0 Hz), 
6.09 (d, 1H, Ar-H3, J=2.1 Hz), 4.17 (t, 2H, OCH2, J=6.7 Hz), 3.32 (q, 2H, NCH2CH3, J=7.0 Hz), 3.21 (t, 
2H, NCH2CH2, J=7.7 Hz), 2.50 (q, 2H, CH2SH, J=7.3 Hz), 1.65 (p, 2H, OCH2CH2, J=7.2 Hz), 1.50 – 1.19 
(28H, alkyl), 1.13 (t, 3H, NCH2CH3, J=6.9 Hz), 0.87 (t, 3H, alkyl-CH3, J=5.5 Hz); 
13C NMR (CDCl3, 300 
MHz) δ 170.2, 158.1, 151.2, 141.9, 131.0, 111.5, 109.9, 105.0, 98.5, 64.7, 50.7, 45.3, 34.3, 32.1, 29.90, 
29.81, 29.78, 29.59, 29.51, 29.45, 29.35, 28.65, 27.93, 27.49, 27.41, 24.9, 23.0, 14.4, 12.7; HRMS for 
C30H51NO3S [M + Na] 528.3482, found 528.3431. 
tert-Butyl 2-(triphenyl-λ5-phosphanylidene)-propanoate (8). This compound was prepared 
according to the literature procedure.6  
tert-Butyl E-3-{4-[N-(11-acetylsulfanyl-undecyl)-N-ethyl-amino]-2-hydroxy-phenyl}-2-
methyl-propenoate (9). A solution of protected salicylaldehyde 5 (1.5 g, 3.8 mmol) and ylid 8 (1.7 g, 4.4 
mmol) in benzene (10 mL) was stirred in the dark at room temperature for 2 d. The mixture was 
concentrated and subjected to a silica plug eluting with 3 : 1 hexanes : EtOAc. The filtrate was 
concentrated and dried to give 1.8 g (95 %) of an orange-yellow oil. 1H NMR (CDCl3, 300 MHz) δ 7.66 
(s, 1H, ArCH=C), 7.09 (d, 1H, Ar-H6, J=8.7 Hz), 6.20 (dd, 1H, Ar-H5, J1=8.8 Hz, J2=2.6 Hz), 6.10 (d, 
1H, Ar-H3, J=2.4 Hz), 3.26 (q, 2H, NCH2CH3, J=7.0 Hz), 3.13 (t, 2H, NCH2CH2, J=7.7 Hz), 2.78 (t, 2H, 
CH2S, J=7.4 Hz), 2.26 (s, 3H, COCH3), 1.96 (s, 3H, C=CMe), 1.45 (s, 9H, t-Bu), 1.45 – 1.2 (18H, alkyl), 
1.10 (t, 3H, NCH2CH3, J=6.9 Hz); 
13C NMR (CDCl3, 300 MHz) δ 196.7, 169.2, 156.5, 150.0, 134.0, 
131.4, 110.9, 104.7, 99.2, 80.47, 60.9, 50.9, 45.3, 31.0, 29.99, 29.90, 29.87, 29.81, 29.55, 29.46, 29.18, 
28.62, 28.05, 27.56, 21.4, 14.7, 12.8; HRMS for C29H47NO4S [M + Na] 528.3118, found 528.3100. 
E-3-{4-[N-(11-Acetylsulfanyl-undecyl)-N-ethyl-amino]-2-hydroxy-phenyl}-2-methyl-
propenoic acid (10). A solution of ester 9 (1.8 g, 0.76 mmol) in TFA / CH2Cl2 (1 / 1, 10 mL) was stirred 
Chapter 8 
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at room temperature for 2 h. The mixture was then poured into excess AcOH / AcONa buffer (pH ~ 4.5) 
and extracted with CH2Cl2 (3x). The combined organic layers were dried (MgSO4), filtered and 
concentrated to give a thick oil. After extensive drying under high-vacuum (to remove remaining acetic 
acid), a yellow solid (1.4 g, 82 % based on aldehyde 5) was obtained. m.p. 86 – 96 °C; 1H NMR (CDCl3, 
300 MHz) δ 7.95 (s, 1H, ArCH=C), 7.30 (d, 1H, Ar-H6, J=8.7 Hz), 6.52 (br s, 1H, Ar-H3), 6.40 (d, 1H, 
Ar-H5, J1=7.3 Hz), 3.35 (q, 2H, NCH2CH3, J=7.0 Hz), 3.27 (t, 2H, NCH2CH2, J=7.7 Hz), 2.81 (t, 2H, 
CH2S, J=7.4 Hz), 2.29 (s, 3H, COCH3), 2.06 (s, 3H, C=CMe), 1.50 (p, 2H, SCH2, J=6.8 Hz), 1.30 – 1.2 
(16H, alkyl), 1.10 (t, 3H, NCH2CH3, J=6.9 Hz); 
13C NMR (CDCl3, 300 MHz) δ 196.6, 175.2, 156.8, 
150.4, 134.2, 131.6, 128.9, 110.8, 104.8, 98.7, 50.9, 45.8, 34.4, 30.04, 29.93, 29.90, 29.60, 29.47, 28.77, 
28.01, 27.55, 25.1, 21.0, 14.7, 12.8; HRMS for C25H39NO4S [M + Na] 472.2492, found 472.2512. 
7-{N-(11-acetylsulfanyl-undecyl)-N-ethyl-amino}-2-oxo-2H-chromene (11). A solution of 
cinnamate 6 in d4-MeOH (∼40 mM) was photolyzed exhaustively at 374 nm and then in room light in an 
NMR tube. The photolysis was very clean and the only products present were 11 and n-octanol. Except 
for alkyl CH2-groups, their NMR-signals were clearly resolved and the following data are those of 11. 
1H 
NMR (d4-MeOH, 300 MHz) δ 7.66 (d, 1H, ArCH=C, J=9.2 Hz), 7.25 (d, 1H, Ar-H6, J=8.9 Hz), 6.58 (dd, 
1H, Ar-H5, J1=8.9 Hz, J2=2.5 Hz), 6.38 (d, 1H, Ar-H3, J=2.5 Hz), 5.88 (d, 1H, ArC=CH, J=9.3 Hz), 3.35 
(q, 2H, NCH2CH3, J=7.0 Hz), 3.27 (t, 2H, NCH2CH2, J=7.6 Hz), 2.74 (t, 2H, CH2S, J=7.2 Hz), 2.19 (s, 
3H, COCH3), 1.50 – 1.19 (18H, alkyl), 1.13 (t, 3H, NCH2CH3, J=6.9 Hz); HRMS for C24H35NO3S [M + 
Na] 440.2230, found 440.2236.  
2-[2-(2-Methoxy-ethoxy)-ethoxy]-ethanethiol (12). This compound was prepared from 
tris(ethyleneglycol)monomethyl ether according to a 3-step patent procedure.16  The crude orange oil was 
subjected to vacuum-distillation and the lowest boiling fraction was collected to give the product as a 
clear colorless liquid. No NMR or MS data for this compound were reported in the patent.  1H NMR 
(CDCl3, 300 MHz) δ 3.66 – 3.53 (m, 10H), 3.37 (s, 3H, OMe), 2.7 (q, 2H, SCH2), 1.62 (t, 1H, SH, J=8.4 
Hz); 13C NMR (CDCl3, 300 MHz) δ 73.1, 72.2, 70.8-70.4, 59.2, 24.5; HRMS (as disulfide) for 
C14H30O6S2 [M+Na] 381.1376, found 381.1376. 
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9.1 Summary 
9.1.1 Synthesis and chain-breaking antioxidant activity of 6-amino-3-pyridinols 
Mammals cannot exist without molecular oxygen, yet oxidative damage is a serious 
threat to their existence. One of the main biological targets of oxidative damage is the 
unsaturated diene moiety in lipids (LH). Nature’s best defense against oxidative damage is the 
use of antioxidants, a group of compounds that, by definition, can prevent or inhibit oxidation. 
The class of phenolic chain-breaking antioxidants (ArOH), such as α-Tocopherol (Vitamin E), 
acts by breaking the radical chain involved in lipid peroxidation. This occurs by H-atom 
donation from the phenol to propagating peroxyl radicals (LOO•, Eq. 1).  
 
LOO     +   ArO-H
kinh
LOOH + ArO                          Eq. 1 
 
Over the years considerable efforts have been made to improve on Nature by making 
phenolic antioxidants that are more effective than Vitamin E and this has met with varying 
success. The general strategy for improving the antioxidant activity has been to substitute the 
aromatic ring with electron donating substituents. This results in stabilization of ArO• and hence 
lower Bond Dissociation Enthalpy (BDE) for the phenolic –OH bond (Eq. 1). However, this 
approach has severe limitations, since air stability decreases as well upon those structural 
modifications. The first part of this thesis deals with the design, synthesis and evaluation of new 
antioxidants. 
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In Chapter 1, an introduction on oxidative damage and its implications in the human body 
is given. For example, oxidized Low Density Lipoprotein particles, the main carrier of 
cholesteryl esters in the body, play an important role in the early stages of atherosclerosis. The 
mechanism of antioxidant defense is described and some successful examples of improved 
antioxidants are highlighted. Lastly, the research objectives, the design, synthesis and testing of 
6-amino-3-pyridinols, are presented. The design is inspired by the recent findings that substituted 
2-amino-5-pyrimidinols, i.e. with two ring N-atoms, are efficient antioxidants while they possess 
relatively higher air stability than the correspondingly substituted phenols. Inductive effects of 
the ring N-atoms in conjunction with resonance-interaction by the ring-substituents can account 
for this trend. Calculations have shown that this effect might be even more pronounced in the 
pyridine series, especially when aliphatic rings are being annelated. 
 
N
OH
N
R1 R
1: R=R1=Me
4: R=C20H41, R1=Me
7: R=C20H41, R1=H
N
OH
N
R
N
OH
N
R
2: R=Me
5: R=C20H41
3: R=Me
6: R=C20H41
 
 
Figure 9.1: Overview of designed, synthesized and tested pyridinols. 
 
Chapter 2 deals with efforts to synthesize the desired 6-amino-3-pyridinols (Fig. 9.1), a 
class of compounds which received scarce attention in the literature. The general strategy 
involves a low temperature arylbromide-to-phenol conversion in the last step. Since the phenolic 
moiety is a reactive part of the molecule, its introduction in the last step was envisioned to 
minimize conceivable decomposition of precursors. Simple pyridinol 1 was synthesized in this 
way in 33 % overall yield following a three-step sequence. Compounds 2 and 3 required prior 
construction of the bicyclic structure. Thus, 2 was prepared utilizing a 6-step intramolecular 
Friedel-Crafts strategy in 4 % overall yield. This low yield is mainly attributable to a 
compromised yield in the final hydroxylation step. Compound 3 required an 11-step sequence 
with a thermal intramolecular inverse-demand Diels-Alder reaction between a pyrimidine ring 
and an alkyne as the key-step. The entire synthesis for this compound was accomplished in 6 % 
overall yield, 22 % until the final hydroxylation step. Using analogous strategies, lipophilic 
derivatives 4-7 were prepared by replacing the N-methyl group with a N-3,7,11,15-
tetramethylhexadecyl chain.  
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In Chapter 3, the reactivities of the pyridinols in solution were investigated.  Methyl 
linoleate autoxidations were greatly inhibited by the presence of these compounds, more so than 
by the presence of α-tocopherol. The kinh values (Eq.1 ) for N-methyl derivatives 1, 2 and 3 were 
measured by a peroxyl radical clock and/or by inhibited styrene autoxidations. The values were 
1.6 ± 0.6 x 107, 8.8 ± 3.2 x 107 and 28.0 ± 18 x 107 M-1s-1, respectively. Given the kinh for α-
tocopherol (0.32 x 107 M-1s-1), this means that these new pyridinolic antioxidants trap peroxyl 
radicals faster than α-tocopherol, ca. 5, 28 and 88 times, respectively. Pyridinols 1, 4 and 7 are 
stable towards air, whereas 3 and 6 show considerable decomposition, viz. ∼20 % decomposition 
over 3 hours in an aerated solution at 37 °C. The stability of 2 and 5 is intermediate. 
Measurements using N,N-diphenyl-N’-picryl-hydrazyl free radical indicated that H-atom 
donation, rather than electron transfer followed by a fast acid-base reaction, is the mechanism by 
which the peroxyl radicals are quenched by the pyridinols. It was found that the annelated 
pyridinols are so electron rich that they can also react with hydroperoxides (LOOH) directly. The 
mechanism for this was tested but has not been fully elucidated yet. In brief, the newly 
synthesized pyridinols are moderately to very stable and are the most effective phenolic chain-
breaking antioxidants reported hitherto. 
 
In Chapter 4, the antioxidant behavior of the pyridinols in a more biological system, 
namely in Low Density Lipoprotein (LDL), is described. LDL was isolated from human blood 
plasma, supplemented with the lipophilic pyridinols 4-7 and subjected to oxidations induced by 
water-soluble peroxyl radicals. All pyridinols were reproducibly able to protect LDL from 
oxidative damage of the core lipids. In addition, the lifetime of endogenous α-tocopherol was 
prolonged in all cases. Most notably, 5 and 7 seemed quite effective and these compounds 
exhibited certain lag times in which α-tocopherol (α-TOH) was not consumed at all. Evidence 
has been provided that the pyridinols are not efficient pro-oxidants, an inherent problem well 
known for α-tocopherol. More specifically, the pyridinyloxy radicals (PyrO•) formed in LDL 
upon oxidative conditions did not readily induce lipid peroxidation, likely due to their higher 
stability with respect to α-TO•. Measurements of the fluorescence signals for the pyridinols and 
Apo B100 Tryptophan residues in LDL suggest that the pyridinols partially reside on the surface 
of the LDL particle and are able to exert antioxidant behavior there as well, for example in 
protecting the protein. In addition, an alternative assay was developed to determine the 
concentration of LDL in purified plasma using the fluorescence of the tryptophan residues. 
 
In Chapter 5, preliminary results for the total synthesis of a 6-amino-3-pyridinolic 
isostere of α-Tocopherol are described. This synthetic effort is of considerable interest because 
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of the preferential absorption of (RRR)-α-tocopherol in the human body. The research was 
focused on establishing a route in which the α-N quaternary center, which is a potential 
bottleneck, could be constructed in a relatively straightforward way. Compounds 8 and 9 were 
selected as the immediate targets (Fig. 9.2). A general strategy using [1,8]-naphthyridines as the 
starting material was developed. The key step, namely the addition of a long chain alkyllithium 
to the unsubstituted naphthyridine (R=H), proceeded well and subsequent application of the 
established chemistry (Chapter 2) afforded compound 9 in a total of 6 steps. However, 9 proved 
not useful due to its very limited stability towards air. Synthesis of 8 involves an unprecedented 
addition of alkyllithiums to α,α’-disubstituted [1,8]-naphthyridines (R=Me). This particular 
transformation proved to be very sensitive to solvent effects, i.e. no reaction occurred in DMPU 
or THF whereas a ∼70 % total yield of isomeric 1,2-addition products was obtained with n-BuLi 
in ether/hexane mixtures. This effect was explained in terms of competing addition and 
deprotonation. Incorporation of this step in the sequence towards target 8 afforded this product in 
6 steps in ∼1 % overall yield. A regioselectivity problem in the alkyllithium addition and 
compromised yield in the final hydroxylation step were the main reasons for this very low yield. 
 
N N R
a [1,8]-naphthyridine
N
HO
N
H
8: (all-rac), R=Me
9: (all-rac), R=H
R
 
 
Figure 9.2: Retrosynthetic analysis for isosteres of vitamin E. 
 
9.1.2 Photochemistry of CdSe nanocrystals covered with functionalized cinnamates 
Semiconductor nanocrystals (NC) with diameters in the 1 – 20 nm range have attracted 
considerable interest in recent years. This is because their unique optical, electronic and 
mechanical properties differ substantially from the properties of the corresponding bulk material. 
Studies on CdSe NC, one of the most widely studied materials, were initiated in the beginning of 
the 1990s. This material possesses many interesting size-dependent properties which are all the 
result of the quantum confinement phenomenon. This phenomenon stems from the fact that the 
dimensions of the nanocrystal are smaller than the bulk Bohr radius. Scientists from several 
disciplines have recognized the potential use of these properties and as a result many interesting 
applications have been reported over the years. A major part of these applications involves the 
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size-dependent absorption and fluorescence properties of NC that are kinetically stabilized by 
surface ligands. For example, CdSe NC covered with functionalized thiols as bioactive ligands 
have been used as stable in vivo dyes and markers on several occasions. The second part of this 
thesis deals with the photochemistry of CdSe NC covered with a new class of functionalized 
organic ligands. 
 
Chapter 6 gives an introduction on CdSe nanocrystals. The history of their research was 
briefly mentioned followed by a description of their synthesis and basic physical properties. In 
the brief literature review, special attention was given to the status quo of the use of 
functionalized organic ligands with CdSe NC. In recent years, biomolecules, such as DNA or 
proteins derivatized with thiol reagents, as well as purely synthetic small compounds have been 
described as ligands for CdSe NC. It was demonstrated that the field of CdSe surface coverage 
with small functionalized organic ligands is relatively unexplored and as a result the 
understanding of the NC-ligand interaction is still underdeveloped. Lastly, the research 
objectives for the project were outlined. The (photo)interaction of NC with its surface ligands 
forms the main focus in this project, while mono-functionalization of the NC is the ultimate 
application of these studies. The actual structural features of the ligands were inspired by 
previous work on photo-active cinnamate molecules.  
 
Chapter 7 deals with the photochemistry of CdSe NC covered with cinnamate thiol 
ligands (Fig. 9.3). Several cinnamate thiols were synthesized by a 5-step Wittig sequence (∼40 % 
overall yield) and exchanged onto the NC surface. The resulting NC-cinnamate aggregates 
retained the usual NC spectral features, for example the absorption of visible light. The NCs are 
very photo-active as became evident by two observations. First, coverage with cinnamate ligands 
made the NC dramatically more sensitive to aerobic photo-oxidation than the NC before ligand 
exchange. It was shown that increased electron transfer from NC to molecular oxygen is the 
likely reason for this. Secondly, irradiation of the NC by a wide range of wavelengths, including 
visible light, led to the release of coumarin 10 with a high efficiency under both aerobic and 
anaerobic conditions. In order to rationalize both phenomena, it is proposed that the excited NC 
transfers an electron to the cinnamate surface ligand. The resulting cinnamate radical anion can 
undergo trans-cis isomerization (Step A), which was independently confirmed by 
electrochemical studies. Depending on the conditions, the radical anion can transfer an electron 
to an acceptor in solution, leading to NC decomposition, or back to the NC. Meanwhile, any 
cinnamate that is in the cis-form can lactonize to give 10 and a hydroxy-undecyl surface ligand 
(Step B). Thus, it proved possible to efficiently release simple caged organic molecules from a 
CdSe NC surface using visible light. 
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Figure 9.3: Proposed photo-interaction of CdSe with O-substituted cinnamate ligands. 
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Figure 9.4:  Proposed photo interaction of CdSe with N-substituted cinnamate ligands. 
 
In Chapter 8, it is shown how this light-induced release of coumarin 10 can be extended 
to N-functionalized cinnamates, leading to the photolytic release of alcohols from the NC surface 
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(Fig. 9.4). An N-substituted cinnamate thiol was synthesized in a 9-step sequence (∼18 % overall 
yield) and subsequently exchanged onto the NC surface by the same general strategy as shown in 
Chapter 7. The resulting NC showed entirely analogous photochemical properties as observed 
before for NC covered with O-substituted cinnamates. Thus, they showed increased tendency 
towards photo-oxidation in comparison to NC without cinnamate ligands and they released n-
octanol from the surface upon irradiation with (visible) light. These particular structural features 
can be useful for linking CdSe NC to –OH containing active sites of enzymes. 
 
Summaries in English and Dutch conclude this thesis. 
 
9.2 Samenvatting 
9.2.1 De synthese van 6-amino-3-pyridinolen en hun efficiëntie in de verbreking van 
radicaalkettingreacties 
Zoogdieren kunnen niet leven zonder moleculair zuurstof. Echter, oxidatieve schade is 
een serieuze bedreiging voor hun bestaan. Een van de belangrijkste biologische locaties voor 
oxidatieve schade zijn de onverzadigde diëen-fragmenten in vetzuren (LH). Het beste 
afweermechanisme dat de Natuur voorhanden heeft tegen oxidatieve schade is het inzetten van 
antioxidanten. Dit is een groep verbindingen die, per definitie, oxidatie voorkomen of 
verhinderen. De klasse van fenolische antioxidanten, waartoe α-tocoferol (Vitamine E) behoort, 
verbreekt de radicaalkettingreacties betrokken bij vetzuren oxidatie. Dit gebeurt door donatie van 
een H-atoom van de fenol-groep naar propagerende peroxyl radicalen (Eq. 1). 
 
LOO     +   ArO-H
kinh
LOOH + ArO                          Eq. 1 
 
Gedurende de laatste decennia zijn veel pogingen ondernomen om de Natuur te verslaan 
door phenolische antioxidanten te maken die effectiever zijn dan Vitamine E. Echter, er is slechts 
mondjesmaat succes behaald. Verbetering van de antioxidant-activiteit behelst in het algemeen 
de substitutie van de phenol-ring met electronstuwende groepen.  Dit heeft een grotere stabiliteit 
van ArO• en daarmee een lagere OH-BDE (Bond Dissocation Enthalpy) tot gevolg (Eq. 1). 
Echter, deze strategie heeft duidelijke grenzen, aangezien de stabiliteit in lucht ook afneemt als 
gevolg van deze structurele aanpassingen. Het eerste deel van dit proefschrift handelt over het 
ontwerpen, de synthese en het evalueren van nieuwe antioxidanten. 
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In Hoofdstuk 1 wordt een introductie gegeven over oxidatieve schade en de gevolgen 
ervan voor het menselijk lichaam. Er wordt bijvoorbeeld vermeld dat geöxideerde LDL (Low 
Density Lipoprotein) deeltjes, de belangrijkste dragers van cholesteryl esters, betrokken zijn bij 
atherosclerose. Het afweermechanisme van antioxidanten en een aantal succesvolle voorbeelden 
van verbeterde antioxidanten wordt beschreven. Als laatste worden de onderzoeksdoelen 
gepresenteerd, namelijk het ontwerpen, de synthese en het testen van 6-amino-3-pyridinolen. De 
inspiratie voor deze doelmoleculen lag in de recente resultaten verkregen met gesubstitueerde 2-
amino-5-pyrimidinolen (twee N-atomen in de ring). Deze resultaten laten zien dat deze 
pyrimidinolen goede antioxidanten zijn en daarnaast een veel betere lucht stabiliteit hebben in 
vergelijking met analoge phenolen. Dit kan verklaard worden door een combinatie van 
inductieve effecten van de N-atomen en resonantie-interactie van de ring-substituenten. 
Berekeningen hebben aangetoond dat dit effect zelfs nog groter kan zijn in de pyridine-serie, in 
het bijzonder als er een aliphatische ring wordt aangehecht. 
  
N
OH
N
R1 R
1: R=R1=Me
4: R=C20H41, R1=Me
7: R=C20H41, R1=H
N
OH
N
R
N
OH
N
R
2: R=Me
5: R=C20H41
3: R=Me
6: R=C20H41
 
 
Figuur 9.1: Overzicht van de ontworpen, gesynthetiseerde en geteste 6-amino-3-
pyridinolen. 
 
In Hoofdstuk 2 wordt de synthese van de gewenste 6-amino-3-pyridinolen beschreven 
(Fig. 9.1). Deze klasse van verbindingen wordt slechts zelden beschreven in de literatuur. De 
laatste stap in de algemene strategie behelst een omzetting van een pyridylbromide tot een 
pyridinol bij lage temperatuur. Er werd verwacht dat dit ontleding van precursors zou 
minimaliseren, aangezien de fenol de reactieve groep is. Pyridinol 1 werd aldus in 33 % totale 
opbrengst gesynthetiseerd in drie stappen. Voor verbindingen 2 en 3 was het nodig om de 
vereiste bicyclische structuren eerst te bereiden. Verbinding 2 werd bereid in 4 % totale 
opbrengst in zes stappen op basis van een intramoleculaire Friedel-Crafts strategie. De lage 
opbrengst was grotendeels te wijten aan isolatie-moeilijkheden na de laatste hydroxylatie-stap. 
Voor verbinding 3 was een 11-staps route nodig waarbij gebruik werd gemaakt van een 
thermische intramoleculaire “inverse-demand” Diels-Alder van een pyrimidine ring met een 
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alkyne zijketen. De synthese van deze verbinding werd gerealiseerd in 6 % totale opbrengst, 22 
% tot de laatste stap. Gebruikmakende van vergelijkbare synthese strategieën werden de lipofiele 
derivaten 4-7 bereid door de N-methyl groep te vervangen met een N-3,7,11,15-
tetramethylhexadecyl-keten. 
 
In Hoofdstuk 3 wordt de reactiviteit van de verschillende pyridinolen in oplossing 
onderzocht.  Methyllinoleaat autoxidaties in de aanwezigheid van de pyridinolen resulteerden in 
veel minder oxidatie dan in aanwezigheid van equimolaire hoeveelheden α-tocoferol. De 
snelheidsconstantes kinh (Eq.1 ) voor N-methyl derivaten 1, 2 en 3 werden gemeten met behulp 
van een peroxylradicaal-klok en/of styrene autoxidaties en bedroegen respectievelijk 1.6 ± 0.6 x 
107, 8.8 ± 3.2 x 107 en 28.0 ± 18 x 107 M-1s-1. Dit betekent, gezien het feit dat de kinh voor α-
tocoferol 0.32 x 107 M-1s-1 bedraagt, dat deze pyridinolen respectievelijk 5, 28 and 88 keer 
sneller reageren met peroxylradicalen dan α-tocoferol. Pyridinolen 1, 4 en 7 zijn stabiel in lucht, 
echter 3 en 6 zijn aanzienlijk minder stabiel, gelet op de ∼20 % ontleding in drie uur in lucht  in 
oplossing bij 37 °C. De stabiliteit van 2 and 5 ligt er tussen in. Metingen met het N,N-diphenyl-
N’-picryl-hydrazyl vrije radicaal suggereren dat donatie van een H-atoom het mechanisme is 
voor het afvangen van een peroxylradicaal, en niet een electronenoverdracht gevolgd door een 
snelle zuur-base stap. Echter, sommige pyridinolen zijn zo electronrijk dat ze direct kunnen 
reageren met de hydroperoxides (LOOH). Het mechanisme voor deze stap werd onderzocht maar 
is nog niet volledig opgehelderd. Kort samengevat kan gezegd worden dat de gesynthetiseerde 
pyridinolen een redelijke tot zeer goede luchtstabiliteit hebben en dat ze de meest effectieve 
fenolische kettingreactie-verbrekende antioxidanten zijn die tot nu toe beschreven zijn . 
 
Hoofdstuk 4 handelt over de antioxidant-activiteit van de pyridinolen in een meer 
biologisch systeem, namelijk in Low Density Lipoprotein (LDL). Dit LDL werd geїsoleerd uit 
menselijke bloedplasma, gesupplementeerd met de lipofiele pyridinolen 4-7 en dan onderworpen 
aan oxidaties geїnduceerd door water-oplosbare peroxylradicalen. Alle pyridinolen bleken in 
staat om op een reproduceerbare wijze LDL te beschermen tegen oxidatieve schade aan de 
vetzuren in het binnendeel. Bovendien werd in alle gevallen het van nature aanwezige α-
tocoferol enigszins gespaard. Vooral 5 en 7 bleken effectief en deze verbindingen toonden “lag-
times” gedurende welke α-tocoferol (α-TOH) niet geconsumeerd werd. Er werd bewijs 
gevonden dat de pyridinolen geen effectieve pro-oxidanten zijn, een welbekend probleem voor 
α-tocoferol. Specifieker gezegd: de pyridinyloxy-radicalen (PyrO•), die onder de oxidatieve 
omstandigheden gevormd werden in LDL, blijken niet makkelijk vetzure oxidaties te induceren, 
hetgeen waarschijnlijk te verklaren is door de hogere stabiliteit van PyrO• in vergelijking met α-
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TO•. Metingen aan de fluorescentie signalen van de pyridinolen en de tryptrofaan-residuen in 
Apo B100 suggereren dat de pyridinolen zich gedeeltelijk ophouden aan het oppervlak van het 
LDL deeltje en dat ze daar in staat zijn om oxidatieve schade aan het eiwit te voorkomen. Ook 
werd een alternatieve methode ontwikkeld om de concentratie van LDL in gezuiverd plasma te 
bepalen met behulp van de fluorescentie signalen van de tryptofaan-residuen. 
 
N N R
a [1,8]-nafthyridine
N
HO
N
H
8: (all-rac), R=Me
9: (all-rac), R=H
R
 
 
Figuur 9.2: Retrosynthetische analyse voor de isosteren van vitamine E.  
 
In Hoofdstuk 5 worden de eerste resultaten beschreven van de synthese van 6-amino-3-
pyridinolische isosteren van α-tocoferol. Deze syntheses zijn uitermate interessant omdat van de 
8 mogelijke stereoisomeren alleen de (RRR)-stereoisomeer van α-tocoferol effectief wordt 
geabsorbeerd in het menselijk lichaam. Het onderzoek richtte zich vooral op het vinden van een 
route waarin het α-N quaternaire koolstof, dat een potentiële bottle-neck is, relatief eenvoudig 
kon worden geconstrueerd. De verbindingen 8 en 9 werden geselecteerd als doelmoleculen (Fig. 
9.2). Een algemene aanpak, gebruikmakend van [1,8]-nafthyridines als uitgangsstof, werd 
ontwikkeld. De sleutelstap, nl. de additie van een lange-staart alkyllithium verbinding aan het 
ongesubstitueerde [1,8]-nafthyridine (R=H), verliep uitstekend. Vervolgens kon verbinding 9 in 
drie stappen worden verkregen, gebruikmakend van de methoden beschreven in Hoofdstuk 2. 
Echter, 9 bleek onbruikbaar aangezien het aan de lucht snel oxideerde. De synthese van 8 
omvatte een additie van alkyllithium aan een α,α’-digesubstitueerde [1,8]-nafthyridine (R=Me), 
een type reactie dat nog niet eerder beschreven was. Deze omzetting was erg gevoelig voor 
oplosmiddeleffecten. In DMPU of THF vond geen reactie plaats, terwijl in hexaan/ether 
mengsels met n-BuLi de twee isomere 1,2 additie producten werden verkregen in een opbrengst 
van ∼70 % . Dit oplosmiddeleffect werd verklaard aan de hand van een competitie tussen 
deprotonering en additie. Opname van deze additie stap in de synthese van doelmolecuul 8 
leidde tot dit product in 6 stappen in ∼1 % totale opbrengst. Een probleem met de 
regioselectiviteit in de additiestap en een lage opbrengst in de hydroxylatie-stap waren de 
belangrijkste oorzaken voor deze lage opbrengst. 
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9.2.2 Fotochemie van CdSe nanokristallen voorzien van gefunctionaliseerde cinnamaat-
liganden 
Halfgeleider nanokristallen (NC) met diameters van 1 tot 20 nm hebben in recente jaren 
grote belangstelling getrokken. Dit komt omdat hun unieke optische, electronische en 
magnetische eigenschappen aanzienlijk verschillen van de eigenschappen van het bulk materiaal. 
Studies aan CdSe NC, één van de meest bestudeerde materialen, begonnen in het begin van de 
negentiger jaren. Dit materiaal bezit vele interessante eigenschappen die opmerkelijk variëren 
met de grootte van het kristal. Dit is het gevolg van het quantum confinement fenomeen. Dit 
fenomeen vloeit voort uit het feit dat de dimensies van het nanokristal kleiner zijn dan de bulk 
Bohr-straal. Wetenschappers van verscheidene disciplines hebben het potentiële gebruik van 
deze eigenschappen erkend en over de jaren zijn vele interessante toepassingen gepubliceerd. 
Een groot deel van deze toepassingen maakt gebruik van de dimensie-afhankelijke absorptie en 
fluorescentie eigenschappen van NCs die kinetisch gestabiliseerd zijn door liganden aan het 
oppervlak. Zo zijn CdSe NC, bedekt met gefunctionaliseerde thiolen als bioactieve liganden, 
gebruikt als stabiele in vivo kleurstoffen en markeerders. Het tweede deel van dit proefschrift 
handelt over de fotochemie van CdSe nanokristallen bedekt met een nieuwe klasse van 
gefunctionaliseerde organische liganden. 
 
In Hoofdstuk 6 wordt een introductie over CdSe nanokristallen gegeven. De geschiedenis 
van het CdSe onderzoek wordt behandeld, gevolgd door een beschrijving van de synthese en 
fundamentele fysische eigenschappen. In het beknopte literatuur overzicht wordt ook de status 
quo van het gebruik van gefunctionaliseerde organische liganden vermeld. Biomoleculen zoals 
DNA en eiwitten, gefunctionaliseerd met thiol-reagentia, alsmede kleine puur synthetische 
liganden zijn beschreven in de literatuur. Dit overzicht laat zien dat het gebruik van kleine 
synthetische moleculen als CdSe liganden tot dusver weinig onderzocht is. Een gevolg daarvan is 
dat de NC-ligand-interactie nog niet goed begrepen is. Als laatste worden de onderzoeksdoelen 
voor het project geformuleerd. De (foto)interactie tussen de NC en liganden aan het oppervlak 
staat centraal in het project, terwijl mono-functionalisering van de NC als mogelijke toepassing 
van deze studies wordt gezien. De structurele kenmerken van de ontworpen liganden zijn 
geїnspireerd door eerder werk aan foto-actieve cinnamaten.  
 
Hoofdstuk 7 handelt over de fotochemie van CdSe NC bedekt met cinnamaat thiol-
liganden (Fig. 9.3). Diverse cinnamaat-thiolen werden gesynthetiseerd in 5 stappen (∼40 % totale 
opbrengst), waaronder een Wittig reactie, en aangebracht op  het NC oppervlak. De resulterende 
NC-cinnamaat aggregaten behielden de typische spectrale kenmerken van NC, bijvoorbeeld de 
absorptie van zichtbaar licht. De NC bleken erg fotoactief en dit kwam naar voren bij twee 
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waarnemingen. Ten eerste bleek dat de cinnamaat liganden de NC veel gevoeliger maakten voor 
aërobe foto-oxidatie dan NC met standaard liganden. Aangetoond werd dat toegenomen 
electronenoverdracht tussen de NC en moleculair zuurstof hiervoor waarschijnlijk de reden is. 
Ten tweede leidde bestraling van de NC onder een breed scala van golflengtes, inclusief 
zichtbaar licht, tot de vorming van coumarine 10 met hoge efficiëntie, onder zowel aërobe als 
anaërobe condities. Centraal in de verklaring voor beide fenomenen staat een 
electronenoverdracht van de aangeslagen toestand van de NC naar de cinnamaatliganden. Het 
resulterende cinnamaat-radicaalanion kan een trans-cis isomerisatie ondergaan (Stap A), hetgeen 
bevestigd werd door electrochemische experimenten. Afhankelijk van de omstandigheden kan 
het cinnamaat-radicaalanion vervolgens een electron overdragen aan een electronacceptor in 
oplossing of terug aan de NC. Electronenoverdracht aan een acceptor in oplossing leidt tot 
ontleding van de NC. Op elk willekeurig moment kan de cis-vorm van het cinnamaat 
lactoniseren tot coumarine 10 in een licht-onafhankelijke stap (Stap B). Samengevat bleek het  
mogelijk om met (zichtbaar) licht efficiënt organische moleculen af te splitsen van CdSe NC 
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Figuur 9.3: Voorgestelde foto-interactie tussen CdSe en O-gesubstitueerde cinnamaat 
liganden. 
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In Hoofdstuk 8 wordt beschreven hoe de licht-geïnduceerde afsplitsing kon worden 
uitgebouwd naar N-gesubstitueerde cinnamaten, waarbij alcoholen worden afgesplitst in plaats 
van coumarine (Fig. 9.4). Een N-gesubstitueerde cinnamaat werd bereid volgens een 
vergelijkbare strategie als toegepast in Hoofdstuk 7 (∼18 % opbrengst) and vervolgens 
vastgehecht aan het NC oppervlak. De resulterende NC toonden veelal hetzelfde fotochemische 
gedrag als waargenomen voor NC bedekt met O-gesubstitueerde cinnamaten. De NC waren veel 
gevoeliger voor foto-oxidatie als NC zonder cinnamaat liganden en tijdens bestraling met 
(zichtbaar) licht werd n-octanol afgesplitst. De structurele karakteristieken van de beschreven 
cinnamaat liganden kunnen zich goed lenen voor het koppelen van CdSe NC aan enzymen met 
een –OH groep in de “active site”. 
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Figuur 9.4:  Voorgestelde foto-interactie tussen CdSe en N-gesubstitueerde cinnamaat 
liganden. 
 
Een samenvatting in het Engels en Nederlands besluit dit proefschrift. 
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Abbreviations 
 
AAPH 2,2’-azobis-(2-amidinopropane) dihydrochloride 
AMP antioxidant mediated peroxidation 
AMVN 2,2′-azobis(2,4-dimethylvaleronitrile) 
AOX antioxidant 
Apo B100 apoprotein B100 
BDE bond dissociation enthalpy 
BHT butylated hydroxy-toluene 
C-0 2,2’-azobis(2-(2-imidazolin-2-yl)propane) .2HCl 
Coumarin 7-diethylamino-chromen-2-one 
CV cyclic voltammetry 
DAT dopamine transporter protein 
DCC dicyclohexylcarbodiimide 
DCE dichloroethane 
DCM dichloromethane 
DDQ dichloro-dicyano-benzoquinone 
DETAPAC diethylenetriaminopentaacetic acid 
DMAP 4-(dimethylamino)-pyridine 
DMF N,N-dimethylformamide 
DMPU N,N-dimethylpropylene urea 
DMSO dimethylsulfoxide 
DPPH N,N-diphenyl-N’-picrylhydrazyl, free radical 
DTT  2,3-dihydroxy-1,4-dithiobutane 
e electron 
EDCI 1-ethyl-3-(3’-dimethylaminopropyl)carbodiimide.HCl 
EPR electron paramagnetic resonance 
Fc ferrocene 
FRET fluorescence resonance energy transfer 
GC gas chromatography 
h hole or hour 
HDL high density lipoprotein 
HMPA N,N,N’,N’,N’’,N’’-hexamethyl-phosphoric amid 
HOMO highest occupied molecular orbital 
HPLC high performance liquid chromatography 
HRMS high resolution mass spectrometry 
IDL intermediate density lipoprotein 
In initiator 
InOO• initiator peroxyl radical 
IP ionization potential 
L lipid 
LAH lithium aluminium hydride 
LDL low density lipoprotein 
LOO• lipid peroxyl radical 
LOOH lipid hydroperoxide 
LOH lipid alcohol 
LUMO lowest unoccupied molecular orbital 
MeOAMVN 2,2’-azobis(4-methoxy-2,4-dimethylvaleronitrile) 
min minute 
NC CdSe nanocrystal(s) 
NC* excited CdSe nanocrystal(s) 
NHE normalized hydrogen electrode 
NOESY nuclear Overhauser effect spectrosopy 
NRP non-radical products 
PBS phosphate buffered saline 
PD10 PD10 size exclusion chromatography columns 
PEG poly-ethyleneglycol 
Phyt(yl) 3,7,11,15-tetramethylhexadecyl 
PMB para-methoxybenzyl 
PPA polyphosphoric acid 
PUFA polyunsaturated fatty acids 
Py-NC pyridine coated CdSe nanocrystals 
PyrOH 6-amino-3-pyridinol 
RBS Rutherford backscattering 
ROS reactive oxygen species 
rpm rotations per minute 
r.t. room temperature 
SDS sodium dodecyl sulfate 
SE supporting electrolyte 
SEC size exclusion chromatography 
TBAHP tetra-n-butylammonium hexafluorophosphate 
TEMPO 2,2,6,6-tetramethylpiperidinyloxy, free radical 
TFA trifluoroacetic acid 
THF tetrahydrofuran 
TMP tocopherol mediated peroxidation 
TMPD N,N,N’,N’-tetramethylphenylenediamine  
TNM  tetranitromethane 
γ-TOH γ-tocopherol, less potent form of Vitamin E 
δ-TOH δ-tocopherol, less potent form of Vitamin E 
α-TOH α-tocopherol, most potent form of Vitamin E 
TOPO trioctyl-phosphine oxide 
trityl triphenylmethyl 
Trp tryptophan 
VLDL very low density lipoprotein 
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